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ABSTRACT
Resolution of inflammation requires the clearance of a large number of
inflammatory cells in an ordered manner, such that the tissue
architecture returns completely to normal. Neutrophils have been
shown to undergo apoptosis and be ingested by inflammatory
macrophages (Mo) thus providing a unique method for their clearance
that does not induce further pro-inflammatory signals. The fate of the
inflammatory Mo however remains unclear. Hence this work
investigated the fate of the Mo during the resolution of inflammation.
To test whether the Mo was capable of undergoing apoptosis, human
peripheral blood monocytes were isolated and matured into Mo in vitro.
Using DNA gel electrophoresis to demonstrate the typical "ladder
pattern" characteristic of apoptosis and quantifying this by acridine orange
fluorescence staining and flow cytometry, we showed that the Mo did not
undergo significant constitutive apoptosis (unlike the neutrophil) but
cycloheximide could induce apoptosis in these cells. Surface marker
changes associated with the induction of apoptosis included the loss of
CD14 and a range of cytokine receptors, whilst HLA-DR and Fas were
retained far into the apoptotic process. A range of pro and anti¬
inflammatory mediators (TNF-a, IL-1, IL-4, IL-6, TGF-(3, dexamethasone),
implicated in induction of apoptosis in other cells, were shown to have
little effect on the Mo. Despite this relative resistance to apoptosis, during
differentiation into the Mo human monocytes lost the ability to express
bcl-2; suggesting either the involvement of a different bcl-2 family
member or a non-bcl-2 mechanism protecting the cells from apoptosis.
To study the fate of inflammatory Mo during the resolution of
inflammation in vivo, a murine model of resolving peritonitis was
developed in which the fate of semi-allogeneic adoptively transferred
donor inflammatory Mo could be tracked. Red fluorescent labelled donor
H_2kd inflammatory Mo were transferred into the peritoneal cavity of
recipient H-2^ mice which were at the same stage of resolving
inflammation. Donor, recipient, and donor cells which had been
phagocytosed by recipient Mo, could be distinguished by two colour flow
cytometry using a FITC conjugated anti H-2^ monoclonal antibody, the
phagocytosed cells being red fluorescent labelled but H-2^ negative.
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Adoptively transferred live inflammatory Mo disappeared steadily from
the peritoneal cavity, being undetectable 96 hours post transfer and
minimal phagocytosis was evident during this process. In contrast, fixed
donor Mo were rapidly phagocytosed by the recipient Mo and these cells
could be detected up to a week later. These data suggested that adoptively
transferred live inflammatory Mo emigrated from the peritoneal cavity
during the resolution phase of inflammation. Labelled cells were
detected specifically in the draining lymph nodes and later in small
quantities in the liver and spleen but not in a range of other tissues.
Thus by contrast with the neutrophil, which meets its fate during the
resolution of inflammation locally by undergoing apoptosis and being
ingested by inflammatory Mo the inflammatory Mo appears to emigrate
from the inflamed site to the local lymph nodes (and possibly the liver
and spleen) where it then meets its fate by as yet obscure mechanisms.
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ABBREVIATIONS.
ATCC American Type Culture Collection
BSA Bovine serum albumin
C5a Complement fragment 5a
cAMP Cyclic adenosine monophosphate
CCE Countercurrent centrifugal elutriation
CSF-1 Colony stimulating factor-1
db-cAMP Dibutyryladenosine 3'5'-cyclic monophosphate
ECACC European Collection of Animal and Cell Cultures
EDTA Ethylene diamine tetra-acetic acid




G-CSF Granulocyte colony stimulating factor
GM-CSF Granulocyte macrophage colony stimulating factor
GPI Glycosyl-phosphatidylinositol
HBSS Hank's balanced salt solution
HBSS w/o HBSS without calcium and magnesium
ICE Interleukin-ip converting enzyme
IFN-y Interferon-y
i.p. Intraperitoneal
IL Interleukin (1 - 13)





MCP Monocyte chemotactic protein
M-CSF Macrophage colony stimulating factor
MIP Macrophage inflammatory protein
MPO Myeloperoxidase
NO- Nitric oxide
NMS Normal mouse serum
PBS Phosphate buffered saline
PE Phycoerythrin
PMN Polymorphonuclear leukocyte
ROI Reactive oxygen intermediates
SCF Stem cell factor
S.D. Standard deviation of mean
S.E. Standard error of mean
TG Thioglycollate
TGF-p Transforming Growth Factor-P







It was Elie Metchnikoff who coined the term "macrophage" (Mo) to
describe the large mononuclear phagocytic cells that he observed in
inflamed tissues, thus distinguishing them from the more numerous
microphages (polymorphonuclear leukocytes; PMN) (Metchnikoff, 1905).
Mo are now very well recognized as a major protective element in the
host's defense against both invading micro-organisms and against
tumour cells. Their potential for injury to the host itself and the delicate
balance that must be struck between the protective and destructive roles
of this cell have also now been clearly established (Adams, 1992).
Although there is great heterogeneity among Mo throughout the body,
they all belong to the mononuclear phagocyte system (van Furth, 1972), a
system which includes cells believed to share common functional and
developmental characteristics, exhibiting most of the following features:
• Distinctive morphology.
• Capacity for phagocytosis.
• Surface expression of Fc and complement receptors.
• Enzyme specificity e.g. non-specific esterase, peroxidase, lysozyme.
• Specific monoclonal antibody binding.
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Mo are complex cells and can fulfill a number of often interlinked roles
including:
1) The inflammatory response:
• Recognize and remove inflammatory stimuli.
• Kill invading micro-organisms
• Present antigen and invoke protective immune responses.
• Secrete substances:





- Cytokines and colony stimulating factors.
- Free radicals.
2) The resolution of inflammation:
• Tissue debridement and repair.
• Scavenging of effete cells and cell debris.
• Stimulation of fibroblasts and control of matrix deposition.
• Angiogenesis.
3) Protection against tumours.
4) Regulation of haematopoiesis.





• Langerhans and dendritic cells.
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1. 2 INFLAMMATION AND THE ROLE OF THE MACROPHAGE.
1. 2.1 The Inflammatory Response.
Perhaps the most crucial role for the Mo is as a central coordinating cell
in the inflammatory response where they play an essential role in host
defence. The inflammatory response is summarized at the macroscopic
level by the well known phrase "calor, rubor, tumor, dolor" and "functio
laesa" or loss of function. When viewed at the microscopic level
inflammation is a most complex and highly organized process involving
cellular and humoral or vascular components. There is close interaction
between cells already present at the inflamed site - the vascular
endothelial cells, tissue Mo and later fibroblasts, those entering the site,
such as platelets, PMN and monocytes as well as more systemically with
stimulation of both humoral and cellular immunity. The unique co¬
ordination of the many cells involved in the inflammatory response
requires excellent communication between cells. This is directed by
secretion and activation of a highly complicated pattern of mediators
including the coagulation system, the complement system, the kinins,
the fibrinolytic system and the cytokine network (Dale, 1989a).
The first blood leukocytes to arrive at the site of inflammation are the
PMN, seen within two hours (Issekutz, 1981; Haslett, 1989; Doerschuk,
1994). In response to a variety of chemotactic and pro-inflammatory
signals they adhere to the vascular endothelium then actively migrate
through to the inflamed site where they engulf, kill and digest micro¬
organisms (Dale, 1989b). Circulating monocytes also accumulate at the
inflamed site, following similar pathways to the PMN and once there
they mature into inflammatory Mo (van Furth, 1992). The accumulation
of monocytes is temporally delayed when compared with PMN but
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unlike PMN, monocyte influx does not cease within the first 24 hours,
thus Mo become the predominant cell type as inflammation progresses
(Issekutz, 1981 and 1993; Adams, 1992; Bellingan, 1996a). Mo were
initially thought to function mainly to remove and degrade damaged
tissue but their role is far broader, their influence extending throughout
the inflammatory response.
In the acute phase of inflammation Mo engulf and kill micro-organisms
and through presentation of antigen to lymphocytes, engender highly
specific adaptive immune responses to defend the host from invading
pathogens (Davies, 1989). During the later stages of inflammation with
tissue repair and remodelling, Mo function to debride tissue and in their
absence wound healing is impaired (Riches, 1988). Mo secrete growth
factors that stimulate fibroblasts, smooth muscle cells and endothelial
cells and initiate the fibrotic response characteristic of the repair phase
(Leibovich, 1975; Riches, 1988; Davidson, 1992). Not only are Mo a source
of growth factors for fibroblasts and other mesenchymal cells but they
promote neovascularisation especially in a hypoxic micro-environment
(Riches, 1988). Mo also act to remove other inflammatory cells, efficiently
phagocytosing effete PMN thus helping damp down the inflammatory
response (Haslett, 1994).
1. 2. 2 Mechanisms by Which the Macrophage can Damage the Host,
The inflammatory response can injure the host when initiated or
perpetuated inappropriately, either in response to agents that are not
threatening to the host or when deployed to excess (Dale, 1989a; Adams,
1992). The Mo can damage tissue by histotoxic enzyme release
(Dannenberg, 1975; Adams, 1992), release of free radicals which damage
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normal cells (Adams, 1992; McCord, 1993; Halliwell, 1995) and nitric oxide
(NO) which can contribute to the vascular paresis characteristic of septic
shock (Szabo, 1995). In addition presentation of antigen may result in
inappropriate lymphocyte activation, as well as persistent cytokine
secretion (Nathan, 1987; Klareskog, 1988; Khalil, 1989; Harris, 1995). The
resolution of acute inflammation is characterized by the clearance of
recruited PMN and Mo and the return to normal tissue architecture but
often acute inflammation does not resolve, rather it persists, with the
development of chronic inflammation and fibrosis, exemplified by a
number of diseases including chronic bronchitis and emphysema (Khalil,
1989), glomerulonephritis (Baker, 1994) and rheumatoid arthritis (Koch,
1991 and 1994). The mechanisms underlying the development of chronic
inflammation are poorly understood but a hallmark of this is Mo
accumulation. Mo are also implicated in other chronic pathological
events including atherogenesis, carcinogenesis and granulomatous
inflammation which will not be discussed further here. It is clear from
this that a knowledge of Mo functions and of the controls on their influx,
persistence and removal from the inflammatory site are central to our
understanding of the pathogenesis of acute and chronic inflammation.
1. 2. 3 Macrophage Functions in Acute Inflammation.
1. 2. 3.1 Enzyme Secretion.
Mo secrete a number of enzymes important in the inflammatory
response including the antimicrobial enzymes lysozyme (a good marker
of Mo activation) (K^shav, 1991) and the cathepsins (Adams, 1992).
There is also abundant evidence that activated Mo damage, degrade and
remove connective tissue at the inflamed site. Important enzymes in
this process are the neutral proteases, elastase, collagenase and
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plasminogen activator, although the acid hydrolases will contribute in
acidic micro-environments (Riches, 1988; Leenen, 1993). Unless this
enzyme secretion is tightly controlled it will damage host tissues and
impair organ function. Controls include a2-macroglobulin which, on
exposure to proteolytic enzymes, has a negative feed back effect,
inhibiting further protease secretion (Feldman, 1985) and the anti-
proteases including al-anti-protease and plasminogen activator inhibitor
(Adams, 1992).
1. 2. 3. 2 Reactive Oxygen Intermediates.
1. 2. 3. 2a Generation of Reactive Oxygen Intermediates.
One of the major antimicrobial mechanisms the Mo possess is the
production and release of free radicals (Babior, 1975; Reiss, 1978; Adams,
1992). Free radicals are molecules containing one or more unpaired
electrons, the presence of which greatly increase the reactivity of the
species. Substances providing electrons to oxygen (or any other electron
acceptor) are oxidized whilst the substance gaining electrons is reduced.
Molecular oxygen has a strong affinity for four more electrons, when it
gains these it also acquires four protons from the solvent and the bond
between the two oxygen molecules breaks providing two molecules of
water
02 + 4e- + 4H+ = 2H20
There is an initial kinetic barrier to this complete reduction of oxygen
that enzymes with a binding site for oxygen can overcome hence gaining
the huge amounts of energy available from providing electrons to
molecular oxygen. Oxygen can however sometimes gain unpaired
electrons in non-enzymatic auto-oxidations (McCord, 1993; Halliwell,
1995). The gaining of a single unpaired electron produces the superoxide
1 0
free radical O2", activated phagocytes produce superoxide anions by an
enzymatic process in which electrons are transferred from NADPH to
molecular oxygen (Weening, 1975; Forman, 1986; McCord, 1993). Transfer
of two electrons yields hydrogen peroxide H2O2 which itself is not a free
radical but is still a powerful oxidant, gaining one further electron
yielding water and the hydroxyl radical OH- (Repine, 1979). In the
phagocyte, the enzyme superoxide dismutase catalyses the conversion of
superoxide radical to hydrogen peroxide and the hydroxyl radical is
produced from hydrogen peroxide by the Fenton reaction whereby iron in
its ferrous state is oxidized by hydrogen peroxide to yield ferric iron and
the hydroxyl radical (Forman, 1986; McCord, 1993). Thus, superoxide,
hydrogen peroxide and the hydroxyl radical are all reactive oxygen
intermediates (ROI); they are not all free radicals. There are other
biologically relevant free radicals not simply derived by the incomplete
reduction of oxygen, including hypochlorous acid, NO- and the more
related reactive species peroxynitrite (Leenen, 1993).
1. 2. 3. 2b Antimicrobial Action of Reactive Oxygen Intermediates.
The ability of the Mo to kill a wide range of pathogens including
Leishmania (Murray, 1982), Toxoplasma, Trypanosoma and Candida
(Nathan, 1982) is directly related to its ability to secrete hydrogen peroxide
(Adams, 1992). Both PMN and Mo utilize ROI for killing
microorganisms, although there are differences between these cell types.
PMN possess significant levels of myeloperoxidase (MPO) enabling
generation of hypochlorous acid; the role of the peroxidase-hydrogen
peroxide-halide system in the Mo, which is relatively deficient in MPO, is
more questionable. Mo do however express the inducible form of nitric
oxide synthase generating NO-. This is another powerful free radical with
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diverse functions including as a vasoactive agent and a neurotransmitter
but also with antimicrobial actions, its production being again closely
linked to the antimicrobial capacity of Mo (Green, 1990; Fortier, 1992).
1. 2. 3. 2c Deleterious Actions of Reactive Oxygen Intermediates.
There is increasing evidence that free radicals can be damaging to cells
and tissues and they have been implicated in a number of disease states,
including the "major killers" - cancer and cardiovascular disease (Rice-
Evans, 1995) and HIV disease (Greenspan, 1994; Sandstrom, 1994).
Reaction of free radicals with non radicals can result in a free radical
chain reaction, the most important of these being that of lipid
peroxidation (McCord, 1993; Halliwell, 1995). Free radicals can also
damage DNA and react together to produce toxic compounds such as
peroxynitrite - a product of superoxide and NO- (Schraufstatter, 1987;
Halliwell, 1995). A chronic imbalance between the production of ROI and
the level of antioxidants has been proposed to result in the cumulative
effects of oxidative stress, which may cause disease (Rice-Evans, 1995).
There is good evidence that acute free radical induced damage results
from excessive phagocyte activation in lung disease and inflammatory
bowel disease (Cantin, 1987; Maier, 1993). Experimentally the addition of
the free radical generating system xanthine/xanthine oxidase results in
acute lung injury in rats that can be blocked by superoxide dismutase
(Johnson, 1981). Extracellular fluid from lungs of patients with idiopathic
pulmonary fibrosis has below normal levels of the antioxidant reduced
glutathione (GSH), whilst phagocytes from these patients release greater
quantities of ROI than control phagocytes (Cantin, 1987). Aerosolized
glutathione is now in trial as a therapy for pulmonary fibrosis (Maier,
1993).
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1. 2. 3. 3 Cytokine Secretion.
The main groups of currently described cytokines are shown in Table 1. 1.
Table 1.1






Molecular messengers acting between the
leukocytes (IL-1 to IL-16).
(M-CSF, GM-CSF, G-CSF Erythropoietin
SCF and IL-3).




Low molecular weight chemotactic cytokines.
Chemokines containing two adjacent cysteine
residues (C-C) (including IL-8, MIP-2a, MIP-2|3
and platelet factor 4).
Chemokines containing two cysteine residues
separated by another amino acid (C-X-C)
(include MIP-loc, MIP-ip, RANTES, MCP-1
MCP-2 and MCP-3).
Growth factors: (erythropoietin, SCF, monocyte chemotractant
protein, transforming growth factor, platelet
derived growth factor etc.).
Cytokines play a central role, co-ordinating both the inflammatory
response and tissue repair. They are low molecular weight proteins that
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can act both locally and systemically, binding to specific cell surface
receptors, initiating or modulating a wide variety of functions. Since Mo
exhibit considerable functional plasticity, the cytokine milieu to which
Mo or newly recruited monocytes are exposed will be important in
determining the functional and phenotypic states which the cell will
acquire. Early in the inflammatory response the dominant forces are the
pro-inflammatory cytokines such as TNF-a and IL-1, which have
powerful Mo activating potential. During resolution the levels of these
cytokines wane and colony stimulating factors and growth factors
predominate; Mo phenotype varying accordingly (Leenen, 1993).
1. 2. 3. 3a Pro-inflammatory Cytokines.
TNF-a, and IF-1 are the archetypal pro-inflammatory cytokines, central to
the initiation and potentiation of the inflammatory response (Dinarello,
1984, 1986, 1991 and 1993; Tracey, 1986, 1989 and 1994; Cannon 1990;
Witsell, 1992). These two cytokines, along with IL-6, are released early in
the course of inflammation. After bacterial or lipopolysaccharide (LPS)
challenge in vivo, TNF-a can be detected within 30 minutes (Tracey, 1986;
Natanson, 1989; Collart 1990), IL-1 within 3 hours (Okusawa, 1988) and IL-
6 within 6 hours (Gauldie, 1987; Wong, G. 1988). IL-6 differs from TNF-a,
and IL-1 in that it does not cause tissue injury, shock and death upon
infusion into animals and may act as a protective rather than pro¬
inflammatory cytokine (Gauldie, 1987; Oritani, 1992; Gillan, 1993). TNF-
a, IL-1 and IL-6 are all synthesized and secreted by the Mo, which also
express receptors for each of these three key inflammatory cytokines, thus
emphasizing the importance of the Mo in inflammation (Heinrich, 1990;






TNF-a In vitro Stimulates release of cytokines, ROI
and expression of adhesion molecules.
Primes and activates inflammatory cells.
Promotes phagocytosis. Differentiation
factor for monocytes.
In vivo Endogenous pyrogen. Infusion




IL-1 In vitro Stimulates release of cytokines,
ROI, acute phase proteins and adhesion
molecule expression.
In vivo Endogenous pyrogen. Infusion
induces acute lung injury, shock and death.
CDw 121a
CDw 121b
IL-6 In vitro Stimulates release of acute phase
proteins and production of proteinase
inhibitor and fibrinogen. Interacts with
CSF's to stimulate myeloid proliferation
and Mo differentiation. Stimulates B cells.
In vivo Endogenous pyrogen. Does not cause
shock or death upon infusion.
CD 126
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TNF-a is a trimeric peptide that binds to two different receptors
(Hohmann, 1989). There are two IL-1 proteins, IL-la and IL-ip, which
exist within cells in their pro-forms. The conversion of pro-IL-ip into the
active mature form has been shown to be performed by the cysteine
protease interleukin-ip converting enzyme (ICE) located on the external
cell surface (Cerretti, 1992; Thornberry, 1992; Wilson, 1994; Singer, 1995).
Recently ICE deficient mice have been generated that in addition to a
major defect in IL-lp synthesis also show an unexpected impairment in
IL-la production (Li, 1995). Only the mature form of IL-ip has activity
whereas both forms of IL-la are active. The predominant monocyte
product is IL-ip but as the cell matures into a Mo, IL-la becomes the
major IL-1 protein in vivo (Beuscher, 1992). The mechanism of their
release is not fully understood, as the IL-1 proteins have no signal
peptides thus cannot be released from via the secretory pathway.
Hogquist et al. have shown that with cell necrosis there is release of both
the pro and mature forms of IL-la but only the inactive pro-IL-lp, whilst
apoptotic cell death allows IL-ip to be efficiently processed to its active
form and released; the significance of this is not yet clear (Hogquist, 1991a
and b).
1. 2. 3. 3b Growth Factors and Colony Stimulating Factors.
In addition to their role in the inflammatory process, cytokines are vital
for the growth, repair, differentiation and survival of a range of cell types.
This is exemplified by the growth factors, for example - transforming
growth factor-P, (TGF-P) (Wahl, 1987; Border, 1990 and 1992;
Broekelmann, 1991; Shah, 1992) and the colony stimulating factors M-CSF
and GM-CSF (Tushinski, 1982; Warren, 1986; Wiktor-Jedrzejczak, 1990;
Hamilton, 1993a and b; Finbloom, 1993; Gillan, 1993). The murine colony
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stimulating factor (CSF-1) has direct survival, proliferative and
differentiating effects on murine Mo. It has been more difficult to show
such an effect with the human counterpart M-CSF on Mo progenitor cell
proliferation and monocyte survival. In the murine system CSF-1 will
induce more than 90% of bone marrow derived Mo to proliferate
whereas less than 5% of human cells will be similarly induced by M-CSF
(Cheung, 1992). M-CSF alone is also unable to induce human monocyte
to Mo differentiation but anti-M-CSF antibodies inhibit the
differentiation-promoting effects of serum, suggesting it does have a part-
role (Becker, 1987; Brugger, 1991). The Mo is a significant source of TGF-(3
at the inflammatory focus and as TGF-[3 has the ability to induce its own
production and it is chemotractant for monocytes, a potential positive
feedback loop exists (Border, 1992). Table 1. 3 shows some of the actions of
growth factors and colony stimulating factors.
Table 1. 3
Growth Factors and Colony Stimulating Factors.
Cytokine Action Receptor
TGF-(3 In vitro Regulates fibroblast and epithelial TGF-(3-R
cell growth and extracellular matrix
deposition, composition and degradation.
Monocyte cheenoattractant. Suppresses Mo
secretion of pro-inflammatory cytokines.
In vivo Facilitates normal embryonal
growth and regeneration following injury.
Implicated in many chronic scarring
conditions.
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Table 1. 3 (cont.)
Growth Factors and Colony Stimulating Factors.
Cytokine Action Receptor
M-CSF In vitro CSF-1 promotes survival, prolif- c-fms
(Human) eration differentiation and activation of product
CSF-1 murine Mo. Less clear proliferation and
(Murine) differentiation effect of M-CSF on human
Mo progenitors. Promotes pro-inflammatory
cytokine release from adherent cultured Mo.
In vivo Important in osteoclast maturation.
GM-CSF In vitro Promotes growth and differentiation CDw 116
of haemopoietic cells. Primes Mo,
up-regulates HLA-DR and IFN-y receptor
expression and IL-lra and plasminogen
activator production. Activates PMN.
In vivo Differentiation and survival of
PMN. Important in Langerhans cell
differentiation.
Three structurally and functionally related isoforms of TGF-(3 are
expressed by man, of which TGF-(3i, a dimeric protein, is mainly of
haematopoietic cell origin (McCartney-Francis, 1994). The colony
stimulating factors are a group of glycoprotein hormones that act on the
bone marrow stem cells to coordinate the growth and differentiation of
the various haemopoietic cells (Weisbart, 1989). Most are monomeric
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proteins with the exception of M-CSF and IL-5 which exist as
homodimers (Morris, 1991). Many cytokines are involved in the growth
and differentiation of other cells of the monocyte lineage. Gene knockout
experiments demonstrate that M-CSF and c-fos regulated gene products
are critically important in osteoclast maturation (Wiktor-Jedrzejczak,
1990) whilst GM-CSF and IL-4 are important in Langerhans cell
differentiation. TNF-a and GM-CSF have also been shown to be
involved in the differentiation of stem cells into dendritic cells and Mo
(Santiago-Schwarz, 1992; Gordon, 1995).
1. 2. 3. 3c IL-4 and Interferon-y.
Some of the actions of these two cytokines are shown in Table 1. 4. In
mice T helper cells can be differentiated into the two subsets TH1 and
TH2, but most human T cell clones do not fit into these categories
(Mosmann, 1986; Modlin, 1993). IFN-y, produced by TH1 cells, is an
important cytokine for Mo function and cellular immune responses
(Black, 1987; Kemmerich, 1987; Adams, 1989; Nicod, 1993; Munn, 1995).
IL-4, which has powerful modulatory effects on Mo function, is produced
by TH2 cells along with IL-5, IL-6 and IL-10. The Mo is a rate limiting
effector cell in wound healing (Leibovitch, 1975) which not only secretes
but also responds to a number of growth factors like TGF-(3 and other
cytokines including IL-4 that are critical to the successful resolution of the
inflammatory lesion (Border, 1992; Davidson, 1992; Allen, 1993). Mo play
many vital roles during repair and resolution events, contributing to
appropriate fibroblast function including matrix deposition, angiogenesis
and to clearance of effete cells and these functions are influenced by a






IFN-y In vitro Stimulates TNF-a and IL-1 production. CDw 119
Monocyte differentiation factor. Induces
MHC class II expression.
In vivo Important for effective cellular
immunity, protection against intra-cellular
pathogens and for granuloma formation.
IL-4 In vitro Supports B and T cell proliferation. CDw 124
Inhibits pro-inflammatory and MlP-la
cytokine production by Mo. Enhances
antigen presentation and MHC class II
expression. Down regulates CD14
expression, NO generation and superoxide
release.
In vivo Promotes uptake of pathogens and
suppresses chronic inflammation.
1. 2. 3. 4 Cytokine Receptors and Receptor Shedding.
Cytokines communicate with cells via specific cell surface receptors, the
expression of which is closely controlled. Binding of cytokines to their
specific receptors may then initiate cellular responses, although receptor
expression does not necessarily indicate that they are functionally active.
There are now known to be structural similarities between different
receptors allowing them to be grouped into families as shown in Table 1.




a) Immunoglobulin superfamily, with tyrosine kinase activity:
IL-1 receptor CDw 121a, M-CSF receptor, Platelet derived growth
factor receptor ((3 subunit) and IL-6 receptor.
b) Hematopoietin superfamily, with conserved Trp-Ser-X-Trp-Ser
sequence: erythropoietin receptor, growth hormone receptor,
prolactin receptor, IL-2 receptor ((3 and y subunits), IL-3 receptor (a
and (3 subunits), IL-5 receptor (a and (3 subunits), GM-CSF receptor
(a and (3 subunits), IL-6 receptor (a subunit), ciliary neurotrophic
factor receptor, leukemia inhibitory factor receptor, gp 130, IL-4
receptor (a subunit), IL-7 receptor, IL-9 receptor and G-CSF receptor.
c) TNF superfamily, with several cysteine rich domains: both TNF
receptors CD120a and CD120b, low affinity nerve growth factor
receptor and Fas amongst its members.
There remain a number of other cytokine receptors, including TGF-p and
the high affinity receptors for the chemokines, whose structures are
unknown and have not been classified in this way as yet.
Many cytokine receptors are composed of more than one protein, for
example the GM-CSF receptor (GM-CSFR) consists of an a and a (3
component, as do receptors for IL-3 and IL-5. These three members of the
hematopoietin family, have their own specific a protein but share a
common |3 subunit. The actual mechanism of signal transduction by
these receptors is still unclear as the (3 subunit has no intrinsic kinase
activity (Miyajima, 1992b). Similarly the IL-6 receptor consists of two
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polypeptide chains - an 80-kD low affinity binding protein (CD126) that
has domains representative of both the hematopoietin and the
immunoglobulin families and a 130-kD protein, gp 130, that allows high
affinity binding of IL-6 to the receptor and is required for signal
transduction (Hibi, 1990). Like the GM-CSF/IL-3/IL-5 receptor system, IL-
6 receptor shares the signal transducing element gp 130 with other
receptors including ciliary neurotrophic factor, leukemia inhibitory factor
and oncostatin M (Kishimoto, 1992; Stahl, 1993).
TNF-a has two cell surface receptors, and although commonly co-
expressed epithelial cells express more CD120a whereas myeloid cells
express more CD120b. Likewise IL-1 has two receptors, CDw 121a - widely
expressed on endothelial cells, hepatocytes, T cells and Mo, and CDw 121b
- expressed on Mo and some B cells and has not been shown to transduce
signal (Sims, 1988; McMahan, 1991; Kikutani, 1995).
A number of receptors are shed from the Mo surface upon activation,
including both TNF receptors, the IL-4 receptor, IL-6 receptor and CSF-1
receptor (Porteu, 1990; Kikutani, 1995; Leeuwenberg, 1995; Mullberg, 1995).
Shedding is mediated by proteolytic cleavage and for the TNF receptor -
CD120a and IL-6R but not M-CSF receptor this shedding has been shown
to be inhibitable by a specific metalloprotease (Mullberg, 1995). Most shed
receptors act as circulating antagonists but the IL-6 receptor complexed
with IL-6 can act as an agonist by binding to gpl30 (Fraser, 1993). Receptor
loss can also be a consequence of apoptosis with CD16 loss paralleling the
onset of apoptosis in PMN (Dransfield, 1994).
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I. 2. 3. 5 CD 14.
The M0 is the archetypal LPS binding cell, this binding inducing secretion
of pro-inflammatory mediators, up-regulation of adhesion molecule
expression and an increase in oxygen consumption. LPS binds to
multiple cellular receptors, the best characterized of which is CD14
(Wright, 1990 and 1992; Ferrero, 1993; Ziegler-Heitbrock, 1993; Cohen,
1995). CD14 is a 55kD glycoprotein located mainly on myeloid cells that is
anchored to the cell membrane by a glycosyl-phosphatidylinositol (GPI)
linkage (Haziot, 1988; Bazil, 1991). LPS binding by CD14 is dependent
upon the presence of the plasma protein lipopolysaccharide binding
protein (Wright, 1990 and 1992). The mechanism of signal transduction
remains unclear as the CD14 molecule has no intracytoplasmic tail. CD14
is not expressed on early myelomonocytic cells but expression can be
induced by differentiating agents such as vitamin D3 (Rigby, 1984), more
mature cells constitutively express CD14 (Zeigler-Heitbrock, 1993).
Differentiation of monocytes into Mo in vitro can result in increased,
unchanged or decreased expression of CD14 and CD14 expression in vivo
may be determined by tissue localization with peritoneal Mo expressing
higher levels than alveolar Mo and microglial cells (Franklin, 1986;
Zeigler-Heitbrock, 1993). CD14 expression changes with the activation
state of the cell, in granulocytes and Kupffer cells CD14 expression is up-
regulated with activation and TNF-a, IL-1 and IL-6 all increase Mo
expression of CD14 (Zeigler-Heitbrock, 1993). LPS stimulation has been
reported to both increase and decrease CD14 expression (Zeigler-
Heitbrock, 1993) and IFN-y and IL-4 have been shown to down-regulate
CD14 expression on Mo within minutes (Landmann, 1992). Decrease in
CD14 expression is mainly by receptor shedding via a proteolytic
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mechanism, soluble CD14 can present LPS to cells and can be detected in
Mo culture supernatants and in urine from patients (Bazil, 1991).
1. 2. 3. 6 Receptor Expression on Macrophages.
In keeping with their wide range of functions, mononuclear phagocytes
express a vast array of receptors (Miller, 1985; Fraser, 1993; Bellingan,
1995). These are listed in Table 1. 6.
Table 1. 6
Receptor Expression on the Macrophage.
• The immunoglobulin superfamily.
(e.g. FcR, IL-1R, M-CSFR, MCH I and II and (32M).
• The hematopoietin receptor superfamily.
(e.g. IL-2R, IL-4R, IL-6R and GM-CSFR).
• The integrin superfamily.
(e.g. CDlla, CDllb, CDllc, CD18, CD29/49d).
• The selectin superfamily.
(L selectin).
• Matrix component receptors.
(e.g. AGE (advanced glycosylation end product receptor) and CD44).
• Lectin receptors.
(e.g. Mo mannose receptor, sialoadhesin).
• Scavenger Receptors.
(type 1 and type II).
• Soluble receptors.
(e.g. IL-4R, IL-6R, both TNF receptors, M-CSFR, CD14)
• MHC
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In particular monocytes and Mo express receptors for a number of
cytokines including; TNF, IL-1 (Uhl, 1989), IL-2 (Cox, 1990), IL-4 (Feldman,
1990), IL-6, IL-10, M-CSF, GMCSF and IFN-y (Fraser, 1993; Munck-
Petersen, 1990; Bellingan, 1995). The expression of a number of surface
receptors is known to alter during Mo maturation, with expression of
CDlla/CD18, CDllb/CD18, CD14, la and transferrin receptors all
increasing with increasing maturity, whilst in the mouse F4/80 is also a
maturation marker (Flume, 1983; Miller, 1985; Gessani, 1993). Monocyte
production and Mo maturation is closely controlled, being regulated by a
number of cytokines including M-CSF, IFN-y and vitamin D3 as discussed
earlier. Any changes in expression of cytokine receptors during monocyte
to Mo maturation will be very relevant to the participation of these cells
in the inflammatory response. Activation induces further changes in
cytokine receptor expression, in particular it induces receptor shedding as
discussed in section 1. 2. 3. 4. Although some of the surface phenotype
changes associated with Mo maturation have been analyzed the changes
in cytokine receptor expression during the differentiation of these cells
has not been documented (Andreesen, 1990).
1. 2. 3. 7 The Macrophage and the Immune Response.
Mo play a part in regulation of virtually all facets of the immune
response. They process and present antigens thus stimulating adaptive
immune responses by T cells, stimulate B cell reactivity through secretion
of cytokines including IL-1 and IL-6 and also mediate suppression of
lymphocyte reactivity by secretion of IL-4 and other cytokines (Dale, 1989a;
Davies, 1989). Mo, dendritic cells and B cells are the major antigen
presenting cells (Austyn, 1990; Steinman, 1991; van Vugt, 1993a). For
appropriate presentation, antigen must be taken up and processed to the
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form of an antigenic peptide such that it can be combined with MHC class
I or II molecules on the cell surface (Chain, 1993). Binding of antigen
specific cells expressing the T cell receptor, CD4 or CD8 molecules and
adhesion molecules along with delivery of an appropriate co-stimulatory
signal by the antigen presenting cells then elicits a positive T cell response
(Chain, 1993). Although Mo are competent antigen presenting cells, only
a proportion express class II molecules and their role may be restricted to
evoking a memory T cell response, in contrast with dendritic cells which
are by far the most effective antigen presenting cells for provoking
primary T cell responses (Steinman, 1991). The relative antigen
presenting activity of dendritic cells and Mo in vivo needs to be clarified
(Chain, 1993). Dendritic cells are non-phagocytic and possess few
lysosomes suggesting a limited capacity for intracellular protein
degradation. Thus despite their great efficacy in antigen presentation it
has been proposed that they are relatively inefficient at processing
antigens. Suggestions as to how this is overcome in vivo include the
possibility of close cooperation between Mo and dendritic cells and/or the
possibility that peripheral antigen processing cells could mature into
dendritic cells (Steinman, 1991; Chain 1993). Certainly dendritic cells and
Mo seem to be derived from a common progenitor cell and there is
evidence that not only can dendritic cell differentiation be selectively
promoted from a common Mo/dendritic stem cell but that dendritic cell
morphology may be a transient feature of cells of the monocyte/Mo
lineage (Santiago-Schwarz, 1992). In the peritoneum there are normally
only 1 - 2% dendritic cells and only 13% of the resident peritoneal Mo are
la positive, with activation the percentage of la expressing Mo increases to
45% (Kimberly, 1992; van Vugt, 1993a). The relative contribution of these
la positive Mo to the development of adaptive immune responses is not
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known. Certainly both dendritic cells and Mo have been shown to traffic
from tissues to the draining lymph nodes (Rosen, 1990, van Furth, 1992,
Lan, 1993, Xia, 1995; Bellingan 1996a). In the lung, alveolar Mo have been
shown to down-regulate the antigen presenting capacities of pulmonary
dendritic cells; thus the role of Mo migration may even be as immune
modulator rather than immunostimulator (Holt, 1993; Xia, 1995).
1. 3 THE LIFE OF THE MACROPHAGE.
1. 3.1 Origin.
Aschoff in 1924 grouped the Mo into the reticuloendothelial system, a
wide ranging system including monocytes, Mo, histiocytes, fibroblasts,
endothelial cells and reticular cells on the basis of their structural
association (Aschoff, 1924). The reticuloendothelial classification was
replaced in 1969 with the concept of the mononuclear phagocyte system,
which includes cells believed to share common functional and
developmental characteristics (van Furth, 1972). Mo are found in every
tissue in the body and along with this wide distribution there was found
to be considerable Mo heterogeneity. Investigation of Mo origins and
development sought to determine whether this heterogeneity arose as a
result of specific Mo sub-populations or a complex function of site, degree
of differentiation and state of activation. Mo are originally derived from
the bone marrow. The multipotent haematopoietic stem cell (CFU-S)
yields the granulocyte-macrophage colony forming cell which divides
under the influence of the appropriate colony stimulating factors to give
rise to the monoblast. The monoblast, defined in 1975 by van Furth and
colleagues, divides once to yield two promonocytes which further divide
to give rise to the monocyte which leaves the bone marrow to enter a
circulating and marginated pool (van Furth, 1992). van Furth and
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colleagues also demonstrated that circulating monocytes were a source for
resident peritoneal Mo, Kupffer cells, splenic Mo, alveolar Mo and
inflammatory Mo. Thus, the single lineage model of Mo development
suggests that under normal steady state conditions monocytes, derived
from bone marrow precursors, migrate to tissues and body cavities and
there differentiate into Mo (van Furth, 1992; Ginsel, 1993). However
recent evidence suggests that there is also local cell division of Mo
depending on the tissue site (Dougherty, 1984; Ginsel, 1993). The extent to
which local proliferation occurs is a matter of contention; van Furth and
colleagues maintain that newly arrived monocytes have only a limited
capacity for division (van Furth, 1992), whilst others present evidence
that extensive local proliferation occurs (Volkman, 1976; Bouwens, 1986;
Melnicoff, 1988a; Ginsel, 1993).
Monocytes can be shown to mature and differentiate into Mo,
undergoing extensive changes in surface receptors, enzyme activity and
secretory ability. This functional and phenotypic plasticity is used as
evidence that the single lineage model holds true, although it is difficult
to explain all the intra-population heterogeneity observed in this way.
Depletion of local Mo populations and use of parabiotic animals
suggested that the bone marrow was not (entirely) the source for
replenishment of tissue Mo populations (Volkman, 1976; Bouwens, 1986;
Sawyer, 1986; Tarling, 1987). For these reasons a dual lineage model for
Mo development has been proposed which suggests resident Mo
populations are maintained mainly by local proliferation and are thus
distinct from circulating monocytes and inflammatory Mo (Ginsel, 1993).
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1. 3. 2 Heterogeneity.
The mononuclear phagocyte system classification includes resident
peritoneal Mo, alveolar Mo, Kupffer cells, splenic Mo, circulating
monocytes, exudate or inflammatory Mo and a number of other
specialized cells such as microglia and osteoclasts. This demonstrates the
great diversity within the classification of Mo-like cells. Part of this
heterogeneity arises due to localization at different sites within the body.
A clear example of this is seen with the differences in Fey and C3 receptor
and other surface antigen expression on circulating monocytes, resident
peritoneal Mo and alveolar Mo (van Furth, 1992). This heterogeneity
extends not only to phenotype but functional abilities as well as antigen
and enzyme expression (van Furth, 1992).
Within Mo all located in one compartment there is also considerable
variation - intra-population heterogeneity. Some of this may be due to
mixing of Mo populations such as resident Mo with monocytes newly called
in by an inflammatory stimulus. Another source of heterogeneity is the
phenotypic and functional changes associated with differentiation and
activation since a population is unlikely to be synchronous with respect to
either of these processes.
1. 3. 3 Differentiation.
Some investigators define development of the monocyte from its
precursor promonocyte and monoblast as maturation whilst generation
of diversity is defined as differentiation (Leenen, 1993). In contrast with
activation, both maturation and differentiation are irreversible steps in
the life of the Mo and this contrasts with activation. Differentiation
includes, cytochemical changes, acquisition of new functional capacities,
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along with an increase in size and altered surface phenotype (Dougherty,
1984). The process of differentiation is tightly regulated by a number of
cytokines including M-CSF, GM-CSF, IL-3 and TNF-a as well as by other
agents including steroid hormones (Dougherty, 1984; Leenen, 1993).
Exposure of cells to different environments will further alter their
characteristics, for example exposure to high or low oxygen
concentrations (Albina, 1995). Within each specific micro-environment,
the matrix, the local cytokine milieu and a host of other factors will
combine to induce specific Mo differentiation characteristics.
1. 3. 4 Activation.
Further heterogeneity is associated with differing Mo activation states,
although there is still controversy about the terms "primed" and
"activated" when applied to Mo. The concept of Mo activation was
introduced in the 1960's by Mackaness who demonstrated that Mo
resistance to intracellular parasites was brought about by the action of T
lymphocytes. After exposure to lymphokines derived from sensitized T
cells, Mo gained the ability to kill a range of intracellular pathogens and
were described as "angry" or "activated" cells (Mackaness, 1970).
"Activation" is applied to intrinsic adaptive changes undergone by Mo to
enable it to respond, enhancing microb t cidal capacity (North, 1978) and
cytotoxicity for tumor cells (Adams, 1989). One potential source of
confusion is that changes in effector molecule expression during Mo
differentiation may allow definition of Mo with the capacity for a
particular function (Cohn, 1978; Karnovsky, 1978). Flowever receptor
expression does not necessarily equate with functional competence. Thus
Adams has suggested that Mo activation should be viewed in terms of
competence to perform a complex function, thereby distinguishing
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between potential capacities of the cell such as expression of a specific
receptors and functions such as the killing of microbes, antigen
presentation or chemotaxis (Adams, 1989). There is not one single
"activated" state for Mo. A Mo which, through various signals from its
environment, has acquired the ability to perform one particular function
need not be capable of performing a different complex function (North,
1978; Campbell, 1984; Adams, 1989). In terms of the inflammatory
response, considerable Mo functional heterogeneity is likely to exist due
to a number of factors including; the cytokine profile to which the cells
are exposed, the inciting stimulus, the site of inflammation and stage of
the inflammatory response (Dougherty, 1984; Lemaire, 1991; Leenen,
1993). For the steady state resident Mo, the local environment normally
provides for a low activation state, whilst the inflammatory Mo at the
inflamed site will be some way down the activation pathway(s).
Whatever the origin of Mo heterogeneity, clear distinctions exist between
monocytes, resident Mo and inflammatory Mo, which differ from each
other in their expression of a range of receptors and enzymes (van Furth,
1992) as well as their ability to phagocytose and kill pathogens (Cohn,
1978; North, 1978; Lepay, 1985; Black, 1987; Kemmerich, 1987).
1. 3. 5 Monocyte Migration - Adhesion and Chemotaxis.
Monocytes migrate into acute inflammatory reactions in response to
many different stimuli, listed in Table 1. 7 (Wahl, 1987; Riches, 1988;
Schall, 1990; Issekutz, 1993; Kasama, 1993; Meurer, 1993). Monocytes leave
the circulation under the influence of chemotactic signals and
accumulate at the site of acute inflammation. This emigration requires
transendothelial migration which, as with the PMN, involves multiple
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stages including rolling along then firm adhesion to the endothelium,
allowing traversing of the junctional space (Meerschaert, 1995). Again as
with PMN, L-selectin (CD62L) is involved in the initial rolling (Spertini,
1992) while the P2 integrin family member CD11/CD18 and (3i integrin
family member CD49d/CD29 or VLA-4 are both involved in tight binding
to endothelial cells (Meerschaert, 1995). The platelet-endothelial cell
adhesion molecule-1 (PECAM-1, or CD31) is required for movement of
monocytes through endothelial intercellular junctions (Muller, 1993;
Liao, 1995). The adhesion molecules involved in the migration of Mo
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There is great diversity among chemotactic signals. Many of these agents,
for example collagen type 1 and fibronectin proteolytic fragments, show
specific chemotactic activity for Mo but not for PMN. Similarly both C5a
des arg and C5a are chemotactic for monocytes, whilst the conversion of
C5a into C5a des arg reduces the PMN response 15 fold. This contrasts
with IL-8 which is an extremely potent chemotactic agent for the PMN
with little effect on monocytes.
1. 3. 6 Cell Culture Systems for Macrophage Study.
Peripheral blood monocytes can be isolated by a variety of techniques
including density gradient centrifugation, adherence, or countercurrent
centrifugal elutriation (CCE). Monocytes cultured in vitro in the presence
of serum, either adherent to tissue culture wells, or in suspension in
hydrophobic Teflon foils (Johnson, 1977; Andreesen, 1983; Becker, 1987;
Helinski, 1988) undergo a number of functional, biochemical and
morphologic changes consistent with differentiation or maturation into
Mo (Becker, 1987). Cultured monocytes have been shown to become
functionally competent phagocytes (Helinski, 1988). Monocytes in culture
show increased intracellular levels and secretion of lysozyme, 5'
nucleotidase, tissue transglutaminase, creatine kinase, cAMP-dependent
protein kinase 1 and non-specific esterase activity, but lose MPO,
paralleling the process of Mo differentiation in vivo (Johnson, 1977;
Andreesen, 1983; Riches, 1988). Along with these functional alterations,
monocytes become bigger, more granular and have altered cell surface
antigen expression during in vitro differentiation (Becker, 1987; Helinski,
1988; Gordon, 1995). Monocyte derived Mo in in vitro culture gain new
expression of CD16 and CD51 and increased expression of CDlla, CDllb,
CDllc, CD14, CD71 and HLA-DR, as do in vivo Mo (Andreesen, 1990;
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Gessani, 1993; Bellingan, 1993; Zang, 1994). These changes indicate that
human peripheral blood monocytes mature into functional Mo in vitro
whether they are cultured adherently or in suspension (Andreesen, 1983;
Becker, 1987) and this mimics the functional, biological and
morphological changes accompanying in vivo maturation of monocytes
passing from the blood stream into tissue in response to inflammatory
stimuli (Riches, 1988).
In the absence of serum Mo differentiation does not occur, monocytes fail
to increase in size, or gain new surface molecule expression (Andreesen,
1990). There has been considerable interest in what serum factor(s) may
cause this differentiation. Musson demonstrated that a factor for
survival/differentiation co-isolated with albumin and several workers
have shown that for murine Mo, CSF-1 is an important differentiation
co-factor but that a number of other cytokines, including GM-CSF, IL-1,
IL-3, IL-4, IL-6, TNF-a and IFN-y were all ineffective (Tushinski, 1982;
Becker, 1987; Brugger, 1991). The role of M-CSF in human cells is less
clear, Munn et al. finding it was an essential survival factor for
monocytes whilst Cheung et al. demonstrated little effect and Brugger et
al. showed that it was unable to directly induce differentiation (Brugger,
1991; Cheung, 1992; Munn 1995). Other factors implicated include
vitamin D3 and there is evidence that adhesion via fibronectin receptors
to insolubilized fibronectin also induces monocyte differentiation
(Riches, 1988). With this uncertainty, a defined "maturation medium" is
not in existence and serum, with the inherent variability entailed, is used
as standard.
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1. 3. 7 In Vivo Monocyte/Macrophage Kinetics.
1. 3. 7.1 Non-inflamed Steady State.
Most studies on monocyte/Mo kinetics have been performed on the
mouse. In the non-inflamed steady state monocytes remain in the bone
marrow for less than 24 hours before entering the circulation, where they
have a half life of approximately 17 hours (van Furth, 1973). The pool of
circulating and marginating monocytes in an adult mouse is estimated at
0.62 and 0.92 x 106 cells respectively (van Furth, 1992). This compares
with 9 x 106 tissue Mo in the liver and 2.4 x 106 in the peritoneal cavity.
As these pool sizes remain constant there must be a constant
disappearance of monocytes and/or Mo (Richardson, 1994). Should tissue
Mo be replenished from circulating monocytes (single lineage model)
then approximately 1.5 x 106 Mo must be removed per day (van Furth,
1992). Alternatively, if tissue Mo are mainly replaced by self replication,
1.5 x 106 circulating monocytes must then be removed per day, with a
much lower rate of Mo removal, since typically less than 5% of tissue Mo
are seen to be synthesizing DNA. Certainly the half life of the monocyte
is considerably shorter than that of resident tissue Mo. Rosser reported
that after adoptive transfer of radiolabeled resident peritoneal Mo more
than half the labelled cells could be recovered in the peritoneal lavageate
2 weeks after cell transfer (Rosser, 1970). van Furth concluded that the
mean turnover times for different Mo populations varied between 3.8
days for Kupffer cells and 14.9 days for peritoneal Mo (van Furth, 1992).
1. 3. 7. 2 Giant Cell Formation.
One of the hallmarks of the granulomatous response to infection or
inflammation is the formation of multinucleate giant cells. Giant cells
occur in association with fungal or mycobacterial infection or with certain
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forms of chronic inflammation as characterized by sarcoidosis or the
response to a foreign body. It is understood that multinucleate giant cells
are formed by Mo fusion but the cause and mechanism of this is unclear
(Sone, 1981; Enelow, 1992). In culture, multinucleate giant cells are not
observed until at least the 4th day, consistent with the requirement for
these cells to mature into Mo (Chow, 1989). In suspension cultures no
cell fusion could be detected at all (Enelow, 1992). The cells of certain
human donors have a marked tendency to giant cell formation, the
reason for this is unknown (Hassan, 1989; Enelow, 1992). Agents known
to induce multinucleate giant cell formation include, vitamin D3,
concanavalin-A, IL-3, GM-CSF, IFN-y and phorbol myristate acetate (PMA)
(Mclnnes, 1988; Hassan, 1989; Enelow, 1992; Takashima, 1993). Both a
positive (Mclnnes, 1988) and negative (Enelow, 1992; Takashima, 1993)
effect of IL-4 on giant cell formation has been reported. The usual rate of
giant cell formation in the absence of a specific stimulus is low and this
does not represent a major fate of Mo.
1. 3. 7. 3 Acute Inflammation.
During inflammation the production of monocytes increases due to both
shortening of the promonocyte cell cycle times and to an increase in the
absolute numbers of promonocytes. This results in a doubling of the
number of monocytes entering and leaving the circulation during the
first few days of acute inflammation (van Furth, 1992). The bulk of Mo
accumulation at the inflamed site is due to an influx of monocytes
(Issekutz, 1981 and 1993; van Furth, 1992). A number of investigators
have tackled the question of the kinetics of monocyte influx into
inflammatory foci and the mechanisms underlying this (Issekutz, 1981
and 1993; Rosen, 1990; Spertini, 1992; van Furth, 1992; Meerschaert, 1995).
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Monocyte accumulation at the acutely inflamed site often begins early,
certain stimuli can elicit substantial accumulation within 1 hour of the
onset of inflammation (Issekutz, 1981). The rate of monocyte
accumulation can peak at any time between 4 and 18 hours after the
insult (Doherty, 1988) but immigration continues for at least 24 hours
depending upon the stimulus (Paz, 1962; Perper, 1974; Issekutz, 1981 and
1993). This contrasts with the PMN which migrates into the acute
inflammatory lesion in vast numbers over the first 6 hours but thereafter
influx virtually ceases (Haslett, 1989). This, coupled with the relatively
short life span of the PMN means that the monocyte becomes the
predominant cell after 12 to 48 hours depending on the stimulus
(Issekutz, 1981; Doherty, 1988). Labelled monocytes have been used to
identify the migration kinetics into inflammatory foci in the lung
(Doherty, 1988), peritoneum (Rosen, 1990), skin and footpad (Issekutz,
1981; van Furth, 1992). Resident peritoneal Mo labelled and returned
intravenously have been shown to be a useful surrogate for circulating
monocytes as, unlike exudate derived or formalin fixed Mo, these cells
can migrate into acute inflammatory lesions (Rosen, 1990).
1. 3. 7. 4 Resolution of Inflammation.
The method of clearance of inflammatory Mo during the resolution of
acute inflammation is not clear. Mo from inflammatory lesions can
migrate to the draining lymph nodes but the importance of this as a
mechanism of clearance is unknown (Lan, 1993). Both the mesangial cell,
a Mo-like professional phagocyte in the kidney, and the PMN, die by
apoptosis and are cleared by local phagocytes (Baker, 1994). Thus, the Mo
could meet its fate mainly by death in situ and be cleared by the
remaining tissue Mo. Although adoptive transfer of labelled Mo has also
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been used to track the migration of Mo into inflamed sites, such a study
of the kinetics of inflammatory Mo during the resolution of
inflammation has not been performed.
The factors that cause Mo to be cleared from the inflamed site and the
timing of this are not well understood, however, since a failure to clear
Mo from the inflammatory site could lead to the development of chronic
inflammation, knowledge of these factors could be of central importance
to our understanding of the inflammatory response.
1. 3. 8 Fate of the Macrophage In Vivo.
Little is known about the ultimate fate of monocytes and Mo. Mangan e t
al. have shown that, in the absence of pro-inflammatory stimuli,
monocytes in vitro die by apoptosis (Mangan, 1991a and b). Recently
Munn et al. suggested that early exposure to IFN-y may be required for
monocytes and Mo to undergo apoptosis (Munn, 1995). Mo have been
shown to die by apoptosis in response to a number of signals, including
NO, pathogens, silica and toxins (Waring, 1990; Zychlinsky, 1992; Sarih,
1993a and b), but the physiological significance of this is unknown. As
with mesangial cells and PMN (Baker, 1994), it is possible that
inflammatory Mo die at the inflamed site. Migration of Mo to local
lymph nodes has been demonstrated and as Mo are uncommon in
efferent lymph it is possible that they die there (Rosen, 1990; van Furth,
1992; Lan, 1993; Thepen, 1993). The relevance of Mo migration to local
nodes is unclear and the importance of this route of clearance over death
in the tissues is unknown. There is evidence that lung Mo leave via the
airspaces but this is unlikely to be a major route for elimination (Nicol,
1958). The possibility of different clearance mechanisms for resident
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tissue M0 and inflammatory Mo during the resolution of inflammation
has not been addressed.
1. 4 CELL DEATH.
All cells die. Two main forms of cell death have been described, necrosis
and apoptosis. As certain cells have been shown to have a genetic
programme controlling the onset of apoptosis this form of cell death is
also known as programmed cell death. The causes, controls,
characteristics and consequences of apoptosis and necrosis are markedly
different and are reviewed below.
1. 4.1 Necrosis.
Necrosis occurs where there are gross perturbations in the cellular
environment such as trauma, large fluctuations in temperature or pH, or
in the presence of lethal concentrations of metabolic poisons. A common
pathological event leading to necrosis is vascular occlusion leading to
lack of perfusion of cells, the resultant hypoxia causes cellular necrosis
within minutes, this is evident by light microscopy within hours
(Jennings, 1975 and 1978). Initially reversible changes including mild
cellular and mitochondrial swelling, lead to irreversible events including
gross swelling, rupture of endoplasmic reticulum, disruption of internal
organelles and finally plasma membrane disruption (Trump, 1976).
Accompanying necrosis there is usually evidence of a significant acute
inflammatory reaction (Wyllie, 1988). These morphological changes are
accompanied by a fall in ATP levels with a loss of function of vital ion
pumps leading to loss of potassium to the extracellular environment
whilst sodium and water enter the cell (Trump, 1975). A number of
enzymes are activated leading to hydrolysis of membrane phospholipids
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and proteins, potentiating the cellular disruption (Farber, 1973). Necrosis
does not occur in a developmental context and unlike apoptosis, does not
require expression of new mRNA (Cohen, 1993; Schwartz, 1993).
1. 4. 2 Apoptosis.
1. 4. 2.1 Morphology.
The first descriptions of cell death as a positive contribution to normal
vertebrate development were made relatively recently (Glucksmann,
1951; Saunders, 1966). The term apoptosis was first introduced in 1972 by
Kerr describing a form of cell death morphologically distinct from
necrosis (Kerr, 1972). It is now believed that programmed cell death is a
normal default pathway for most living cells, protecting the organism
from uncontrolled cell proliferation (Raff, 1992). Apoptosis is
characterized by both nuclear and cytoplasmic condensation (Kerr, 1972),
which is strikingly rapid and seen clearly by time-lapse video microscopy
(Russell, 1972). Initially nuclear condensation can be seen underlying the
nuclear membrane, then progressing to involve the entire nucleus
(Cohen, 1992). Later the nucleus can fragment into numerous smaller
spheres. Within the cytoplasm the endoplasmic reticulum is seen to
dilate despite the cell's great decrease in volume. Some of the more
superficial dilated ducts fuse with the plasma membrane giving it a pitted
appearance on scanning electron microscopy (Wyllie, 1988). The plasma
membrane retains its integrity well into the apoptotic process although
there is loss of specialized surface structures, loss of cell-cell contact and
blebbing of membrane bound bodies (Cohen, 1992). Unlike necrosis there
is no associated acute inflammatory reaction even in the face of
significant levels of apoptosis (Gerschenson, 1992). In the absence of
40
phagocytic cells to engulf it, the apoptotic cell undergoes further
disintegration, a stage called secondary necrosis.
1. 4. 2. 2 Biochemical Changes Associated with Apoptosis.
Accompanying these morphological changes there are distinct enzymatic
processes, the most characteristic being activation of an endonuclease
which acts to cleave DNA into approximately 180 base pair
oligonucleosomes (Wyllie, 1980; Arends, 1990; Pietsch, 1993). Although
apoptosis has been reported to occur in the absence of DNA laddering
(Gromkowski, 1986 and 1988), electrophoretic analysis of DNA - showing
a characteristic ladder pattern - remains a powerful method of
distinguishing apoptotic and necrotic death (Wyllie, 1980; Gerschenson,
1992). In addition to the activation of nuclear enzymes, apoptosis is also
associated with activation of other enzymes, including tissue
transglutaminase (Fesus, 1987) and ICE (Hogquist, 1991a; Miura, 1993;
Wang, 1994). Other changes on the surface of apoptotic cells include
phosphatidyl serine translocation from the inner to outer membrane
(Fadok, 1992a; Martin, 1995) and shedding of CD16 (Dransfield, 1994).
1. 4. 2. 3 Apoptosis: Cytokines and Serum Survival Factors.
Not only do cytokines influence cellular growth, development and
function but they are also important in controlling cell death. There is
much evidence that certain cytokines can promote or inhibit apoptosis
itself, some examples are given in Table 1. 8 (GM-CSF - Brach, 1992: TNF-
a - Colotta, 1992; Grell, 1994; Polunovsky, 1994: IL-2 - Duke, 1986: IL-3 -
Rodriguez-Tarduchy, 1990: IL-4 - Rodriguez-Tarduchy, 1991: IL-5 - Stern,
1992: IL-6 - Afford, 1992). Indeed Raff postulates that without continual
cell - cell communication all cells will undergo apoptosis (Raff, 1992).
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The concept of cell death in the absence of survival factors is thus well
established.
Table 1. 8














Monocyte and Mo survival had already been shown to be dependent on
CSF-1 in murine cells in the absence of serum (Tushinsky 1982; Becker,
1987; Brugger, 1991). For human monocytes, serum is of critical
importance to in vitro survival, an effect which is partially abrogated by
adherence (Johnson, 1977). In suspension cultures in the absence of
serum, survival rates of 1 - 12% have been reported over 5 days whilst
corresponding recovery rates in the presence of serum are 30 - 75%
(Andreesen, 1983 and 1990; Helinski, 1988; Brugger, 1991; Mangan, 1991a).
Improved monocyte recovery rates can be achieved by adherent culture
and the addition of serum doubles cell recovery at 5 days (Becker, 1987).
Mangan et al. have shown that in the absence of serum monocytes die by
apoptosis and that this is delayed by the addition of pro-inflammatory
cytokines, although interestingly not by monocyte chemotactic cytokines
(Mangan, 1991a and b). They did not examine the effect of cytokines on
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M0 survival. The effect of serum on Mo survival seems to be less
pronounced and the induction of apoptosis by serum withdrawal has not
been reported.
1. 4. 2. 4 Role of Free Radicals in the Induction of Apoptosis.
There is now growing evidence that free radicals and ROI can induce not
only necrotic, but also apoptotic cell death; low levels inducing apoptosis
whilst high levels induce necrosis (Lennon, 1991; Fernandes, 1994).
Apoptosis can be induced in a wide variety of cells by different types of
oxidative stress including ionizing radiation (hydroxyl radical
production) TNF-a (cellular ROI stimulation) and exogenously added
ROI (hydrogen peroxide) (Abello, 1994; Forrest, 1994; Sarafian, 1994;
Hannah, 1995). In addition, the induction of apoptosis in different cells
can be blocked by antioxidants, even when the apoptotic stimulus was
apparently ROI independent for example, apoptosis resulting from
growth factor withdrawal (Sandstrom, 1993; Mayer, 1994; Sarafian, 1994;
Troy, 1994), suggesting that ROI may be mediators of the apoptotic
process. Despite the fact that phagocytes produce free radicals, an excess of
ROI is detrimental to these cells and their armoury of antioxidants has
been shown to be of critical importance to preserving their function
(Baehner, 1977). Roos and co-workers showed that normal PMN and
monocyte function during oxidative stress (phagocytosis-induced ROI
production and exogenous hydrogen peroxide generation) depended on
intact antioxidant protective systems (Roos, 1979 and 1980; Voetman,
1980). Phagocytes have developed several systems to protect themselves
against oxidative stress. Superoxide dismutases catalyze the conversion
of superoxide into hydrogen peroxide which is then degraded to water
and oxygen by the action of the enzyme catalase. GSH produced as a part
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of the glutathione redox system protects cells by reacting with free radicals
and peroxides (Roos, 1979; Fernandes, 1994). Other antioxidants that
protect cells from apoptotic cell death include the vitamin E group of
compounds, the major one being a tocopherol and it's synthetic soluble
analogue Trolox (Sandstrom, 1993; Forrest, 1994; Mayer, 1994; Troy, 1994;
Hannah, 1995). They act to block free radical chain reactions by
scavenging the intermediate peroxyl radicals, the tocopherol radical being
much less reactive than the corresponding lipid peroxyl radical. Vitamin
C is also important in the antioxidant system in that it recycles the
tocopherol radical (Halliwell, 1995).
1. 4. 2. 5 Intra-cellular Signalling in Apoptosis.
The signal pathways leading to apoptosis are incompletely understood
but as multiple signals can induce apoptosis in a cell, it is likely that these
signals will mediate their effects though distinct signal transduction
pathways (Schwartz, 1993). A rise in intracellular free calcium seems to
be a critical event for apoptosis in many cells but this is neither specific
for cell death, being involved in signalling for a plethora of cellular
activities, nor is it an absolute requisite for the induction of apoptosis
(McConkey, 1989; Rodriguez-Tarduchy, 1990). Indeed in PMN, calcium
ionophores induced a dramatic slowing of apoptosis (Whyte, 1993). Other
intracellular signalling moieties have also been implicated including the
inositol phosphate, IP3 and cAMP (Berridge, 1989; McConkey, 1990).
cAMP promotes the activity of protein kinase A (Soderling, 1990),
activation of which promotes apoptosis. Protein kinase C activation -
with phorbol esters - prevents apoptosis, whilst inhibition of protein
kinase C with H7 increases apoptosis (McConkey, 1990). It needs to be
emphasized that the exact mechanism(s) whereby such a variety of
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environmental and genetic factors act to trigger cell death is not clearly
understood. Whether there is one "final common pathway" is
unknown. There is even dispute as to whether the morphologic changes
in the nucleus are central to the apoptotic process or simply represent an
epiphenomenon as cytoplast death has many features of apoptosis
(Jacobson, 1994; Henkart, 1995).
1. 4. 2. 6 Genetic Control of Apoptosis.
There is much evidence that for the normal functioning of an organism,
cell death is genetically controlled, hence the term "programmed cell
death" (Lockshin, 1965). Studies of the nematode Caenorhabditis elegans
(C. elegans) have shown that there is genetic control of cell death,
engulfment of these dead cells and the degradation of the cellular debris
(Ellis, 1991). The genes ced (cell death abnormal) 3 and ced 4 acting to
cause programmed cell death, ced 1, 2, 5, 6, 7, 8 and 10 all control
engulfment while nuc-1 directs the degradation of nuclear material in the
dead cells (Hedgecock, 1983; Ellis, 1986; Yuan, 1990). Unique is ced 9
which acts to prevent cell death (Hengartner, 1992 and 1994). This
programmed cell death has many of the morphological characteristics of
apoptosis although there is still dispute as to whether they are truly one
and the same (Schwartz, 1993; Henkart, 1995).
Although our understanding of the control of mammalian cell death,
especially its genetic control, is not as well advanced as it is in
nematodes, there are indicators that similar genetic controls exist. In
mammalian cells ICE, the mammalian homologue of ced-3 (Miura, 1993),
is associated with apoptosis and bcl-2, the human homologue of ced 9 has
been shown to protect mammalian cells from apoptosis (Vaux, 1992;
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Hengartner, 1994). Other mammalian genes including p53, c-fos, c-myc
and abl have also all been implicated in the apoptotic process (Buttyan,
1988; Yonish-Rouach, 1991; Martin, 1995). For many cells there is an
absolute requirement for protein synthesis in the apoptotic process; RNA
and protein synthesis inhibitors completely blocking apoptosis (Cohen,
1984; Wyllie, 1984; Schwartz, 1993), providing evidence for a genetic
switch for apoptosis. It is noteworthy that some cells (PMN and Mo)
undergo apoptosis when exposed to RNA or protein synthesis inhibitors,
suggesting that these cells have continuous synthesis of an anti-apoptotic
protein, inhibition of which leads constitutively to apoptosis, the
machinery for this being in place in the absence of protein synthesis
(Waring, 1990; Haslett, 1994; Polunovsky, 1994).
1. 4. 2. 7 bcl-2 and the bcl-2 Family in Apoptosis.
The oncogene bcl-2 is of interest because of its proposed anti-apoptotic
and anti-oxidant roles. Transfer of bcl-2 expression into a cell prolongs
survival by preventing apoptosis in a variety of systems including
hydrogen peroxide, chemotherapeutic, heat shock and ionizing radiation
induced apoptotic cell death (Reed, 1994). The exact mechanism by which
this is achieved is unclear but expression of bcl-2 prevents oxidative stress
induced apoptosis across cell types and across phyla (Hockenbery, 1993;
Buttke, 1994; Sarafian, 1994). Although initially suggested to act at the
level of the mitochondrial membrane (Hockenbery, 1990), the
distribution of the bcl-2 gene product has been shown to be much wider
than this; bcl-2 expression can also prevent apoptosis in cells lacking
mitochondrial DNA (Jacobson, 1993), thus bcl-2 does not seem play a role
in oxidative phosphorylation. It also blocks the cellular accumulation of
lipid peroxides and restores growth in cells deficient in manganese
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superoxide dismutase (Hockenbery, 1993). Since different antioxidants
can be substituted for bcl-2 expression and still prevent apoptosis induced
by growth factor depletion (Buttke, 1994), it has been proposed that the
protective action of bcl-2 is by inhibiting generation or action of ROI.
Recent work with cells in very hypoxic conditions shows that although
ROI-induced apoptosis is thus inhibited, a protective effect of bcl-2 on
non-ROI-induced apoptosis persists (Jacobson, 1995; Shimizu, 1995). Thus
although this does not exclude any effect of bcl-2 on ROI induced death, it
does indicate that ROI are not required for cell death and that bcl-2
protection is broader that just protection against ROI mediated
mechanisms alone.
A number of gene products share significant sequence homology with
Bcl-2, including Bax, Bcl-xs, Bc1-xl and Bak (Reed, 1994; Chittenden, 1995;
Kiefer, 1995) and have been found to have a role in apoptosis. Bax and
Bcl-xs primarily act to enhance apoptotic death whilst Bc1-xl acts like Bcl-
2 to delay apoptosis (Chittenden, 1995; Kiefer, 1995).
1. 4. 2. 8 Other Oncogenes and Apoptosis.
Other oncogenes, unrelated to the bcl-2 family, can also protect against
apoptosis and abl is of note in this regard. Virtually all chronic myeloid
leukaemia (CML) patients are found to have a unique translocation
between the bcr oncogene loci on chromosome 22 and abl on
chromosome 9 (Yin, 1995). Expression of chimeric bcr-abl prevents
apoptosis in CML myeloid precursors, permitting the expansion of the
CML leukaemic clone (Bedi, 1994). Other oncogene products acting to
modulate apoptosis include c-Myc , p34 and p53 (Amanti, 1993; Marin,
1994; Vaux, 1994). c-Myc is a short lived protein that dimerises with a
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long lived heterologous protein - Max, the heterodimer binds to DNA in
a sequence specific manner (Marcu, 1992). Myc expression is tightly
controlled in non-transformed cells. Mitogen induced c-Myc expression
in the presence of appropriate survival factors results in cell cycling,
whereas if cells over-express c-Myc or are deprived of survival factors
they default to apoptosis (Harrington, 1994). Tissue expression of c-Myc is
thus related to the level of cell cycling and the level of expression of c-
Myc and degree of apoptosis are correlated (Marcu, 1992).
1. 4. 2. 9 Physiological Relevance of Apoptosis.
Apoptosis is uniquely suited to deletion of cells in normal growth and
development, allowing precise control of cell death without invoking
pro-inflammatory responses. Apoptosis has been well described in
normal embryonal development and metamorphosis (Glucksmann,
1951; Saunders, 1966; Kerr, 1974; Pierce, 1989).
Many hormone sensitive tissues regress by apoptosis in the absence of the
appropriate trophic hormone, including the uterus after progesterone
withdrawal (Hopwood, 1976; Nawaz, 1987; Rotello, 1989), regression of
the lactating mammary gland and prostate epithelial cells (Walker, 1989;
Thompson, 1994). Apoptosis also plays an important role in the immune
system, selective cell death helping to regulate B and T cells (Liu, 1989;
Shi, 1989; Cohen, 1992; Howie, 1994). Activation induced death of
immature thymocytes exposed to anti-CD3 has been shown to be by
apoptosis in both organ culture and in intact animals (Smith, 1989; Shi,
1991). Furthermore, using transgenic mice, direct evidence is provided
that clonal deletion is the result of apoptosis (Murphy, 1990). Mature
helper and cytotoxic T cells that have proliferated during an immune
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response are cleared by apoptosis; having become IL-2 dependent they die
rapidly in its absence (Gillis, 1978; Duke, 1986). Apoptosis is also induced
in virally infected cells, tumour cells or allogeneic cells by cytotoxic T
lymphocytes (CTL), natural killer (NK) cells and K cells (Duke, 1983;
Russell, 1983; Duval, 1986; Zychlinsky, 1991; Cohen, 1992).
Thus the life-span of the cell is tightly controlled, both environmental
and genetic influences being able to induce selective death. Any
impairment in the controls on cell death can be detrimental, resulting in
either excessive cell proliferation or uncontrolled cell death. Pathological
states arise where too many cells die such as in central nervous system
degenerative diseases or HIV disease where there is inappropriate
induction of apoptosis in T cells (Terai, 1991). The converse state exists
with neoplasia where the balance between cell proliferation and cell
death is shifted resulting in increasing tumour size (Dive, 1991).
1. 4. 2.10 The Role of Apoptosis in Acute Inflammation.
Apoptosis has an important part to play in control of acute inflammation
(Haslett, 1994). The resolution of acute inflammation requires the
removal of large numbers of inflammatory cells in a controlled fashion
and phagocytic clearance of these apoptotic cells at inflammatory sites in a
manner that does not invoke a pro-inflammatory response (Savill, 1989a
and b; Grigg, 1991; Haslett, 1994). In in vitro culture, PMN (Savill, 1989a)
and eosinophils (Stern, 1992) undergo apoptosis constitutively, the rate of
which is modulated by cytokines normally present at the inflamed site
(Lee, 1993). These apoptotic cells are efficiently phagocytosed by Mo (and
fibroblasts) and this phagocytic capacity is also modulated by the cytokine
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milieu present (Lee, 1993; Hall, 1994; Ren, 1995); this phagocytosis also
occurs at the inflamed site (Savill, 1989a; Grigg, 1991).
The apoptotic process induces specific changes that enables the
recognition, binding and phagocytosis of these apoptotic cells by
phagocytes (Savill, 1989a and b, 1990 and 1992; Hall, 1994). This utilizes a
novel recognition mechanism that does not induce pro-inflammatory
responses by the Mo (Meagher, 1992). A model for the recognition
mechanism has been proposed, involving CD36 and av(33 - the
vitronectin receptor - on the Mo surface, with thrombospondin acting as
a molecular bridge to as yet unidentified structure(s) on the apoptotic cell
surface (Savill, 1990). It has also been proposed that Mo recognize
exposed phosphatidyl serine residues on the apoptotic cells surface
(Fadok, 1992a). This alternative recognition system was shown in
murine peritoneal Mo and not in murine bone marrow derived Mo or in
human monocyte derived Mo, suggesting that there may be alternative
recognition mechanisms for different Mo populations (Fadok, 1992b).
1. 4. 2.11 Monocyte and Macrophage Apoptosis.
During the resolution of inflammation PMN undergo apoptosis and
subsequent engulfment by Mo, resulting in their clearance in large
numbers in a non-phlogistic manner. The fate of the Mo is however less
clear (van Furth, 1992). As discussed in sections 1. 3. 7. 1 and 1. 3. 8 it has
been suggested that Mo may die locally in the tissues or migrate to the
draining lymph nodes. The relative contribution of these alternative
sites for Mo disposal and the mechanism for Mo death in vivo are
unknown. At the outset of this project there were very few reports on
Mo apoptosis (Waring, 1990; Hogquist, 1991a) and only one group had
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described monocyte apoptosis (Mangan, 1991a and b). We have now
shown that Mo can undergo apoptosis following exposure to
cycloheximide (Bellingan, 1994a). A number of other papers have also
since emerged showing that Mo are capable of undergoing apoptosis in
response to a range of other stimuli including: NO- (Albina, 1993; Sarih,
1993a), silica (Sarih, 1993b), ricin (Khan, 1993), anti-Fas antibody (Iwai,
1994), cross-linking CD69 (Ramirez, 1994), M-CSF depletion (Moore, 1994)
and pathogenic organisms including Shigella (Zychlinsky, 1992) and
Mycobacteria (Gan, 1995). Despite this, the relevance of this in vivo is
unknown. The Mo is usually though to be a long lived cell (Rosser, 1970;
Melnicoff, 1988b; van Furth, 1992), hence for the inflammatory Mo at the
site of resolving inflammation it is not clear whether apoptosis is their
normal immediate fate. Indeed, the in vivo controls on Mo longevity are
poorly understood, many of the demonstrated inducers of Mo apoptosis
have been pharmacological rather than physiological agents (Waring,
1990; Khan, 1993; Iwai, 1994; Richardson, 1994). Furthermore, much of
the recent experimental work has been on Mo-like cell lines and this may
not be relevant to the Mo itself (Cotter, 1992; Zychlinsky, 1992; Kitajima,
1994). There may also be differences in survival characteristics between
monocytes and Mo as well as between Mo populations resident in
different sites. Certainly the experiments of Mangan and Wahl, showing
rapid (<48 hour) monocyte apoptosis in the absence of pro-inflammatory
cytokine stimulation (Mangan, 1991 a and b) suggested to me that a
difference in the constitutive rates of apoptosis between monocytes and
Mo may exist.
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1. 4. 2.12 Mechanisms of Macrophage Apoptosis.
There are some clues as to the mechanisms Mo employ to prevent the
induction of apoptosis. Ramirez et al. have shown that monocytes
exposed to LPS undergo apoptosis when the activation antigen CD 69
(part of the natural killer complex) is cross-linked, or when they are
exposed to IL-4. Pre-treatment with pertussis toxin prevents death due to
the cross-linking of CD 69 but not that induced by IL-4. This suggests the
existence of different apoptosis inducing pathways in the monocyte
(Ramirez, 1994). Apo-1 or Fas (CD95) is a 43-kD membrane protein
member of the TNF receptor gene family that transmits an apoptosis
inducing signal to a variety of cells upon ligand binding (Itoh, 1991;
Oehm, 1992). Fas is constitutively expressed on PMN, monocytes, Mo, a
proportion of lymphocytes and a subset of endothelial cells. Activated T
cells express a functional Fas ligand (Suda, 1993 and 1994) suggesting that
T cells could induce Mo apoptosis through Fas ligation (Richardson,
1994). Although Fas ligation induces apoptosis in PMN, only a fraction of
Mo are susceptible and Fas ligation has no effect on endothelial cells. It
has been suggested that this difference could be explained by differential
levels of expression of bcl-2 (Iwai, 1994; Richardson, 1994), or by ROI
damage (Kohno, 1996) but this remains unproven. Activation induces
susceptibility to Fas-mediated apoptosis in B cells (Schattner, 1995) and T
cells (Rovere, 1996) and may explain differences in Mo sensitivity to CD95
mediated apoptosis (Richardson, 1994). Mo, like PMN, undergo apoptosis
in response to protein synthesis inhibition (Bellingan, 1994a; Khan, 1993;
Haslett, 1994). This argues for a continual expression of an inhibitor of
apoptosis, depletion of which allows apoptosis to proceed. Interestingly,
it has been shown that in the presence of effective protein synthesis
inhibition, adherence of Mo prevents apoptosis (Waring, 1990). Long
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term M0 cultures can be maintained in serum free medium however,
suggesting some degree of resistance to these requirements during
differentiation (Darfler, 1982; Helinski, 1988), which may in part be due to
paracrine production of survival factors including M-CSF, TNF-a and
GM-CSF (Moore, 1994). It has already been suggested that reduced TNF-a
binding capacity may explain reduced sensitivity to TNF-a induced
apoptosis of bone marrow derived PMN compared with normal PMN
(Tsuchida, 1995). As monocytes have been reported to be short lived cells
whilst Mo survival is in the order of weeks or months, similar variations
in the expression of cytokine receptors and thus responsiveness to
cytokine driven pro or anti-apoptotic signals may help to explain these
survival characteristics.
1.5 AIMS.
The aim of this work was to investigate the fate of the Mo and to shed
some light on the mechanisms controlling the clearance of Mo from the
site of inflammation during resolution. Work described in this thesis
will be considered in two broad sections, corresponding to in vitro and i n
vivo studies.
The mechanisms and controls on monocyte and Mo apoptosis were
investigated in vitro using human peripheral blood monocytes,
monocyte derived Mo, alveolar Mo, the monocyte-like cell line, U937 and
murine bone marrow derived Mo. Reliable systems for the isolation and
culture of pure populations of monocytes and Mo were established and a
number of independent methods for identifying and quantifying
apoptosis in these cells were investigated. To attempt to understand the
physiological controls on Mo longevity, the role of a range of cytokines
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and influence of changes in expression of cytokine receptors, the effect of
serum withdrawal and specific culture conditions, the influence of free
radicals and anti-oxidants, as well as the expression of various oncogenes
was determined on the induction/prevention of apoptosis in this range
of cells.
The fate of the inflammatory Mo during the resolution of inflammation
was investigated in vivo using a murine model of resolving peritonitis.
In this model semi-allogeneic, fluorescent labelled, inflammatory Mo
from H-2k/d mice were adoptively transferred into the peritoneal cavity
of recipient H-2k mice at the same stage of resolving peritoneal
inflammation. Dual colour flow cytometry permitted discrimination
between donor cells, recipient cells and donor cells which had been
phagocytosed by recipient Mo. Tissue localization and migration kinetics
of Mo could be tracked. These studies allowed investigation of the
relative contributions of Mo death at the inflamed site with phagocytosis
locally and Mo emigration, on the clearance of inflammatory Mo during
the resolution of inflammation. They also permitted a comparison of
inflammatory and resident Mo emigration kinetics, providing a powerful
analytical tool to follow Mo kinetics during resolution of inflammation
and open the way to investigating some of the mechanisms controlling







2.1.1 Cell Culture Reagents.
Culture medium including Iscove's modification of Dulbecco's modified
Eagles medium (IDMEM), Hank's balanced salt solutions (HBSS) and
culture supplements (L-glutamine, HEPES and antibiotics) were
purchased from Gibco (Gibco Laboratories, Paisley, Scotland) and sterile
tissue cultureware from Falcon (Falcon Plastics, Becton Dickinson,
Oxford, U.K.).
2.1. 2 Chemical and Biological Reagents.
All chemicals were obtained from Sigma (Sigma Chemical Co., Poole,
U.K.) unless otherwise stated. Stock solutions of the following were
prepared and stored at -20°C: cycloheximide (10 mM), prepared in
ethanol; dibutyryladenosine 3'.5'-cyclic monophosphate (db-cAMP) (20
mM in IDMEM); acridine orange (1 mg/ml in IDMEM); dexamethasone
(David Bull Laboratories, Warwick, U.K.) (8.2 mM in water, stored at
room temperature).
2.2 Antibodies.
All antibodies and monoclonal antibodies (mAb) were stored at 4°C for
short periods and -20°C for long term storage.
2. 2.1 Antibodies for Indirect Immunofluorescence on Human
Cells.
Monoclonal antibodies 38, an IgG2a anti-CDlla and 44, an IgGl anti-
CDllb were both kinds gifts from Dr. N. Hogg, ICRF, London (Dransfield,
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1989). The hybridoma clone 3G8, secreting an IgGl anti-CD16 mAb was
the generous gift of Dr. J. Unkless, Mount Sinai Medical School, New
York (Fleit, 1982). Anti-Bcl-2 mAb (IgG2a clone 124) and anti-c-myc mAb
(IgG2a) were both kind gifts Professor T. Cotter, University College, Cork,
Ireland and anti-CD14 IgG2a (clone UCHM1), a gift from Dr. Peter
Beverley, University College London (Hogg, 1984). BOB 78, an IgM mAb
against an intracellular antigen of unknown specificity was generously
supplied by Dr. J. Ross, Lister Laboratories, Edinburgh. Anti-HLA DR, an
IgGl mAb was provided by the Scottish Antibody Production Unit
(SAPU, Lau hospital, Carluke, Airshire); anti-CD43, an IgGl mAb (clone
WR-14), was purchased from Serotec (Serotec, Kidlington Oxfordshire),
anti-p8,14 mAb from Dako, (Dako, High Wycombe, Bucks.) and anti-BCR-
ABL sheep polyclonal antibody from Cambridge Research Biochemicals
(Cambridge Research Biochemicals, Northwich, Cheshire). Antibodies
against the range of cytokine receptors listed in section 5. 2 were obtained
from the Fifth International Workshop on White Cell Differentiation
Antigens (Kikutani, 1995). They were supplied at 1 mg/ml purified
protein without azide unless stated, the titer for use was suggested by the
laboratory of origin in each case, all were murine mAb except C002 and
C006, which were rat mAb.
2. 2. 2 Antibodies for Indirect Immunofluorescence on Murine
Cells.
The following mAb were used: F4/80 (Austyn, 1981), an IgG2b murine
Mo specific mAb, produced by the HB 198 clone (purchased from
American Type Culture Collection (ATCC), Rockville, MD; Ml/70 an
IgG2b rat mAb to murine Mac-1 (CDllb) expressed on Mo and PMN
(Serotec); MRC OX-78 an anti-CD48 IgG2a rat mAb to murine CD48,
5 7
binding B cells, T cells and M0 (Serotec); 7/4 a rat mAb to a polymorphic
antigen on murine PMN (Serotec); MRC OX-6, a mouse anti-mouse la
IgGl mAb to dendritic cells, B lymphocytes and some Mo (Serotec). The
clone Mac 51, secreting an IgG2b rat anti-potato cytochrome mAb was
used as a negative control (purchased from European Collection of
Animal Cell Cultures (ECACC), Porton Down Wilts.); the hybridoma
MOPC-21C secreting a non-binding murine IgGl mAb (purchased from
ECACC) was also used as a negative control.
2. 2. 3 Directly Conjugated Antibodies (Human).
A direct fluorescein isothiocyanate (FITC)-conjugated anti-
myeloperoxidase mAb (Serotec), and a FITC-conjugated 3G8 anti-CD16
mAb (kind gift Dr. I. Dransfield, University of Edinburgh) were used as
indicated.
2. 2. 4 Directly Conjugated Antibodies (Murine).
FITC-conjugated mouse anti-mouse H-2D^ IgM mAb (Pharmingen, San
Diego, CA); FITC-conjugated mouse anti-human CD15 IgM mAb (Dako)
as control; FITC-conjugated mouse anti-mouse H-2K^ IgG2a mAb
(Pharmingen); FITC-conjugated mouse anti-human T cell CD45RO IgG2a
mAb (Dako) as control; MRC OX-6, (MCA 46F) a FITC conjugated mouse
anti-mouse la IgGi mAb (Serotec) was used to determine the level of
Class II expression.
2. 2. 5 Secondary Antibodies for Indirect Immunofluorescence.
FITC-conjugated F(ab')2 rabbit anti-mouse (Dako); FITC-conjugated
donkey anti-sheep (Serotec); FITC-conjugated F(ab')2 rabbit anti-rat
(Serotec). Phycoerythrin (PE)-conjugated F(ab')2 rabbit anti-mouse (Dako).
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2. 3 Isolation and Culture of Human Peripheral Blood
Monocytes.
2. 3.1 Purification of Mononuclear Cells by Discontinuous
Percoll Gradient Centrifugation.
All purification procedures were performed under sterile conditions,
using sterile reagents and plasticware in a class II hood. Mononuclear
cells were prepared by the methods described by Dooley et al. (Dooley,
1981) and modified according to Haslett et al. (Haslett, 1985). Briefly
blood was obtained under sterile conditions from a pool of normal
healthy volunteer male and female donors, with an age range of 20 -55
years. Venous blood (36 mis/tube) was drawn into 50 ml polyethylene
tubes, mixed with 4 mis/tube of 3.8% w/v sodium citrate, each donor
providing 6 tubes (216 mis of blood). The citrated blood was centrifuged
at 300 x g for 20 minutes at room temperature in a MSE Mistral 3000
centrifuge (Sanyo Gallenkamp, Loughborough, U.K.). Platelet rich
plasma (PRP) supernatant was aspirated and autologous serum and
platelet poor plasma prepared from this by centrifuging a portion of the
PRP at 2500 x g for 20 minutes to prepare platelet poor plasma
supernatant, serum was prepared from the remainder by recalcification of
10 mis PRP/glass tube with 220 jllI 0.32% calcium chloride solution and
incubating at 37°C for 30 minutes. The blood cell pellet was meanwhile
mixed gently with 5 mis of 6% dextran (500 000 m. w.) (Pharmacia Fine
Chemicals, Piscataway N.J.), the volume corrected to 50 mis with 0.9%
w/v saline at 37°C and sedimentation of erythrocytes allowed to proceed
at room temperature for 30 minutes. After dextran sedimentation the
leukocyte enriched upper layer was aspirated and washed with normal
saline. A discontinuous Percoll (Pharmacia) gradient was prepared from
a stock solution of Percoll containing 9 parts Percoll and 1 part 10 x
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Phosphate Buffered Saline (10 x PBS) (thus isotonic). Percoll of different
percentages (70% and 81%) were prepared by diluting stock Percoll with
appropriate quantities of Hank's balanced salt solution without calcium
and magnesium (HBSS w/o) and the gradients produced by carefully
overlayering 3 mis 70% Percoll upon 3 mis 81% Percoll in 15 ml tubes (1
tube per 80 mis of citrated blood). The cell pellet after dextran
sedimentation was mixed with 55% Percoll, layered over the 70% Percoll
and centrifuged at 700 x g for 20 minutes at room temperature. The
mononuclear cells were aspirated from the 55/70% interface, granulocytes
from the 70/81% interface and erythrocytes were pelleted at the bottom of
the tube. Cells were washed 3 times, twice in HBSS w/o and finally in
HBSS, counted on a Neubauer haemocyometer. Viability was assessed by
determining the proportion of cells which were able to exclude the vital
dye, trypan blue. Viability was routinely >98% and preparations with
viabilities less than 98% were discarded. Cells were then resuspended as
required.
2. 3. 2 Purification of Monocytes from Mononuclear Cells.
2. 3. 2.1 Plasma Plate Adherence.
Monocytes were separated from the more numerous lymphocytes on the
basis of adherence, using minor adaptions of well established methods
(Ackerman, 1978). Briefly, 140 mM tissue culture dishes were coated with
plasma by diluting autologous platelet poor plasma 1:10 with lx PBS and
adding 3 mis/plate. These plates were incubated for 1 hour at 37°C then
washed twice with PBS. Mononuclear cells were resuspended at 4 x
106/ml in IDMEM with 10% autologous serum and 7 mis added per plate.
Plates were incubated at 37°C in 5% CO2 for 1 hour and the non-adherent
cells washed off with HBSS w/o, using sterile transfer pipettes. In order
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to detach adherent monocytes 3 mis of pre-warmed 5 mM ethylene
diamine tetra-acetic acid (EDTA) (BDH, Glasgow, U.K.) in PBS containing
20% autologous serum was added per plate for 10 minutes at 37°C. Cells
were rinsed off vigorously with IDMEM and washed twice again in
IDMEM containing 0.1% gelatin before culture. Yields of between 10 and
30 x 106 monocytes/216 mis of blood were usually achieved, with a purity
of 90.2% (range 84.6 to 96%, n = 81), assessed by cytospin morphology and
flow cytometry (section 3. 2. 1. a).
2. 3. 2. 2 Tissue Culture Plastic Adherence.
Washed mononuclear cells from the discontinuous Percoll gradient were
suspended in IDMEM at 4 x 106/ml and allowed to adhere for 1 hour to
either 24 or 96 well tissue culture plates (1 ml/well for 24 well plates or
150 pl/well for 96 well plates) at 37°C in 5% CO2 in a humidified
incubator (standard conditions). The non-adherent cells were then
removed by vigorous and repeated washing with HBSS w/o using a
sterile transfer pipettes. The remaining adherent monocyte were
cultured on in situ under standard conditions.
2. 3. 2. 3 Purification of Monocytes using Counterflow Centrifugal
Elutriation (CCE).
Monocytes, granulocytes and lymphocytes can be prepared using CCE,
which separates cells on the basis of their differential sedimentation
velocities (Figdor, 1983). A schematic diagram of an elutriator is shown
in Figure 2. 1. Sedimentation velocity is determined by several factors
including cell density, size ,shape and cell membrane characteristics
allowing accurate separation of cells. During elutriation the centrifugal
force, provided by the centrifuge, is balanced by the inward flow of
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medium (IDMEM plus 0.2% autologous serum) pumped by a variable
speed peristaltic pump. Cell suspensions are maintained in the
elutriation chamber and then by increasing the pump speed (or
decreasing the centrifugal force), cells of increasing sedimentation
velocity can be separated, normally with good yields and minimal loss of
viability (Wahl, 1984).
A J-21 Beckman centrifuge fitted with a JE-6B elutriation rotor was used
along with a Masterflex peristaltic pump (both supplied by Beckman
Instruments, High Wycombe, U.K.). The elutriator was cleaned and
sterilized with 100% ethanol and distilled water then primed with
medium, ensuring all bubbles were removed and the flow rate calibrated
by varying the pump speed. The cell pellet after dextran sedimentation
was washed, resuspended in 5 mis HBSS w/o and injected into the CCE
sample chamber using tap A, with the by-pass tap B switched to by-pass
the sample chamber. Cells were then loaded into the elutriation chamber
by switching tap B to pump medium through the sample chamber (see
Figure 2. 1). Initially a flow rate of 18 mis/minute and a rotor speed of
2500 r.p.m. was used to elute off erythrocytes, this was increased to 21
mis/minute for lymphocytes and 24 to 27 mis/minute for monocytes;
precise flow rates varying with each separation. Cells were collected in 50
ml fractions and purity assessed by flow cytometry before significant
adjustments were made to the pump speed. PMN were finally eluted out
by increasing the pump speed to 35 mis/minute. Yields of between 15
and 44 x 106 monocytes/216 mis of blood were obtained, with a purity of
91.2% (range 80 to 96%, n = 31 experiments).
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Figure 2. 1 Schematic Diagram of an Elutriator.
Pressure Viewing
Legend for Figure 2. 1 Schematic diagram of an elutriator showing how
medium was drawn from a reservoir into the elutriation chamber which
lay within the rotor arm of the elutriator. To introduce cells into the
elutriator, tap B was switched to allow the flow of medium to by-pass the
sample chamber and the cells were injected into the sample chamber
using tap A. Cells were then loaded into the elutriation chamber by
switching tap B to pump medium through the sample chamber. The
flow rate of the variable speed peristaltic pump was then steadily
increased and cells were collected in 50 ml fractions.
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2. 4 Maturation of Monocytes into Macrophages.
Three methods of monocyte culture were employed; for all experiments
culture medium consisted of IDMEM containing 10% autologous serum,
100 units/ml penicillin and 100 pg/ml streptomycin (standard culture
media unless otherwise stated) and cells were cultured under standard
conditions.
2. 4.1 Suspension Culture in Hydrophobic Teflon Trays.
Teflon foils of varying sizes from 1 to 5 cm square and 1 cm deep were
made by sealing the edges of Teflon fluorinated ethylene propylene sheets
(Teflon; ChemFab, Handforth, Cheshire, U.K.) using a modified HM3000
Impulse heat sealer (Hume Martin Ltd., London, U.K.) and autoclaved
prior to use. These foils could hold between 1 and 12 mis of medium.
Monocytes were washed twice in IDMEM containing 0.1% gelatin,
resuspended at 1 x 106/ml in standard culture medium and placed in a
Teflon foil of appropriate size. These were seated in a covered 140 mM
petri dish and incubated for 5 days under standard conditions. For certain
experiments autologous serum was withheld, an equal volume of
IDMEM being added to maintain the final concentration at 1 x 106
cells/ml. Suspension culture yielded Mo with a purity of 92.9% (range
85.6 - 98%, n = 73 experiments) and a viability consistently >99%.
2. 4. 2 Adherent Culture on Tissue Culture Plastic.
Adherent monocytes in 24 or 96 well plates (section 2. 3. 2. 2) were
covered with 1 ml or 150 (ll respectively of culture medium and
incubated. The medium was replaced after 3 days, non-adherent cells
being washed off and fresh culture medium replaced. Adherent Mo
populations of 96 to 98% purity were obtained.
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2. 4. 3 Adherent Culture in 8 Well Slides.
Mononuclear cells were resuspended at 1 x 106 cells/ml in IDMEM and
170 pl/well added to 8 well detachable tissue culture slides (Nunc -
supplied by Falcon Plastics), this was made to a final volume of 200
pi/well with the addition of autologous serum, test reagents or further
IDMEM, as described for each experiment. Slides were covered and
incubated under standard conditions until used. The percent apoptosis
and the number of cells remaining in each treatment well was assessed at
6, 18 and 42 hours and at 5 days, separate slides being prepared for each
time point. Paired experiments were performed on Mo from the same
donors, these being matured in Teflon foils for 5 days, washed twice in
IDMEM containing 0.1% gelatin and placed in wells as described for
monocytes and assessed again at 6, 18 and 42 hours.
2. 5 Isolation and Culture of Other Leukocytes.
2. 5.1 Preparation of Human Polymorphonuclear Leukocytes.
PMN were prepared either by discontinuous Percoll gradient
centrifugation by collecting cells at the 81% interface (section 2. 3. 1) or by
CCE at pump speeds of 35 mls/min. (section 2. 3. 2. 3). Cells were washed
twice in IDMEM containing 0.1% gelatin and resuspended in culture
medium. Cell preparations were >99% viable as assessed by the ability to
exclude the vital dye trypan blue and were >97% pure as assessed by Dif
Quik™ stained cytospin preparations. For aging overnight to induce
apoptosis the cells were placed in 75 cm2 tissue culture flasks at 4 x 106/ml
with 10% autologous serum at 37°C in 5% CO2. In experiments to assess
the effect of ROI or anti-oxidants on PMN apoptosis, 2% rather than 10%
autologous serum was used and cells were resuspended at a final
concentration of 1 x 106 cells/ml after addition of test reagents and at a
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final volume of 400 (Lil per well in 8 well slides, these were covered and
incubated under standard conditions for 8 to 24 hours.
2. 5. 2 Preparation of Human Lymphocytes.
Lymphocytes were obtained from the non-adherent cells following the
plasma plate adherence step of the monocyte preparation (section 2. 3. 2.
1). These cells were re-adhered to plasma coated plates to further reduce
the number of contaminating monocytes and the non-adherent cells
from this second adherence step were collected, yielding a population
containing >89% lymphocytes as assessed by flow cytometry and 87% as
assessed by Dif Quik™ stained cytospin preparations. The lymphocytes
were placed in culture medium at 1 x 106 cells/ml in Teflon foils and
cultured under standard conditions until used.
2. 5. 3 Human Alveolar Macrophages.
From time to time human alveolar Mo became available following
bronchoalveolar lavage of normal volunteers, all of whom had abstained
from smoking for at least 12 hours. Lavage was performed by Dr. D.
Morrison and Dr. W. MacNee (Respiratory Medicine Unit, Royal
Infirmary, Edinburgh, in standard fashion under local anaesthesia using
150 mis of PBS as the lavageate. Cells were strained through sterile gauze,
washed and resuspended at 1 xl06/ml in IDMEM with penicillin,
streptomycin with or without 10% heat inactivated human AB serum
(Sigma). Heat inactivated serum was prepared by heating pooled human
AB serum (Sigma) to 56°C for 30 minutes and allowing it to cool before
filtering through 0.45 |im filters (Millipore, Watford U.K.) and storing at -
20°C until used. Cells were placed in Teflon foils and incubated.
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2. 5. 4 Preparation of Murine Bone Marrow Derived Macrophages.
2. 5. 4.1 Preparation of CSF-1 Containing Medium.
L929 cells, a murine fibroblastoid cell line known to secrete CSF-1
(Akagawa, 1988), were obtained from ECACC (Catalogue No. 85011425)
and grown to confluence over 7 days in 175 cm2 tissue culture flasks
using IDMEM containing penicillin, streptomycin and 10% Foetal Calf
Serum (FCS) (Life Technologies, Paisley, U.K.). The supernatant was
harvested, cleared of cells by centrifugation at 2500 x g and filtered
through 0.22 (Xm filters (Millipore) and stored frozen at -70°C until
required.
2. 5. 4. 2 Isolation and Culture of Murine Bone Marrow Derived
Macrophages.
Outbred BKW mice 8-12 weeks old were killed by cervical dislocation,
both femurs were dissected, cleaned of muscle and connective tissue and
the epiphyses cut off exposing the medullary cavity from which the
marrow was flushed out using a 25 gauge needle and 2 mis standard
murine culture medium (IDMEM, 25% FCS, 25% L929 cell supernatant
with addition of penicillin (100 U/ml) and streptomycin (100[ig/ml)and
HEPES buffer to a final concentration of 25 mM) (van der Meer, 1983).
Cell clumps were disrupted and cells washed, counted and seeded into
Teflon foils at 0.25 - 0.5 x 106 cells/ml in standard murine culture
medium. After 5 days culture under standard conditions cells were
transferred into fresh medium and were used on day 7 to 9 (Tushinski,
1982). To demonstrate the Mo morphology, surface marker expression
and functional characteristics of these cells the following tests were
performed. Cytospin preparations stained with Dif Quik™ demonstrated
uniform cell morphology with large slightly vacuolated appearance and a
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single large nucleus typical of Mo, the cells all stained positive (although
weakly) for non-specific esterase. Antibody labelling confirmed that they
were positive for F4/80 and Mac 1 and weakly positive for CD48. Flow
cytometry confirmed the cells were a single population with forward and
side scatter characteristics similar to those of murine peritoneal Mo.
Functional studies demonstrated the cells were capable of ingesting
opsonized zymosan and apoptotic human PMN.
2. 6 U937 Cell Culture.
Cells from the myelomonocytic U937 cell line (ECACC Catalogue No
87010802), derived from a human histiocytic lymphoma, were cultured at
1 x 106 cells/ml in 75 cm2 tissue culture flasks in standard U937 cell
culture medium (RPMI plus 10% FCS, penicillin, streptomycin and 2mM
L-glutamine). They were passaged on alternate days, washed and
resuspended at approximately 1 x 106 cells/ml prior to use. In certain
experiments serum was omitted or IDMEM rather than RPMI was used.
2. 7 Assessment of Purity of Monocytes and Macrophages.
2. 7.1 Cytospin Preparations: Dif Quik™ and Non-specific Esterase
Staining.
Cytospin preparations were made using a Shandon Cytocentrifuge
(Shandon, Pittsburgh, PA.). Approximately 0.2 x 106 cells in 100 |il
medium containing 10% serum were added per cytospin chamber,
centrifuged onto glass microscope slides at 300 r.p.m. for 3 minutes, air
dried, fixed in methanol and stained. Routine staining was with Dif
Quik™ stains (Baxter, Thetford, Norfolk) after which a coverslip was
applied and cells examined by light microscopy at 400 x magnification. To
determine the proportion of monocytes or Mo in a cell population, 400
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cells were examined per slide. Selected slides were stained for non¬
specific esterase according to the methods of Yam et al. (Yam, 1980;
Shibata, 1985). Briefly, slides were fixed in ice cold formalin acetone (pH
6.6), washed with distilled tap water and air dried. Pararosaniline
hydrochloride was neutralized using 5 molar sodium hydroxide and was
then hexazoatized by incubation with fresh sodium nitrite (4%) for 1
minute. This was added to sodium phosphate buffer, then a-napHthyl
acetate, dissolved in ethylene glycol mono-methyl ether was added giving
a white precipitate. The solution was filtered and slides incubated in the
filtrate for 45 minutes at 37°C then washed thoroughly and
counterstained with methyl green (1% w/v). Microscopic examination
revealed characteristic brown staining with non-specific esterase activity.
2. 7. 2 Flow Cytometry.
2. 7. 2.1 Identification of Cell Populations using "Size and
Granularity" Criteria.
Flow cytometry was performed using a Coulter EPICS II™ flow cytometer
(Coulter Electronics, Luton, U.K.) and cell sorting was performed using a
Becton Dickinson FACStar Plus cell sorter (Becton Dickinson U.K.). The
optical alignment of the flow cytometer was optimized prior to each run
using Immunocheck fluorospheres (Coulter). Different cells have
distinct forward and side scatter characteristics, allowing "gates" to be
created for the following:
Gate 1 Monocyte/Macrophages Mo Gate
Gate 2 Lymphocytes Lymphocyte Gate
Gate 3 Polymorphonuclear leukocytes PMN Gate
Gate 4 Apoptotic Macrophages Apoptotic Mo Gate
(see validation in results section 3. 2. 8)
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Figure 2. 2 Identification of Leukocytes by Flow Cytometry using
Forward and Side Scatter.
"Gates" were created as follows:
1) Mo Gate, 2) Lymphocyte Gate, 3)
PMN Gate, 4) Apoptotic Mo Gate.
Pure monocytes, lymphocytes, PMN
and mononuclear cells were used to
verify the gates, as shown for i)
mononuclear cells from Percoll
preparation, ii) monocytes and iii)
PMN from CCE run. Corresponding
cytospins are shown for ii) and iii).
ii) Monocytes (x 200).
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iii) PMN (x 400).
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The first three gates were validated by running populations with known
ratios of cells, determined from cytospin stained preparations. Figure 2. 2
shows representative cytospin preparations of monocyte and PMN
elutriation fractions and the corresponding flow cytometric results.
Indirect immunofluorescence analysis using specific antibodies for each
cell type and back-gating onto the forward/side scatter plot confirmed
these gates were appropriate. The advantage of this method of cell
assessment was both its rapidity and accuracy with 5000 cells being
counted per assay. Non-apoptotic and apoptotic Mo could also be
distinguished on the basis of forward and side scatter (section 3. 2. 8 and
Figure 3. 7), allowing surface receptor characteristics of these two
populations to be determined.
2. 7. 2. 2 Immunolabelling of Cells.
2. 7. 2. 2a Direct and Indirect Immunofluorescence of Intact
Cells.
Both direct and indirect cell labelling was performed at 4°C using pre-
cooled materials. For immunolabelling of murine peritoneal Mo, cells
were blocked with normal mouse serum (NMS) for 15 minutes at 4°C
prior to each step and all antibodies were diluted in NMS. Cells were
suspended at 2 x 106 cells/ml and 150 pi placed into relevant wells of 96
well flexible assay plates supported in 96 well tissue culture plates (Costar,
High Wycombe, Bucks.). All cells were washed twice with Tris buffered
saline containing 0.2% bovine serum albumin (BSA) and 0.1% sodium
azide (pH 7.4), resuspended in 25 pi of saturating concentrations of
primary antibody solution and incubated for 30 minutes on ice. After a
further three washes cells were resuspended in 25 pi of appropriate FITC-
conjugated second layer antibody, incubated for 30 minutes, washed three
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times and fixed in PBS containing 0.5% formaldehyde. For direct
immunofluorescence the primary antibody was directly conjugated to a
fluorescent marker, hence the second incubation was omitted. Negative
controls for direct immunofluorescence were provided by directly
conjugated non-binding antibodies. In all cases cells were only designated
as having positive binding when the fluorescence intensity was greater
than that for the isotype control non-binding antibody. Analysis of
fluorescence was done on a 4 decade log scale and reported as i) percent
positive; indicating the percentage of the population with a fluorescent
intensity greater than that of the control antibody and ii) relative mean
fluorescence whereby the mean channel fluorescence for the test
population was divided by that of the isotype matched non-binding
control antibody.
2. 7. 2. 2b Immunofluorescence of Permeabilised Cells.
The intracellular levels of protein product of the following oncogenes
were determined: bcl-2, c-myc and bcr-abl. To confirm that the
antibodies were binding, HL-60 cells (kind gift of Dr. S. Hannah,
University of Edinburgh) were permeabilised and used as positive
controls for the anti-Bcl-2 antibody and fibroblast primary cultures (kind
gift of Dr. L. Biddlestone, University of Edinburgh) for the anti-c-Myc
antibody. Use of non-permeabilised cells confirmed that the oncogenes
were indeed intracellular proteins whilst an antibody against the
intracellular antigen p8,14 was included as a positive control and MOPC-
21C as a negative control, sheep serum was used as control for the sheep
polyclonal anti-Abl antibody (where a FITC conjugated donkey anti-sheep
antibody (Serotec) was used for the second layer). A direct conjugate
FITC-anti-myeloperoxidase antibody was also employed, reduction in
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expression confirming monocyte maturation into Mo. Cells were placed
in a 96 well plate at 3 xlO5 cells per well, washed and permeabilised by
adding 50 fil of permeabilising solution for 15 minutes at 37°C
(permeabilising solution final concentrations; Lysophosphatidylcholine
0.01% w/v Formaldehyde (BDH) 3.7% v/v made up with PBS). Cells
were washed twice in Tris buffered saline containing 0.4% BSA, the
primary antibody added for 30 minutes at 4°C, washed twice, the FITC
conjugated second layer antibody then added for 30 minutes and washed
twice more before flow cytometric analysis.
2. 7. 2. 3 Dual Colour Immunofluorescence.
2. 7. 2. 3a Apoptosis Induced Changes in Neutrophil Cytokine
Receptor Expression.
Changes in human PMN cytokine receptor expression with apoptosis
were determined using dual colour immunofluorescence, taking
advantage of the fact that apoptotic PMN lose expression of the antigen
CD16 (Dransfield, 1994). Cells were incubated with anti-cytokine receptor
antibodies, washed, incubated with PE conjugated F(ab')2 rabbit anti-
mouse (Dako) as the second layer, washed again and incubated with FITC-
conjugated anti-CD16 mAb (FITC-3G8) before final washing. To
compensate for any signal recorded as red fluorescence from a green
signal and vice versa, specific controls were run. First a double negative
with no added first layer or FITC-3G8 was run and then a green positive
control with FITC-3G8 added but no PE anti-mouse used. Any red signal
from this green control was electronically "removed", likewise a red only
positive control with anti-CD43 (Serotec) then PE anti-mouse but no
FITC-3G8 was run which allowed electronic compensation to be made for
any red signal cross-over into the green fluorescence. MOPC-21C was
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used as an IgGl isotype non-binding control with PE anti-mouse and
FITC-3G8. To control for any uptake of antibody due to loss of membrane
integrity, the antibody BOB78 which binds to an unknown intra-
cytoplasmic antigen in PMN was used (I. Dransfield, personal
communication). Non-apoptotic and apoptotic PMN were thus
distinguished on the basis of their CD16 expression (green fluorescence)
and gating on these two populations, their expression of cytokine
receptors could be determined using red fluorescence by their binding of
PE conjugated second layer.
2. 7. 2. 3b Quantification of Macrophage Phagocytosis In Vivo
During Resolution of Acute Inflammation.
The degree of phagocytosis of donor murine peritoneal Mo by recipient
Mo in vivo was quantified using dual colour immunofluorescence.
Donor Mo expressed H-2k/d whilst recipient Mo expressed H-2k only.
Approximately one third of the donor Mo were also labelled with the red
fluorescent cell tracking dye PKH26-PCL (section 2. 9. 3. lb). Donor and
recipient Mo could be distinguished by expression of H-2d, detected with a
direct FITC-conjugated anti-d mAb, furthermore recipient cells that had
phagocytosed donor Mo would gain red PKH26-PCL fluorescence but
remain anti-d negative (summarized in Figure 2. 3). Using highly
purified cells (>94% Mo) obtained by adherence preparation from BHK
coated plates (section 2. 9. 5. 1) the forward and side scatter characteristics
of inflammatory Mo were determined and a gate on Mo set. This was
confirmed by indirect immunofluorescence using the following mAb:
F4/80, Ml/70 (anti-CDllb), MRC OX-78 (anti-CD48), with Mac 51 (anti-
potato cytochrome) as the control, shown in (Figure 2. 4a and b).
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Figure 2. 3 Use of Dual Colour Immunofluorescence to Distinguish
Donor Macrophages, Recipient Macrophages and
Phagocytosed Donor Macrophages.
ANTI H-2 ' ISOTVPE CONTROL
ANTI H-2 ISOTVPE CONTROL
Log Red Fluorescence. Log Red Fluorescence.
Legend for Figure 2. 3 Representative experiment showing two colour
flow cytometry of Mo from peritoneal lavage of a C3H recipient mouse
(H-2k), 48 hours after adoptive transfer of 30 x 106 live cells from a CB1
(H-2k/d) donor mouse, one third of which were PKH26-PCL labelled.
Green fluorescence (FITC-conjugated mAb) on the y axis and red
fluorescence (PKH26-PCL) on the x axis. Binding of anti-H-2d and H-2k
mAb and their isotype controls are shown. Four regions are identified for
each mAb: 1 = green positive, red negative, 2 = green positive, red
positive, 3 = green negative, red negative and 4 = green negative, red
positive. PKH26-PCL labelled cells were thus [anti-k region 2 - isotype
control region 2], H-2^ positive cells were [anti-d region 1 and 2 - isotype
control region 1 and 2] and phagocytosed cells [anti-d region 4 - anti-k
region 4].
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Figure 2. 4a Use of Indirect Immunofluorescence to Confirm Purity of
Murine Inflammatory Macrophage Preparations.
j Control jj F4/80
iii CD48 iv CDllb
Control vi la
Legend for Figure 2. 4 Indirect immunofluorescence of murine
inflammatory Mo, showing binding of the following mAb i) isotype
control mAb (for ii - iv), ii) mAb F4/80, iii) MRC OX-78; anti-CD48, iv)
Ml/70; anti-CDllb, v) isotype control mAb for (vi) and vi) MRC OX-6,
anti-la. This demonstrates little la expression (<10% of cells) but all Mo
express CDllb, CD48 and bind mAb F4/80.
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Legend for Figure 2. 4b Forward and side scatter profiles of inflammatory
Mo from peritoneal lavage of mice five days after i.p. TG injection are
shown in i). Using back-gating from CDllb, F4/80, CD48 and la profiles as
shown in Figure 2. 4a, the gate A was set for Mo, confirming that 85% of
cells in this preparation were Mo. Mo were further purified by adherence
to BHK coated plates, the flow cytometry profiles of the non-adherent
cells washed off are shown in ii) and the adherent Mo were then lifted off
using EDTA, their profile is shown in iii) where 95.8% of cells were Mo.
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The red and green fluorescence parameters of these Mo could then be
determined by dual colour flow cytometry; cells from peritoneal
lavageates were examined for expression of PKH26 (red fluorescence) and
H-2^, H-2^ or Mo surface markers (green fluorescence). Anti-H-2d and H-
2k binding was expressed relative to isotype control direct conjugate mAb
and PKH26 expressed relative to non-labelled Mo. Using quad-stats, gated
on Mo, 4 regions could thus be identified for each antibody: 1 = green
positive, red negative, 2 = green positive, red positive, 3 = green negative,
red negative and 4 = green negative, red positive. PKH26 fluorescent red
positive cells were thus [anti-k region 2 - isotype control region 2] whilst
H-2d positive cells were [anti-d region 1 and 2 - isotype control region 1
and 2]. Phagocytosed cells were [anti-d region 4 - anti-k region 4], (Figure
2. 3).
2. 7. 2. 4 Cell Sorting.
Cells were sorted at a rate of 200 000 cells/hour on the basis of size
determined by forward and right angle light scatter and collected into ice
cold IDMEM containing 10% autologous serum to minimize further
changes.
2. 7. 3 Induction of Apoptosis in Cultured Cells: Effect of Addition
or Withdrawal of Agents.
2. 7. 3.1 Serum Withdrawal.
Serum was withdrawn from cells in suspension culture by washing three
times in IDMEM with the addition of 0.1% gelatin to maintain cell
viability during recovery. Adherent Mo were simply washed three times
with IDMEM to remove serum. Yield and percentage apoptosis was
determined at 6, 18 and 42 hours.
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2. 7. 3. 2 Cytokines and Other Agents.
All cytokines were purchased from Genzyme, (Genzyme, West Mailing,
U.K.), the following were tested: recombinant human TNF-a,
recombinant human IL-la, recombinant human IL-4 for human cells and
recombinant murine IL-4 for murine Mo, recombinant human IL-6,
recombinant human GM-CSF and ultrapure natural human TGF-p.
Lyophilized cytokines were diluted with culture medium containing 1%
BSA as per manufacturers instructions and stored at -70°C until use
(within 6 months of purchase). Cytokines were diluted from stock prior
to addition to cell cultures such that a final volume of 5 pi was added per
ml of cells, control cells had 5 pi medium plus 1% BSA added. In
collaboration with other members of the laboratory, cytokine activity
from each batch was confirmed by testing on other cell types and showing
activity as expected according to published data: GM-CSF (50 units/ml)
and IL-la (1000 units/ml) significantly inhibited PMN apoptosis (A. Lee,
personal communication; Lee, 1993); TNF-a (1000 units/ml) significantly
increased PMN apoptosis (J. Murray, personal communication). IL-4 was
active on monocyte cultures themselves, promoting shape change whilst
TGF-P (1 ng/ml) promoted eosinophil apoptosis (L. Meagher, personal
communication). Other agents investigated were: cycloheximide,
ethanol, db-cAMP and dexamethasone.
2. 7. 3. 3 Reactive Oxygen Intermediates and Antioxidants.
For all these experiments cells were incubated at 1 x 106 cells/ml in 8 well
covered slides at a final volume of 400 pi/well for PMN and 200 pi/well
for Mo. Cells were incubated for 8 or 24 hours in standard conditions in
the presence or absence of H2O2 as the ROI, with or without addition of
antioxidants. As serum contains significant antioxidant capacity all
7 9
incubations were performed in the presence of 2% serum unless stated.
H2O2 was purchased as a 30% stock solution and used at final
concentrations between 0.1 and 5 mM, stock concentration at the time of
use was confirmed by measuring absorbency at 230 nm. Antioxidants
were used at a final concentration of 10 mM for Trolox and 2 mM for
GSH. Trolox, a soluble a tocopherol (vitamin E) analogue, was prepared
fresh for each experiment, it was dissolved in IDMEM by sonication and
the pH adjusted to 7.4 with sodium bicarbonate.
2. 7. 3. 4 Antioxidant Capacity of Serum.
Serum from each donor was stored at -70°C for later measurement of the
Trolox equivalent antioxidant capacity (TEAC), defined as the
concentration of Trolox which had the equivalent antioxidant capacity to
an equal volume of the solution under investigation. The normal range
for human serum is 1.0 - 1.5 mM (Miller, 1993). Assay tubes were
prepared with 497 pi PBS, 300 pi ABTS [2,2-Azino-bis (3-
Ethylbenzthiazoline-6-sulfonic acid)], 36 pi metmyoglobin and 167 pi of
H2O2 - giving final concentrations of ABTS of 150 pM, metmyoglobin of
2.5 pM and H2O2 of 75 pM, absorption at 734 nm of this mixture was
determined after 12 minutes incubation. The presence of antioxidants
quenches this absorption, hence a standard curve was constructed using
10 - 50 pi of Trolox (2.5 nMol/10 pi, adjusting the final volume of PBS to
still yield 1000 pi) and the reduction of absorption of 10 pi of the test
serum determined and related to that of Trolox.
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2. 7. 4 Assessment of Apoptosis.
2. 7. 4.1 DNA Electrophoresis.
The presence of DNA cleavage products was demonstrated using the Lee
et al. modification of the methods previously described for lymphocytes
(Trauth, 1989; Lee, 1993). Cells were washed and resuspended in 0.5 ml
STE buffer (100 mM sodium chloride, 10 mM Tris, 0.1 mM EDTA pH 8.0)
containing 1% sodium dodecyl sulfate (SDS) and 0.2 mg/ml proteinase K
for 12 hours at 37°C. One DNA extraction with a phenol: chloroform:
isoamyl alcohol mixture (25:24:1 v/v/v) and two with a chloroform:
isoamyl alcohol mixture (24:1 v/v) were performed. Two volumes of
ethanol and one tenth volume of 5 M sodium chloride were then added
to precipitate the DNA which was stored at -20°C for 12 hours before
being pelleted by centrifugation at 13 000 x g and resuspended in TBE
buffer (89 mM Tris, 89 mM boric acid, 2 mM EDTA, pH 8.0). After 15
minutes predigestion with 100|ig/ml ribonuclease at 37°C, samples were
mixed with 0.1 volumes of loading buffer (TBE buffer containing 30%
Ficoll 400, 0.25% bromophenol blue, 0.25% xylene cyanol). The DNA was
electrophoresed in a 1.8% agarose gel in 0.5 pg/ml ethidium bromide for
30 minutes, along with a XDNA ECoRl/Hind III digest as size marker.
When viewed under ultra violet light a ladder pattern indicated
internucleosomal cleavage, resulting from endogenous endonuclease
activation - the biochemical hallmark of apoptosis.
2. 7. 4. 2 Morphology.
2. 7. 4. 2a Light Microscopy.
PMN apoptosis was assessed by examining Dif Quik™ stained
cytocentrifuge preparations under oil-immersion light microscopy at a
magnification of xlOOO, apoptotic PMN being defined as cells containing
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one or more darkly stained pyknotic nuclei (Savill, 1989a). Apoptotic
monocytes and Mo proved to be much more fragile than PMN and
cytocentrifugation destroyed their morphology, hence this method was
not used for these cells (Figure 3. 2).
2. 7. 4. 2b Acridine Orange Fluorescent Microscopy.
Apoptosis in monocytes and Mo, PMN, lymphocytes and U937 cells was
quantified by acridine orange fluorescence microscopy, another well
recognized method for the detection of apoptosis (Arends, 1990; Stern,
1992). Figure 3. 3 shows the characteristic morphology of apoptotic and
non-apoptotic monocytes and Mo stained with acridine orange and
viewed under green fluorescent light. Suspension cultured cells were
resuspended, 10 pi placed on a microscope slide to which 5 pi of stock
acridine orange solution (10 pg/ml) was added and protected with a
coverslip. Cells were scored as apoptotic or non-apoptotic on the basis of
their nuclear morphology as seen under green fluorescence and the
percentage of apoptotic cells determined by counting >500 cells. For
adherence cultures in 8 well slides, 1.5 pi of stock acridine orange
solution (1 mg/ml) was added per well, incubated for 10 minutes and
then viewed on an inverted fluorescent microscope at x 400. One
thousand cells were counted, scoring as above. The number of cells per
high power field was also recorded, counting ten or more fields per
treatment. Fields were chosen at random with the field sufficiently out of
focus to be unable to identify cell morphology, but to be able to identify
the well boundaries.
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2. 7. 4. 2c Electron Microscopy.
For examination by transmission electron microscopy a million cells
were washed, pelleted, fixed in 1% glutaraldehyde in 0.1 M cacodylate
buffer, then treated with 1% osmium tetroxide and processed for
transmission electron microscopy using standard techniques in
collaboration with the electron microscopy facility, Department of
Pathology, University of Edinburgh. Apoptotic cells demonstrated dense
chromatin aggregation and cytoplasmic vacuolation whilst their plasma
membrane remained intact (Figure 3. 9).
2. 7. 4. 3 Flow Cytometry.
2. 7. 4. 3a Quantification of Macrophage and U937 Cell
Apoptosis.
The percent apoptotic Mo and U937 cells could be determined simply on
the basis of forward and side scatter parameters using flow cytometry as
verified in sections 3. 2. 8 and 4. 2. 1 respectively.
2. 7.4. 3b Cytokine Receptor Expression.
Flow cytometry was used to distinguish non-apoptotic and apoptotic Mo
and U937 cells on the basis of forward and side scatter, allowing the
relative changes in surface molecule expression of these populations to be
determined. Binding of antibodies from the cytokine receptor panel
(section 5. 2. 1) was determined for apoptotic and non-apoptotic Mo that
had been exposed to cycloheximide. Comparison of non-apoptotic,
cycloheximide treated Mo and control Mo also allowed the relative effects
of protein synthesis inhibition and apoptosis to be distinguished. For
U937 cells, culture in serum free medium for 12 hours was used to induce
apoptosis and apoptotic and non-apoptotic cells specifically gated on,
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allowing relative cytokine receptor expression determined (Figure 4. 1).
In all cases binding was related to that of a non-binding control antibody,
MOPC-21C and to two positive controls; anti CD14 and HLA-DR (see
section 3. 2. 9 and Figure 5.1).
2. 7. 4. 4 Cell Counts.
To control for the possibility of phagocytosis of apoptotic Mo by non-
apoptotic Mo, reducing the number of apoptotic cells observed, the final
number of cells remaining in culture at the end of each experiment was
determined, giving an indication of any reduction in cell number for
each treatment. Suspension cultured cells were counted using a
haemocytometer, following vigorous resuspension of the cells (>400 cells
were counted per treatment and trypan blue exclusion was determined
simultaneously). A correction was made for any loss of volume over the
period of culture (always less than 10%) to correctly relate the initial and
final counts. The Teflon foils were stained with Dif Quik™ after
aspiration of the resuspended cells to identify whether any cells remained
adherent. The number of adherent cultured cells (and nuclei) was
estimated for each treatment well by counting the number of cells (and
nuclei) per microscope field, a minimum of 8 fields were examined per
treatment and the mean ± SE of the cells (and nuclei) determined. To
control for the effect of giant cell formation by cell fusion, numbers were
expressed as the number of nuclei per microscope field rather than the
number of cells. By racking down from the surface, the number of non¬
adherent cells floating in each treatment well could be counted, very few
of such cells were seen in any wells. Initially after counting under
fluorescence microscopy, medium was aspirated, wells removed from the
base of the slide which was fixed in methanol and Dif Quik™ stained. A
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further count of the number of fixed stained cells per microscope field
was undertaken, as a double check. This corresponded very closely with
the acridine orange counts.
2. 8 Protein Synthesis Inhibition Assay.
This was performed according to the methods of Walt et al. (Walt, 1985).
Briefly Mo were washed twice in methionine free MEM (Gibco), divided
into three Teflon foils, each with 4 x 106 cells, suspended in MEM with
10% dialyzed FCS (to remove molecules of mw < 10 000). To each of
these foils 3.14 ml 35S (20 mCi) was added. In addition, foil a) had 18.7 pi
of MEM added (control) foil b) had 1.87 pi of cycloheximide stock and
16.83 pi MEM (5 pM cycloheximide) and foil c) had 18.7 pi of
cycloheximide stock added (50 pM cycloheximide). After 18 hours
incubation, cells were harvested, counted and the percent apoptosis
determined morphologically. Cells were washed three times, the
supernatant saved each time and the final cell pellet was suspended in
200 ml PBS to which 15 ml 20% PBS was added. For protein precipitation
this was heated to 95°C for 5 minutes, cooled, trichloroacetic acid added to
a final concentration of 10% (24 ml of 100% trichloroacetic acid) and
centrifuged at 13000 x g for 10 minutes at 4°C. The pellet was washed
twice with cold ethanol and resuspended in 400 ml PBS, this pellet and all
the washes were counted in a (3 counter.
2. 9 In Vivo Methods.
2. 9.1 Mice and Inflammatory Challenge.
Mice BALB/c (H-2d), C3HF/KAM (H-2k) and their F1 hybrid, CB1 (H-
2k/d) breeding colonies were established locally, with the kind help of Mr.
J. Verth, Department of Medical Microbiology, University of Edinburgh.
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Female CB1 mice were used as donor mice and female C3HF/KAM as
recipients for adoptive cell transfer experiments unless indicated, all mice
were used between 11 and 15 weeks of age. Apart from one day of poor
feeding and ruffled fur after inflammatory challenge, mice remained well
throughout; of the mice used in the entire course of the experiments only
one mouse died.
2. 9. 2 Inflammatory Challenge and Macrophage Kinetics.
Murine cell transfer experiments were performed with the help of Miss
Helen Caldwell, Respiratory Medicine Unit, University of Edinburgh.
The kinetics of the inflammatory cell response to the intraperitoneal (i.p.)
challenge of two different sterile inflammatory agents, 2 ml of 1% starch
or 2 ml of 4% thioglycollate (TG) (Difco, East Molesey, Surrey) was
followed for 21 days (days 3, 5 and 10 for starch) to identify the resolution
phase of inflammation in both CB1 and C3H/KAM mice. A minimum
of 4 or more mice were terminally anaesthetized with ether at each time
point for each strain and total cell number, viability and differential
counts performed on peritoneal lavages.
2. 9. 3 Adoptive Cell Transfer.
2. 9. 3.1 Fluorescent Labelling of Cells.
Fluorescent labelling using the PKH26 cell linker kit (Sigma) allows stable
cell labelling for prolonged periods without elution of dye or apparent
alteration of cell physiology (Melnicoff, 1988a and b; Horan, 1990). Cells
could be labelled in vitro using the red fluorescent cell linker dye PKH26-
GL for general cell labelling or in vivo with the red fluorescent cell
linker dye PKH26-PCL for phagocytic cell labelling. The fluorescent label
was the same in both cases but the diluent differed.
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Figure 2. 5 PKH26 Fluorescence after In Vivo and In Vitro Cell
Labelling.
In vitro General Cell Labelling
a
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Legend for Figure 2. 5 Photomicrographs of Mo after (a and b) vitro
general cell and (c and d)in vivo phagocytic cell labelling. This confirms
that all cells are red fluorescent after vitro general cell labelling as all
cells that can be seen under light microscopy (a) are also seen under red
fluorescent microscopy (b). As only a fraction of cells have incorporated
the dye with invivo phagocytic labelling, many cells seen under light
microscopy (c) cannot be visualised under red fluorescent microscopy (d).
The fluorescent label is the same for both labelling methods, only the
diluent differs. With in vitro cell labelling the aliphatic fluorescent
PKH26-GL chromophore is incorporated into the lipids of all cell
membranes, whilst for phagocytic invivo cell labelling, the diluent
creates PKH26-PCL dye aggregates that need to be ingested and the degree
of labelling depends on the volume of dye injected (section 7. 2. 2. 2).
87
The PKH26 dye is an aliphatic fluorescent chromophore that allows
labelling in the lipids of the cell membrane for the general cell labelling
whilst for phagocytic cell labelling, dye aggregates are formed and
phagocytosed (Horan, 1990), thus all cells are labelled by the in vitro
technique whilst only phagocytes are labelled using in vivo labelling (see
Figure 2. 5).
2. 9. 3. la In Vitro Labelling.
Free peritoneal cells were lavaged using 5 mis of sterile PBS and counted,
then aliquots containing 1 x 107 cells were transferred into 15 ml
polypropylene tubes and washed. Meanwhile 3 pM dye (2x stock dye) was
prepared by diluting stock with Diluent C (supplied by the manufacturer
as part of the kit). The cell pellet was resuspended in 1 ml of Diluent C,
which was rapidly added to 1 ml of 2x stock dye, incubated for 2 minutes
and the labelling stopped by addition 2 mis of FCS. Cells were washed
three times, transferring to a fresh tube each time.
2. 9. 3. lb In Vivo Labelling.
Under sterile conditions 100 pi of dye was mixed with 900 pi of absolute
ethanol, 50 pi of this was dissolved in 10 mis of Diluent B (provided by
the manufacturer as part of the kit). Using a fresh sterile syringe and 26
gauge needle each time, 0.5 - 2 mis was injected into the peritoneal cavity
of donor mice 1-24 hours prior to sacrifice, control mice received an
equal volume of PBS. Since PKH26-PCL had not previously been used for
i.p. labelling during inflammation, there was no information from the
manufacturers on labelling protocols, hence I tried 1, 1.5, 2, 18 and 24
hours labelling prior to lavage and injection of between 0.5 and 2 ml i.p.
PKH26-PCL. No difference in the labelling intensity, percentage cells
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labelled, cell recovery or viability was apparent between these labelling
times and 1.5-2 hours was chosen for future experiments. Increasing the
injectate volume increased the percent cells labelled but with 2 mis
PKH26-PCL the cell viability decreased as discussed in section 7. 2. 2. 2.
2. 9. 3. lc Analysis of PKH-26 Fluorescent Cells.
Flow cytometric analysis was used to analyze in vitro and in vivo PKH-
26 cell labelling efficiency. This confirmed that the in vitro method
labelled all cells, Mo, lymphocytes and granulocytes, equally, whilst the i n
vivo method labelled only phagocytic cells as expected (Figure 2. 5). As
by the 5th day post inflammation there were less than 3% PMN, in vivo
labelling was essentially restricted to Mo. This analysis also showed that
upon i.p. injection of 0.5 mis PKH-26 PCL, only approximately 1/3 of the
cells took up the dye, as discussed in section 7. 2. 2. 2 but that the percent
Mo labelled increased to 74% using 1 ml dye. In certain experiments
spleen and selected lymph nodes were collected in PBS, washed
vigorously 4 times and disrupted either mechanically or by enzymatic
digestion with 0.5 mg/ml collagenase for 15 minutes. The resultant cell
suspension was analyzed by flow cytometry for the presence of PKH26 red
fluorescence.
2. 9. 3. 2 Protocol for Adoptive Cell Transfer.
This protocol was designed with help from Dr. Sarah Howie, Department
of Pathology, University of Edinburgh. Peritoneal inflammation was
induced by i.p. TG or starch in both donor and recipient mice 5 days prior
to cell transfer, such that both groups of mice were at the same stage of
inflammation. For adoptive transfer of in vitro labelled Mo, the
peritoneal cavities of donor mice were lavaged 5 days after inflammatory
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challenge, recovered cells were labelled, counted and viability
determined, then between 5 and 30 x 106 cells resuspended in 2 mis PBS
were injected into the peritoneal cavity of recipient mice using a 21 gauge
needle. For adoptive cell transfer after in vivo labelling, donor mice
underwent peritoneal lavage 1.5 hours after PKH26-PCL injection.
Lavaged cells were suspended in PBS with 10% FCS at 4°C, washed twice
(250 x g), counted and viability determined. In certain experiments cells
were fixed in 2% formalin for 5 minutes and washed a further three
times prior to transfer. Cells (live or fixed) in 2 ml PBS at the
concentrations stated were re-injected into the peritoneal cavity of
recipient mice (at the same stage of inflammation as the donors) using a
21 gauge needle. In all cases the donor cells were >85% Mo, the
remaining cells were mainly lymphocytes, the viabilities differed between
labelling procedures however. With in vivo labelling, viabilities were
always >95% - whilst considerable problems were encountered in in vitro
labelling. Initial poor viabilities during in vitro labelling may have been
due to excessive spin speeds during washing (using the gravitational
force as recommended by the manufactures - 400 x g), however with
slower speeds viabilities of <80% were still encountered. These were
improved by reducing the concentration of the stock dye, however the
best viabilities were still only 90%. For this reason in vivo labelling was
chosen for the rest of this work. After cell transfer, recipient mice were
sacrificed at various times between 4 hours and 1 week later, their
peritoneal cavities lavaged and tissue taken for histology and
fluorescence studies (summarized in Figure 2. 6). Some mice received
unlabelled inflammatory Mo to serve as controls for flow cytometry and
frozen section studies.
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Legend for Figure 2. 6 Summary of the experimental protocol employed.
Both donor (H-2d/k) and recipient (H-2k) mice received sterile
inflammatory challenge at the same time. Five days later donor mice
received i.p. injection of PKH26-PCL to label phagocytic cells in vivo.
These donor cells (>85% Mo, 27 - 42% PKH26-PCL labelled) were lavaged
and injected into the peritoneal cavity of recipient mice at the same stage
of resolving inflammation as the donor mice. These mice were sacrificed
between 4 and 168 hours later, their peritoneal cavities lavaged and tissue
taken to determine the distribution of donor cells. The possible labelling
patterns of Mo in peritoneal lavage of recipient mice are shown.
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2. 9. 4 Tissue and Cell Staining.
Tissue for frozen section was immediately snap frozen in liquid nitrogen,
3 |iM sections were cut, mounted on slides and the distribution of the
PKH26 label determined under red fluorescence using an Olympus BH-2
RFCA fluorescent microscope. Specificity of labelling could be confirmed
by viewing the section under green fluorescent light as PHK26 labelled
cells were only red fluorescent (Figure 2. 7), occasional artifact was both
red and green fluorescent. Staining for the presence of H-2d was also
performed on these sections, however as fixation abolished PKH26
fluorescence, an unfixed section was viewed first for the presence of
PKH26 before the remainder were fixed. Despite attempts using a range
of fixatives (alcohol, acetone, paraformaldehyde and formalin), no useful
double labelled sections were obtained due to loss of dye. Sections were
stained in a Sequenza™ (Shandon, Pittsburg PA) to reduce background
staining. Slides were blocked sequentially with NMS, Avidin D and
biotin blocking solution (Vector Laboratories, Bretton, Peterborough)
before addition of biotin conjugated mouse anti-mouse H-2D^ mAb
(Pharmingen). Slides were washed and ABComplex/AP (avidin/
biotinylated alkaline phosphatase kit, Dako) and Vector® Red alkaline
phosphatase substrate kit added (Vector Laboratories) before
counterstaining with haematoxylin. Control slides were stained in the
absence of the biotinylated anti-H-2d mAb; tissue from H-2k/d mice acted
as positive controls and from H-2^ mice as negative controls in each run.
Formalin-fixed tissue was paraffin embedded, cut sections were stained
with haematoxylin and eosin.
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Figure 2. 7 Specificity of PKH26-PCL Red Fluorochrome Labelling,
i) Red Fluorescence.
ii) Green Fluorescence.
Legend for Figure 2. 7 Tissue section of parathymic LN 48 hours after i.p.
adoptive cell transfer of 15 x 106 semi-allogeneic cells (>85% Mo and 40%
PKH26-PCL labelled) showing clear definition of cells in the LN viewed
under red fluorescent light but no cross-over when viewed under green
fluorescent light. Any occasional artefact could be distinguished as this
would be visualised under both red and green fluorescence (x 200).
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2. 9. 5 Cell Culture for In Vivo Studies.
2. 9. 5.1 BHK Plates.
To obtain the very pure populations of inflammatory Mo needed to
confirm gating parameters and immunofluorescence, an adherence
method was employed to enrich 5 day peritoneal lavage cells for
inflammatory Mo. Coating of tissue culture plastic with matrix proteins
can alter the adherent substrate; this was used to improve Mo
detachment (Ackerman, 1978). BHK cells (BHK 21, clone 13: ECACC)
were grown to confluence on 140 mM tissue culture dishes in Glasgow's
BHK-21 medium containing 10% Tryptose phosphate broth (Gibco) and
10% FCS. Treatment of the monolayer with 10 mM EDTA easily detached
cells in sheets, after three washes the sterile matrix coated plates were
stored at -70°C until used. Peritoneal lavage cells were cultured on pre-
warmed BHK matrix coated plates in IDMEM at 2 x 106 /ml for 1 hour.
Non-adherent cells were washed off and the adherent cells then lifted off
by 5 minutes incubation with 5 mM EDTA on ice (Figure 2. 4b). These
cells were >94% Mo by non-specific esterase staining and indirect
immunofluorescence. Low recovery and possible activation following
adherence precluded their use in adoptive cell transfer experiments.
2. 9. 5. 2 In Vitro Culture of PKH-26 Labelled Peritoneal
Macrophages.
To determine the retention of PKH26 label and the effect of PKH26
labelling on cell viability with time, fresh and formalin fixed cells were
cultured in IDMEM supplemented with 100 units penicillin,
streptomycin and 10% FCS, in hydrophobic Teflon foils at 37°C in 5%
CO2. Samples were removed daily for viability, PKH26 (GL or PCL), H-
2k/d expression and differential cell counts. The effect of brief formalin
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fixation on donor cell function was confirmed by examining cell
adherence to tissue culture treated plastic slides, live cells were strongly
adherent whilst fixed cells were completely non-adherent.
2.10. Statistical Analysis.
Statistical analysis was performed in collaboration with Dr. W Adams,
Medical Statistics Unit, University of Edinburgh. The percentages of
PKH26 labelled cells , H-2k/d cells and phagocytosed cells in peritoneal
lavage were logarithmically transformed using the equation
y = loge (1 + 10p)
where p = the percentage. This converted the values into a normal
distribution allowing calculation of geometric means and 95% confidence
intervals. The log means and variance are shown below for the transfer
of live and formalin fixed PKH26-PCL labelled cells.
Log Mean (m) for each time point Variance
24 48 72 96 168 (hours) (s)
Live cell transfer:
% PKH26-PCL 4.71 4.2 4.02 2.49 3.21 0.533
% H-2k/d 5.7 5.07 5.02 0 1.48 0.646
% Phagocytosed cells 2.24 2.12 1.42 0.64 3.21 0.505
No. Mice 8 4 5 5 7
Fixed cell transfer:
% PKH26-PCL 4.33 - 3.69 4.52 2.85 1.92
% H-2k/d 2.41 - 0.54 1.85 0.87 2.08
% Phagocytosed cells 4.31 - 3.55 3.89 3.29 1.81
No. Mice 6 6 6 5
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The plots of percentages shown (Figures 7. 5, 7. 6 and 7. 7) were achieved
by transformed data back into linear scale, the conversion being:
p = eX -1
10
These plots suggested that there was a linear decline was to zero by 96
hours for labelled donor cells after live cell transfer (see section 7. 2. 3) but
not for fixed cells (see section 7. 2. 4). With 4 equi-spaced time points (24,
48, 72 and 96 hours), linearity can be tested for by means of orthogonal
(independent) polynomials obtained via ANOVA. For the 4 points there
are 3 components, linear, quadratic and cubic; if points lie on a straight
line then the linear component will be significant and the others will not.
Using the following equation:
tv = lim lJiim? + 13I£L3Ui141IL4
Vs2 (l2i/ni + l22/n2 + l23/n3 + l24/n4)
t tests for each time can be determined, where v is the time after cell
transfer, 1 is a weighting for each of the components as shown in the
table below, m are the log means for each time point, n the number of
mice at each time point and s the variance.
Linear Quadratic Cubic
h -3 1 -1
h -1 -1 3
I3 1 -1 -3
14 3 1 1
For example, after transfer of live PKH26-PCL labelled Mo the linear
component of the equation reads:
t24 = -3 x 4.71 - 4.20 + 4.02 + 3 x 2.49
VO.533 (9/8 + 1/4 + 1/5 + 9/7)
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Using this we see that:
PKH26 labelled Mo after PKH26 labelled Mo after





Only the linear component is significant for live cell transfer, none are
for fixed cell transfer. Hence the decline of PKH26-PCL labelled cells after
live adoptive transfer was linear to 96 hours but no such trend existed for
formalin fixed cells.
Regression analysis was employed to determine whether there was
concordance of the curves at 96 hours after cell transfer of 15 or 30 million
donor cells (section 7. 2. 3). The total number of Mo free in the peritoneal
cavity at each time point for CB1 and C3H/KAM mice were compared
using ANOVA. A difference in the recovery rates of labelled cells in the
presence or absence of inflammation was tested for using Wilcoxon's
rank sum test for non-parametric data. All tables and graphs display the
mean ± the standard error (SE) of the mean unless otherwise stated. For








A reproducible model to allow investigation of the controls on
monocytes and Mo survival in vitro required the reliable isolation of
monocytes from peripheral blood, the in vitro culture of Mo and the
identification and quantification of monocyte and Mo apoptosis.
Although several systems for monocyte purification have been described,
the morphology, characteristics and quantification of Mo apoptosis had
not been described.
The most common and accepted methods for determining and
quantifying apoptosis are based on morphological criteria. Light
microscopy of stained cytological preparations (Savill, 1989a; Dransfield,
1994), fluorescence microscopy using acridine orange or DAPI (McConkey,
1988; Gregory, 1991) and electron microscopy (Wyllie, 1984; Savill, 1989a)
have all bemused to identify and quantify apoptotic cells. Traditional
measures that distinguish live from necrotic cells, such as exclusion of
trypan blue are not sensitive for cells in the initial stages of apoptosis as
they are still able to exclude vital dyes, a capacity which may be preserved
late into the life of the apoptotic body (Haslett, 1994). Gel electrophoresis
of DNA can be used to confirm endonuclease activity associated with
apoptosis and it is possible to quantify this either by separating
fragmented and intact DNA (Wyllie, 1980; Sellins, 1987) or by using
densitometry techniques (Waring, 1990). Apoptotic cells can also be
distinguished by flow cytometry using propidium iodide or other DNA
binding fluorochromes (Ojeda, 1990; Nicoletti 1991; Telford, 1994) and by
the technique of terminal deoxynucleotidyl transferase mediated dUTP-
biotin nick end-labelling or TUNEL, facilitating immunohistochemical
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staining of apoptotic cells at the single cell level in tissue sections
(Gavrieli, 1992; Tornusciolo, 1995).
Mangan et al. provided a clear picture of monocyte apoptosis,
documenting DNA fragmentation and demonstrating the correlation
with loss of cell volume, propidium iodide uptake and characteristic
electron microscopy findings (Mangan, 1991a and b). Although Mo
apoptosis had been described in response to ATP treatment (Hogquist,
1991a), co-culture with cytotoxic T lymphocytes (Zychlinsky, 1991) and
protein synthesis inhibition (Waring, 1990), this had only been quantified
by using DNA fragmentation. My preliminary work showed that
morphological assessment of monocyte and Mo apoptosis was difficult;
apoptotic monocytes and Mo proved too fragile to withstand
cytocentrifuge preparation (Figure 3. 2) and flow cytometry using PI was
found to be not generally applicable as some Mo populations, especially
alveolar Mo, had high autofluorescence that obscured any selective
uptake of PI.
It has been clearly established that Mo specifically recognize and ingest
apoptotic cells, a novel recognition mechanism for this has been
described (Savill, 1989a and b, 1990 and 1992; Fadok, 1992a). This suggests
that cell surface changes during the process of apoptosis allow for
recognition and removal of apoptotic cells by Mo, but not by monocytes.
As a description of the morphology of Mo apoptosis was lacking, the
surface molecular changes associated with monocyte/Mo apoptosis had
also not been investigated.
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My aims initially were:
• To find the most suitable method for monocyte preparation and Mo
culture.
• To establish a methodology for assessment of apoptosis in monocytes
and Mo.
• To establish a system for the reproducible induction of apoptosis
allowing characterization of the apoptotic process in Mo with
particular reference to their cell surface characteristics.
• To investigate the possibility that Mo phagocytose apoptotic Mo and
monocytes within the same culture.
3.2 RESULTS.
3. 2.1 Purity of Monocyte and Macrophage Populations.
3. 2.1.1 Monocytes.
Monocytes isolated by CCE or by discontinuous Percoll gradient
centrifugation and plasma plate adherence were of similar purity and
initial viability 91.2% (range 80 - 96%; >99% viable, n = 31) for CCE
compared with 90.2 % (range 84.6 - 96%; >99% viable, n = 81) for density
gradient centrifugation. Average yields from CCE were 30.2 x 106
cells/preparation (range 15.6 - 44 x 106) when 216 mis of blood were taken
from each donor, thus providing 1.40 x 105 monocytes per ml of blood.
Density gradient centrifugation and adherence provided a mean of 21.5 x
106 cells/preparation (range 10.5 - 30 x 106), again 216 mis of blood were
taken, each donation yielding 1.00 x 105 monocytes per ml of blood. The
mean mononuclear count after dextran sedimentation and density
gradient centrifugation of 216 mis blood was 165 x 106 cells of which 20.7%
(range 12.4 - 29.9%) were monocytes as determined by flow cytometry.
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Thus using plasma plate adherence 62.5% of the total monocytes were
recovered, CCE provided a better monocyte recovery at 88% of the total.
3. 2.1. 2 Macrophages.
Monocytes cultured in IDMEM with 10% autologous serum in
suspension culture or adherent to 24 well plates matured into Mo over 5
days. The purity of these cultures were as follows:
92.9% (range 85.6 - 98%, n = 73) assessed by Dif Quick™ stained cytospins;
93% (range 91 - 96%, n = 5) assessed by non-specific esterase staining;
92.5% (range 89-98%, n = 48) assessed by flow cytometry using forward and
side scatter parameters;
90.2% (range 84.3 - 93.8%, n = 24) assessed by flow cytometry using indirect
immunofluorescence to determine CDlla/CD18, CD14 and HLA-DR
expression.
Mo viability was greater than 99% determined by trypan blue exclusion.
The non-adherent cells from 24 well plates were 96% Mo after 5 days and
the remaining adherent cells, after lifting off with 5 mM EDTA, were 98%
Mo as assessed both by cytospin and flow cytometry characteristics (n = 4).
3. 2.1. 3 Adverse Effects of Elutriator on Monocyte Viability.
The initial viability of monocytes and corresponding Mo yields after 5
days in cultures were similar whether the cells were prepared by
discontinuous Percoll gradient centrifugation or by CCE. However after 4
months of elutriator use and for reasons as yet unclear, the viability of
monocytes isolated by CCE declined rapidly during in vitro culture, with
less than 10% of cells still viable after 48 hours. Monocyte death occurred
without any evidence of infection and was not prevented by rigorous
cleaning and sterilizing of the elutriator, changing all the tubing and the
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chamber, or by altering the percent autologous serum in the elutriation
medium from 0 to 2%. In an attempt to eliminate any possible problems
with elutriator hardware an alternative rotor was used without
improvement in monocyte viability. Maintaining the elutriation
medium on ice had only a slight beneficial effect. Elutriation medium
that had passed through the elutriator did not reduce the viability of cells
prepared by discontinuous gradient centrifugation. Greater than 80% of
elutriated U937 cells were viable after 48 hours, however these cells were
maintained in the elutriator for less than an hour while monocyte
elutriation often lasted 80 - 90 minutes. PMN prepared by CCE had
similar survival to those prepared by discontinuous gradient
centrifugation and were in the elutriator for longer than monocytes.
Because of this unexplained pro-apoptotic effect on elutriator prepared
monocytes, cells were prepared by discontinuous Percoll gradient
centrifugation and plasma plate adherence for the remainder of the
project.
3. 2. 2 Changing Concentration of Monocytes in Culture Affects
Macrophage Yield.
To determine the optimum concentration at which to culture monocytes
in suspension for maximal five day Mo yield, eight experiments were
performed. Monocytes were cultured at initial concentrations of 0.1, 0.5,
1.0, 2.0 and 5.0 x 106/ml, the results for each experiment are shown in
Table 3. 1. Maximum Mo yields occurred when monocytes were seeded at
an initial concentration of 1 x 106/ml, hence this was the concentration
used throughout the rest of this project. In Table 3. 1 we see that
comparison of Mo recovery starting with 0.1 x 106 monocytes/ml with
that from 0.5 to 5.0 x 106/ml, using Students paired t test, shows that only
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an initial monocyte concentration of 1.0 x 106/ml results in a significantly
greater Mo recovery. Recovery from starting concentrations of 0.5 to 5.0 x
106/ml do not differ significantly from each other.
Table 3.1
Effect of Altering the Initial Culture Concentration of Monocytes
on Final Yield of Macrophages.
Initial Concentration % Macrophages Recovered Mean ± SE p
of Monocytes {experiments a - h}.
(106/ml) a) b) c) d) e) f) g) h)
0.1 x 106/ml 32,22,25,21,36 27.2 ± 2.9% -
0.5 x 106/ml 40, 31, 22, 34, 52 35.8 ± 5.0% n/s
1.0 x 106/ml 48,39,34,67,45,53,21,41 43.5 ± 4.5% <0.05
2.0 x 106/ml 51, 37, 33, 61, 23, 40, 27, 29 37.6 ± 4.5% n/s
5.0 x 106/ml 51. 33. 31. 51. 28. 40. 22. 39 36.9 ± 3.7% n/s
Legend for Table 3.1
Results of varying the initial concentration of monocytes on the final
yield of Mo after 5 days culture. Mo yield as a percent of the initial
monocyte concentration are shown for 8 separate experiments (only 5
for concentrations 0.1 to 5.0 x 106 /ml), labelled a) to h), mean ± SE for
each initial monocyte concentration shown on the right.
3. 2. 3 Assessment of Constitutive Monocyte/Macrophage
Apoptosis.
Culturing human peripheral blood monocytes for 5 days yielded
functionally mature Mo with typical expression of non-specific esterase
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(Figure 3. 1) and loss of peroxidase activity (section 6. 2. 5), surface
adhesion molecule expression (section 3. 2. 9) and ability to phagocytose
opsonized zymosan and apoptotic PMN after 3 days in culture (section 3.
2. 10). There was a steady attrition in monocyte numbers over this
culture period with recovery of approximately 46.5% (n = 24) of the
original number cultured. The decline in cell number was relatively
constant each day over this five day period. Unlike apoptotic PMN,
apoptotic Mo did not retain their morphology during cytospinning, as
shown in Figure 3. 2, thus this could not be used to quantify apoptosis in
these cells. Propidium iodide (PI) staining, a commonly used technique
to identify and quantify apoptotic cells (Nicoletti, 1991) was of limited use
for Mo as the well known autofluorescence of Mo increased steadily
during differentiation and was especially high in alveolar Mo (Viksman,
1994), effectively obscuring the degree of uptake of PI. Staining these cells
with acridine orange (Arends, 1990) however proved to be a very
sensitive method to demonstrate those cells with apoptotic morphology
(Figure 3. 3) and allowed quantification of apoptosis. The percent of Mo
exhibiting apoptotic morphology at any one time was on average 4.3%,
this remained relatively constant over the culture period as shown in
Table 3. 2, and discussed in Appendix 1. Morphological counts assessed
both apoptosis and necrosis, although necrotic cells were rarely seen and
accounted for less than 0.05% of cells. Only a small decline in cell
number could be accounted for by giant cell formation (i.e. cell fusion), in
suspension culture this was relatively uncommon and only seen in the
last 24 hours of culture when less than 5% of nuclei fused into giant cells.
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Figure 3. 1 Non-specific Esterase Staining of Human Macrophages.
Legend for Figure 3.1 Cytospin of human Mo stained for non-specific
esterase as described in section 2. 7. 1, showing positively stained Mo
(brown) and a small non-specific esterase negative lymphocyte (x 400).
Figure 3. 2 Fragility of Apoptotic Macrophages During Cytospinning.
? • * ' *
Legend for Figure 3. 2 Cytospin preparation of cycloheximide treated Mo
stained with Diff Quik showing many fragmented cells without nuclei.
Many non-apoptotic (NA) and apoptotic (A) cells are seen but the large
number of cells without clear morphology makes this an inappropriate
method for assessment of Mo apoptosis (x 100).
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Table 3. 2







0 2.1 ±1.1 2.00
2 4.4 ± 0.8 ND
4 4.1 ±0.5 ND
6 4.4 ± 0.9 1.90
8 4.2 ± 0.4 ND
10 4.0 ±1.0 ND
12 4.6 ±0.8 ND
18 4.5 ± 0.9 1.79
36 4.2 ±0.7 1.64
72 3.9 ± 0.4 1.29
96 3.6 ± 0.9 1.15
120 3.7 ±1.1 0.92
Legend for Table 3. 2
Monocytes were cultured in suspension in 10% autologous serum for
five days and cell number and the percentage of apoptotic cells
determined at the time points indicated. Apoptosis was determined
by acridine orange staining and cell numbers by haemocytometer
counts. Standard errors for cell numbers were all within 10% of the
means; ND = not done. The percentage of apoptotic cells was
significantly lower at the start than at any other time point (p<0.05)/
there was no significant difference between the percentage of
apoptotic cells at the other time points. Results are expressed as mean
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± SE, n = 8 for 0, 6, 18, 24, 36 and 120 hours and n = 3 for 2, 4, 8, 10, 12,
72, and 96 hours.
When 8 well slides of monocytes cultured for up to 72 hours were viewed
following acridine orange staining, indistinct bodies that did not contain
any nuclear material could be seen. These bodies, which were the size
and shape of cells, were difficult to quantify as they were often very faint,
there were never more than 4% per well except in the presence of
cycloheximide when up to 12% could occasionally be seen (Figure 3. 4).
They were never seen when cells cultured in Teflon foils were
resuspended, placed onto a microscope slide and stained with acridine
orange. Likewise, attempts at resuspending adherent cultured monocytes
destroyed these bodies, suggesting that they were fragile and disrupted
during resuspension. Due to the interaction of acridine orange and
trypan blue, the ability of these bodies to exclude vital dyes could not be
determined. Cycloheximide treatment increased the number of apoptotic
cells and led to an increase in these indistinct "ghost cell" bodies.
Furthermore the nuclei of apoptotic cells were seen to condense into
smaller and smaller fragments. These "ghost cell" bodies probably
represented late apoptotic bodies that had fully extruded their nuclear
material, this is considered more fully in the discussion. Few "ghost cell"
bodies were seen in Mo cultures and then only in the presence of
cycloheximide. Also in the presence of cycloheximide, a number of non-
apoptotic Mo could be seen to contain apoptotic cell bodies. This
phagocytosis could be demonstrated both in suspension cultures using
acridine orange fluorescent microscopy and in adherent cultures stained
with Dif Quik™ (Figure 3. 5).
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Figure 3. 3 Use of Acridine Orange Fluorescent Staining to Distinguish
Apoptotic, Non-Apoptotic and Necrotic Macrophages,
i) Non-Apoptotic and Apoptotic Macrophages.
Legend for Figure 3. 3 i Suspension cultured human Mo were exposed to
50 pM cycloheximide for 18 hours to induce apoptosis in a proportion of
cells. They were stained with acridine orange and viewed under green
fluorescent light (section 2. 7. 4. 2). Two typical non-apoptotic Mo, with
large open nuclei are shown on the left and the condensed characterless
nucleus of an apoptotic Mo on the right (taken at x 400).
ii) Necrotic Macrophages.
Legend for Figure 3. 3 ii Mo from the same donor were exposed to 2
cycles of freeze/thawing to induce necrosis and were again stained with
acridine orange. Pictured are 4 examples demonstrating the clear
morphological differences between necrosis and apoptosis. Necrotic cells
are swollen, the internal architecture of the cell is disrupted and they
have lost cytoplasmic membrane integrity (taken at x 200).
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Figure 3. 4 Monocyte: Apoptosis and "Ghost Cell" Bodies,
i) 26 Hour Monocyte Cultures in 10% Serum.
Legend for Figure 3. 4 Cycloheximide induced monocyte apoptosis; non-
apoptotic (NA) cells have an open nucleus, apoptotic cells (A) have
condensed characterless nucleus and "Ghost cell" bodies (GB) are
indistinct bodies without nuclear material. Note the multiple
fragmented nuclear bodies in the 36 hour cycloheximide culture -
increasing nuclear disintegration is a feature of late apoptosis (x 200).
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Figure 3. 5 Macrophage Phagocytosis of Apoptotic Macrophages,
i) Acridine Orange Fluorescent Microscopy of Macrophages in
Suspension Culture Showing 2 Examples of Phagocytosed
Apoptotic Cells (Arrows).
€t§
ii) Diff Quik Stained Adherent Cultured Macrophages Demonstrating
Apoptotic Macrophage (A) and Phagocytosis of Apoptotic Cell (P).
(All taken at x 400)
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3. 2. 4 Apoptosis vs. Necrosis: Comparison of Morphology.
To ensure that the distinct morphological changes accompanying
apoptosis could be distinguished from those of necrosis, a population of
Mo were divided, half were exposed to 50 (J.M cycloheximide to induce
apoptosis and the other half underwent two freeze/thaw cycles to induce
necrosis. The differences between these cell populations were clear and
unmistakable when viewed by acridine orange fluorescent microscopy
and conformed to the morphological criteria previously used to identify
these states (Figure 3. 3). Furthermore necrotic Mo remained clearly
distinguishable when viewed 4 hours later indicating that they were
relatively robust.
3. 2. 5 Characterization of Cycloheximide Induced Apoptosis In
Human Macrophages.
3. 2. 5.1 DNA Electrophoresis Data.
Mo, cultured either in suspension (n = 14) or adherent to 24 well plates (n
= 4), were exposed to cycloheximide (50 |iM), an equal volume (5 jil/ml)
of ethanol (the diluent for cycloheximide) or medium for 18 hours. In all
experiments gel electrophoresis demonstrated that only the addition of
cycloheximide induced characteristic DNA fragmentation associated with
apoptosis (Figure 3. 6). DNA fragmentation was time dependent in that
no laddering could be seen after 5 minutes but was apparent after 2 hours
(n = 3) of cycloheximide treatment and pronounced laddering was
apparent after 8 hours (n = 4) and still detectable after 40 hours (n = 2).
Cycloheximide also specifically induced DNA fragmentation in 8 and 9
day old cultures of murine bone marrow derived Mo (n = 6) and in
alveolar Mo (n = 4).
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Legend for Figure 3. 6 Photomicrograph of ethidium bromide stained
agarose gel viewed under ultraviolet light with DNA from 1 x 106
cells/lane, extracted as described in section 2. 7. 4. 1. Ladder pattern typical
of apoptosis seen in lanes 3, 4 and 7-11. Lanes are as follows:
1 A, DNA ECoRl/Hind III digest - size marker.
2 Adherent Cultured Mo (5 pl/ml Ethanol for 18 hours).
3 Adherent Cultured Mo (50 |iM Cycloheximide for 18 hours).
4 Suspension Cultured Mo (50 pM Cycloheximide for 18 hours).
5 Suspension Cultured Mo (5 pl/ml Ethanol for 18 hours).
6 Suspension Cultured Mo (50 pM Cycloheximide for 5 minutes).
7 Suspension Cultured Mo (50 pM Cycloheximide for 2 hours).
8 Suspension Cultured Mo (50 pM Cycloheximide for 8 hours).
9 Suspension Cultured Mo (50 pM Cycloheximide for 18 hours).
10 Suspension Cultured Mo (50 pM Cycloheximide for 40 hours).
11 Aged PMN with 55% apoptotic cells as positive control.
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Figure 3. 7 Flow Cytometric Analysis of Apoptotic Macrophages,
a) Control i) Control ii)
~i—i rnrnr
1 0 100
b) Cycloheximide i) Cycloheximide ii)
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Legend for Figure 3. 7 Forward and side scatter parameters of a) control
Mo and b) cycloheximide treated Mo from two different donors - donors
i) (contours) and ii) (dots). Acridine orange fluorescent microscopy
confirmed there were <1% apoptotic Mo in the control cultures whilst
after cycloheximide treatment (50pM for 14 hours), 21.5% of Mo from
donor i) and 21% of Mo from donor ii) were apoptotic. This mirrored
flow cytometric results with 1.1% and 0.8% Mo in apoptotic Mo gate in
the control cultures but 18.1% and 30.9% in cycloheximide treated Mo.
Gates: 1) Mo, 2) Lymphocytes, 3) PMN, 4) Apoptotic Mo.
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3. 2. 5. 2 Morphological Characteristics and Time Course.
As described in section 2. 7. 2. 1, monocytes and Mo had distinct forward
and side scatter characteristics when examined by flow cytometry,
allowing definition of a monocyte /Mo gate (Mo Gate) encompassing
these cells (Figure 2. 2). The addition of cycloheximide (50 |lM) to
suspension cultures of Mo was shown to induce forward and side scatter
changes indicating a loss of volume in a proportion of the Mo population
which was not seen for cells treated with ethanol or medium alone
(Figure 3. 7). Likewise a gate encompassing Mo with reduced cell volume
after exposure to cycloheximide was created (Apoptotic Mo Gate) (see
section 3. 2. 8 for validation that these were apoptotic Mo). Cells exposed
to ethanol or medium alone had only 3.2% ± 0.6% (n = 8) cells within this
Apoptotic Mo Gate after 18 hours (Figure 3. 7a), whereas 33.3% ± 4.8% (n =
8) of cells exposed to cycloheximide fell within this gate at 18 hours
(Figure 3. 7b), the percentage of cells in the Apoptotic Mo Gate increasing
with time after exposure to cycloheximide as summarized in Figure 3. 8.
In the same 8 experiments listed above, fluorescent microscopic analysis
revealed that 29.3% ± 6.3 of cells were apoptotic at 18 hours in the
cycloheximide treated group whilst 2.2 ± 0.3% of untreated cells had an
apoptotic morphology. The percentage of apoptotic cells determined
morphologically by acridine orange increased with time, paralleling the
changes determined by flow cytometry as shown in Figure 3. 8. It is
noteworthy that there was a significant increase in the number of non¬
viable cells concomitant with the induction of apoptosis but the
morphological count of necrotic cells was less than 0.1%. Thus, unlike
PMN where very few of the apoptotic PMN are trypan blue positive
1 15
(Haslett, 1994), apoptotic M0 do not retain the ability to exclude vital dyes
for long.
Figure 3. 8
Comparison of Acridine Orange and Flow
Cytometric Assesment of Apoptosis.
60 " ■ Flow Cytometry













Legend for Figure 3. 8
Cycloheximide (50 |iM) was added to suspension cultures of human
Mo, the percentage apoptosis was determined over time using
acridine orange fluorescent microscopy and by flow cytometry using
forward and side scatter. The percentage non-viable cells estimated by
trypan blue exclusion are shown for the same time points, these are
significantly less than the percentage apoptotic cells (p<0.05) for the 6
and 18 but not the 42 hour time points. Mo exposed to an equal
volume of ethanol or medium alone were included as controls
where the percent apoptosis was never greater than 5% at any time
point, assessed by either method (Mean ± SE, n = 8).
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Figure 3. 9 Electron Microscopy of Apoptotic Macrophages,
i) Non-Apoptotic Macrophages From Control Cultures.
iii) Corresponding DNA Gel Electrophoresis.
1 DNA size marker.
2 M0 + Cycloheximide (Donor
3 Mo + Ethanol (Donor 1)
4 Mo + Ethanol (Donor 2)
5 Mo + Cycloheximide (Donor
Legend for Figure 3. 9 Human Mo from two donors exposed to ethanol
(control) or cycloheximide (50 |iM) for 18 hours. Mo exposed to ethanol
all had normal electron microscopy characteristics whilst many of the
cycloheximide treated Mo demonstrated typical electron microscopic
appearances of apoptosis with condensed nuclei and loss of cell volume;
apoptosis was confirmed by DNA electrophoresis showing laddering.
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3. 2. 5. 3 Electron Microscopic Analysis of Macrophage Apoptosis.
In two experiments, electron microscopy was compared with acridine
orange fluorescent microscopy counts of apoptosis and DNA gel
electrophoresis findings. Suspension cultures of human Mo (94.4 and
96% pure) were treated with either ethanol or with 50 pM cycloheximide
and incubated for 18 hours. Cycloheximide treatment resulted in 24 and
32% apoptosis as assessed by acridine orange fluorescent microscopy
compared with only 1.2 and 4.4% apoptotic cells in untreated controls.
Both of the cycloheximide treated populations exhibited a typical ladder
pattern on DNA gel electrophoresis, whereas the control populations did
not. In the cycloheximide treated population many cells exhibited
characteristic electron microscopic features of apoptosis, including dense
chromatin aggregation and cytoplasmic vacuolation (Figure 3. 9), none
were seen in the controls.
3. 2. 5. 4 Effect of Cycloheximide on Lymphocytes.
Lymphocytes represented between 2 to 10% of the mononuclear
population under investigation, depending on the preparative method
used. To exclude the possibility that apoptotic lymphocytes could be
contributing to the counts of apoptotic cells, the effect of cycloheximide
on lymphocyte survival was investigated. In 3 separate experiments,
non-adherent lymphocyte rich cell populations were incubated in Teflon
foils for 24 hours with 50 (iM cycloheximide or an equivalent volume of
ethanol and compared with monocytes isolated from the same donor.
The percent apoptosis was determined for each cell type using acridine
orange fluorescence microscopy and the results presented in Figure 3. 10.
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Figure 3. 10

















Legend for Figure 3.10
Comparison of the percent apoptosis induced in monocyte enriched
(92 ± 2% monocytes) and lymphocyte enriched (89 ± 1% lymphocytes)
populations after incubation with cycloheximide (50 pM) for 24
hours. Cycloheximide induced a significant increase in apoptosis
(determined by acridine orange fluorescence microscopy) only in the
monocyte enriched cells (p<0.05). (Mean ± SE, n = 3).
This shows that cycloheximide induces a 6.6 fold increase in the percent
apoptotic cells in the monocyte rich population (p<0.05) whilst only a 1.6
fold increase in the lymphocyte rich population (p = n/s), indicating that
cycloheximide does not significantly promote lymphocyte apoptosis.
Lymphocyte preparations initially contained 11 ± 1% monocytes. After 24
hours there were 9 ± 0.4% non-apoptotic monocytes in the controls but
only 3.5 ± 0.4% in the cycloheximide treated population, raising the
possibility that apoptosis in the contaminating monocytes may partially
account for the small rise in the percentage of apoptotic cells in the
lymphocyte enriched population. There was no significant increase in
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the percentage of apoptotic cells in lymphocyte enriched populations
cultured for 72 hours (data not shown). This would be consistent with
previously published data showing that cycloheximide does not promote
lymphocyte apoptosis (Wyllie, 1984; Shi, 1990).
3. 2. 6 Dose Response for Induction of Apoptosis in Macrophages
by Cycloheximide.
Using acridine orange as the standard method to quantify apoptosis
together with confirmation by flow cytometry, the dose response of
cycloheximide (1 - 500 pM) for induction of Mo apoptosis was
determined. The percent apoptosis was assessed after 14 hours and the
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Legend for Figure 3.11
Suspension cultures of human Mo were incubated with increasing
concentrations of cycloheximide or an equivalent volume of ethanol
as control (Cycloheximide 0 pM). After 14 hours, the percentage
apoptosis was determined morphologically by acridine orange
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fluorescence microscopy and by flow cytometry and viability by the
ability to exclude trypan blue, results are expressed as mean ± SE, n =
5. There was no significant difference between percentage apoptosis
as assessed morphologically or by flow cytometry. At concentrations
of 10 and 50|iM cycloheximide the percentage apoptotic cells were
significantly greater than the non-viable cells. In two separate
experiments - not plotted - 500 |iM cycloheximide was also used,
where 70.2 ± 8.9 % cells were apoptotic by flow cytometry, 61 ± 11% by
acridine orange, 51 ± 4.9% cell were non-viable.
Cycloheximide exerted similar pro-apoptotic effects upon alveolar Mo
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Legend for Figure 3.12
Suspension cultures of 7 day murine bone marrow derived Mo and
human alveolar Mo were incubated with increasing concentrations
of cycloheximide or with 10 |ll ethanol (equivalent to the maximum
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volume cycloheximide added) as control (Cycloheximide 0 pM).
Percent apoptosis was determined morphologically by acridine orange
fluorescent microscopy after 18 hours. In control cultures 4.3 ± 2.0%
of murine bone marrow Mo and 10.8 ± 2.2% of alveolar Mo were
non-viable as determined by trypan blue exclusion, this increased to
6.3 ± 4.2% and 17.8 ± 3.4% for 50 pM cycloheximide and 10 ± 3.5% and
27 ± 3.1% for 100 pM cycloheximide. Mean ± SE, n = 4 for each cell
type.
3. 2. 7 Effect of Cycloheximide as a Protein Synthesis Inhibitor.
An experiment was performed to confirm that cycloheximide, at the
concentrations used in this project, was acting to inhibit protein synthesis
in Mo; the methods are detailed in section 2. 8. Briefly, Mo were washed
in methionine free medium, 35S methionine added and 4 x 106 Mo in
methionine free medium were placed into Teflon foils, containing either
5 or 50 pM cycloheximide or ethanol as control. The cells were harvested
after 20 hours incubation and the percentage apoptosis counted by
acridine orange fluorescence microscopy. Mo were washed 3 times and
the protein pellets precipitated, these fractions were counted in a beta
counter to assess the incorporation of label as a measure of new protein
production, the results are shown in Table 3. 3. Incubation of Mo in 50
pM cycloheximide resulted in almost total inhibition of protein
synthesis, this was the dose that was subsequently used in all
experiments. Since this experiment required a large number of cells (12 x
106 Mo, corresponding to an initial 28 - 34 x 106 monocytes), necessitating
a large volume of blood (300 mis) from a single donor, this experiment
was performed only once.
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Table 3. 3
Protein Synthesis Inhibition Induced by Cycloheximide.
Cells Protein Pellets
% Apoptosis cpm Counts as % control
Control 3 49179 100
5 pM cycloheximide 5 8452 17
50 pM cycloheximide 60.5 945 1.9
Wash Wash 1
cpm
Wash 2 Wash 3
Control 2 726 624 58 256 158 477
5 pM cycloheximide 3 219 768 112 003 20 137
50 pM cycloheximide 3 195 009 80 620 13 937
3. 2. 8 Flow Cytometric Separation of Apoptotic and Non-
Apoptotic Cells.
Cycloheximide treated Mo were separated on the basis of cell size using a
Becton Dickinson Cell Sorter. Three experiments were performed where
Mo were treated with 50 pM cycloheximide for 18 hours yielding 18.1, 70.1
and 30.9% "shrunken" cells in the Apoptotic Mo Gate and 21.5, 63 and
21% apoptotic cells by acridine orange counts respectively. After sorting
Mo on the basis of forward and side scatter into normal size and
shrunken cells, the percentage of apoptotic cells in the Mo Gate and
apoptotic Mo Gate on the EPICS II flow cytometer were determined and
related to the percentage of apoptotic cells determined using acridine
orange fluorescence microscopy, results are shown in Table 3. 4.
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Table 3. 4
Acridine Orange and Flow Cytometry Counts of Macrophage Apoptosis
Parallel Each Other.
% Apoptotic Cells in
Mo Gate





















Legend for Table 3. 4
Results from three separate suspension cultures of human Mo from
different donors, exposed to cycloheximide for 18 hours and sorted on
the basis of cell size using a Becton Dickinson Cell Sorter. The % cells
morphologically apoptotic when stained with acridine orange (AO)
were compared with the % cells falling into the Mo Gate and the
Apoptotic Mo Gate determined by forward and side scatter parameters
on a Coulter EPICS II flow cytometer.
Hence the percent cells in the Apoptotic Mo Gate closely paralleled the
acridine orange count of apoptotic cells. To confirm that these cells were
indeed Mo, their expression of HLA-DR was determined. Relative to the
non-binding control mAb MOPC-21C, 96.3% of cells from within the Mo
Gate and 86% within the Apoptotic Mo Gate were HLA-DR positive, with
a mean fluorescence of 120 and 28.4 respectively.
124
Gel electrophoresis of the DNA extracted from the sorted population
confirmed that there was DNA fragmentation in those cells falling in the
Apoptotic Mo Gate. In contrast there was only a very weak ladder pattern
in the normal size cell population (Mo Gate), consistent with the low
percentage of apoptotic cells remaining.
3. 2. 9 Surface Molecule Changes Associated with Macrophage
Apoptosis.
The effect of apoptosis on the expression of 4 key Mo surface markers,
CDlla, CDllb, CD14 and HLA-DR was determined, relative to that of the
non-binding MOPC-21C control mAb. Since apoptotic and non-apoptotic
Mo could be distinguished on the basis of forward and side scatter using
flow cytometry, the relative binding of different mAb to non-apoptotic
and apoptotic cells could be determined flow cytometrically by specific
gating. Monocyte expression of these markers was determined and
compared with Mo from the same donors, matured in Teflon foils over 5
days. These Mo were treated with 50 (iM cycloheximide for 14 hours or
an equivalent volume of ethanol as control. The effect of cycloheximide
induced protein synthesis inhibition on Mo was controlled for by
determining the surface expression on non-apoptotic Mo which had been
exposed to cycloheximide for the same length of time as those that were
apoptotic and comparing this with control Mo not exposed to any
cycloheximide. The results are displayed in Table 3. 5, demonstrating that
there is a decrease in the expression of CDlla, CDllb and CD14 on Mo
relative to that of monocytes whilst the expression of HLA-DR increased
during maturation. Although apoptotic Mo showed significant loss of
expression of all 4 molecules compared with cycloheximide treated non-
apoptotic Mo, the almost total (96.1%) loss of CD14 was far greater than
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that of any of the other molecules tested (63.4% for HLA-DR, 68.1% for
CDlla and 80% for CDllb).
Table 3. 5
Expression of Macrophage Surface Markers During Differentiation and
Apoptosis.
Macrophages
Surface Control Non-Apoptotic Apoptotic
Marker Monocytes CHX treated CHX treated
CD14 111 ±5.1 42.9 ± 6.7§ 23.4 ± 4.11 1-7 ± 0.2**
HLA-DR 25.7 ± 2.1 93.9 ± 17.6# 96.4 ± 18.7 35.1 ± 12.3*
CDlla 63.5 ±4.4 9.6 ± 2.0§ 11.6 ±2.2 3.7 ± 0.5*
CDllb 68.1 ±5.7 9.2 ±4.36 14.5 ±3.5 2.9 ± 0.5*
§ Significant decrease from monocytes (p< 0.01)
* Significant increase from monocytes (p< 0.01)
1 Significant decrease in expression due to cycloheximide alone
(p<0.05)
* Significant decrease in expression due to apoptosis (p<0.01)
* * Significant decrease in expression due to apoptosis (p<0.0005)
Legend for Table 3. 5
Change in expression of CDlla, CDllb, CD14 and HLA-DR during
monocyte to Mo maturation and the further changes associated with
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cycloheximide induced apoptosis. The effect of cycloheximide alone
is controlled for by determining the expression of the surface
molecules on non-apoptotic Mo exposed to cycloheximide for the
same period of time as those that undergo apoptosis. Results are
expressed as mean fluorescence relative to that of a non-binding
control mAb, MOPC-21C. Results are sequential data from 19
individuals, expressed as mean ± SE.
This loss of CD14 seems to be a relatively early event during the apoptotic
process as continued culture of these apoptotic cells for a further 8 hours
allowed further loss of expression of the integrins CDlla, CDllb and
CD18 whilst CD14 had all been shed before the first determination of
surface molecule expression occurred (data not shown).
3. 2.10 Investigation of Phagocytosis in Macrophage Cultures.
Glucosamine has been shown to inhibit Mo uptake of apoptotic PMN
(Savill, 1989b). To investigate whether it could prevent Mo phagocytosis
of apoptotic Mo (i.e. any intrinsic "cannibalism"), cells were incubated for
14 hours in standard medium with added glucosamine (10 mM),
glucosamine (50 mM) or an equivalent volume of PBS (100 pi) as control
and the percent apoptotic cells then determined morphologically (n = 3).
Inclusion of glucosamine had no significant effect on the percentage of
apoptotic Mo at 14 hours, occasional phagocytosis was still observed and
cell recoveries were identical between treatments. To confirm inhibition
of uptake of apoptotic cells, a proportion of Mo from one of the
experiments were incubated with aged PMN (65% apoptotic) in the
presence and absence of glucosamine (50 mM) for 30 minutes.
Glucosamine reduced the percentage of phagocytosis from 28.7% and
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25.1% in the 2 control wells to 20.4% and 19.2% in the glucosamine
treated wells, approximately a 24% inhibition in this experiment.
Glucosamine had no effect on Mo phagocytosis of opsonized zymosan.
None of the documented inhibitors of phagocytosis of apoptotic cells
(including amino sugars, blocking mAb to av(33 and CD36) produce
complete inhibition of uptake (Savill, 1989b, 1990 and 1992). Even if the
bulk of clearance of apoptotic Mo was by phagocytosis, to try and assess
this using only partial inhibitors is unsatisfactory. Unless the rate of
clearance of apoptotic cells by the remaining uninhibited Mo was
previously saturated and could not be increased, any effect of a partial
inhibitor could be obscured by increased phagocytosis by the remaining
functional Mo.
To address the question in a different manner, Mo were labelled with
fluorescent microspheres and apoptosis induced by cycloheximide. The
aim was to separate apoptotic cells using a cell sorter and then quantify
the ingestion of apoptotic Mo by their non-apoptotic counterparts.
Technically this proved impossible due to release of significant quantities
of the microspheres from "fragile" apoptotic cells.
The increase of apoptotic Mo in the presence of cycloheximide (section 3.
2. 5) suggested that although phagocytic clearance undoubtedly occurs it
does not account for the bulk of apoptotic Mo. The presence of "ghost
cell" bodies in monocyte cultures suggests that not all apoptotic cells are
phagocytosed and they can instead continue to disintegrate in culture
progressing towards secondary necrosis as described by Arends et al. for
thymocytes (Arends, 1990). In view of these technical constraints, the
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poor inhibition achieved with glucosamine and the lack of information
on the time course of inhibition of phagocytosis and of any specific
inhibitors capable of total blockade of apoptotic Mo uptake, this line of
investigation was not pursued further.
3.3 DISCUSSION
In this chapter I have shown that human monocytes can be isolated in
sufficient quantity and purity by both density gradient centrifugation and
by CCE and that these cells can be successfully matured into Mo either i n
suspension cultures in Teflon foils or by adherence to tissue culture
plastic. The yields and purity were slightly greater from elutriation
prepared monocytes but due to insoluble problems with cell viability
during in vitro culture this preparative method had to be abandoned.
There was a steady attrition of monocyte numbers during maturation
into Mo and to maximize Mo yields, the ideal starting concentration of
monocytes in culture was shown to be 1 x 106 cells/ml. Over 5 days in
culture nearly 55% of monocytes were lost, approximately 11% daily.
Approximately 4.3% apoptotic monocytes were seen at any one time
which suggested that apoptotic monocytes last for only 8 to 10 hours (see
Appendix 1). Multinucleate giant cell formation, an uncommon event in
suspension culture, did not account for the observed decline in cell
numbers. The morphological counts also confirmed that cell necrosis, at
less than 0.1% could not explain this loss either, especially as data from
the freeze/thaw experiments (section 3. 2. 4) demonstrated that necrotic
Mo had a life span of several hours. The greater than 40 fold excess in
apoptosis over necrosis suggested that cells died by apoptosis whilst the
lack of correlation between the percent apoptosis seen at any one time
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and loss of cells demonstrated by total counts indicated that the apoptotic
cells were short lived. A similar rate of loss was not observed for Mo.
The mechanism underlying the disappearance of these cell bodies rather
than their persistence and accumulation needs to be explained. Certainly
after the first 3 days in culture the cells have gained phagocytic ability and
this could explain the disappearance of the apoptotic cells. In support of
this was the fact that non-apoptotic Mo could be seen to contain apoptotic
bodies with reasonable frequency (Figure 3. 5). This is not an isolated
observation, Mo phagocytosis of apoptotic Mo has now been
demonstrated by Khan et al. (Khan, 1993). Interestingly, results from
three experiments suggest that glucosamine, an inhibitor of interaction of
Mo with apoptotic PMN (Savill, 1989b), did not increase the percentage of
apoptotic Mo observed in culture, although there are a number of
problems with interpretation of this data, as discussed in section 3. 2. 10.
In the in vitro system described here, the persistence of the apoptotic
body may be limited not because of phagocytosis but because of fragility.
Certainly during the first 3 days in culture, prior to monocytes gaining
phagocytic capacity, a different mechanism is needed to explain the
disappearance of cells. An alternative explanation would be a relatively
short life-span for the apoptotic monocyte. Unlike populations of
apoptotic PMN, 95% of which retain the ability to exclude the vital dye
trypan blue for 20 hours after the onset of significant apoptosis (Savill,
1989a), apoptotic monocytes and Mo are not so resilient. Although after
18 hours incubation with 50 |iM cycloheximide the percentage Mo
apoptosis was significantly greater than the percentage trypan blue
positive cells, at other times and with other concentrations of
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cycloheximide, the percentage monocytes and Mo that were trypan blue
positive was often 50% or more of that of the percent apoptotic cells (see
Figures 3. 8 and 3. 11). This suggests a greater membrane fragility of
apoptotic monocytes and Mo than that of apoptotic PMN. This fragility
was further demonstrated on cytospin preparations. Apoptotic PMN are
relatively robust cell bodies which withstand the process of
cytocentrifugation, which was not the case for apoptotic monocytes and
Mo which usually fragmented completely and were poorly demonstrated
by cytospin, hence the requirement for morphological counts of apoptosis
by the relatively gentle method of acridine orange fluorescent staining.
Finally, when acridine orange stains of 8 well slides of monocytes were
viewed over the first 72 hours, indistinct bodies could be seen that did not
contain any nuclear material (Figure 3. 4). These "ghost cells" were
fragile and disrupted during resuspension. Others have reported trypan
blue positive bodies without any defined nuclear or cytoplasmic structure
in myeloid cell lines treated with cytokines to induce apoptosis (Lotem,
1992). Furthermore cycloheximide treatment of monocytes not only
increased the numbers of apoptotic cells but with time progressively
smaller apoptotic nuclear fragments and increasing numbers of "ghost
cells" were seen (Figure 3. 4iii). Together these data suggest that "ghost
cells" are fragile late monocyte apoptotic bodies that have extruded all
nuclear material. It seems most likely from the above considerations that
monocytes undergo constitutive apoptosis at a rate of approximately 0.5%
per hour in the presence of serum and that apoptotic monocytes are short
lived relatively fragile bodies. During the early stages of monocyte
culture, apoptotic cells progressively lose their nuclear material,
remaining only as intact apoptotic cells for 8-10 hours thereafter
becoming indistinct "ghost cell" bodies, thus only approximately 4% of
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apoptotic cells will be observed in any single "snapshot" of these cells.
Later when Mo gain phagocytic competence they may cannibalize the
apoptotic cells although the relevance of this route of clearance is still
unclear. For this reason I used both morphologic counts of apoptosis and
estimates of total cell number to determine cell loss.
The protein synthesis inhibitor cycloheximide consistently induced
apoptosis in monocytes and Mo, providing a reproducible model for the
study of Mo apoptosis. This finding is in accord with that of Waring who
demonstrated that the protein synthesis inhibitors ricin and
cycloheximide, as well as actinomycin D all induced apoptosis in murine
Mo (Waring, 1990). Cycloheximide is known to also induce apoptosis in
PMN (Haslett, 1994) but to retard the rate of apoptosis in thymocytes
(Wyllie, 1984). Cycloheximide also increased the percent apoptotic cells in
monocyte enriched cultures from 3.5 to 23.2% but in lymphocyte enriched
cultures apoptosis was only increased from 4 to 7% and this increase was
considered to represent increasing apoptosis among contaminating
monocytes. The differential effect of cycloheximide on the induction of
apoptosis in cells is of interest mechanistically as it suggests that distinct
cell populations have different controls on the induction of apoptosis.
Monocyte and Mo apoptosis was confirmed by a number of methods
including the two "gold standards" - electron microscopy and DNA
electrophoresis. However for rapid quantification alternative methods
were sought. Acridine orange morphological counts and flow cytometric
determination of apoptosis were shown to parallel each other and as
there was little evidence of cell disruption they were suitable for routine
use. Cell sorting techniques, verified by DNA gel electrophoresis
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confirmed that both acridine orange fluorescent microscopy and flow
cytometry were accurate and reproducible methods for determining
apoptosis in monocyte and Mo populations.
Other investigators have used a number of different methods to assess
cell survival, viability and cell numbers. The direct cell count of fixed
cells conforms with the methods of Johnson et al. , whilst Mangan et al.
used propidium iodide (PI) staining of DNA to determine cell viability
and apoptosis (Johnson, 1977; Mangan, 1991a). It is unlikely that PI
staining would distinguish "ghost cells", as they do not have any nuclear
material as demonstrated by acridine orange staining. I investigated PI
staining but found that the high background fluorescence of Mo
populations, especially alveolar Mo, obscured changes associated with
apoptosis. Furthermore, there was an increase in PI uptake with time
during monocyte culture, making comparisons over time difficult.
Interestingly, CD14 was found to be extensively lost from the surface of
apoptotic Mo. The significance of this observation was investigated by
examining the changes in surface expression during the apoptotic process
of a number of functionally important molecules. Despite reduction in
expression during apoptosis of both the integrins CDlla and CDllb and
in HLA-DR expression, the loss of CD14 was a much more pronounced
event, being ten fold greater in magnitude. There may be interesting
parallels with the loss of the GPI linked molecule CD16 on apoptotic
PMN (Dransfield, 1994). Like apoptotic Mo, apoptotic PMN lose only
specific surface molecules with apoptosis, notably apoptotic PMN also
retain CDllb/CD18 expression (Dransfield, 1995). The loss of CD14 is
unlikely to be due to any prior cellular activation, TNF, IL-1 and LPS
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having all been shown to increase CD14 expression (Zeigler-Heitbrock,
1993). Despite the GPI linkage it seems that CD14 shedding does not occur
by phosphatidyl inositol cleavage, rather it is by protease digestion (Bazil,
1991). The physiological relevance of this to the apoptotic process is
unknown but it is of interest that this loss of CD14 seems to occur early in
the apoptotic process. This may "functionally isolate" these Mo and thus
act as a control on Mo responses, however soluble CD14 in combination
with LPS binding protein may retain the capacity to present LPS to non-
CD14 expressing cells (Haziot, 1993). Thus it is possible to argue that
receptor shedding may both increase or decrease responses to LPS.
Hence in summary, a reliable system for isolation and culture of
monocytes was established that allowed for their maturation into Mo.
Exposure to 50 pM cycloheximide for 14 - 18 hours consistently induced
apoptosis which could be easily quantified by acridine orange fluorescence
microscopy and/or flow cytometry along with an estimate of total cell
numbers. Acridine orange morphological counts were used routinely as
many experiments included both suspension and adherence cultures, and
acridine orange counts could be easily performed on the adherence
cultures without disturbing the cells. Where suspension cultures alone
were used, both methods of assessment were usually employed. With
this essential background information relating to monocyte and Mo
culture in vitro and preliminary characterization of the apoptotic process
in these cells, I sought to investigate factors affecting monocyte and Mo
apoptosis (detailed in Chapter 4 and 6) and to further characterize the
changes in surface phenotype of these apoptotic cells (detailed in Chapter
5). The investigation of the in vivo relevance of Mo apoptosis during
the resolution of inflammation is discussed in Chapter 7.
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3. 4 Appendix 1
After 120 hours in vitro suspension culture (10% serum), monocytes
numbers had declined linearly to approximately 46.5% of the starting
number (see Table 3. 2). For a starting cell count of 1 x 107 cells this would
represent a final recovery of 4.65 x 106 cells, or a loss of 5.35 x 106 cells over
120 hours, which - if this truly is a linear decline - represents a loss of 44
600 or 0.446% cells/hour. In the following table the life-span of an
apoptotic monocyte was taken to be 10 hours. Using this assumption, the
expected number of monocytes and corresponding percentage of apoptotic
cells in culture are shown and are compared with the actual counts.
Time Total cells Apoptotic cells Actual Apoptosis
(Hrs) (No.) (No.) (%) (%)
0 10 000 000 0 0 2.1
1 9 955 400 44 600 0.446 -
2 9 910 999 89 001 0.890 4.4
3 9 866 789 133 204 1.33 -
4 9 822 783 177 210 1.77 4.1
5 9 778 973 221 020 2.21 -
6 9 735 359 264 634 2.65 4.4
7 9 691 939 308 054 3.08 -
8 9 648 713 351 280 3.51 4.2
9 9 605 680 394 313 3.94 -
10 9 562 839 437 154 4.37 4.0
11 9 520 189 435 204 4.37 -
12 9 477 729 433 263 4.37 4.6
13 9 435 458 431 331 4.37 -
14 9 393 376 429 407 4.37 -
After 10 hours the initial 44 600 apoptotic cells will have disappeared (by
disintegration or being eliminated by some other means) hence the total
number of apoptotic cells will peak at this time and there after decline.
Although new apoptotic cells will be added they will come from a smaller
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pool of non-apoptotic cells. The percentage of apoptotic cells will remain
constant however at 4.37% as the slowly declining pool of apoptotic cells
remains a constant proportion of the slowly declining total number of
cells. Using similar calculations it can be seen that if the life-span of
apoptotic cells was longer, e.g. 20 hours then the percentage of apoptotic
cells would steadily increase to 8.54% by 20 hours and then remain
constant. Likewise if the half life was shorter e.g. 5 hours the percentage
of apoptotic cells would plateau at 2.21% after this time in culture.
Comparison of this calculation with the actual results obtained (shown in
italics here - full results in Table 3. 2) demonstrate several things:
• The measured percentage of apoptotic cells was 4.3% at any single time
point, so this calculation would suggest that the life-span of these cells
was approximately 10 hours.
• The measured percentage of apoptotic cells differed from that expected
using this simple calculation over the first few hours, if the life-span of
the apoptotic cells was 10 hours. This calculation suggests that there
would be a steady increase in the percentage of apoptotic cells to a
maximum of 4.37%, however in reality the percentage of apoptotic cells
was similar at 4, 6, 8, 10, 12 and 18 hours.
• This calculation assumes that there are no apoptotic cells at the start
while infact approximately 2% of the cells were apoptotic at this time.
Recalculating, starting with 2% apoptotic cells, still underestimates the
true percentage of apoptotic cells over the first four hours.
• This suggests that although there is a relatively steady decline in cell
number, the rate with which cells undergo apoptosis may not be constant.
Initially there may be a small wave of apoptosis and thereafter a relatively
constant number of cells become apoptotic and these apoptotic cells may
well have a life-span of approximately 10 hours. This suggests, as would
be expected, that human peripheral blood monocytes are unlikely to be a




CYTOKINES AND SERUM SURVIVAL FACTORS IN
MONOCYTE AND MACROPHAGE APOPTOSIS.
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4.1 INTRODUCTION.
Despite clear evidence that the life and death of cells are influenced by
cytokines and survival factors in serum, the factors contributing to Mo
longevity are unknown. It is well established in vivo that Mo survive
for many days (van Furth, 1992) and this has also been shown for Mo in
in vitro cultures (Helinski, 1988; Brugger, 1991). Cell survival is
influenced by many factors, principally by cytokines and growth factors
but also by cell - cell contact and cell - matrix interactions and in vitro by
adherence (Khan, 1993). In vitro cultured Mo require serum for
appropriate survival (Mangan, 1991a; Munn 1995) and differentiation
(Brugger, 1991). The exact nature of the survival factor(s) in serum are
unclear although certainly in the murine system CSF-1 is crucially
important (Tushinski, 1982).
At the outset of this project there were only two reports on factors that
could induce Mo death, both on murine Mo; ATP, cytotoxic T
lymphocytes and protein synthesis inhibition (cycloheximide or
actinomycin D) had been shown to cause Mo apoptosis whilst 20 mM
hydrogen peroxide and freeze thawing caused necrosis (Waring, 1990;
Hogquist, 1991a). These studies provided insight into mechanisms
involved in the apoptotic process, demonstrating the importance of the
protein synthetic machinery for Mo survival (Waring, 1990) and
implicating a role for ICE during Mo apoptosis (Hogquist, 1991a). These
studies did not address the issue of physiological controls on Mo survival
and the mechanisms involved in Mo longevity. Mangan et al.
demonstrated that monocytes rapidly undergo apoptosis in response to
serum withdrawal and that this could be prevented by physiologically
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relevant activating signals including LPS, TNF-a and IL-1 (Mangan 1991a
and b). They proposed that monocytes may be short lived cells requiring
continued stimulation to survive. This suggested to me that there may
be a difference between monocyte and Mo survival characteristics.
If control of monocyte or Mo longevity represents an important
mechanism through which inflammation is limited then one may
postulate that cytokines could exert differential regulatory effects on
survival of these cells. The early pro-inflammatory cytokines TNF-a and
IL-1 would be expected to delay apoptosis, whilst the cytokines involved
in the resolution stages of inflammation, such as TGF-(3 or IL-4 may be
pro-apoptotic.
I therefore aimed to investigate the physiological controls of monocyte
and Mo survival including the influence of serum, adherence, the effects
of a range of cytokines and the relationship between these factors. To
explore the possibility of a difference in monocyte and Mo survival
characteristics I examined a range of cell types; the promonocytic U937 cell
line, human monocytes, human monocyte-derived Mo, alveolar Mo, as
well as murine bone marrow derived Mo. This spectrum of cells was
chosen as differential sensitivities to potential regulatory factors might be
expected to be revealed at different maturational stages.
4.2 RESULTS.
4. 2.1 U937 Cells Die Rapidly by Apoptosis in the Absence of
Serum.
U937 cells, maintained in log phase growth, had a doubling time of
approximately 2-3 days cultured in RPMI supplemented with 10% FCS
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and 2 mM L-glutamine. When washed twice and resuspended at
approximately 1 x 106 cells/ml these cultures contained 7 ± 1.8% (n = 4)
apoptotic cells, determined both morphologically and by flow cytometry.
This was confirmed by CCE separation of non-apoptotic and apoptotic
cells (Figure 4. 1). As shown in Figure 4. 2, there was no significant
increase in apoptosis over 6 hours when U937 cells were cultured in
RPMI containing 10% FCS and L-glutamine. This contrasted with a huge
rise in apoptosis within 1 hour when cells were cultured in RPMI plus L-
glutamine alone (no 6 hour time point reported as extensive secondary
necrosis invalidated morphological assessment of apoptosis and
estimates of cell recovery). There was also a significant rise in the
number of apoptotic U937 cells after 6 hours culture in IDMEM alone (p <
0.01, n = 4). Cell counts in RPMI with 10% FCS rose from 1.14 ± 0.08 at the
start to 1.43 ± 0.06 x 106/ml after 1 hour and 1.57 ± 0.09 xlO6/ml by 6 hours.
The corresponding count for RPMI at 1 hour was 0.48 ± 0.15 x 106 cells/ml
(p<0.05, n = 4) and for IDMEM at 1 and 6 hours were 1.18 ± 0.05 xl06/ml
and 0.89 ± 0.08 106/ml respectively.
To determine whether altered pH accounted for this rapid death in RPMI,
the pH of the media was determined at 1 hour and was 7.61, 7.60 and 7.74
for RPMI with 10% FCS, IDMEM and RPMI respectively, suggesting that
there may be differences in the buffering capacity of the media that
account for these findings. There was no further change in the pH of the
medium by the 6 hour time period (7.59 and 7.60 for RPMI with FCS and
IDMEM respectively) indicating that the later rise in the apoptosis levels
in IDMEM may be a serum depletion effect.
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iii) DNA Gel Electrophoresis.
1 U937 Cells Pre-CCE
2 Post-CCE (a) Non-Apoptotic
3 N/A
4 Post CCE (b) Apoptotic
5 Post CCE (b) Apoptotic
Legend for Figure 4. 3 Flow cytometry of serum free cultures of U937 cells
using forward and side scatter demonstrated 2 populations/ these were
separated by CCE and using both acridine orange fluorescence microscopy
(not shown) and DNA gel electrophoresis, the larger cells (a) were shown
to be non-apoptotic and the smaller cells (b) were shown to be apoptotic.
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Figure 4. 2



















Legend for Figure 4. 2
U937 cells were washed, resuspended at approximately 1 x 106
cells/ml and cultured in RPMI supplemented with 2 mM L-
glutamine and 10% FCS (Serum), RPMI with 2 mM L-glutamine
(RPMI) or IDMEM with 2 mM L-glutamine (IDMEM). Flasks were
resuspended at either 1 or 6 hours when cells were counted,
percentage apoptosis determined by acridine orange fluorescent
microscopy and flow cytometry and the pH of the media measured.
4. 2. 2 Effects of Serum Withdrawal and Adherence on Monocyte
and Macrophage Survival.
Serum withdrawal caused a significant loss of adherent cultured
monocytes, with a 25 ± 4.3% reduction in number over 42 hours in
culture, compared to only a 1.3 ± 1% reduction in the presence of serum
(p< 0.01, n = 6) as shown in Figure 4. 3. After the initial 3 washes to
remove serum, cells remained undisturbed until counted, hence this
difference could not be attributed to cell detachment and loss during
washes. Cell counts were performed by racking down through the depth
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of the culture medium in order to detect non-adherent cells; there were











Effect of Serum Withdrawal and Adherence








Legend for Figure 4. 3
Loss of human monocytes and Mo after 42 hours culture in the
presence of 10% autologous serum (Serum) or medium alone (No
Serum). Cells were cultured either adherent to 8 well slides or in
suspension in Teflon foils, the percentage of the original number of
cells remaining after 42 hours was estimated from changes in
haemocytometer counts after resuspension of cells (for suspension
cultures) and by counting the number of cells per high power field
(HPF) (in adherent cultures). Results are sequential data for
monocytes and Mo derived from 6 individuals and expressed as
mean ± SE.
Figure 4. 3 also shows that the recovery of monocytes was lower when the
cells were cultured in suspension, whether in the presence or absence of
serum. Cell loss was significantly greater for monocytes cultured in the
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absence of serum (76 ± 3% reduction in cell number in the absence of
serum compared with 43 ± 9% with serum, p <0.05). In contrast to
monocytes, culturing Mo in the presence or absence of serum, whether
adherent or not, did not affect the number of cells recovered, as shown in
Figure 4. 3 there was no significant change in Mo cell number over the 42
hour time course, raising the possibility that there are differences in the
regulation of apoptosis for monocytes and Mo.
4. 2. 3 Monocytes Die by Apoptosis in the Absence of Serum.
Figure 4. 4 demonstrates that adherent cultured monocytes had
significantly higher levels of apoptosis in the absence than the presence of
serum by 18 hours, this effect increasing at 42 hours and 5 days.
Figure 4. 4




18 Hours 42 Hours 120 Hours
Time in Culture
Legend for Figure 4. 4
Percentage apoptosis in adherent monocytes cultured in the presence
(Serum) or absence (No Serum) of 10% autologous serum in 8 well
slides. Apoptosis determined by acridine orange fluorescent
microscopy. Data are sequential results from 13 individuals expressed
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as mean ± SE. At each time point there is a significantly greater
percentage apoptotic cells in the absence than the presence of serum
(p<0.05 at 18 hours, p<0.01 at 42 hours and p<0.0001 at 120 hours). In
the absence of serum the percentage of apoptotic cells increases
significantly at 42 hours (p <0.01) and again at the 120 hours (p < 0.01),
in the presence of serum there is no significant change.
Comparison of the percentage apoptosis with the percentage of cell loss in
the absence of serum (percentage apoptosis of 8.3 ± 1.9% and 18.5 ± 3.6%
for 42 hours and 5 days whilst cell loss of 25 ± 4.3% and 76 ± 3.2%
respectively) revealed that cell losses were greater at each time point than
the recorded morphological levels of apoptosis. There was no
morphological evidence of necrosis at any time and DNA electrophoresis
confirmed the morphological findings of increased monocyte apoptosis
in the absence of serum.
As noted earlier, there was no significant decrease in Mo recovery
following 42 hours culture in the presence or absence of serum.
Although there was a very small, statistically significant increased
percentage of apoptosis in Mo cultured in the absence of serum (1.6 ±
1.2% vs. 2.2 ± 1.3% in the presence and absence of serum respectively), the
low percentages did not affect cell numbers significantly. Monocytes had
significantly greater levels of apoptosis after 42 hours in the absence of
serum than Mo (8.3% vs. 2.2% p<0.01) and likewise for cell loss (25 ± 4.3
vs. 2.2 ± 1.3 p <0.001).
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4. 2. 4 Murine Bone Marrow Derived Macrophages Die Rapidly in
the Absence of Serum.
Seven day murine bone marrow derived Mo were cultured in either
standard medium (IDMEM, 25% FCS, 25% L 929 cell supernatant) or in
IDMEM alone. After 6 hours there was a significant increase in apoptosis
in those cells cultured in the absence of both serum and L929 supernatant,
this difference was more marked by 18 hours when it was also reflected in
changes in cell numbers. After 42 hours in culture marked differences in
recovery were obvious but far less apoptosis was evident as shown in
Table 4. 1. The addition of FCS but not CSF-1 partially prevented this cells
loss suggesting that serum and CSF-1 were acting independently.
Table 4.1
The Effect of Serum and CSF-1 on Murine Bone Marrow Derived
Macrophage Survival Over 42 Hours.
6 Hours 18 Hours 42 Hours
Apop Recovery Apop Recovery Apop Recovery
(%) m (%) m m m
Medium 14.2± 3** 100 ± 5 38.3 ± 10** 70 ± 5* 4.8 ±1 34 ± 7**
FCS - - - - 2.0 ± .5 60 ± 6*
FCS + CSF-1 1.7 + 1 100 ±3 2.8 ± 2 110 ±4 0.3 ± .1 95 ± 3
Legend for Table 4.1
Murine bone marrow derived Mo, seeded in Teflon foils at 0.375 x 106
/ml, were washed on day 5, resuspended at 1 x 106/ml, washed twice
on day 7 and resuspended at 1.75 ± 0.3 x 106/ml in either IDMEM
alone (Medium), IDMEM with FCS (FCS) or IDMEM, FCS and L929
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supernatant (FCS + CSF-1). Percentage apoptosis was determined by
acridine orange fluorescent microscopy and cell numbers by
haemocytometer counts. Cell recoveries at 6, 18 and 42 hours are
expressed as percentage of the initial cell number with 100%
representing no change (n = 4). Comparison is made between FCS +
CSF-1 and other treatments for each time point and significance
denoted by * for p<0.05 and ** for p<0.01.
4. 2. 5 Alveolar Macrophages Die by Apoptosis in the Absence of
Serum.
Culturing human alveolar Mo in suspension for 84 hours in the absence
of serum resulted in a 30 ± 9% reduction in the number of cells recovered
compared with a loss of only 10 ± 3 % in the presence of serum (n = 3). At
this time point there were 27.1 ± 12% and 5.4 ± 1.2% apoptotic cells in the
absence and presence of serum respectively. There was no difference in
the amount of apoptosis at 18 hours: 8.95 ± 2.5% and 8.75 ± 2.25% in the
presence and absence of serum respectively (n=8). Due to difficulties in
recruiting volunteers to undergo bronchoalveolar lavage these numbers
did not achieve statistical significance, however a trend towards increased
apoptosis in the absence of serum was apparent.
4. 2. 6 Effect of Cytokines on Monocyte and Macrophage Apoptosis.
4. 2. 6.1 Effect of TNF-a on Monocyte and Macrophage Apoptosis.
TNF-a at 1000 units/ml delays monocyte apoptosis in serum free
medium (Mangan, 1991a) but induces apoptosis in PMN at a
concentration of 100 to 1000 units/ml (Takeda, 1993; Tsuchida, 1995). Data
presented below demonstrates that the addition of 200 -2000 units of TNF-
a (approx. 10 - 100 ng/ml) did not alter the percent apoptosis seen for
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either monocytes or Mo when cultured in the presence of serum. This
was true for both suspension and adherent cultures. Results are
summarized in Table 4. 2.
Table 4. 2








Control 4.9 ± 2.9 4.3 ± 2.6 1.7 ±0.5 1.1 + 0.4
TNF-a 4.1 ±3.1 4.3 ±2.1 1.3 ±0.9 1.8 ±0.8
n
Legend for Table 4. 2
Percentage of apoptotic monocytes or Mo after 42 hours suspension
culture (seeded at 1 x 106/ml) or adherent culture (8 well slides) in the
presence or absence of 2000 units/ml TNF-a. The results were the
same for 200 and 800 units/ml of TNF-a (data not shown). There was
no significant difference between any of the treatments.
As TNF-a exhibits an early (6 hour) apoptosis promoting effect and a later
(20 hour) apoptosis preventing effect when added to PMN (Dr. E.
Chilvers, personal communication), apoptosis counts were made at 6, 18
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and 42 hours for both monocytes and Mo cultured in serum in 8 well
slides to determine if the same pertained for these cells. The results,
shown in Table 4. 3, demonstrate that TNF-a had no significant effect on
apoptosis at any of these time points.
Table 4. 3
TNF-a has no Time Dependent Effect on Monocyte or Macrophage
Apoptosis.
% Apoptosis
6 hours 18 hours 42 hours
Monocytes
Control 4.9 ±0.9 3.7 + 1.1 3.2 + 1.1
TNF-a 4.2 ±1.0 4.0 ± 0.9 5.1 ±1.3
Macrophages
Control 1.7 ±0.6 1.9 ± 0.4 2.5 ± 1.0
TNF-a 1.9 ±0.3 1.9 ±0.5 2.4 ± 0.8
Legend for Table 4. 3
Percentage apoptosis for adherent cultures of monocytes and Mo in
the presence or absence of 2000 units/ml TNF-a. Results are the
means ± SE, n = 3, p = n/s. TNF-a does not affect cell recovery
(cells/HPF) for cells cultured in the presence of serum.
Examination of cell recovery after 5 days suspension culture showed no
difference between control and TNF-a treated cells. Monocytes were
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cultured at 1 x 106/ml in 10% autologous serum in the presence or
absence of 2000 units/ml TNF-a and cell counts after 5 days were 0.46 ±
0.09 x 106/ml and 0.50 ± 0.10 x 106/ml respectively (p = n/s, n=3).
4. 2. 6. 2 TNF-a and Serum Withdrawal.
Figure 4. 5 shows that 2000 units but not 200 units/ml TNF-a significantly
prevented the pro-apoptotic action of serum withdrawal on adherent
cultured human monocytes.
Figure 4. 5
TNF Partially Reverses the Pro-apoptotic
Effect of Serum Withdrawal on Monocytes
12 "1
TNF No TNF TNF No TNF
+ SERUM No SERUM
Legend for Figure 4. 5
Results are means ± SE for 4 paired experiments with human
monocytes cultured in the presence or absence of serum with or
without TNF-a 200 or 2000 units/ml, in 8 well slides under standard
conditions for 24 hours. The percentage of apoptotic cells was
determined morphologically by acridine orange fluorescent
microscopy. Serum withdrawal significantly increased the percentage
of apoptotic cells (p<0.001). There was no significant difference
between percent apoptosis with or without 200 or 2000 units/ml TNF-
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a in the presence of serum or in the absence of serum for 200
units/ml TNF-a. At 2000 units /ml TNF-a significantly reduced the
percent apoptosis in the absence of serum p<0.01, n = 4.
The addition of TNF-a also significantly prevented the cell loss associated
with suspension culture of monocytes in the absence of serum, shown in
Figure 4. 6 which demonstrates a significant but not complete protective
effect of 2000 units/ml TNF-a in the absence of serum (p<0.05, n = 4). As
with apoptosis counts, 200 units/ml TNF-a did not demonstrate any
protective effect on cell recoveries (data not shown).
Figure 4. 6
TNF Partially Reverses Monocyte Loss
Induced By Serum Depletion.
0.6 ~i —r—
TNF No TNF TNF No TNF
+ SERUM No SERUM
Legend for Figure 4. 6
Effect of 2000 units/ml TNF-a on monocyte numbers after 5 days in
suspension culture, seeded initially at 1 x 106/ml. Teflon foils stained
after resuspension demonstrated no significant cell adherence.
Results are the means ± SE of 4 separate experiments.
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A similar result pertained for adherently cultured monocytes, counting
the number of nuclei per high power field (HPF) after 5 days culture with
or without serum and TNF-a. In these experiments, cell recovery in the
absence of serum was 61% of that in the presence of serum. Addition of
2000 units/ml TNF-a increased this to 91% of the recovery in the
presence of serum (p<0.01). Once again 200 units/ml TNF-a had no effect
on this loss (n = 4).
There were no significant pro-apoptotic effects of serum withdrawal on
Mo, with 2.4 ± 1.1% apoptosis in the absence of serum, the addition of up
to 2000 units/ml TNF-a had no effect on this (2.0 ± 0.4% n = 3).
4. 2. 6. 3 TNF-a and Cycloheximide.
To further investigate the mechanism of TNF-a rescue of monocytes in
the absence of serum I tested whether TNF-a could rescue cells from
apoptosis induced by cycloheximide. Human monocyte derived Mo
cultured on 8 well slides were exposed to cycloheximide (50 pM) for 24
hours when 13.6 ± 2.7% apoptosis was observed. Surprisingly the
addition of 2000 units/ml TNF-a, followed by cycloheximide 15 minute
later, doubled this level of apoptosis to 28.3 ± 1.1% (p<0.05). If the
cycloheximide was added 15 minutes prior to TNF-a the level of
apoptosis at, 26.6 ± 8.2%, was still almost double that observed with
cycloheximide alone (n = 4). There was a highly significant decline in the
number of nuclei per HPF when cycloheximide was added to the culture
medium with 178 ± 9 nuclei per HPF in the control wells and 69 ± 8 in the
cycloheximide treated wells (p<0.001, n = 4). The addition of both
cycloheximide and TNF-a resulted in a further significant decrease in
numbers to 44 ± 8 (p<0.05, n = 4).
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4. 2. 6. 4 TNF-a with Other Cytokines.
Culturing monocytes or Mo in serum in the presence of the following
four combinations: TNF-a with IL-la, TNF-a with IL-4, TNF-a with IL-6
and TNF-a with all three (i.e. IL-la, IL-4 and IL-6), all had no effect on the
baseline levels of apoptosis. When monocytes were cultured in the
absence of serum, the partial protective effect of TNF-a persisted in the
presence these cytokine combinations (data not shown). These
combinations of cytokines had a similar pro-apoptotic effect on Mo in the
presence of cycloheximide to that of TNF-a alone, suggesting that the
effect of TNF-a predominated both as a protective cytokine in the absence
of serum and as a pro-apoptotic agent in the presence of cycloheximide.
4. 2. 6. 5 Effect of IL-la, IL-4, IL-6, GM-CSF and TGF-p on Monocyte
and Macrophage Apoptosis.
These cytokines had all been shown to influence apoptosis in myeloid
cells. In previous studies, 1000 units/ml of IL-la was found to retard
apoptosis in monocytes induced by serum withdrawal (Mangan, 1991b).
IL-4 (10 units/ml) prevents apoptosis in IL-3 dependant cells (Rodriguez-
Tarduchy, 1992). IL-6 has been reported to induce apoptosis in U937 cells
and PMN at 20 ng/ml (Afford, 1992) and at 1000 units/ml in the
hematopoietic cell line, Y6 (Oritani, 1992). GMCSF at a concentration of
50 units/ml inhibits PMN apoptosis by 50% over 18 hours (Lee, 1993).
TGF-P 1 has been reported to induce myeloid cell apoptosis at 2 ng/ml
(Lotem, 1992).
To investigate the relative effects of cytokines during differentiation,
monocytes and Mo from the same donor were exposed to a range of
concentrations of these cytokines in both suspension and adherent
cultures and in certain experiments cells were also deprived of serum.
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Table 4. 4
Effect of Cytokines on Monocyte and Macrophage Apoptosis.
Cytokine Cone. Monocytes (% Apop) Mo (% Apop)
(units/ml) No Serum Serum No Serum Serum
Control - 11.2 ±2.8 2.0 ±1.3 1.3 ±0.3 0.9 ±0.2
IL-loc 2250 9.4 ±0.4 1.7 ±0.6 1.0 ±0.2 0.7 ±0.3
IL-6 9000 8.8 ±1.2 3.5 ±0.8 1.3 ±0.2 1.5 ±0.5
GM-CSF 100 10.9 ±0.9 3.8 ±1.0 0.5 ± 0.3 0.6 ± 0.2
IL-4 1500 - 2.9 ±0.9 - 0.5 ±0.1
TGF-p lOng/ml - 4.4 ± 0.4 - 1.3 ±0.8
IL-la + IL-4 - 2.9 ±0.8 - 0.9 ± 0.2
IL-la + IL-6 - 3.1 ±0.9 - 0.3 ±0.3
IL-4 + IL-6 - 2.2 ±1.1 - 0.5 ±0.1
Legend for Table 4. 4
Human peripheral blood monocytes were cultured adherent to 8 well
slides in the presence or absence of 10% autologous serum (Controls)
or with the addition of the cytokines stated at the concentrations
stated (Cone.) in units/ml. The percentage of apoptotic cells was
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determined morphologically by acridine orange staining at 42 hours.
Data for cell recovery determined at the same times are shown in
Table 4. 4. Monocytes from the same donors were matured in vitro
in suspension for five days, these Mo were also plated onto slides and
cultured in the presence or absence of serum and examined at 18 and
42 hours. Results are expressed as mean ± SE for 4 different donors.
As shown in Tables 4. 4 and 4. 5 none of these cytokines had any effect on
the levels of constitutive apoptosis for monocytes or Mo and did not
influence cell recoveries over the time in culture. The percentage of
apoptotic cells was determined at 18 and 42 hours but as the results were
the same at 18 hours (except for monocytes cultured in the absence of
serum), Table 4. 4 only shows the results for 42 hours. For monocytes
cultured in the absence of serum the mean percentage of apoptotic cells at
18 hours was 7.05 ± 1.3% compared with 10.8 ± 0.9% at 42 hours. As with
the 42 hour results however, none of the cytokines tested had any effect
on the percentage of apoptosis at 18 hours in the absence of serum. The
addition of these cytokines also had no effect on the percentage of
apoptosis for monocytes cultured in suspension (data not shown).
Although only one concentration is shown for each cytokine in Table 4. 4,
lower concentrations were used but did not affect the results; IL-1 was
tested at 225 and 2250 units/ml, IL-4 at 150 and 1500 units/ml, IL-6 at 1800
and 9000 units/ml, GM-CSF at 10, 50 and 100 units/ml, TGF-(3 was only
used at 10 ng/ml. Combinations were used at the highest concentrations
only. IL-la, IL-6 GM-CSF and TGF-p did not obviously influence cell
morphology but using forward scatter parameters, monocytes cultured in
the presence of 10 ng/ml TGF-P for 5 days were smaller than control cells:
43.8 ± 2.1 vs. 45.8 ± 1.9 (p <0.01 n=3). IL-4 is discussed in section 4. 2. 7. 1.
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Table 4. 5
Effect of Cytokines on Monocyte and Macrophage Recovery.
Cytokine Cone. Monocytes Mo
(as % of serum control) (as % of serum control)
(U/ml) No Serum Serum No Serum Serum
Control - 76 ±3.1 100 ±2.1 100 ±1.3 100 ±1.7
IL-la 2250 77 ±3.6 102 ±4.1 98 ±3.4 97 ±3.9
IL-6 9000 75 ±3.3 107 ±4.3 103 ±4.5 96 ± 4.5
GM-CSF 100 82 ±3.2 96 ± 1.9 99 ±4.6 107 ±4.3
IL-4 1500 - 96 ±3.6 - 95 ±5.1
TGF-[3 10 ng/ml - 102 ± 2.9 - 105 ± 3.9
IL-la + IL-4 - 106 ±4.0 - 96 ±4.0
IL-la + IL-6 - 108 ±5.1 - 99 ±5.3
IL-4 + IL-6 - 95 ±4.9 - 96 ±3.8
Legend for Table 4. 5
This table shows cell recoveries for cells cultured as described in Table
4. 4. Results are shown for adherent cultured monocytes and Mo and
were determined by estimating the number of cells per high power
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field (HPF), a minimum of 10 fields were examined per treatment.
The number of cells per HPF for monocytes and Mo cultured in the
presence of serum were taken as 100% and the cell recovery for cells
cultured in the absence of serum or in the presence of cytokines were
related to these values.
As noted in section 4. 2. 2, cell recoveries were lower in suspension than
in adherent culture, none of the cytokines tested influenced this reduced
recovery in suspension culture at 18 or 42 hours in any way (data not
shown). Furthermore IL-la, IL-6, GM-CSF and TGF-(3 did not affect the
number of monocytes recovered after 5 days suspension culture, with a
mean of 51 ± 7% recovery in control cultures and 53 ± 8, 49 ± 4, 50 ± 3, and
53 ± 7% in the presence IL-la, IL-6, GM-CSF and TGF-(3 respectively (p =
n/s, n = 4).
GM-CSF, IL-4, IL-6 and TGF-(3, used at the same concentrations as in Table
4. 4, were also unable to protect Mo from cycloheximide induced
apoptosis. Apoptosis counts in controls (10% autologous serum only)
were 0.6 ± 0.2% after 14 hours, these compare with 12.2 ± 2% (n = 4) for
cycloheximide treated cells and 12.6 ± 2.2%, 10.9 ± 1.9, 13.3 ± 0.9 and 13.1 ±
1.1 for GM-CSF, IL-4, IL-6 or TGF-P plus cycloheximide (50 pM) treated
cells respectively, with equivalent recoveries for all treatments (p = n/s, n
- 4).
4. 2. 7.1 Effect of IL-4 on Macrophage Morphology.
IL-4 induced many adherent cells to adopt a fibroblast-like morphology,
with others having spindle shaped projections. IL-4 was the only
cytokine to induce gross morphological changes, an effect which
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predominated over other cytokines when cells were co-cultured with
TNF-a, IL-1 or IL-6 and IL-4 together. These cells were more adherent
even in suspension cultures in Teflon foils as shown in Table 4. 6.
Table 4. 6
Recombinant IL-4 Increases Monocyte Adherence to Teflon but does Not
Alter Total Cell Recovery or Constitutive Apoptosis.
Treatment
Control IL-4
Exp. Count ApoptosisCount Apoptosis
(xl06/ml) (%) (xl06/ml) (%)
Pre-EDTA Total Pre-EDTA Total
1 (0.65) 0.67 2.1 (0.44) 0.61 2.0
2 (0.49) 0.47 3.6 (0.38) 0.50 3.9
3 (0.351 0.38 3.8 (0.201 0.35 2.9
Mean (0.491 0.51 3.2 (0.341 0.49 2.9
Legend for Table 4. 6
Monocytes, seeded at 1 x 106 /ml, were cultured in Teflon foils in the
presence or absence of IL-4 (50 ng/ml) for 5 days when cells were
resuspended and counted, the results are shown in brackets (Pre-
EDTA). IL-4 induced an adherent morphology, the remaining
adherent cells after resuspension were removed using EDTA (5 mM);
the total of the pre and post EDTA counts are then shown (Total)
demonstrating a much greater degree of adherence in the IL-4 treated
cells. The percentage of apoptotic cells for the total cell population is
shown and does not differ between treatments.
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The number of monocytes after 42 hours adherent culture in the presence
or absence of added IL-4 (50 ng/ml) were assessed. There were
significantly more cells in the control than in IL-4 treated wells: 121 ± 7
cells per HPF in the control wells and 85 ± 7 in IL-4 wells (p <0.001 n = 6).
However more giant cells were present in the IL-4 treated wells and
comparison of the number of nuclei per HPF eliminated any difference
between treatments: 150 ± 7 vs. 168 ± 8 (p = n/s, n=6). Using forward
scatter parameters on flow cytometry, IL-4 treated cells were also shown to
be significantly larger than controls, (49.2 ±1.5 vs. 45.8 ±1.9 p<0.05 n=3).
4. 2. 7. 2 IL-4 Augments and Cycloheximide Prevents Giant Cell
Formation.
There was variability in the extent of giant cell formation between
donors, certain donors were found to form large numbers of giant cells
over the 5 days culture whilst others did not. Although donor variability
was the predominant influence on giant cell formation, culture
conditions could further alter the number and multinuclearity of giant
cells. Suspension culture of monocytes significantly reduced the
formation of cells with more that two nuclei when compared with
adherent culture for five days (4.2 ± 0.7% vs. 11.2 ± 1.5%, n = 7
respectively). There was no difference when the percentage giant cells
was determined from Dif Quik™ stained cytospin preparations or by
acridine orange fluorescent microscopy of resuspended cells. TNF-a had
no effect on giant cell formation for any donors, IL-4 significantly
increased giant cell formation and cycloheximide prevented
multinucleate giant cell formation as shown in Figure 4. 7.
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Figure 4. 8 Giant Cell Formation in Macrophage Cultures,
i) Giant Cells in 5 Days Adherent Human Macrophage Culture,
Stained for Non-Specific Esterase.
Legend for Figure 4. 8 Two photomicrographs of adherent cultured
human Mo demonstrating different giant cell morphologies. Figure i)
shows typical giant cell formation from a donor whose Mo regularly
formed a large numbers of giant cells in culture (x 200). Figure ii) shows
the massive size of some giant cells after exposure of monocytes to IL-4
(1500 units/ml) for 5 days (section 4. 2. 7. 1) (x 200).
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Figure 4. 7
IL-4 Promotes and Cycloheximide inhibits
Giant Cell Formation
*
Control TNF IL-4 CHX CHX+TNFCHX+IL-4
Legend for Figure 4. 7
Monocytes were cultured on 8 well slides for 5 days in the presence of
10% autologous serum (Control), TNF-a (2000 units/ml), IL-4 (1500
units/ml), cycloheximide (CHX; 50 pM ), or both cycloheximide and
TNF-a (CHX + TNF) or cycloheximide and IL-4 (CHX + IL-4). TNF-a
and IL-4 were added at the start of culture but CHX was added on day
4. Giant cells determined by Dif Quik™ staining adherent cells and
counting % giant cells. Results are means ± SE , n = 7.
IL-4 (1500 units/ml) had variable effects when a high level (12% or more)
of giant cell formation was apparent, increasing fusion in one donor but
with no effect in two others. Where giant cell formation was less than
6%, IL-4 significantly up-regulated giant cell formation in adherent
cultures, from 5.1 ± 1.4% in control cultures to 9.8 ± 0.9% in IL-4 treated
cultures (1500 units IL-4/ml), (p<0.05, n = 4). This effect was dose
dependant with lower doses (e.g. 150 units/ml) being less effective. The
more dramatic effect of IL-4 (1500 units/ml) was that it increased the
number of nuclei per giant cell, control cultures having a mean of 4.6 ±
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0.6 nuclei per giant cell whilst IL-4 treated cells had 11.4 ± 2.2 nuclei per
giant cell (p<0.01/ n = 7) (Figure 4. 8). This effect on the number of nuclei
per giant cell was also seen with low dose IL-4 (150 units/ml) where
multinucleate giant cells had a mean of 10.8 ± 2.0 nuclei/cell (p<0.01, n =
3). Other cytokines tested {GM-CSF (50 units/ml) IL-la (1000 units/ml),
IL-6 (9000 units/ml) and TGF-(3l (10 ng/ml)} had no effect on giant cell
formation. When cycloheximide (50 |iM) was added on day 4 of culture
there was a significant decrease in the percentage giant cells present at day
5, with a mean of 4.8 ± 0.8% giant cells after addition of cycloheximide
compared with 11.2 ± 1.5% in control cultures (p <0.05, n = 7). There were
5.1 ± 1.4% giant cells in adherent culture monocytes after 4 days in culture
suggesting that giant cell formation may be a process dependant upon
new protein production.
4. 2. 8 Cytokines Do Not Affect Alveolar Macrophage Apoptosis.
The baseline level of apoptosis in human alveolar Mo suspension
cultures immediately after washing and resuspension was 8.8 ± 1.8% (n =
8) as determined by acridine orange fluorescence microscopy, this
remained unchanged after 18 hours in culture (9.0 ± 2.5%, n = 8). Figure
4. 9 shows the effect of a range of cytokines on alveolar Mo apoptosis and
compares this with the effect of cycloheximide. Serum withdrawal for 18
hours did not alter alveolar Mo apoptosis, (8.8 ± 2.3%, n = 4) and TNF-a
had no additional effect on the levels of alveolar Mo apoptosis in the
absence of serum (7.1 ± 0.9%, n = 3), no assessment was made at 84 hours
due to insufficient cell numbers.
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Figure 4. 9
Cytokines Exert Little Influence on Alveolar Mo Apoptosis
*
Control TNF IL-1 IL-4 IL-6 CHX
Legend for Figure 4. 9
Alveolar Mo, cultured in standard conditions in Teflon foils in the
presence of 10% human AB serum were incubated with TNF-a (2000
units/ml), IL-la (1000 units/ml), IL-4 (50 ng/ml), IL-6 (9000 units/ml),
cycloheximide (CHX; 50 pM) or no addition (Control) for 18 hours.
The percent apoptosis was determined morphologically and results
expressed as mean ± SE for 4 different donors.
4. 2. 9 Effect of Cytokines on Murine Bone Marrow Macrophage
Cultures.
4. 2. 9.1 Effect of TNF-a, IL-1, IL-4, IL-6 and TGF-(3 on Murine Bone
Marrow Derived Macrophages.
Murine bone marrow Mo, cultured as described in section 2. 5. 4, were
used on day 7. As shown in Table 4. 7 the addition of the following
cytokines; IL-1, IL-4, IL-6 or TGF-(3l had no effect on apoptosis or on cell
recovery. Apart from IL-4, all these cytokines cross reacted with murine























0.25 1.94 ± 0.3
0.05 1.70 ± 0.3
30.5* 1.58 ±0.3
17.2* 1.54 ±0.3








2.0 1.40 ± 0.3
0.6 1.90 ±0.4
0.0 2.20 ± 0.2*
100* 0.6 ± 0.1 §





* significantly greater than control p<0.05
§ significantly lower than control p<0.05
Legend for Table 4. 7
Effect of various cytokines on percentage apoptosis and cell recovery
of murine bone marrow derived Mo in suspension culture. Cells
were seeded at 0.375 x 106/ml, washed on day 5 and resuspended at 1 x
106/ml. On day seven, 1.75% of cells were apoptotic and cell counts
were 1.75 ± 0.3 x 106/ml. Cells were divided into 9 Teflon foils and
treatments added as per Table; control cells were cultured in medium
plus 25% FCS and 25% L929 cell supernatant. Cell recovery was
expressed as mean ± SE, n = 3. Percentage apoptosis did not vary by
more than 10% of the mean for each treatment hence only the means
are shown.
There was no difference in the cell recovery after 24 hours for any of the
treatments, but by 72 hours significantly fewer cycloheximide treated cells
were recovered (p<0.05, n = 3) and significantly more TNF-a (2000
units/ml) treated cells were recovered (p<0.05, n = 3). As with human
Mo, cycloheximide promoted apoptosis and this effect was augmented
over 24 hours by TNF-a. DNA electrophoresis also demonstrated greater
fragmentation with the combination of cycloheximide and TNF-a than
for cycloheximide treated cells alone (Figure 4.10).
4. 2. 9. 2 Murine Bone Marrow Derived Macrophages: Growth Factor
Depletion and Effect of TNF-a, IL-la and IL-6.
As discussed in section 4. 2. 4, culturing murine bone marrow derived
Mo for 42 hours in the absence of serum and CSF-1 significantly reduces
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cell recovery. Figure 4. 11 shows that TNF-a but not IL-1 or IL-6
significantly augments cell recovery both in the presence and absence of
serum plus CSF-1.
Figure 4. 11





Nil TNF IL-1 IL-6
Legend for Figure 4.11
Cells were seeded in Teflon foils at 0.375 x 106 cells/ml, washed and
resuspended at 1 x 106/ml on day 5. On day 7 cells were washed twice
and resuspended at 1.75 ± 0.3 x 106/ml in either medium alone (No
Serum) or medium + FCS and L929 supernatant (Serum) in the
presence of TNF-a (2000 units/ml), IL-la (1000 units/ml), IL-6 (9000
units) or and equal volume of culture medium (Nil). Cell recovery
after 42 hours, expressed as mean ± SE for 3 experiments. Cell
recovery in the absence of serum with Nil, TNF-a, IL-la or IL-6 were
all significantly lower than that for the corresponding cells cultured
in the presence of FCS + CSF-1 (p<0.05, n = 3). TNF significantly
increased the cell recovery from that of Nil or IL-1 or IL-6 in the
presence and absence of serum plus CSF-1.
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Figure 4.10 TNF-a Augments Cycloheximide Induced Macrophage
Apoptosis.
Legend for Figure 4.10 Photomicrograph of ethidium bromide stained
DNA gel taken under ultraviolet light. Murine bone marrow derived
Mo were cultured for 7 days then exposed to cycloheximide (50 |iM) (Lane
1), an equal volume of the diluent - ethanol (Lane 2) or cycloheximide (50
pM) plus TNF-a (2000 units/ml) (Lane 3) for 24 hours. One million cells
per well were lysed and their DNA extracted. The agarose gel
demonstrates the ladder pattern typical of apoptosis in the cycloheximide
treated cells but not the control (ethanol treated) cells. TNF-a
significantly increased the percentage of apoptotic cells (section 4. 2. 9. 1),
this was also clearly seen on the gel.
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4. 2.10 Effect of Dexamethasone and cAMP on Macrophage
Apoptosis.
4. 2.10.1 Dexamethasone.
Glucocorticoids are known to promote apoptosis in thymocytes (Wyllie,
1980) and eosinophils (Stern, 1992) although interestingly they delay
apoptosis in PMN (Meagher, 1996). In view of the perceived anti¬
inflammatory action and pro-apoptotic effect of dexamethasone on
various cell types, its effect on Mo survival was investigated. The
standard concentration used to promote apoptosis on thymocytes and
eosinophils is lpM, Table 4. 8 shows that dexamethasone over a range of
concentrations from 0.5 to 2.0 |iM had no effect on Mo apoptosis.
Furthermore dexamethasone did not prevent or enhance the pro-
apoptotic effect of cycloheximide. As with Mo, dexamethasone had no
effect on human monocyte apoptosis, there being 5.9 + 1.2 % apoptotic
cells after 18 hours suspension culture in the presence of 10% autologous
serum alone and 4.8 ± 2.0% with the addition of 1 (iM dexamethasone.
Dexamethasone was unable to prevent the pro-apoptotic effect of
cycloheximide, with 29 ± 4.9% apoptotic monocytes after 18 hours
incubation with 50 pM cycloheximide and 26.4 ± 3.8% with the
combination of 50 pM cycloheximide and 1 pM dexamethasone (n = 3).
Dexamethasone also had no effect on the percent apoptosis after 18 hours
when either monocytes, monocyte derived Mo, human alveolar Mo or
murine bone marrow derived Mo were cultured in the absence of
autologous serum (data not shown).
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Table 4. 8
Dexamethasone does Not Promote Macrophage Apoptosis or Prevent
Cycloheximide Induction of Apoptosis.
Treatment Apoptosis Cell Count Non-viable P
(%) (x 106/ml) (%)
Control 2.6 ± 1.2 0.64 ± 0.07 3.7 ±0.8
Dexamethasone
0.5 pM 3.1 ±0.8 0.60 ±0.06 3.8 ±0.5 n/s
1.0 pM 2.6 + 0.9 0.63 ± 0.09 4.3 ±0.9 n/s
2.0 pM 4.2 ± 1.4 0.61 ±0.13 3.1 ±1.4 n/s
CHX 16.0 ± 1.5 0.57 ± 0.05 10.4 ±1.1 0.04
Dex + CHX 15.2 + 0.7 0.59 ± 0.07 11.6 ±1.4 0.01
Legend for Table 4. 8
Human monocyte derived Mo were cultured in Teflon foils at 0.60 x
106/ml in the presence of 10% autologous serum (Control) or treated
with dexamethasone (0.5 to 2.0 pM), cycloheximide (CHX; 50 pM) or a
combination of both dexamethasone 1.0 pM and cycloheximide (Dex
+ CHX). After 18 hours cells were resuspended, counted, viability
determined and the percentage apoptosis counted morphologically by
acridine orange fluorescent microscopy. The percent apoptotic cells
in the control foils was compared with those for other treatments, the
significant p values are shown. Results are the means ± SE for 4
separate experiments.
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4. 2.10. 2 db-cAMP.
In view of the postulated involvement of cAMP in the transduction of
the apoptotic signal (McConkey, 1990), I investigated the effect of cAMP
on Mo apoptosis, adding the membrane permeable analogue db-cAMP to
increase intracellular cAMP levels. This had a delayed effect, with no
significant difference in percentage of apoptotic Mo in control or db-
cAMP cultures after 24 hours, however by 72 hours db-cAMP significantly
increased the percentage of apoptotic Mo, as shown in Table 4. 9.
Table 4. 9
Dibuteryl-cyclic Adenosine Monophosphate has a Late Pro-apoptotic



















5.3 ±1.6 0.89 ±0.08
14.3 ± 2.4* 0.71 ± 0.10
4.9 ±1.2
19.1 ±4.2
Legend for Table 4. 9
Human monocyte derived Mo were cultured in Teflon foils at 1.0 x
106/ml in the presence of 10% autologous serum (Control) or treated
with 2 mM db-cAMP. After 24 and 72 hours cells were resuspended,
counted, viabilities determined and the percentage apoptotic cells
counted morphologically. There were no significant differences
between Control and db-cAMP treated cells after 24 hours, however
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by 72 hours, there were significantly (*) more apoptotic cells in the db-
cAMP treated foils (p< 0.05, n = 4).
A similar late pro-apoptotic effect was found on monocytes cultured
adherent to 8 well slides (data not shown) and on murine bone marrow
derived Mo, incubation of 7 day cells with db-cAMP for 72 hours
increased the percentage of apoptotic cells from 3.8 ± 0.6 to 12.2 ± 0.5 (p<
0.05, n = 3). As with other culture systems that induced monocyte
apoptosis, "ghost cell" bodies were observed in the presence of db-cAMP
associated monocyte apoptosis.
4.3 DISCUSSION.
Monocyte survival during in vitro culture is affected by the presence of
serum and by adherence to culture plastic. In contrast to culture in the
presence of serum, serum withdrawal leads to a 25% loss in numbers of
adherent monocytes as seen in Figure 4. 3. Suspension culture in the
presence of serum leads to a 43% loss of monocyte number, which
increased to a 76% loss when cultured both non-adherently and in the
absence of serum. These results are comparable with previously
published data, demonstrating a significant loss of human monocytes in
culture that is increased by serum withdrawal and further increased by
suspension culture (Johnson, 1977; Andreesen, 1983; Becker, 1987;
Helinski, 1988; Brugger, 1991; Mangan, 1991a and b). These results also
confirm the findings of Andreesen et al. and Helinski et al. that despite
losses, monocytes can be matured successfully to Mo in Teflon foils
(Andreesen, 1983; Helinski, 1988). Monocyte losses are accompanied by
morphological and biochemical evidence of apoptosis but without
evidence of necrosis. The percentage of apoptotic monocytes recorded at
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each time point (Figure 4. 4) were consistently lower than cell losses
(Figure 4. 3) and "ghost cell" bodies were commonly observed at later
time points when monocytes were cultured in the absence of serum, in
the presence of cycloheximide or with the combination of cycloheximide
and TNF-a suggesting that they represent "late" apoptotic monocytes, as
discussed in Chapter 3.
One key finding in this work is that there are powerful survival
differences between the monocyte and the Mo. Monocyte losses in
suspension are in the order of 22% over 42 hours even in the presence of
serum whilst over the same time course Mo losses are approximately 8%.
Furthermore monocyte losses are augmented by serum withdrawal,
whereas Mo are resistant to these effects. Although several papers
describe methods for long term Mo culture (Helinski, 1988; Bennett,
1993), no comparison of the rates on monocyte and Mo death had been
made and this distinction between monocyte and Mo survival had not
been investigated before although very recently Munn et al. also
documented this differential sensitivity to apoptosis between monocytes
and Mo (Munn, 1995). This raises the important question of the
mechanism of this increased resistance of the Mo to the induction of
apoptosis which we address in subsequent chapters.
Adult mouse serum contains approximately 600 U/ml of M-CSF, which
is adequate for both cell survival, although proliferation may require
more (Tushinski, 1982). Similarly the reported normal level of M-CSF in
human serum is 550 ±110 U/ml, hence withdrawal of this factor alone
may have had a significant effect on cell survival (Brugger, 1991). Becker
et al. showed that addition of 1000 U/ml of M-CSF to human monocyte
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cultures provided better cell recovery than 5% serum (Becker 1987),
whilst Mangan et al. showed that GM-CSF, M-CSF, IFNy and IL-1 all
prevented apoptotic cell death, and found that IL-1 was the most potent
(Mangan, 1991b). There are conflicting reports in the literature as to
whether colony-stimulating factors can induce synthesis of pro¬
inflammatory cytokines and thus provide an additive protective effect
(Hamilton, 1993a and b). Data presented in this thesis demonstrates that
serum significantly promoted monocyte survival, while both serum and
CSF-1 promoted murine bone marrow derived Mo survival. TNF-a
exerted a significant survival effect on monocytes and murine bone
marrow derived Mo but the colony stimulating factor GM-CSF and the
cytokines IL-la, IL-4, IL-6 and TGF-p all were shown to have no influence
on monocyte or Mo apoptosis or survival.
Thus cytokines which are predominant during the early inflammatory
response (IL-1, GM-CSF and IL-6) as well as those with defined role
during late inflammation and resolution (IL-4, GM-CSF and TGF-P 1) had
remarkably little effect on monocyte and Mo survival. All cytokines were
added in concentrations known to exert pro/anti-apoptotic effects on
other cells. Monocytes cultured in the presence of autologous serum die
steadily by apoptosis and none of the cytokines tested altered this in any
way, despite evidence for a pro-apoptotic effect of IL-6 (Afford, 1992;
Oritani, 1992) and TGF-p 1 (Lotem, 1992) and an anti-apoptotic effect of IL-
1 (Mangan, 1991b), IL-4 (Rodriguez-Tarduchy, 1992) and GM-CSF (Lee,
1993) on other myeloid cells. The lack of cytokine effect was irrespective
of the duration of treatment - cells were examined after 6, 18, and 42
hours and 5 days - and irrespective of whether the cytokines were only
added at the beginning or if they were continually supplemented
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throughout the culture period. As monocyte survival is greater when
adherent, cytokines were added to both suspension and adherent
monocyte cultures to see if this could unmask an effect on cell survival
but neither cell recovery nor apoptosis were influenced by any of the
cytokines tested for either of these culture conditions. The level of
monocyte apoptosis was found to be increased by serum withdrawal and
in this study TNF-a was shown to inhibit this effect.
Mo were resistant to the induction of apoptosis, consistent with their
recognized long life in vivo (van Furth 1992). None of the cytokines
tested, either on their own or in combination, were shown to promote
apoptosis in Mo cultures, a finding which was consistent among those
sources of Mo available to us: human peripheral blood monocyte derived
Mo, human alveolar Mo and murine bone marrow derived Mo.
The only cytokine which had any significant effect on apoptosis was TNF-
a. This could be shown to significantly but not completely prevent the
pro-apoptotic effect of serum withdrawal (Figure 4. 5) on human
monocytes and to promote survival (Figure 4. 6). TNF-a also partially
inhibited the pro-apoptotic effect of growth factor (CSF-1) withdrawal on
murine bone marrow derived Mo (Figure 4. 11). In addition TNF-a
promoted murine bone marrow Mo proliferation in the presence of
serum and CSF-1 (Table 4. 7). As there was no pro-apoptotic effect of
serum withdrawal on Mo, no survival effect of TNF-a could be
demonstrated for these cells. The effect of TNF-a was dose dependent,
2000 units/ml were protective whilst 200 units/ml were not.
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When TNF-a was combined with cycloheximide it had a powerful pro-
apoptotic effect, significantly augmenting cycloheximide induced
apoptosis in both human and murine Mo. One consequence of this effect
was a reduction in total cell recovery when TNF-a and cycloheximide
were combined. Synergism between TNF-a and cycloheximide has been
reported for PMN, with more than a fivefold increase in apoptosis
(Tsuchida, 1995). Furthermore, although PMN and monocytes required
similar concentrations of cycloheximide alone to induce apoptosis (36 vs.
50 jig/ml respectively), when combined with TNF-a, PMN required
much lower concentrations of cycloheximide than monocytes to induce
similar levels of apoptosis (3.6 vs. 50 (ig/ml) (Takeda, 1993; Tsuchida,
1995).
TNF-a has been shown to cause apoptosis in a number of primary cell
types including PMN (Takeda, 1993; Tsuchida, 1995), thymocytes
(Hernandez-Castelles, 1993) and endothelial cells (Polunovsky, 1994). The
pro-apoptotic effect has also been well documented in a range of cell lines
including U937 (Jarvis, 1994), HL60 (Obeid, 1993), KYM-1 (a
rhabdomyosarcoma cell line; Grell, 1994) and the T cell line PC60 when
transfected with TNFR (Vandenabeele, 1995). The inability of TNF-a
alone to induce apoptosis in monocytes and Mo is thus of interest,
especially as these cells express functional TNF receptors (section 5. 2. 1).
One possible explanation for the results obtained with TNF-a is that
monocytes and murine bone marrow Mo are dependent for their
survival upon anti-apoptotic factor(s) which are induced by growth factor
(or serum) stimulation via a protein synthesis dependent mechanism. In
the absence of growth factors (or serum) TNF-a can continue to induce
production of this factor but when protein synthesis is inhibited by
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cycloheximide this action is blocked and other pro-apoptotic effects of
TNF-a are unmasked, contributing to increased cell death. The normal
serum levels of TNF-a in non-septic subjects are very low suggesting that
TNF itself does not account for this serum effect. It is attractive to
speculate that the redox state of the cell may be important in this latter
process. It has been reported that transiently inducible protective proteins
such as superoxide dismutase and heat shock proteins render cells
resistant to TNF-a-induced cytotoxicity (Wong, W. 1988) and could
partially compensate for the loss of anti-oxidant protection normally
afforded by serum. TNF-a also induces increased superoxide generation
and reactive nitrogen intermediates (Hauschildt, 1992; Hennet, 1993).
Hence TNF-a stimulation would induce an increase in ROI but their pro-
apoptotic effect would be balanced by co-induction of superoxide
dismutase and heat shock proteins. Cycloheximide would prevent the
synthesis of these protective proteins unmasking TNF-a induced free
radical toxicity.
Data presented in this thesis demonstrates that serum depletion
promotes monocyte apoptosis, an effect which can be partially inhibited
by TNF but not by IL-la, IL-4, IL-6, GM-CSF or by TGF-pl. The protective
effect that TNF-a accords monocytes during serum withdrawal has been
reported by Mangan et al. who showed that a range of cytokines and
inflammatory agents could delay monocyte apoptosis (Mangan, 1991a and
b). Monocyte survival was promoted by IL-ip, TNF-a, LPS, GM-CSF, IL-1-
a, IFN-y, M-CSF and IL-3 in descending order of effectiveness, whilst IL-6,
TGF-J31, MCP-1, fMLP and C5a all had no effect. There are a number of
differences between data reported by Mangan et al. and that presented
here.
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Already mentioned is the failure of GM-CSF and IL-la to protect
monocytes from serum depletion induced apoptosis. Furthermore, even
within the protection afforded by TNF-a there are some differences. I
demonstrated little effect with 200 units/ml TNF-a and only a 50%
protection with 2000 units/ml TNF-a whilst Mangan et al. using 1000
units/ml TNF-a obtained over 75% protection against monocyte
apoptosis (Mangan, 1991a). Several groups have demonstrated that
rather than protecting Mo from apoptosis, IL-la and IL-ip (but not TNF-a
or IL-6) are processed and released during Mo apoptosis, suggesting that
IL-1 may in fact be signalling terminal cellular injury (Hogquist, 1991a;
Sarih, 1993b; Zychlinsky, 1994). Furthermore Brugger et al. have shown
that in a serum free system; IFN-y, IL-la or p, IL-4 or IL-6 had no effect on
monocyte survival (Brugger, 1991). Interestingly, Moore et al. have
recently demonstrated that TNF-a was able to prevent apoptosis induced
by removal of M-CSF in murine bone marrow derived Mo but that TGF-
P, IL-1 and IL-6 had no effect (Moore, 1994), however they also
demonstrated that GM-CSF could prevent apoptosis induced by M-CSF
withdrawal. Together these data indicate that a clear role for TNF-a exists
in protecting monocytes from the pro-apoptotic effects of serum
withdrawal, while the role of other cytokines remains uncertain.
There are several possible explanations for the different findings of this
work and that of Mangan et al.. Importantly the methods of monocyte
isolation used were different, in that Mangan et al. employed CCE
whereas my study relied on monocytes prepared by density gradient and
adherence separation (Mangan, 1991a and b). Although final monocyte
purity is very similar, these two methods could be selecting different
populations. As I demonstrate in section 3. 2. la, a significant proportion
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of monocytes do not remain adherent to plasma coated plates and are
thus lost during preparation, this population is retained by CCE and may
exhibit different survival characteristics. Certainly adherence reduces Mo
sensitivity to the induction of apoptosis but whether this effect persists
after cells have been detached is not known (Khan, 1993). Adherence
may also "prime" monocytes such that later stimulation results in a
significant increase in IL-1 production (Schindler, 1990). Despite these
differences between my experiments and those of Mangan et al. the cell
recoveries after 42 hours in suspension culture in the absence of serum
are not too dissimilar. Comparison of CCE and adherence derived
monocyte phenotype does not demonstrate any significant differences in
cell-surface molecule expression (Dransfield, 1988) thus differences may
be more subtle and related to maturation or activation.
The murine bone marrow derived Mo system described here generally
parallels the human system and none of the cytokines tested promoted
apoptosis. As with monocytes, TNF-a prevented apoptosis induced by
growth factor depletion and in this murine system TNF-a also increased
cell recovery. It is interesting to compare this with the results of Witsell
et al. who demonstrated that TNF-a acts as a monocyte differentiation
factor decreasing murine bone marrow proliferation (Witsell, 1992). This
effect was only evident over a narrow "window" of time, on day 3 of in
vitro differentiation, when TNF-a acted to switch monocyte colony
forming units from proliferation to Mo differentiation. The survival
effect I have shown for TNF-a was evident on day 7 to 10 of in vitro
differentiation, outside the window shown by Witsell and at a time point
they did not examine. By this time monocytes have differentiated into
functional Mo, are competent phagocytes and express typical Mo surface
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markers. Without TNF-a cell numbers decline from day 7 to 10 despite
the presence of serum and CSF-1. In the presence of TNF-a the cell
recovery on day 10 is only slightly greater than that on day 7 but
significantly greater than day 10 cell recoveries in the absence of TNF-a
(Table 4. 7), suggesting that the TNF-a effect may be to promote survival
rather than proliferation. The relative contributions of cell proliferation
and prolonged cell survival to this results would need to be assessed to
address this issue. Again, as with human monocytes, additive effects
between cycloheximide and TNF-a are demonstrated for both apoptosis
and cell recovery.
The level of apoptosis in these different cell cultures may be related to
their proliferation rates. After six hours culture in the absence of serum
the percentage of apoptotic cells are: 20% for U937 cells - highly
proliferative cells (Tushinski, 1982); 14% for murine bone marrow
derived Mo - a recently proliferating system; 8% for human monocytes -
cells capable of limited proliferation (Cheung, 1992; van Furth, 1992,
Bennett, 1993); 2% for alveolar Mo and 0.85% for human monocyte
derived Mo - non-proliferative or with a very low proliferative rate (van
Furth, 1992). This suggestion is of interest in that many genes involved
in the apoptotic pathway also act as regulators of cell division. The
possible contributions of various oncogenes involved in the apoptotic
process is considered further in Chapter 6.
There is a steady and significant decline in murine bone marrow derived
Mo numbers over 42 hours when depleted of serum and CSF-1, with a
30% loss by 18 hours and 66% loss by 42 hours. In comparison to this
increased cell loss, the percentage of apoptotic cells in culture decreases
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between 18 hours (38% apoptotic cells in the absence of serum and CSF-1)
and 42 hours (5% apoptotic cells). Repeated morphological examinations
confirm the absence of significant necrosis and DNA gel electrophoresis
confirm continued apoptosis throughout this time period. This decline
in cell numbers indicates either increasing fragility and reduced life-span
of the apoptotic cells during the process of apoptosis induced by serum
withdrawal, or rapid clearance of the apoptotic cells by functional Mo. As
these cells were cultured in suspension, no "ghost cell" bodies were seen,
the act of resuspension destroying them (section 3. 2. 3). Although
phagocytosed apoptotic cells could be seen occasionally within the
functional Mo this was not quantifiable, so no distinction can be drawn at
present as to the relative contribution of these two processes in the
clearance of apoptotic Mo in vitro. In the light of the efficient clearance of
apoptotic PMN by phagocytic Mo (Savill, 1989a), it is likely that
phagocytosis would be the relevant clearance mechanism in vivo.
The data for U937 cells demonstrates a requirement for serum for
continued growth and in the absence of serum they cease to multiply and
begin to die by apoptosis. In RPMI medium alone this death occurred
rapidly (30 minutes) whereas in IDMEM alone it was slightly delayed (6
hours), thus an extra factor beyond that of serum withdrawal was
involved. Differences in the buffering capacity between the media may
however be a relevant factor as noted in section 4. 2. 1.
Alveolar Mo are long lived cells and more akin to peripheral blood
matured Mo than to monocytes. They also die by apoptosis constitutively
in culture and serum withdrawal acts to promote this. As noted in
section 4. 2. 5, they are not acutely sensitive to serum depletion with no
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significant apoptosis detectable at 18 hours and even in the absence of
serum 70% of cells are still recoverable after 84 hours in culture. Thus, as
with monocyte derived Mo, alveolar Mo are shown to be more resistant
to apoptosis than the monocytes.
I wanted to determine the significance of fates other than apoptosis for
monocytes. There was little evidence that necrosis represented a major
fate for monocytes or Mo and none of the agents investigated induced
this in vitro. Fusion into multinucleate giant cells was observed during
in vitro culture. I showed that suspension culture and cycloheximide
treatment both inhibited giant cell formation and that IL-4 had a small
positive dose dependant effect especially in those donors with a low
intrinsic level of giant cell formation. IL-4 was also shown to
significantly increase the number of nuclei per giant cell. Donor
heterogeneity however was the greatest influence on giant cell formation.
One possibility is that differences in the levels of IL-4 of autologous
serum may account for differences in the tendency to form giant cells.
This could be investigated using antibody inhibition studies and by
determining serum IL-4 levels. A positive effect of IL-4 on giant cell
formation has been reported on murine bone marrow Mo and alveolar
Mo (Mclnnes, 1988). Suspension culture has also been shown to decrease
cell fusion, confirming my findings (Enelow, 1992). Enelow et al. also
showed that TNF-a and IL-6 alone had no effect on giant cell formation
which is in accord with my results (Enelow, 1992). Certainly the usual
fate of the Mo does not seem to be that of giant cell formation, rather this
is a specific morphology adopted in response to particular circumstances
such as in granulomas. IL-4 also caused a gross change in the
morphology of Mo. This increase in size and altered morphology has
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been reported by te Velde et al. who showed that as little as 50 units/ml
IL-4 caused morphological change in monocytes by the 5th day in culture
and an increase in antigen presenting function (te Velde, 1988).
The glucocorticoid dexamethasone had no effect on monocyte or Mo
apoptosis, neither did it alter the extent to which cycloheximide induced
Mo apoptosis. Glucocorticoids are powerful inducers of apoptosis in
thymocytes (Wyllie, 1980), hence this lack of effect on Mo again
underlines differential controls on Mo and lymphoid cell survival. This
differential action of glucocorticoids however appears cell rather than
lineage specific, as emphasized by differences among granulocytes where
glucocorticoids delay the onset of PMN apoptosis and promote eosinophil
apoptosis (Meagher 1996).
cAMP, an activator of protein kinase A, was shown to exert a pro-
apoptotic effect on Mo but the magnitude of this was small and of late
onset, with only 10% apoptosis after 72 hours, thus it is possible that this
is the result of an indirect action. This pro-apoptotic effect, although
small, is of interest as cAMP exerts the opposite effect on PMN (Rossi,
1995). Exposure of U937 cells to db-cAMP however leads to a reduction in
their size with associated nuclear condensation (Sheth, 1988) suggesting
that like Mo, elevations of cAMP may induce apoptosis in these cells.
Together these data demonstrate that there are significant differences in
the survival characteristics of monocytes and Mo. Monocytes undergo
significant constitutive apoptosis, which can be increased by serum
depletion and by loss of adherence, whereas Mo, which have a low level
of constitutive apoptosis, are not influenced by these factors. Given the
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complexity of human serum, the use of serum free media and of blocking
antibodies could help determine the relative contribution of various
factors to monocyte and Mo survival, as would a measure of the relative
levels of synthesis and secretion of these growth factors by both
monocytes and Mo. Supernatant transfer experiments could be
performed between Mo and monocyte cultures to indicate whether
important levels of survival factors were being secreted by Mo. Of the
range of cytokines investigated, none increased monocyte apoptosis and
only TNF-a promoted monocyte and murine bone marrow derived Mo
survival; none had any influence on human Mo longevity. TNF-a in
combination with cycloheximide exerted the opposite effect, significantly
augmenting apoptosis. Monocyte survival characteristics were more in
line with those of U937 cells and murine bone marrow derived Mo
whilst alveolar Mo and monocyte derived Mo were similar in their
resistance to apoptosis and prolonged survival. One possible
interpretation of these data is that susceptibility to apoptosis is related to
changes in the cell cycle controls in monocyte and Mo populations,




CHANGES IN CYTOKINE RECEPTOR EXPRESSION




The M0 is capable of both secreting and responding to a wide range of
cytokines (Gordon, 1992 and 1995). The pattern of secretion changes
according to cell factors such as priming and environmental factors such
as the presence of inflammation. Likewise the pattern of Mo responses to
cytokines alters depending upon a number of factors including the
activation state, and the degree of differentiation (Gordon, 1995). Several
mechanisms may alter the way Mo respond to cytokines, including the
expression of receptors for specific cytokines, the functional capacity of
these receptors and the intracellular environment which can affect signal
transduction (Miyajima, 1992a). Cytokine receptor expression is known
to be dynamic, changing with temperature, activation state and maturity;
furthermore receptor shedding is now recognized to be a common event
(Mullberg, 1995). In the light of the differences in survival characteristics
of monocytes and Mo, I sought to investigate the expression of cytokine
receptors during the process of differentiation from monocyte into Mo
and with the onset of apoptosis itself. Patterns of altered cytokine
receptor expression may be restricted to specific cytokine receptor families.
Moreover, although considerable progress has been made in the
elucidation of the molecules involved in Mo recognition of apoptotic
cells, the nature of the changes on the apoptotic cell surface which signal
phagocytic responses have not been clearly determined. Investigation of
the surface changes associated with apoptosis in a number of different cell
types, including monocytes, Mo, monocyte-like cell lines and PMN may
thus be particularly revealing.
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5.2 RESULTS.
5. 2.1 Cytokine Receptor Expression on Human Monocytes,
Macrophages and U937 Cells and the Changes
Accompanying Apoptosis.
As a participant in the cytokine receptor section of the Fifth International
Workshop and Conference on White Cell Differentiation Antigens I
received a panel of 72 mAb of known and unknown specificity (Kikutani,
1995). Of these 72 mAb, 3 were withdrawn (C008, C035 and C036) and 5
were received too late to be included (C073, C074, C075, C076 and C079).
Thus, I present the data on the remaining 64 antibodies which were tested
by flow cytometry on human peripheral blood monocytes, monocyte
derived Mo, U937 cells and human PMN. For all these cell types,
cytokine receptor expression on both non-apoptotic and apoptotic cells
was determined, apoptosis being induced by three different treatments,
cycloheximide for Mo, serum withdrawal for U937 cells and aging in
culture for PMN.
Fifty one of the mAb provided were raised against either recombinant
molecules or transfectants expressing specific receptors, hence their
specificity's were known, the remaining 13 were of unknown specificity.
At the conference results from all the participating groups were collated
and on that basis new CD numbers (and in cases of inconclusive
evidence, provisional CDw numbers) were allocated to specific cytokine
receptors. Fifty three of the cytokine receptor panel mAb were clustered
(i.e. assigned CD numbers), including all the 51 mAb of known specificity
and 2 with previously unknown specificity, 11 mAb remained
unclustered (Kikutani, 1995). Panel mAb were identified by the letter C
and a three digit number, the mAb tested are listed in Appendix 2
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showing their cytokine panel code and the CD (or CDw) number they
were ascribed at the conference.
To determine human monocyte and Mo cytokine receptor expression
using this panel of mAb I isolated cells as described in section 2. 3. 1. A
proportion of monocytes from each donor was used to determine
cytokine receptor expression and the remainder were matured into Mo.
Mo apoptosis was induced by treatment with 50 pM cycloheximide for 14
hours. Apoptotic Mo (10 - 40% of the population) could be distinguished
from non-apoptotic cycloheximide treated Mo by flow (section 3. 2. 8). By
gating on these two sub-populations, the expression of cytokine receptors
and the changes induced by apoptosis could be determined using indirect
immunofluorescence. Comparison of cytokine receptor expression on
control Mo (cultured for 14 hours in identical conditions but without the
addition of cycloheximide) with the non-apoptotic Mo sub-population
exposed to cycloheximide allowed the effect of cycloheximide alone to be
determined. Thus, the relative effects of protein synthesis inhibition and
apoptosis on human Mo cytokine receptor expression could be
distinguished (Figure 5. 1). Furthermore, comparison with monocytes
allowed changes in cytokine receptor expression occurring during in vitro
differentiation into Mo to be assessed. Apoptosis was induced in the
myelomonocytic U937 cell line by serum withdrawal and again flow
cytometry was used to discriminate between the large non-apoptotic and
small apoptotic cells (section 4. 2. 1 and Figure 4. 1) and their individual
cytokine receptor profiles could be determined. A summary of these
results is provided in Table 5. 1. Appendix 2 shows the results of this
study in full, providing the mean fluorescence for each mAb tested
within each CD group relative to the isotype.
187
Figure 5. 1 Determining Changes in Surface Receptor Expression of
Macrophages with Apoptosis using Flow Cytometry.
i i i i v
Legend for Figure 5. 1 Binding of of i) Isotype control mAb, ii) anti-CD14
mAb, iii) anti-HLA-DR mAb and iv) anti-Fas (CD95) mAb to - control Mo
and - cycloheximide treated Mo. Cyloheximide treatment induced
apoptosis in a proportion of cells as seen by the forward and side scatter
flow profiles. By specifically gating on non-apoptotic cycloheximide
treated Mo and apoptotic Mo and comparing this with receptor
expression on control Mo, the effect of apoptosis and protein synthesis
inhibition on receptor expression on Mo could be demonstrated.
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Table 5.1
Summary of Cytokine Receptor Expression on Monocytes, Changes with
Differentiation and Apoptosis; Comparison with U937 Cells.
Cytokine Mono Macrophages U937
Receptor Control CHX Apop non-Apop Apop
GM-CSFR + ++ + + + + ±
SCFR (c-kit) - + ND ND + ±
IFNyR + + + + + +
TNFR p55 - + ± - + ±
TNFR p75 + ++ ± - + -
IL-1R type 1 - + ND ND + + +
IL-1R type 2 + ++ + + ± + ±
IL-2Ra - + + + + +
IL-2R(3 - ± ± - + -
IL-4R - + + - - -
IL-6R ± ± ± - + -
gpl30 - - ND ND ± ±
Fas Antigen + + + + + +
CDw 84 + ++ + _ ± ±
Legend for Table 5.1
A summary of the cytokine receptor expression of monocytes, Mo,
U937 cells and changes induced by apoptosis:
= No expression.
± = Weak expression.
+ = Significant expression.
++ = Significant increase from already positive value.
ND = Test not done. (IL-7 or IL-8 receptors could not be detected).
189
5. 2. 2 Changes in Cytokine Receptor Expression on Human
Polymorphonuclear Leukocytes Accompanying Apoptosis.
The cytokine receptor profile of human PMN was examined and changes
with apoptosis determined (see section 2. 7. 2. 3a) to see if the pattern of
changes related with that of monocytic cells. This was important as PMN
underwent apoptosis constitutively whilst Mo and U937 cells required
active intervention to induce apoptosis. Twenty four of the cytokine
receptor panel Ab were tested on aged PMN but only 6 cytokine receptor
groups were positive; IL-1R types 1 and 2 (CD 121a and 121b), GM-CSFR
(CDw 116), TNFR p55 and p75 (CD120a and 120b) and the Fas antigen
(CD95). Two groups, IL-6R (CD126) and IL-8R (CDw 128) had one positive
and one negative mAb and the IL-4R was weakly positive. Of the mAb
with positive binding only those against CD120b showed significant
decline on apoptotic PMN although there was a slight decline in CD120a
expression. The results are presented in detail in Appendix 3, with an
adjacent summary reviewing the changes in receptor expression on
PMN, Mo and U937 cells as they undergo apoptosis.
5. 2. 3 Anti-Fas Antibody Does Not Induce Macrophage Apoptosis.
Fas, a member of the TNFR superfamily, has been shown to transduce an
apoptotic signal. Antibodies against Fas induce apoptosis in lymphocytes
(Itoh, 1991; Oehm, 1992). I tested the anti-Fas murine mAb C071 on
human Mo to determine whether apoptosis would be induced. As a
control three other murine mAb, not known to induce apoptosis were
used, an IgM anti-CD25 isotype control and two IgG mAb, an anti-CDw 84
mAb which binds strongly and anti-IL-6R mAb which binds weakly to
Mo. None of the mAb tested had any effect on human Mo apoptosis,
results are presented in Table 5. 4.
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Table 5. 4
Anti-Fas Antibody does Not Induce Macrophage Apoptosis.
Treatment % Apoptosis p
Non-Adherent Adherent value
Control 7.3 ± 1.6 2.0 ±0.7 -
Anti-Fas 4.9 ±2.1 2.9 ± 0.3 n/s
Anti-CDw 84 4.6 ±1.9 1.3 ±0.8 n/s
Anti-IL-6R 6.2 ±0.9 1.1 ±0.9 n/s
Anti-CD25 3.1 ±2.0 2.8 ±0.4 n/s
50 mM CHX 16.8 ±1.5 5.5 ± 0.8 p<0.01
Legend for Table 5. 4
Human monocyte derived Mo (0.5 x 106/ml) cultured in 10%
autologous serum were incubated with medium (Control) or with 0.5
and 50 pg/ml anti-Fas monoclonal antibody (Anti-Fas) or similar
concentrations of anti-IL6R (Anti-IL-6R), anti CDw 84 (Anti CDw 84)
or an isotype control anti-CD25 monoclonal antibody MEM 141 (Anti-
CD25). As a positive control for apoptosis, Mo were incubated in the
presence of 50 |iM cycloheximide. All cells were incubated in
flexiwell 96 well trays in standard conditions for 14 hours, duplicate
wells were prepared for each treatment. Non-adherent cells were
washed off and adherent cells lifted off by 5 minutes treatment with 5
mM ice cold EDTA. Cell recoveries were all within 10% of starting
numbers, non-adherent cells were <5% total for all treatments except
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CHX where 9.5 ± 0.9% of cells were non-adherent. Apoptosis was
assessed by flow cytometry and confirmed by acridine orange
fluorescent microscopy. Results were the same for 5 fig/ml and 50
pg/ml anti-Fas and are presented for 50 pg/ml only. Results are
expressed as mean ± SE, (n = 3). The p value is shown for the
comparison between non-adherent Control and the non-adherent
cells from the other treatments but the same results pertain for
adherent cells.
5.3 DISCUSSION.
Using the panel of monoclonal antibodies against a range of cytokine
receptors provided by the Cytokine Receptor Section of the 5th
International Workshop on Leukocyte Differentiation Antigens, a
comprehensive picture was obtained of the changing pattern of
expression of cytokine receptors accompanying human Mo maturation
and apoptosis (Bellingan, 1993 and 1995). Freshly isolated human
monocytes were shown by flow cytometry to express GM-CSFR (CDw
116), IFNyR (CDw 119), TNFR75 (CD120b), IL-1R type 2 (CDw 121b) and IL-
6R (CD126) as well as Fas antigen (CD95) and CDw 84. They did not
express the following receptors at detectable levels by conventional flow
cytometry: SCFR (CD117), TNFR55 (CD120a), IL-1R type 1 (CDw 121a), IL-
2R a or (3 chains (CD25 and CD122), IL-4R (CDw 124), IL-7R (CDw 127), IL-
8R (CDw 128) or gpl30 (CDw 130). During in vitro maturation Mo gain
expression of SCFR, TNFR55, IL-1R type 1, IL-2R a and (3 chains and IL-4R
and show increased expression of GM-CSFR, TNFR75 and IL-1R type 2.
Of the range of receptors examined, only IL-7R, IL-8R and gp 130 cannot
be detected by flow cytometry on monocytes and Mo, implying that
expression is less than one thousand molecules per cell (Zola, 1990 and
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1995). Expression of IFN-yR, IL-6R and the Fas antigen remain
unchanged. Apoptosis, induced by cycloheximide, resulted in significant
loss of expression of a number of receptors namely: GM-CSFR, TNFR55
and TNFR75, IL-1R type 2, IL-2R ((3 chain only), IL-4R, IL-6R, and CDw 84.
Importantly apoptosis does not induce loss of all receptors, with
unchanged expression of the Fas antigen, the a chain of the IL-2R and the
IFN-yR. The observed specific loss of receptors associated with apoptosis
suggests that this may contribute to functional isolation of apoptotic cells
which may be important in limiting inflammation. In keeping with this
suggestion none of the known cytokine receptors tested were up-
regulated with Mo apoptosis. Protein synthesis inhibition alone results
in significant loss of expression of both types of TNFR, IL-4R and CDw 84
but does not have a global effect, with GM-CSFR, IFNyR, IL-1R type 2, IL-
2R a and [3 chains, IL-6R and Fas antigen all remaining unaffected. This
observation may relate to the levels of receptor turnover in the cell, with
rapidly recycled receptors being lost following cycloheximide treatment.
In relation to specific cytokine receptor families, no pattern of changes
emerged.
U937 cells constitutively expressed all the receptors tested except IL-4R, IL-
7R and IL-8R, they had very low expression of gp 130 and CDw 84.
Apoptosis was induced in these cells by serum withdrawal, this resulted
in the reduction in expression of GM-CSFR, SCFR, TNFR55, IL-1R types 1
and 2 and the complete loss of TNFR75, IL-2R [3 chain and IL-6R. Again
apoptotic U937 cells retain expression of the Fas antigen, IFNyR and IL-2R
a chain. These changes with apoptosis are exactly the same as those
undergone by apoptotic Mo, despite the different system of induction.
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Although other groups, using exactly the same mAb, determined
cytokine receptor expression on monocytes and U937 cells, none followed
monocytes during maturation to Mo and Mo death (Agis, 1995; Ross,
1995). At the workshop 465 antibodies, including a representative
monoclonal antibody from all the cytokine receptor CD classifications,
were analyzed as part of a Blind Panel (Shaw, 1995). This Blind Panel
analysis was performed by flow cytometry in 28 laboratories who
determined expression of the relevant antigens on over 80 different cell
types. In the section below I compare my determination of monocyte and
U937 cytokine receptor expression with those obtained by the Blind Panel
and other groups, showing close agreement particularly for the monocyte.
It is notable that the level of expression of most cytokine receptors are
very low when compared with other Mo surface molecules such as CD14
or HLA-DR, as shown by the controls.
There are three IL-2R isoforms with high, intermediate and low binding
affinities for IL-2 (Smith, 1988). The high affinity IL-2R consists of an a(3y
trimolecular complex, the intermediate affinity form is a (3y heterodimer
complex and the low affinity form consists of the a chain alone (Ishii,
1995). Three different epitopes to CD25 (IL-2Ra) have been recognized
(Sun, 1995). CD25 is expressed mainly on lymphoid cells, in particular on
certain T cells and on NK cells. I did not detect significant binding of any
of the 5 monoclonal antibodies against IL-2R a chain on monocytes but
U937 cells did express the IL-2R a chain which fell significantly with
apoptosis. Likewise none of the Blind Panel detected IL-2Ra expression
on monocytes although Ross et al. and Agis et al. found activated
monocytes to be very weakly positive (Agis, 1995; Ross, 1995). The Blind
Panel did not detect IL-2R a chain on U937 cells.
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The IL-2R (3 chain (CD122) is strongly expressed on NK cells but only
weakly on other lymphocytes (Autschbach, 1995). I did not detect any
expression of the IL-2R (3 chain on monocytes with any of the 7
monoclonal antibodies used, nor did the Blind Panel or Ross et al. ,
however 2 groups did find monocytes to be very weakly positive (Agis,
1995; Ishii, 1995). Although I did not detect any expression on monocytes,
these molecules were expressed on Mo and U937 cells, although both at
very low levels. Expression of the (3 chain fell with Mo and U937 cell
apoptosis. The Blind Panel did not detect binding on U937 cells, possibly
reflecting minor variations in cell phenotype between laboratories.
There are 2 classes of GM-CSFR, a low affinity receptor consisting of the a
subunit alone and a high affinity receptor, a heterodimer of both a and (3
subunits (reviewed in Miyajima, 1992a). The (3 subunit, which is
common to the IL-3 and IL-5 receptors (Kitamura, 1991 and 1995),
enhances binding of the a subunit to the cytokine and facilitates signal
transduction. Early haematopoietic stem cells express GM-CSFR, this is
increased in those cells committed to the myeloid lineage and decreased
in committed lymphoid cells. (Olweus, 1995). All groups at the workshop
found monocytes and U937 cells to express GM-CSFR. These data show
that with maturation into Mo the expression of GM-CSFR is significantly
increased. Inhibition of protein synthesis does not alter GM-CSFR
expression but apoptotic Mo and U937 cells have nearly a 4 fold reduction
in GM-CSFR expression.
The proto-oncogene c-kit encodes the tyrosine kinase transmembrane
SCFR, other members of this family of receptors include CSF-1 and PDGF
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receptors types A and B. Only a minority of bone marrow cells express
SCFR (1-4%), most of these co-express CD34 and represent the progenitor
cells for all haemopoietic lineages (Buhring, 1995). Neither I nor any of
the other groups detected any SCFR expression on monocytes, U937 cells
did express SCFR and apoptosis led to a small but significant fall in
expression.
IFNy is known to be a differentiation factor for Mo and all groups
confirmed monocytes to be 100% positive for IFNyR, although with less
than 10, 000 receptors per cell. Expression of the IFN-yR was not
significantly altered during monocyte to Mo differentiation, protein
synthesis inhibition or with apoptosis. In line with the Blind Panel I
found that U937 cells also expressed the IFNy receptor, with no significant
change in expression during apoptosis.
Although the TNF55R is believed to be the main receptor mediating
TNF-a induced cytotoxicity, both receptors are required for superoxide
production and recent reports demonstrate that both TNF receptors are
important for the induction of apoptosis (Grell, 1994; Richter, 1995;
Vandenabeele, 1995). Mice deficient in the TNF55R are resistant to
endotoxic shock but susceptible to intracellular pathogens, deletion of the
TNF75R has less obvious effects (Beutler, 1994; Pfeffer, 1993). These
receptors show significant homology in their extracellular domains but
their cytoplasmic regions are different and they utilize distinct signal
transduction pathways (Grell, 1994). Using Ficoll-prepared mononuclear
cells none of the Blind Panel showed any positive TNF55R expression,
although with whole blood preparations some laboratories showed weak
TNF55R antibody binding by monocytes. This may represent loss of
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receptor expression during cell isolation or a sensitivity problem with
many cytokine receptors expressed at very low levels on quiescent cells,
requiring high sensitivity flow cytometry to demonstrate expression
(Zola, 1990 and 1995). In contrast both this study and Agis et al. and Ross
et al. demonstrate that the TNFR75 is expressed by monocytes (Agis, 1995;
Ross, 1995). Expression of both receptors increased with maturation into
Mo whilst protein synthesis inhibition and apoptosis both independently
caused a significant loss of expression of both types of receptor. All
groups found U937 cells expressed both the TNF55R and the TNF75R and
I showed that, as with Mo, expression of both fell significantly during
U937 cell apoptosis. TNFR are also known to be shed rapidly from PMN
(Ding, 1992) and monocytes (Leeuwenberg, 1995) when activated, being
proteolytically cleaved and forming soluble proteins that retain TNF
binding capacity (Engelmann, 1989). Whether this generation of soluble
TNFR represents a protective response is as yet unknown.
There are two types of IL-1R, type 1 which transduces signals and type 2
with a short cytoplasmic region that does not, both have three
immunoglobulin domains. The type 1 receptor is known to be weakly
expressed on Mo, certain lymphocytes and endothelial cells (Kikutani,
1995) whilst the type 2 receptor is expressed on a subset of B cells, and on
monocytes (Zola, 1995; Agis, 1995). I demonstrated expression of IL-1R
type 2 but not type 1 on monocytes in accordance with all other
investigators at the workshop, with both types of IL-1R increased during
maturation into Mo, especially the type 2 receptor. Expression of IL-1R by
Mo was unchanged by protein synthesis inhibition but fell markedly with
apoptosis, which together with data for loss of these receptors with
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apoptosis on U937 cells suggests specific changes associated with cell
death.
In agreement with Agis et al. and the Blind Panel, I did not detect IL-4R
expression on monocytes (Agis, 1995) or on U937 cells. Mo expressed IL-
4R and lost this expression with apoptosis but not with protein synthesis
inhibition.
Competitive binding studies using purified IL-6 receptor protein suggests
at least 5 epitopes on the IL-6R as shown in Table 5. 5 (Gaillard, 1995).
Table 5. 5
Epitope Mapping of the IL-6R by Cytokine Receptor Panel Antibodies.
Epitopes
1 2 3 4 5
C014 C019 C015 C020 C059





Monoclonal C063 was not classified.
Binding of all the anti-IL6 receptor mAb to monocytes was weak (except
C060 - see later) and showed no significant increase on Mo, with no
apparent differences between epitope groupings, a finding confirmed by
Ross et al. and the Blind Panel (Ross, 1995). Unexpectedly, C060 showed
very positive binding to monocytes and Mo. This antibody falls within
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epitope group 4, the mAb in this group showing weak binding, as found
for other anti-IL-6R mAb. Agis et al. also reported C060 to be the only
anti-IL-6R monoclonal antibody with which they detected binding to
elutriated monocytes (Agis, 1995). In agreement with the blind panel I
found U937 cells expressed significant levels of IL-6R, which fell
significantly with apoptosis. Expression of C060 was not high on U937
cells. IL-6 signal is transduced by gpl30 which is also associated with
other receptors including IL-11 and thus has a broader tissue distribution
than IL-6R alone. Interestingly, despite demonstrating IL-6R expression
on monocytes I did not detect expression of gpl30, likewise, the Blind
Panel and Agis et al. found monocytes to be negative for gpl30 (Agis,
1995), all groups found U937 cells expressed low levels of gpl30.
I did not detect IL-7R or IL-8R expression on monocytes or U937 cells, nor
did Agis et al. , Morohashi et al. or the Blind Panel (Agis, 1995;
Morohashi, 1995). Ross et al. showed 9% of monocytes bound anti-IL-7R
antibody and this increased to 36% with LPS activation, they did not
detect any IL-8R expression on monocytes (Ross, 1995).
The antigens recognized by anti-APO-1 and anti-Fas are the same (Oehm,
1992; Iwai, 1994). This glycoprotein molecule has three cysteine rich
extracellular domains and is a member of the TNFR superfamily
(Eischen, 1994; Mallett, 1991). The Fas antigen is widely expressed on
cells, including T and B lymphocytes, some NK cells, PMN, monocytes
and endothelial cells; platelets do not express it (Iwai, 1994; Richardson,
1994; Robertson, 1995). Three monoclonals against Fas antigen were
tested by the Blind Panel, all were weakly positive on monocytes and
U937 cells, consistent with my findings. Expression of CD95 remained
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unchanged on Mo and apoptotic Mo and likewise expression did not fall
significantly on apoptotic U937 cells. In keeping with Robertson et al. and
Iwai et al. (Iwai, 1994; Robertson, 1995), I did not demonstrate any increase
in Mo apoptosis when incubated with the anti-Fas monoclonal antibody.
Fas has an important role in T cell selection, defects resulting in loss of
Fas expression are seen in mice homozygous for Ipr
(lymphoproliferation) and cause a striking degree of lymphadenopathy
(Watanabe-Fukunaga, 1992). Antibodies against the Fas antigen are
known to induce apoptosis (Itoh, 1991; Oehm, 1992), including in
activated lymphocytes, suggesting a role for Fas antigen in clonal deletion
of autoreactive T cells (Lenardo, 1991; Nishimura, 1995). Fas interaction
with its natural ligand, Fas ligand, also results in apoptosis; Fas ligand is
expressed on activated T cells and the interaction of Fas with this ligand
results in apoptotic death of these activated T cells (Liles, 1996). Cytotoxic
T cells express Fas ligand and can kill target cells through Fas ligand/Fas
interactions (Lowin, 1994). There is greater controversy about the role of
Fas on other cell types and whether cell activation is required for the
induction of apoptosis. Richardson et al. reported that 3 pg/ml anti-Fas
mAb triggered apoptosis in up to 30% of Mo but not in endothelial cells
(Richardson, 1994). Flowever both Robertson et al. and Liles et al.
demonstrated that monocyte viability was not affected by anti-Fas
antibodies (Robertson, 1995; Liles, 1996). Iwai et al. using 0.03 to 3 pg/ml
anti-Fas mAb could not detect anti-Fas mediated apoptosis on
unactivated lymphocytes and only detected very low levels of DNA
fragmentation in monocytes. In contrast, anti-Fas antibodies caused a
significant increase in PMN apoptosis (Iwai, 1994). Recently, ligation of
Fas has been shown to induce ROI formation, suggesting that cells with
increased anti-oxidant protective mechanisms may be resistant to Fas
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mediated apoptosis (Kohno, 1996). This observation raises the possibility
that the requirement for prior activation for Fas mediated cell death may
be a ROI mediated phenomenon and that the balance of oxidants-anti¬
oxidants can be tipped towards ROI excess by ligation of the Fas ligand.
Whether the observed lack of effect of Fas upon Mo apoptosis reflects lack
of cellular activation or is related to the capacity of the Mo anti-oxidant
mechanisms is unclear at present.
Of the antibodies against unknown antigens submitted to the Cytokine
Receptor section of the Workshop, two (C056 and C057) were clustered
along with one other antibody submitted to the B-cell section, into a
provisional CD classification CDw 84 recognizing a molecule of unknown
function. These two antibodies demonstrated a unique pattern of
expression with low level of binding to B and T-cells whilst monocytes
Mo and platelets were all strikingly positive. I observed a very marked
increase in expression during Mo maturation, with marked reductions
following apoptosis.
None of the other antibodies against unknown antigens were clustered
and apart from C078, these unclustered antibodies did not show
significant reactivity with monocytes or Mo; C078 binding fell with Mo
maturation.
Thus the cytokine receptor expression on monocytes, determined in this
chapter, is closely in accord with that found by other workers using the
same mAb. U937 cells expressed a very wide range of cytokine receptors
including GM-CSFR, IFNyR, TNFR55 and 75, IL-1R type 2, IL-6R, gp 130,
Fas antigen, and CDw 84 as well as lacking expression of IL-4R, IL-7R and
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IL-8R. There were certain differences between my data and results
reported at the Boston workshop, with my data showing U937 cell
expression of IL-2R a and (3 chains, SCFR and IL-1R type 1. Whether this
indicates an outgrowth of a slightly different strain of this cell line is not
clear. Certainly these cells, with typical monocytic cell morphology, were
shown to express CD64 (Fc RI), HLA-DR and CD14 and to be negative for
CD3 and CD16, all consistent with U937 lineage. Changes in cytokine
receptor expression induced on U937 cells with apoptosis were found to
be the same as that for Mo, despite the different method of inducing
apoptosis. Importantly this observation extends also to those receptors
that are retained (Fas antigen, IFNyR and IL-2R a chain). In addition both
Mo and U937 cells are seen to lose CD14 and HLA-DR with apoptosis.
Of the antibodies against unknown antigens, several bound to U937 cells
but not to Mo, including C023, C024, C030, C031, C034, C047 and C078.
There was a significant increase in the binding of C032, C033 and C077 on
apoptotic U937 cells, although it is unlikely that this represents new
expression of apoptosis-related proteins. Since apoptotic monocytes and
PMN did not show increased binding of C032, C033 and C077, expression
does not appear to be a general feature of apoptotic cell death. Secondly,
apoptotic U937 cells were trypan blue positive and bind the mAb BOB78,
an antibody which recognizes an intracellular antigen (Dr. I. Dransfield,
personal communication). This suggests that the increased binding of
these mAb may reflect an early change in the membrane permeability
characteristics of apoptotic U937 cells which exposes cytoplasmic antigens.
Human PMN were shown to express GM-CSFR, TNF55R and TNF75R,
IL-1R type 1 and 2, IL-6R, IL-8R and Fas antigen. The Blind Panel results
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were very similar although they did not demonstrate any binding to
TNF55R or IL-1R type 1. As TNF-a promotes PMN apoptosis and recent
work suggests that both receptors are required for the apoptotic signal to
be effected, it is likely that PMN do express the TNF55R even if only at
very low levels. Differences in cell isolation methods may account for
differences between my results and those of the Blind Panel. PMN, like
Mo and U937 cells lose expression of both TNFR types with apoptosis but
retain expression of the Fas Antigen. Unlike apoptotic Mo and U937 cells,
apoptotic PMN also retain expression of GM-CSFR and both types of IL-
1R. I demonstrated that only one of the IL-8R antibodies (C070) bound
PMN, this was confirmed by Morohashi et al. who showed that there was
no positive immunofluorescence on any peripheral blood cells for C069
but that C070 strongly stained PMN and weakly stained lymphocytes but
did not stain monocytes (Morohashi, 1995).
This work emphasizes that similar changes in surface molecule
expression are observed for apoptotic cell types irrespective of the method
of induction of apoptosis. Notably the two types of TNFR are rapidly lost
from the surface of the apoptotic cells, whilst others, particularly the Fas
antigen are retained. Whether there is any functional significance
associated with maintained expression of these receptors is as yet
unknown.
The mechanism of receptor loss with apoptosis is unknown; they may be
shed, suggesting activation of a proteolytic mechanism, or they could be
internalized. In the case of the Mo, protein synthesis inhibition alone
cannot explain the observed changes as non-apoptotic Mo exposed to
cycloheximide still retained significant cytokine receptor expression.
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Receptor internalization is unlikely to account for altered receptor
expression, indeed for apoptotic U937 cells receptor expression fell with
apoptosis despite cell permeabilization. Receptor shedding is perhaps the
most likely explanation of receptor loss, suggesting activation of a
proteolytic mechanism. Proteolytic cleavage of TNF and IL-6 receptors
with activation has been shown in other cells (Mullberg, 1995; Williams,
1996) and CD14 (Bellingan, 1995) and CD16 (Dransfield, 1994) loss with
apoptosis clearly demonstrated. Future analysis of soluble receptor levels
in cell supernatants, to determine the degree to which shedding is
involved, would be of interest.
In conclusion, this work demonstrates an increased cytokine receptor
repertoire accompanying monocyte to Mo differentiation consistent with
their increased functional capacity. With the induction of apoptosis
many, but not all, of these receptors are lost, possibly by receptor
shedding. Apoptosis associated changes were found to be common to
other cell types (U937 and PMN) and independent of the method of
induction of apoptosis. Certain receptors are retained late into the
apoptotic process including the Fas antigen demonstrating that loss of
surface molecule expression is not a universal event.
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5. 4 Appendix 2
Cytokine Receptor Expression of Human Monocytes and the Changes
with Differentiation into Macrophages and Apoptosis; Comparison with
U937 Cells and their Changes with Apoptosis.









No. 2 6 3 3 3 3
C003 1.01 1.40 1.37 1.15 1.70 1.37
C010 1.12 1.64 - - 8.93 2.501
C012 1.05 1.16 - - 1.57 1.07
C052 1.08 2.50 1.0 1.27 7.10 1.70
C068 1.02 1.16 - - 1.0 1.00
Mean 1.05 1.575 1.19 1.21 4.06 1.531









No. 3 8 6 6 3 3
C007 2.84 5.795 3.39 1.49+* 3.23 1.271









No. 2 4 - - 3 3
C009 1.06 1.11 - - 2.03 1.401
C021 1.02 1.18 - - 2.07 1.301
C055 1.01 1.10 - - 2.57 1.501
C022 1.21 1.31 - - 2.83 3.40
C054 1.06 1.16 - - 2.93 4.301
C072 1.00 1.41 - - 3.60 1.40
Mean 1.06 1.216 - ZM 2.201
CDw 119 (IFNyR)
Panel Mono M0 CHX Apoptotic U937 Apop
Code M0 M0 U937
No. 2 4 3 3 3 3
C049 1.25 2.75 1.50 1.33 2.70 1.60
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CD120a (TNFR type 1 or p55)
Panel Mono M0 CHX Apoptotic U937 Apop
Code M0 M0 U937
No. 3 6 5 5 3 3
C025 1.16 2.55§ 1.77 1.33+* 1.80 1.10
C026 1.03 2.17§ 1.40# 1.13+* 1.80 1.20
C027 1.03 1.88§ 1.22# 1.11* 1.80 1.30
C028 1.04 2.24 1.42# 1.13* 2.10 1.70
C042 1.02 1.648 1.02# 1.06* 1.70 1.30
Mean 1.06 2.108 1.37# 1.15+* 1.84 1.3211
CD120b (TNFR tvoe 2 or p75)
Panel Mono M0 CHX Apoptotic U937 Apop
Code M0 M0 U937
No. 3 9 9 9 3 3
C006 1.93 3.75§ 3.01 1.23+* 3.83 1.43
C029 1.77 4.87§ 1.37# 1.01* 4.20 1.301
C043 1.41 3.28 1.08# 1.06* 2.50 1.201
Mean 1.70 3.978 1.82# 1.10* 3.51 1.311
CDw 121a (IL-1R tvne 1)
Panel Mono M0 CHX Apoptotic U937 Apop
Code M0 M0 U937
No. 3 4 - - 3 3
C001 1.06 1.408 - - 4.20 2.401
CDw 121b (IL-1R tvoe 2)
Panel Mono M0 CHX Apoptotic U937 Apop
Code M0 M0 U937
No. 3 8 7 7 3 3
C002 1.90 4.458 4.39 1.67+* 4.30 1.501
CD122 (IL-2 receptor B)
Panel Mono M0 CHX Apoptotic U937 Apop
Code M0 M0 U937
No. 3 6 4 4 3 3
C044 1.00 1.07 - - 4.10 1.501
C045 1.11 1.65 - - 5.40 1.35
C046 1.16 1.18 1.17 1.20 2.80 1.251
C048 1.05 1.52§ 1.50 1.15+ 4.50 1.451
C051 1.01 1.20 - - 1.00 1.15
C050 1.01 1.14 - - 2.80 1.15
C053 1.01 1.15 1.00 1.09 1.30 1.05
Mean 1.05 1.278 1.22 1.15 3.10 1.271
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CDw 124 (IL-4R)
Panel Mono M0 CHX Apoptotic U937 Apop
Code M0 M0 U937
No. 3 8 6 6 3 3
C004 1.09 1.77 1.46 1.13* 1.03 1.70
CD126 (IL-6R)
Panel Mono M0 CHX Apoptotic U937 Apop
Code M0 M0 U937
No. 3 7 6 6 3 3
C014 1.22 1.56 - - 3.63 1.30
C015 1.41 1.60 1.28 1.43 7.57 1.801
C016 1.20 1.57 - - 5.43 1.501
C017 1.18 1.39 - - 6.17 1.501
C018 1.19 1.71 1.45 1.43 8.60 2.201
C019 1.52 1.91 1.34 1.21 9.90 1.901
C020 1.38 1.84 1.50 1.32 9.20 2.001
C040 1.35 1.36 1.07 1.04 3.27 1.401
C058 1.37 1.46 1.46 1.09 3.80 1.20
C059 1.45 1.45 1.23 1.08+* 3.20 1.20
C060 8.38 21-6§ 16.4 5.92+* 4.40 1.401
C061 1.48 1.32 1.11 1.14 3.97 1.301
C062 1.44 1.48 1.01# 1.05* 3.80 1.30
C063 1.10 1.27 - - 4.10 1.401
C064 1.34 1.31 1.17 1.09 3.50 1.10
C065 1.39 1.34 1.15 1.06 3.30 1.10
C066 1.12 1.47 1.00 1.00 3.60 1.20
C067 1.04 1.09 - - 1.80 1.00
Mean -C060 1.30 1.48 1.23 1.16* 4.96 1.431
Mean +C060 1.69 2.59 1.36 1.53* 4.91 1.321
CDw 127 (IL-7R)
Panel Mono M0 CHX Apoptotic U937 Apop
Code M0 M0 U937
No. 2 4 2 2 3 3
C005 1.08 1.58 1.34 1.12 1.07 1.20
CDw 128 (IL-8R)
Panel Mono M0 CHX Apoptotic U937 Apop
Code M0 M0 U937
No. 2 3 - - 3 3
C069 1.00 1.05 - - 1.10 1.70











No. 2 3 - - 3 3
C041 1.13 1.16 - - 1.27 1.23
CD95 (Anti-Fas)
Panel Mono M0 CHX Apoptotic U937 Apop
Code M0 M0 U937
No. 3 9 7 7 3 3
C071 1.96 2.92 2.69 2.53 3.80 2.20
CDw 84 (unknown function)
Panel Mono M0 CHX Apoptotic U937 Apop
Code M0 M0 U937
No. 2 8 7 7 3 3
C056 4.63 31.1§ 23.0# 3.86+* 1.30 1.10
C057 4.87 34.28 24.2# 4.40#* 1.40 1.20









No. 2 3 3 3 3 3
con 1.01 1.06 - - 1.07 1.40
C023 1.47 2.00 1.19 1.97 2.93 1.331
C024 1.19 1.21 - - 5.57 2.871
C030 1.06 1.34§ 1.30 1.19 3.60 2.47
C031 1.47 1.71 - - 9.10 2.201
C032 1.01 1.10 - - 1.00 1.531
C033 1.03 1.21 - - 1.00 45.31
C034 1.17 1.99 - - 8.53 1.801
C047 1.01 1.22 - - 2.53 1.90
C077 1.00 1.51 2.09 1.24 1.00 2.301
C078 4.69 1.87 1.33 1.52 4.50 1.451
Controls
Antigen Mono M0 CHX Apoptotic U937 Apop
M0 M0 U937
No. 3 7 7 7 3 3
CD14 104 71§ 44# 7.8*+ 6.8 1.71
HLA-DR 32 151§ 135 51*+ 5.9 1.71
BOB 78 - L45 Z21
Legend for Table 5. 2
Results of binding of panel of cytokine receptor mAb, listed by the
cytokine receptor panel code (Panel Code) to human peripheral blood
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monocytes (Mono), macrophages (M0), cycloheximide treated non-
apoptotic macrophages (CHX M0), cycloheximide treated apoptotic
macrophages (Apoptotic M0), U937 cells (U937) and apoptotic U937
cells (Apop U937). Apoptosis was induced by cycloheximide (50 pM)
in Mo and by serum withdrawal in U937 cells. mAb binding was
determined by indirect immunofluorescence, gating on the non-
apoptotic and apoptotic populations which were distinguished by
forward and side scatter flow cytometry parameters. The number of
donors tested for each cytokine receptor and for each cell type are
shown (No.). If a test has not been performed this is indicated by a (-).
Results are expressed as relative mean fluorescence, determining the
logarithmic fluorescence value for each antibody and dividing this by
that of a non-binding control MOPC-21C. A value of 1.00 indicates no
difference between non-binding control and test mAb. Positive
controls were provided by analyzing binding of mAb against the
known Mo associated antigens - CD14 and HLA-DR (see also section
3. 2. 9). The mAb BOB 78 binds to an intracellular antigen. For each
mAb, changes in binding between the following were determined:
1) monocytes and control untreated Mo,
2) cycloheximide treated non-apoptotic and apoptotic Mo,
3) control Mo and apoptotic Mo,
4) control Mo and cycloheximide treated non-apoptotic Mo,
5) Non apoptotic and apoptotic U937 cells.
Significance of p<0.05 (tested for using Students paired t test) is
represented by the following characters:
§ monocytes vs. control Mo,
+ cycloheximide treated non-apoptotic vs. apoptotic Mo,
* control Mo vs. apoptotic Mo,
# control Mo vs. cycloheximide treated non-apoptotic Mo,
^ Non apoptotic vs. apoptotic U937 cells.
The mean results for each receptor are also shown. Note that
antibodies C032, C033 and C054 all have a significant increase in
binding on apoptotic U937 cells but apoptotic U937 cells also bind BOB
78 (which binds an intracellular antigen).
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5. 5 Appendix 3
Cytokine Receptor Expression on Human Polymorphonuclear Leukocytes
and the Changes Associated with Apoptosis. Summary of Changes with
Apoptosis in Neutrophils, Macrophages and U937 Cells.








































































C006 1.99 1.39 n/s <=> II «=>
C029 5.57 1.16 <0.05 II II II
C043 2.22 1.03 <0.05 II II 11













































C020 4.57 2.01 n/s







C069 1.00 1.04 n/s







C071 2.35 3.64 n/s






C056 1.10 1.06 n/s






C023 1.05 1.07 n/s
C033 1.23 1.28 n/s
C077 12.3 7.4 n/s





anti-CD16 105.2 1.21 <0.05








































Legend for Table 5. 3
Results of dual colour immunofluorescence for PMN aged in culture,
mean 62% apoptosis (range 53 - 70%, n = 3). Non-apoptotic PMN
express high levels of CD16 whilst apoptotic PMN lose this; using a
FITC conjugated anti-CD16 mAb non-apoptotic cells with high FITC
fluorescence counts (PMN) could be distinguished from the apoptotic
cells with low FITC fluorescence (Apop PMN). Gating separately on
these two sub-populations the binding of mAb from the cytokine
receptor panel could be determined using a PE conjugated second
layer. Results are expressed as relative mean fluorescence, dividing
the log fluorescent counts of test mAb by that of a PE conjugated non-
binding control (MOPC-21C), no specific binding is indicated by 1.00.
Relative binding for PMN and Apop PMN were compared using
Students paired t test and significance shown in the column labelled
Sig. (n/s = not significant).
On the right side of the table is a summary for each antibody of the
change associated with apoptosis for neutrophils (PMN),
macrophages (M0) and U937 cells (U937) where:
<=> = no change in expression between non-apoptotic and
apoptotic cells,
li = reduced expression with apoptosis,
It = increased expression with apoptosis,
ND = not done.
(Values in brackets indicate a trend only.)
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Chapter 6
THE ROLE OF FREE RADICALS AND ONCOGENES IN
MONOCYTE AND MACROPHAGE APOPTOSIS.
213
6.1 INTRODUCTION.
In this chapter I aimed to investigate potential sources of the differential
sensitivity to the induction of apoptosis noted in Chapter 3 between
monocytes and Mo. In the light of the roles of oncogenes in the
regulation of apoptosis and the relative resistance of Mo to the induction
of apoptosis, I looked the level of expression of specific oncogene products
in monocytes and Mo. Bcl-2 (Hockenbery, 1993) and ABL (Bedi, 1994)
have been shown to be important in preventing and c-Myc (Amanti,
1993) in promoting apoptosis. Although monocytes have been reported
to weakly express bcl-2, changes in expression during monocyte
differentiation have not been investigated (Iwai, 1994). Up-regulation of
bcl-2 expression with Mo maturation could explain the lower levels of
constitutive Mo apoptosis and their resistance to the induction of
apoptosis by factors which cause monocyte apoptosis. As Bcl-2 has been
proposed to protect cells against free radical induced apoptosis and
mononuclear phagocytes are powerful sources of ROI, I also investigated
whether free radicals are important in inducing phagocyte apoptosis and
whether there was a role for endogenous antioxidants in preventing this.
Since monocytes and Mo have a powerful array of endogenous
antioxidants, it is attractive to speculate that their intrinsic resistance to
the induction of apoptosis may reside, at least partially, in their ability to
cope with oxidative stress, either through the action of Bcl-2 or their
endogenous antioxidant capacity.
I determined the levels of expression of Bcl-2, c-Myc and BCR-ABL in
monocytes and the changes in expression with maturation into Mo using
antibody probes in permeabilised cells. As positive controls I employed
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an mAb against p8,14 which are two associated calcium binding proteins
specific to myeloid cells where they are abundant in the cytoplasm
(Edgeworth, 1989 and 1991) and also a mAb against MPO. I also
investigated whether ROI could induce phagocyte apoptosis by the
addition of hydrogen peroxide (H2O2) to cultured cells and the effect of
different antioxidants on the action of H2O2.
6.2 RESULTS:
6. 2.1 Hydrogen Peroxide Promotes Neutrophil Apoptosis in a
Dose Dependent Manner.
Due to their availability, initial studies examined PMN to establish the
dose response for an ROI and antioxidant; investigations were then
extended to monocytes and Mo. H2O2 (1-5 mM) significantly promoted
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Legend for Figure 6.1
Hydrogen peroxide added to fresh PMN cultured in 2% autologous
serum in 8 well slides under standard conditions. After 8 hours cells
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were resuspended and cytospins made. Apoptosis was assessed
morphologically, 400 cells were counted per slide and duplicate slides
were made for each treatment. Results are Mean ± SE, n = 9.
6. 2. 2 Antioxidants Block the Apoptosis Promoting Action of
Hydrogen Peroxide.
Two different antioxidants were initially tested; the soluble vitamin E
analogue Trolox and the endogenous antioxidant GSH. Trolox
significantly inhibited the apoptosis promoting effect of H2O2 on PMN.
Figure 6. 2




CONTROL TROLOX H202 BOTH
Legend for Figure 6. 2
PMN were cultured in 8 well slides in 2% autologous serum
(CONTROL), or with the addition of Trolox 10 mM (TROLOX), ImM
H2O2 (H2O2) or both added simultaneously (BOTH). Apoptosis was
assessed morphologically after 8 hours. * Significant increase in
apoptosis above control level (p<0.005). t Significant reduction in
apoptosis from H2O2 levels (p<0.0005, n = 8). Trolox alone tended to
reduce baseline apoptosis, but was not significant, (p = 0.23, n = 8).
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GSH also appeared to inhibit the apoptosis promoting effect of H2O2, with
the apoptosis levels of control, H2O2 (1 mM) and H2O2 with 2 mM GSH
being 16.4 ± 4%, 20.6 ± 2.1% and 13.9 ± 4.3% respectively, however due to
the small numbers used (n = 3) this did not reach significance. Neither
Trolox or GSH affected cell recovery or trypan blue exclusion rates.
6. 2. 3 Hydrogen Peroxide Promotes Both Monocyte and
Macrophage Apoptosis.
Having established that H2O2 augmented PMN apoptosis, this system was
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Legend for Figure 6. 3
Monocytes and corresponding Mo (matured in vitro for 5 days),
cultured in 8 well slides in 2% autologous serum for 20 hours
(Control) or with the addition of H2O2 1 mM or 2 mM. Apoptosis was
counted morphologically. The addition of 1 mM H2O2 caused a
significant increase in both monocyte and Mo apoptosis (p<0.01) over
217
Control and 2 mM H2O2 caused a further significant increase in both
monocyte and Mo apoptosis (p<0.01) over the 1 mM H2O2 levels.
* Mo apoptosis levels were significantly lower than for monocytes.
Results expressed as mean ± SE, n = 5.
Monocytes were cultured in 2% and 10% serum, the reduction in serum
significantly increased apoptosis rates in the presence of H2O2 as shown.
Table 6.1
Hydrogen Peroxide Causes Apoptosis in Human Monocytes Which is
Partially Prevented by Serum.
Treatment Serum % Monocyte p value n
% Apoptosis (10% vs. 2%)
Control 10% 13.0 + 2.7 6
2% 15.8 ±4.1 n/s 6
1 mM H202 10% 17.6+4.1 5
2% 36.6 ±3.1 <0.01 5
2mMH202 10% 30.6 ±3.1 5
2% 60.4 ±3.2 <0.01 5
Legend for Table 6.1
Monocytes were cultured in 10% or 2% autologous serum for 20
hours on 8 well slides, H2O2 (to a final concentration of 1 or 2 mM)
was added only at the start of the experiment. Apoptosis was
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determined morphologically by acridine orange fluorescent
microscopy, 1000 cells being counted per treatment well. Results
expressed as mean ± SE. Comparison was made between monocytes
cultured in the presence of 10 or 2% serum for Control, 1 mM H2O2
and 2 mM H2O2 using Student's paired t test. There was no
significant difference in the levels of apoptosis for Control cells whilst
for both 1 and 2 mM H2O2 there was significantly greater levels of
apoptosis in the presence of 2% serum than that in 10% serum. The
number of experiments per group is shown in table (n). DNA
electrophoresis again confirmed that apoptosis was associated with
DNA fragmentation and that H2O2 augmented this.
As with serum withdrawal alone, "ghost" cells were seen in monocyte
cultures in the presence of H2O2. They were more abundant when the
percentage of apoptosis was higher but were seldom more than 10% of
cells, again they were rare in Mo cultures. In a single experiment, 1 mM
H2O2 was added to alveolar Mo in an 8 well slide for 12 hours, apoptosis
was increased from 5.6% in the 3 control wells to 12.4% in the 3 well
exposed to H2O2 suggesting that these cells too are susceptible to H2O2
induced cell death.
6. 2. 4 Antioxidant Capacity of Donor's Serum Shows Little
Variability.
To determine whether individual differences in serum antioxidant
capacity could influence the results, the serum Trolox equivalent
antioxidant capacity (TEAC) for a number of donors serum was
determined as described in section 2. 7. 3. 4. The mean TEAC value was
1.12 (range 1.08 to 1.19, n = 5) which was well within the published
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normal range for human serum of 1.0 to 1.5 (Miller, 1993). The tight
range of these results suggests that variations in the antioxidant capacity
of serum was not a significant factor in the results.
6. 2. 5 Oncogene Expression During Monocyte Differentiation.
The expression of Bcl-2, c-Myc and c-Abl were determined in
permeabilized monocytes from 7 donors. Monocytes from the same
donors were matured into Mo and the relative changes in expression of
these oncogene products were followed using indirect
immunofluorescence. Antibodies against the enzyme MPO and the
cytoplasmic protein p8,14 were used as the positive controls. HL-60 cells
were used as a positive control for the anti-Bcl-2 mAb and fibroblasts for
the anti-c-Myc mAb. The relative mean fluorescence of anti-Bcl-2 mAb
on HL60 cells was 10.9 ± 2.6 and that of the anti-c-Myc mAb on fibroblasts
was 23.3 ± 7.8 (S. Hannah, personal communication). Monocytes were
shown to express low levels of Bcl-2 but despite the increased resistance to
the induction of apoptosis shown by Mo, the levels of Bcl-2 expression
fell significantly during the maturation of monocytes into Mo as shown
in Table 6. 2.
220
Table 6. 2
Oncogene Expression in Human Monocytes and Macrophages.
GENE PRODUCT MONOCYTES MACROPHAGES p Value
Bcl-2 3.47 ±0.7 1.8 ±0.3 <0.05
c-Myc 21.8 ±8 7.3 ± 1.5 n/s
c-Abl 1.0 ±0.2 1.4 ±0.5 n/s
Myeloperoxidase 67 ± 18 7.3 ± 2.6 < 0.05
p8,14 78 ±18 45 ±12 n/s
Legend for Table 6. 2
Expression of the gene products of the oncogenes bcl-2, c-myc and c-
abl in monocytes and corresponding Mo populations, shown by mAb
to permeabilized cells (polyclonal antibody for c-Abl). MPO and p8,14
included as positive controls, all binding expressed as relative mean
fluorescence ± SE related to that of the negative control MOPC-21C.
No expression gave a value of 1.0 - the same as the negative control.
For c-Abl, polyclonal sheep serum was used as control. Monocyte and
Mo populations were >95% pure. In the cases where there was
positive expression of gene product, greater than 90% of cells were
positive. Students paired t test used to test for significance, n = 7.
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Although there was an overall fall in the mean expression of c-Myc from
monocyte to Mo this masked the fact that expression was markedly
reduced in three donors whilst in the remaining four slightly increased
expression was observed (Figure 6. 4a). This differed from the results for
Bcl-2 where there was a uniform fall in the levels of gene product during
maturation (Figure 6. 4b). The reasons for the variable pattern of
expression of c-Myc are not clear, the same preparative method was used
for all cells and neither sex nor age could be used to distinguish donors
with a fall or rise in c-Myc. These studies were all performed over a two
month period and the mAb used all came from the same stock. Altering
the time that the cells were exposed to the permeabilization solution did
not affect the results (data not shown). It is of interest that those donors
with high c-Myc expression also had higher Bcl-2 expression.
Figure 6. 4a
Individual Changes in c-Myc Expression
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Figure 6. 4b
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Legend for Figure 6. 4
Changes in expression of Bcl-2 and c-Myc during monocyte to Mo
maturation for each donor (numbered 1 to 7, the same numbers are
used for c-Myc and Bcl-2 expression). Results are shown as relative
mean fluorescence for monocytes and the corresponding values for
the same donors Mo examined 5 days later after in vitro maturation
Looking at the ratio of Bcl-2 to c-Myc for monocytes and Mo a more
consistent pattern emerged with a ratio of 0.26 (range 0.11 to 0.5) for
monocytes and 0.32 (0.12 to 0.68) for Mo, indicating a persistent excess of c-
Myc. The results for c-Abl were somewhat inconclusive as the binding of
the control sheep serum was strikingly positive on monocytes and Mo.
The polyclonal nature of this control may thus have masked any specific
positive binding of the anti-Abl antibody, mAb against c-Abl were not
available at the time.
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6.3 DISCUSSION.
These data demonstrate that the H2O2 significantly increases the rates of
apoptosis for PMN, monocytes and Mo. This is the only "physiological"
agent I have so far tested that does promote apoptosis in the
monocyte/Mo system although it was being used at pharmacological
concentrations. For PMN, the antioxidant Trolox could prevent the pro-
apoptotic effect of H2O2 (see Figure 6. 2), a protective effect which may be
shared by other antioxidants such as GSF1. It is interesting to note that
Trolox also tended to decrease the baseline rate of apoptosis in PMN
which would be consistent with a role for oxidative stress in the normal
constitutive induction of apoptosis in these cells in culture. In these
studies of the effect of exogenous antioxidants, the soluble nature of
Trolox is important. Abello et al. demonstrated that only soluble
antioxidants (dimethyl sulfoxide and the iron chelator - o-
phenanthroline) were able to block endothelial cell apoptosis whilst cell
impermeable scavengers (superoxide dismutase and catalase) were
without effect (Abello, 1994). There is close agreement between the
concentrations of Trolox (10 mM) required in my work to protect cells
against H2O2 induced apoptosis and that used by Forrest et al. (Trolox 10
mM) to protect thymocytes from Ff^ induced damage (Forrest, 1994).
Serum was shown to have a significant protective effect for monocytes
exposed to H2O2. The antioxidant capacity of serum is well recognized
and it is probable that it is though these antioxidant mechanisms that
serum protects monocytes from ROI induced apoptosis. To control for
the possibility that serum from different donors varied in antioxidant
capacity, these levels were determined using the TEAC assay. This
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demonstrated that all the donors had a remarkably similar antioxidant
capacity which fell entirely within the normal range (Miller, 1993).
H2O2 has been shown to induce apoptosis in a number of other cells but at
significantly lower concentrations than needed here. HL60 cells, cultured
in 10% serum, underwent apoptosis in response to only 15 pM H2O2, with
higher concentrations (400 pM) causing necrosis (Lennon, 1991) and as
little as 25 nM H2O2 could result in lymphocytes loss (Greenspan, 1994).
However in my hands PMN, monocytes and Mo all required at least 1
mM H2O2 to induce significant apoptosis without evidence of cell
necrosis, the concentration of the H2O2 used was checked prior to each
experiment as described in section 2. 7. 3. 3. The concentrations of H2O2
required to cause Mo cell death in this work agrees with results obtained
by Schraufstatter et al. who showed that 10 mM H2O2 was required for
rabbit alveolar Mo death (Schraufstatter, 1987). The explanation for the
difference in H2O2 requirement between phagocytes and other cells may
well lie in the endogenous antioxidant capacity of phagocytes. The
susceptibility of cells to ROI induced damage is inversely correlated to
their catalase content (Schraufstatter, 1987), furthermore adult T cell
leukemia cells are protected from ROI mediated cell death by increased
concentrations of glutathione (Kohno, 1996). Activated PMN have been
shown to produce large amounts of superoxide and H2O2 (Weening, 1975;
Forman, 1986). Measurements of H2O2 and superoxide released into the
surrounding medium show production rates of 1000 pM per 1010 PMN
per hour (Joke, 1975). Quantification of the intracellular generation of
oxygen metabolites has not been possible but chemiluminescence assays
indicate that this is in fact greater than the measured extracellular
production (Briheim, 1989). Thus the cell requires considerable
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protection against its own armoury of ROI, hence the redundancy in
antioxidant mechanisms as discussed in section 1. 4. 2. 4.
This chapter also documents changes in oncogene expression during
monocyte to Mo maturation. The two positive controls (MPO and p8,14)
confirmed both Mo maturation and effective cell permeabilization. MPO
is known to decline during the maturation of monocyte into Mo (Savill,
1989a) and this was observed. p8,14 are infact two non-covalently bound
calcium binding proteins that fractionate together. The p8,14 calcium
binding proteins are specific to myeloid cells, representing 45% of PMN
cytosolic protein but considerably less in monocytes (Edgeworth, 1989 and
1991) and provide a useful cytoplasmic antigen positive control that
remained strongly positive in both monocytes and Mo.
Surprisingly, the expression of the oncogene product Bcl-2 was very low
in monocytes and despite the increased resistance of the Mo to the
induction of apoptosis, the expression of Bcl-2 fell significantly with
maturation into the Mo. These findings also corroborate and extend the
work of Delia et al. who demonstrated that in human bone marrow
preparations, the myeloid precursors myeloblasts, promyelocytes and
myelocytes stain positive for Bcl-2 whereas monocytes were negative
(Delia, 1992). The PMN has also been shown to not express Bcl-2 (Delia,
1992; Hannah, 1995). Iwai et al. investigated the expression of Fas antigen
and Bcl-2 on human peripheral blood lymphocytes, monocytes and PMN.
Lymphocytes expressed high levels of Bcl-2 whilst monocytes had only
very weak Bcl-2 expression and PMN did not express it at all, they
correlated this with susceptibility to undergo apoptosis (Iwai, 1994). In
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view of the lack of expression of Bcl-2 by Mo demonstrated in this work,
resistance to apoptosis by these cells must lie in other mechanisms.
As noted in the introduction the bcl-2 oncogene product is part of a large
family of molecules including Bc1-x-l and Bak which are able to inhibit
apoptosis (Reed, 1994; Kiefer, 1995). Due to the absence of suitable
antibodies at the time of this study I was unable to look for these gene
products, hence the possibility remains that despite the absence of Bcl-2
expression, resistance to apoptosis in the Mo could still be conferred by a
Bcl-2 family member. Reed's group have documented the in vivo
expression of Bax and Bcl-X (Krajewski, 1994a and 1994b). They were
unable to clearly distinguish between Bc1-x-l, (an inhibitor of apoptosis)
and Bcl-x-s which like Bax promotes apoptosis. Although Mo are long-
lived cells, they did not single out Mo as notable for Bc1-x-l expression,
indeed Bc1-x-l was not expressed on glial cells and rarely in normal
lymph nodes. In the bone marrow they noted some myeloid precursors
expressed Bcl-X but commented that expression may well be lost with
terminal differentiation. Furthermore Benito et al. have recently
demonstrated that differentiation of erythroid human leukemia cell lines
resulted in loss of Bc1-x-l mRNA and the onset of apoptosis (Benito,
1996). Thus differentiation of monocytes into Mo may not be associated
with significant expression of Bc1-x-l and although other members of the
Bcl-2 family may be involved in Mo resistance to apoptosis, initial studies
do not suggest that Mo are strongly Bc1-x-l positive and Bax negative.
c-Myc levels are related to the stage of cell cycle in proliferating cells and
are known to decline when myeloid cell lines are induced to differentiate,
with a switch from Myc:Max to Mad:Max heterodimers accompanying
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U937 differentiation (Marcu, 1992; Ayer, 1993). However these reports are
not on primary cultures of human cells, hence the changes in expression
of c-Myc with maturation from monocytes into Mo are of interest. The
decline in relative mean fluorescence from 21.8 ± 8 to 7.3 ± 1.5 (Table 6. 2)
fits with that expected from studies using cell lines but masks a wide
individual variation with 4 of the 7 subjects actually showing a small rise
in expression with differentiation (Figure 6. 4a). Thus it would seem
unlikely that changes in c-Myc expression account for the greater
resistance of Mo to the induction of apoptosis than the monocyte.
The BCR-ABL gene has been shown to inhibit apoptosis in myeloid
progenitor cells, inhibition of BCR-ABL gene by anti-sense
oligonucleotides reverses this suppression of apoptosis. This is presumed
to underlie the growth advantage of Philadelphia cells in chronic
myeloid leukaemia (Bedi, 1994). Furthermore over-expresion of abl,
using a temperature sensitive mutant, prevents apoptosis in HL-60 cells
(Martin, 1995). Recently it has also been suggested that the myc gene
cooperates with BCR-ABL during cell transformation (Skorski, 1995). By
the assay used here the detected levels of the c-Abl oncogene product
were extremely low and no significant difference between monocytes and
Mo was observed. This result needs to be interpreted with caution as the
anti-Abl antibody used was a polyclonal and binding of the polyclonal
sheep immunoglobulin control was much greater than that of MOPC-21C
thus maturational changes in c-Abl may have been missed. In summary
these data show that there is no significant change in the ratio of Bcl-2 to
c-Myc, nor in the levels of BCR-ABL during the Mo maturation process.
This suggests that increased Mo resistance to apoptosis is not conferred by
changes in these oncogene products.
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Chapter 7
THE IN VIVO FATE OF THE INFLAMMATORY




Although the inflammatory Mo plays a central role in the inflammatory
process it s fate during the resolution of inflammation is largely
unknown (Adams, 1992). Resolution of acute inflammation is
characterized by the clearance of extravasated PMN and Mo and the
return of normal tissue architecture. However, in a number of disease
processes inflammation does not resolve, rather it persists and is often
associated with fibrosis and loss of organ function (Adams, 1992), as
exemplified by chronic bronchitis, emphysema (Khalil, 1989),
glomerulonephritis (Baker, 1994) or rheumatoid arthritis (Koch, 1991 and
1994). The mechanisms underlying the development of chronic
inflammation are poorly understood but much attention has been
focused on the role of the inflammatory Mo. The Mo can damage tissue
by release of histotoxic enzymes, pro-inflammatory and pro-fibrogenic
cytokines or presentation of antigen to T cells (Nathan, 1987; Khalil, 1989;
Adams, 1992) and although Mo are able to debride tissue and promote
wound healing (Riches, 1988), continued Mo accumulation is also a
hallmark of chronic inflammation. Thus, definition of the mechanisms
controlling not only the influx but also the persistence and removal of
inflammatory Mo are important to our understanding of the
pathogenesis of both acute and chronic inflammation.
The origin and influx of monocytes have been well documented (Ebert,
1939; Rosen, 1990; van Furth, 1992), whilst the fate of the inflammatory
Mo has received comparatively little attention. Inflammatory Mo are
known to be derived from circulating monocytes which migrate into
acute inflammatory reactions, mixing with the resident Mo population
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(van Furth, 1973). The kinetics of resident tissue Mo in the non-inflamed
steady state have also been the subject of investigation (Rosser, 1970; van
Furth, 1992), but resident and inflammatory Mo differ in cell physiology
and activation status (Daems, 1973; Haskill, 1985; Melnicoff, 1988a; van
Furth, 1989) and may differ in ontogeny (Volkman, 1976; Bouwens, 1986;
Ginsel, 1993), hence the direct relevance of studies on the resident Mo to
our understanding of the tissue kinetics of the inflammatory Mo is
unclear.
Some insights into the cellular mechanisms underlying resolution of
inflammation have been provided recently by studies relating to the fate
of extravasated PMN during the resolution of inflammation. These cells
have been shown to undergo apoptosis (Savill, 1989a) and subsequently
are ingested by inflammatory Mo (Savill, 1989a; Grigg, 1991) utilizing a
novel recognition mechanism (Savill, 1989b, 1990 and 1992) which fails to
stimulate the release of pro-inflammatory mediators (Meagher, 1992).
Thus, it has been suggested that this process may represent a non-
phlogistic mechanism for the "silent" clearance of large numbers of
PMN's and their potentially histotoxic contents during the resolution of
acute inflammation (Haslett, 1994). Mo in vitro have now been shown
to undergo apoptosis in response to a number of stimuli (Zychlinsky,
1992; Albina, 1993; Khelef, 1993; Papadimitriou, 1993; Sarih, 1993a and b).
Hence it was entirely conceivable that, in a fashion analogous to the PMN
or another phagocyte, the mesangial cell (Baker, 1994), the inflammatory
Mo might undergo apoptosis in large numbers locally, and themselves
become ingested by local phagocytes.
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In order to address this question I have examined the kinetics of the
inflammatory Mo using two independent labelling systems.
Inflammatory Mo from H-2^/d donor mice were labelled with a red
fluorescent dye and transferred into the peritoneal cavity of recipient H-
2^ mice at the same stage of resolving inflammation as the donor mice.
The use of fluorescent tracking dyes is now a well established technique
allowing the stable labelling of cells in a non-toxic manner without
apparently altering normal cell physiology (Melnicoff, 1988a and b;
Soesatyo, 1993). Immunofluorescence analysis using a FITC anti-H-2d
antibody provided the second method of distinguishing donor or
recipient cells and dual colour flow cytometry allowed identification of
donor Mo that had been phagocytosed by recipient cells.
In the non-inflamed peritoneal cavity the half-life of resident Mo has
been estimated to be 2 weeks or longer (Haskill, 1985; van Furth, 1989).
Data presented in this chapter show that during the resolution process,
adoptively transferred inflammatory Mo rapidly emigrate intact from the
inflamed peritoneum specifically to the draining LN and that this
emigration is complete by 96 hours, with little evidence of death or
engulfment of Mo at the inflamed site. Furthermore the kinetics of
inflammatory Mo emigration from the inflamed site are significantly
faster than those of resident Mo from the non-inflamed peritoneum.
7.2 RESULTS.
7. 2.1 Time Course of Inflammatory Macrophage Response to
Acute Inflammation.
Both CB1 and C3HF/KAM mice had less than 3 x 106 resident Mo in the
peritoneal cavity prior to the induction of inflammation. Approximately
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40% of these cells were Mo, demonstrated by differential cell counts and
by immunofluorescence, the bulk of the remaining cells being
lymphocytes, in agreement with previous studies (Melnicoff, 1988b). TG
induced a prompt PMN influx that declined after 2 days whilst for both
CB1 and C3HF/KAM mice the Mo number (19.6 ± 1.8 x 106) and relative
percentage (>85%) reached a peak on the 5th day after i.p. TG. As shown
in Figure 7. 1 the total number of cells and the number of Mo steadily
declined from the fifth day after TG, thus this was chosen as the optimum
day for cell transfer to track the kinetics of Mo during the resolution
phase of inflammation.
Figure 7.1
Inflammatory Response to i.p. TG;
CB1 Mice
Days after i.p. TG
Legend for Figure 7.1
Inflammatory cell response to i.p. TG for CB1 mice, showing the total
number of leukocytes and the numbers of Mo and PMN in peritoneal
lavageates with time. 2 mis TG was injected i.p. on day 0, cells were
recovered using 5 mis ice cold PBS. Total cell number was estimated
by haemocytometer, >400 cells being counted. Relative % of Mo and
PMN were obtained from duplicate cytospin preparations (stained
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with Dif Quick™ and for non-specific esterase) and by indirect
immunofluorescence using the anti-CR3 mAb Ml/70 for Mo and
mAb 7/4 for PMN. Estimates of % Mo were equivalent for all three
methods. The inflammatory response in C3HF/KAM mice was
identical. Lymphocytes account for the remaining cells in the
differential counts (not shown). Each point represent the mean for at
least 4 mice; SD are not shown as they are all within 10% of the
means . There was no significant difference in the kinetics of the Mo
response to TG between CB1 and C3H mice.
A similar, although less pronounced, pattern was found using starch as
the inflammatory agent, with 9.2 ± 1.4 x 106 cells recovered on the 5th day
after i.p. starch and again >85% were Mo. This declined significantly to
4.1 ± 0.9 x 106 cells by day 10 (p< 0.05). Mo expressed CR3 (Beller, 1982) and
F4/80 (Austyn, 1981; Hirsch, 1982; Hume, 1983), < 10% of cells expressed
la, consistent with the observations of other investigators (Melnicoff,
1988b; Kimberly, 1992), (Figure 2. 4 Chapter 2).
7. 2. 2 Adoptive Transfer of Donor Macrophages.
7. 2. 2.1 In Vitro General Labelled Donor Macrophages.
At the outset it seemed appropriate to use a well defined method that
labelled 100% of the donor cells, as could be achieved with in vitro
PKH26-GL general cell labelling. However the cell viability after in vitro
labelling became a source of concern. Altering a number of procedures
including reducing the centrifuge speeds, number of washes and the
concentration of dye all helped to improve viability however 10% of cells
still were non viable at the time of transfer. Attempts to increase yields of
viable cells by selective adherence to BHK matrix coated plates (see
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section 2. 9. 5. 1) produced minimal improvements. Figure 7. 2 shows the
percentage of PKH26 labelled Mo recovered in peritoneal lavage after
transfer of cells labelled by general in vitro and phagocytic in vivo
labelling methods, the two are completely different in their kinetics. The
in vitro general labelled Mo were handled in a manner similar to that of
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Legend for Figure 7. 2
Plot of recovery of donor CB1 inflammatory Mo from peritoneal
cavities of C3HF/KAM mice after in vitro general cell labelling with
PKH26-GL compared with that after in vivo phagocytic cell labelling
with PKH26-PCL. 20 x 106 live donor in vitro labelled cells (100%
labelled) and 30 x 106 live donor in vivo labelled cells (28 - 42%
labelled) were adoptively transferred into recipient mice at the same
stage of resolving inflammation. Each point representsthe mean ± SE
235
for at least 8 mice receiving in vivo phagocytic labelled cells and 12
mice receiving in vitro general labelled cells.
Furthermore, it became apparent (Figure 7. 3) that there was considerable
phagocytosis of in vitro labelled donor cells by recipient Mo after
adoptive cell transfer, suggesting poor survival of these labelled cells,
possibly as a result of damage during labelling. In view of these problems
an in vivo phagocytic labelling system (PKH26-PCL; section 2. 9. 3. lb and
7. 2. 2. 2) was tried. Figure 7. 3 shows the degree of phagocytosis of in
vitro and in vivo labelled donor Mo after adoptive cell transfer.
Figure 7. 3
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Legend for Figure 7. 3
Plot of recovery from the peritoneum of PKH26 fluorescent labelled
donor Mo that have been phagocytosed, expressed as a percentage of
total number of fluorescent labelled cells recovered after adoptive
transfer of: live donor in vitro general labelled cells (closed squares),
live donor in vivo phagocytic labelled cells (open squares) or donor
Rapid Phagocytosis of General Labelled





in vivo phagocytic labelled cells that were formalin-fixed prior to
adoptive transfer (open circles). Fixed in vivo labelled and live in
vitro labelled cells were all rapidly phagocytosed. In contrast live in
vivo labelled cells remained free in the peritoneum until one week
after transfer when the few remaining cells were all phagocytosed.
Each point represents the mean ± SE for at least 6 recipient mice for in
vivo labelled cell transfer and 4 recipient mice for in vitro labelled
cell transfer.
Thus in vitro labelling, although providing 100% labelling resulted in
poor viabilities and rapid clearance of cells in a similar manner to that of
fixed cells therefore in vivo labelling was adopted as the method of
choice for the rest of this project despite the inability of this system to
label all Mo.
7. 2. 2. 2 Adoptive Transfer of Live In Vivo Labelled Donor
Macrophages.
In the absence of inflammation the phagocytic label PKH26-PCL has been
reported to label all peritoneal Mo but Melnicoff et al. reported that
inflammation significantly reduced the number of cells labelled
(Melnicoff, 1990). I found that in the presence of inflammation, i.p.
injection of 0.5 ml of fluorescent PHK26-PCL dye strongly labelled 1/3 of
Mo (range 27 - 46.7%). This could be increased to 74% (61 - 82%) using 1
ml of dye and to over 80% with 2 mis of dye, although with 2 mis the
viabilities began to fall. The percentage of cells labelled did not alter
whether dye was left in situ for 1.5 or 18 hours prior to lavage. For the
bulk of experiments 0.5 ml PKH26-PCL was used with a labelling time of
1.5 hours. This labelling distribution may reflect the rapid uptake of the
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label and the small volume of the injectate, the supernatant from the
lavage was not able to label further fresh cells in vitro, suggesting a rapid
uptake of the dye locally, rather than the labelling of a subset of Mo.
Indeed the characteristics of the labelled and unlabelled Mo were identical
with regard to expression of CR3, F4/80, H-2d and H-2k as well as cell size,
viability and ability to adhere to plastic and BHK matrix coated plates.
Culture of in vivo labelled cells in vitro confirmed retention of PKH26-
PCL and expression of H-2k/d over the course of the experiment, as
shown in Figure 7. 4, with no difference in the viabilities of labelled or
unlabelled cells; formalin fixation did not affect PKH26-PCL retention or
H-2k/d expression (data not shown).
Figure 7. 4
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Legend for Figure 7. 4
Cells (85.8 ± 1.9% Mo, 100% H-2k/d, <1% non viable) were lavaged
from peritoneal cavity of H-2k/d mice 5 days after i.p. injection of TG
and 2 hours after i.p. injection of PKH26-PCL. These cells were
cultured in vitro in Teflon foils for 7 days and examined daily for
expression of H-2k/d, PKH26-PCL, % Mo and viability, there was no
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significant loss of PKH26-PCL fluorescence or H-2k/d expression
during this time and cells remained fully viable as assessed by the
ability to exclude the vital dye, trypan blue. (Mean ± SE, n = 3)
7. 2. 3 Adoptively Transferred Live Macrophage Numbers Decline
Rapidly at the Inflamed Site.
To follow the resolution kinetics of inflammatory Mo, 30 x 106 CB1 cells
(>95% viable and >85% Mo) all expressing H-2^/d and approximately one
third of which were PKH26-PCL labelled, were transferred into the
peritoneal cavities of C3HF/KAM (H-2k) recipients at the same stage of
resolving inflammation as the donor mice. Figure 7. 5 shows the
recovery of labelled cells from peritoneal lavage of recipient mice at
different times after cell transfer. The percentage of H-2k/d cells and red
fluorescent, PKH26-PCL labelled Mo declined proportionally over 96
hours effectively to zero. The ratio of PKH26-PCL labelled cells to H-2k/d
cells remained approximately 1/3 over these 4 days, suggesting that the
fate of labelled and unlabelled Mo was similar. There was little evidence
of phagocytosis of the transferred Mo in the peritoneal cavity during the
first 96 hours, with more than 90% of PKH26-PCL labelled Mo expressing
donor H-2^/d rather than recipient H-2k antigen. At one week (168
hours) after adoptive cell transfer the small percentage of red fluorescent
cells remaining (3.7%), were almost all recipient Mo that had
phagocytosed donor PKH26-PCL labelled cells. Despite the introduction
of a large load of Mo, the number of Mo free in the peritoneal cavity fell
steadily over the week, with a mean of 7 x 106 cells in the lavage 1 week




Number of Adoptively Transferred Mo
Decline Rapidly at the Inflamed Site
Hours After Cell Transfer
Legend for Figure 7. 5
Donor (H-2k/d) Mo, PKH26-PCL labelled donor Mo and phagocytosed
donor Mo expressed as a percentage of the total number of cells
recovered from the peritoneal cavity of recipient (H-2k) mice with
time after adoptive transfer of 30 x 106 live PKH26-PCL labelled donor
cells. Each point represent the geometric mean of at least 6 recipient
mice with 95% confidence intervals.
Using starch as the inflammatory challenge in an identical set of
experiments, a similar pattern of clearance was seen. Donor Mo as a
percentage of total Mo recovered in peritoneal lavage declined from 25 ±
5% 24 hours after semi-allogeneic cell transfer to 1.1 ± 1.9% 1 week after
cell transfer (p<0.05, n = 3). Again there was little evidence of
phagocytosis of donor Mo.
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Transfer of half the number of donor cells did not affect the pattern of cell
recovery, donor cells still taking 96 hours to completely disappear from
peritoneal lavage (Figure 7. 6) suggesting that the rate of cell clearance was
not dependant on the initial cell load.
Figure 7. 6
Transfer of Half the Cell Number
Does not Alter Kinetics
Hours After Cell Transfer
Legend for Figure 7. 6
Comparison of the decline in H-2k/d labelled Mo with time after the
adoptive transfer of either 30 x 106 (closed squares) or 15 x 106 (open
squares) live donor Mo into the peritoneal cavities of recipient mice.
Each point represents the geometric mean and 95% confidence
intervals for 6 mice for the 30 x 106 plot and 4 mice for the 15 x 106
plot.
The decline in PKH26-PCL labelled cells was also shown to be linear over
the first 96 hours after the transfer of both 15 or 30 million cells,
regression analysis showed that these slopes intersected at 1.5% PKH26-
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PCL labelled cells (95% confidence intervals 0.8 - 2.5%) 96 hours after cell
transfer. The H-2k/d slopes also intersected at 96 hours, their value at this
time was zero, the 1.5% PKH26-PCL labelled cells at 96 hours could be
accounted for by phagocytosis. The percent donor cells recovered 24
hours after transfer of 5, 10, 15, 30 and 50 x 106 cells show a steady increase
as the donor cell load is increased, thus the recovery of donor cells at 24
hours as a percentage of the number initially transferred remains
relatively constant, as shown in Table 7. 1.
Table 7.1
Cell Recovery After 24 hours is Related to the Number of Donor Cells
Adoptively Transferred.
Number of Cells Number of Cells Donor Cell Recovery No. of
Transferred Recovered as % of Cells Transferred Experiments
5 x 106 15.5 x 106 43% 2
lOxlO6 19 ± 1.8 x 106 45% 3
15 x 106 22 ± 1.7x 106 32% 4
30 x 106 28 ± 2.1 x 106 28% 6
50 x 106 32 ± 1.8 x 106 34% 3
Legend for Table 7.1
Increasing quantities of donor inflammatory Mo were transferred
into recipient mice at the same stage of resolving acute
inflammation. The total number of cells recovered 24 hours later
and the number of donor cells recovered, expressed as a percentage of
the initial number of donor cells transferred, were also determined.
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To determine whether the number of transferred cells recovered with
time are appropriate to the original number transferred, the recovery of
H-2k/d cells can be extrapolated back to the time of cell transfer (Figure 7.
5). This would suggest approximately 50% of the cells in the peritoneal
cavity should be donor Mo immediately after adoptive cell transfer. Of
the 30 x 106 cells transferred, 85% are Mo thus 25.5 x 106 will be H-2k/d
Mo. The peritoneal cavity of the recipient mouse already contains
approximately 20 x 106 free cells (Figure 7. 1), thus there are 25.5 x 106 H-
2k/d fy[0 amongst a total of 50 x 106 cells - approximately 50%. A similar
calculation pertains for PKH26-PCL labelled cells demonstrating that the
percent cells recovered with time are appropriate to the number of cells
transferred.
7. 2. 4 Adoptively Transferred Formalin Fixed Macrophages are
Rapidly Phagocytosed at the Inflamed Site.
In order to address the question of whether the decline in live adoptively
transferred cells required active emigration and to confirm that the
system was capable of detecting phagocytosis of donor cells formalin fixed
donor Mo were adoptively transferred in an identical set of experiments.
The time course for recovery of these fixed CB1 cells from the peritoneal
lavage samples after the transfer of 30xl06 formalin fixed CB1 cells (>91%
Mo) into C3HF/KAM recipients (n = 23 mice) is shown in Figure 7. 7.
Virtually all the fixed cells were phagocytosed within 24 hours. In
contrast less than 10% of live cells were phagocytosed over the whole 96
hours. Not only was the magnitude of phagocytic signal grossly different
between live and fixed cells but the kinetics of live and fixed PKH26-PCL
labelled cells also differed significantly by 96 hours. Plots of the
percentage of live H-2k/d and PKH26-PCL labelled donor cells exhibited a
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linear decline to 1.5% 96 hours after transfer whilst fixed cells exhibited
no discernible trend; linearity was tested for by means of orthogonal
(independent) polynomials as discussed in section 2. 11.
Figure 7. 7
Formalin-Fixed Mo are Rapidly
Phagocytosed at the Inflamed Site
« 14] ■ PKH26-PCL labelled M0




Hours After Cell Transfer
Legend for Figure 7. 7
Bar plot of the recovery of total PKH26-PCL labelled cells (black bars),
recipient Mo that have phagocytosed labelled donor cells (stippled
bars), and non-phagocytosed H-2d expressing donor cells (hatched
bars) expressed as a percentage of the total cells recovered, after the
transfer of 30 x 106 formalin fixed donor cells into the peritoneal
cavity of recipient mice. Each point represents the geometric mean
for at least 6 recipient mice with 95% confidence intervals.
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7. 2. 5 Semi-Allogeneic Macrophages Kinetics are the Same as
Syngeneic Macrophages.
To investigate whether the presence of foreign antigen (H-2d) on the
adoptively transferred Mo caused recipient mice to handle these cells
differently to their own, in vivo labelled cells from C3HF/KAM mice
were transferred into C3HF/KAM recipients in an otherwise identical
model of inflammation. The recovery of syngeneic PKH26-PCL labelled
Mo in peritoneal lavage was compared with that of semi-allogeneic Mo,
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Legend for Figure 7. 8
Recovery of PKH26-PCL labelled donor Mo from peritoneal cavity of
recipient mice with time after syngeneic (C3HF/KAM into
C3HF/KAM - shown by closed squares), or semi-allogeneic (CB1 into
C3HF/KAM - shown by open squares) adoptive cell transfer. Each
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point represents the geometric mean of at least 4 recipient mice with
95% confidence intervals.
Kinetics of cells after semi-allogeneic transfer thus closely resemble that
of syngeneic cells. Similar results were obtained for BALB/c as well as
CB1 syngeneic transfers. The absence of any observed renewal of the
acute inflammatory response in either the peritoneal lavage samples or
histology sections was also in accord with these data.
7. 2. 6 Inflammatory Macrophages Emigrate from the Inflamed Site
to the Draining Lymph Nodes.
Since the number of live adoptively transferred Mo free in the peritoneal
cavity declined rapidly and there was no evidence that they were
phagocytosed locally, I sought to identify the tissue fate of these cells.
Frozen sections of peritoneum including omentum, a range of lymph
nodes, liver, spleen, kidney, lung and heart were examined for PKH26
positive cells. Table 7. 2 shows the tissue distribution of PKH26-PCL
labelled cells with time. There was no evidence of widespread adherence
of transferred Mo to the peritoneal lining, with adherent labelled cells
confined only to collections on the omentum (Figure 7. 9). These
collections of varying numbers of PKH26-PCL positive cells, ranging from
a few to dozens of cells appear to represent "milky spots" on the
omentum (Beelen, 1980). These aggregates did not seem to alter in size or
frequency with time being as numerous at 4 hours after transfer as at 1
week.
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Figure 7. 9 Distribution of PKH26-PCL Labelled Macrophages After
Adoptive Cell Transfer,
i) There is No Widespread Adherence to the Peritoneal Membrane,
a) Light Microscopy b) Red Fluorescent Microscopy
■
. * : ■ r
ii) Macrophage Collection in "Milky Spot" on the Omentum.
Legend for Figure 7. 9 Photomicrographs of frozen tissue sections of
recipient mice after adoptive transfer of donor cells (>85% Mo, 36%
PKH26-PCL labelled) 72 hours previously. Figure i) a single PKH26-PCL
positive cell adherent to a large strip of peritoneum, confirming there is
no widespread adherence of donor Mo to peritoneum. Figure ii) shows a
large omental collection of labelled Mo in a "milky spot" (MS). Much of
the omentum remains free of labelled Mo as outlined in area (O). (x 200).
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Table 7. 2
Tissue Distribution of PKH26-PCL Labelled Cells After Adoptive Cell
Transfer of In vivo Labelled Live Cells.
Tissue
Hours After Cell Transfer
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Legend for Table 7. 2
The distribution of PKH26-PCL label with time after transfer of 30 x
106 donor cells (>85% Mo) into the peritoneal cavity of recipient mice
at the same stage of resolving inflammation as the donor mice.
Unfixed 3 pM frozen tissue sections from recipient mice were viewed
under red fluorescence. "Peritoneum" represented peritoneal lining
tissue adjacent to the anterior abdominal wall. A semi-quantitative
assessment of PKH26-PCL labelled cell distribution was made thus:
No PKH26-PCL labelled cells seen/section
± 1-3 PKH26-PCL labelled cells seen/section
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+ 4-8 PKH26-PCL labelled cells seen/section
+ + 8-15 PKH26-PCL labelled cells seen/section
+ + + >15 PKH26-PCL labelled cells seen/section
sp specks not whole cells
Results are means for 8 mice per time point (4 mice for 4 hour time
point). Tissue distribution was the same after transfer of fixed in
vivo labelled cells (n = 6 mice per time point) and after transfer of i n
vitro labelled cells (n = 6 mice per time point), in neither of these
instances was the 4 hour time point performed.
A large number of labelled Mo were detected specifically in the draining
LN of the peritoneum, the parathymic LN. The appearance of label did
not occur before 4 hours after cell transfer, thereafter labelled cells were
detectable for up to 1 week. Despite quantification difficulties there were
clearly more labelled cells in the parathymic LN at later time points (72,
96 and 168 hours) than the earlier time points (4, 24, 48 hours) after
adoptive cell transfer. These cells were initially located in the subcapsular
region, but by 48 hours after cell transfer many cells were also located
deep within the node surrounded by lymphocytes (Figure 7. 10). The
distribution of these cells in relation to B and T cell areas has not been
determined yet but they are most likely to be in the medullary cords
(Rosen, 1990; Havenith, 1993). There was minimal label detected in other
lymph nodes, even those located within the peritoneal cavity, indicating
the specificity of the emigration process (Figure 7. 11). Label was also
detected in the liver and spleen 1 week after cell transfer, at this stage the
label was often dim and in small speckles although a few cells were seen
(Figure 7.11).
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Figure 7. 10 Distribution of PKH26-PCL Labelled Macrophages in the
Draining Lymph Nodes.
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sections from recipient mice after adoptive transfer of donor cells (>85%
Mo, 36% PKH26-PCL labelled) a) 24 hours and b) 48 hours previously.
PKH26-PCL labelled Mo are seen initially in subcapsular space of the LN
(a) but later are widely distributed throughout the node (b).
7.11 Macrophage Emigration is Specifically to the Draining LN.
a) Mesenteric LN b) Liver
Legend for Figure 7.11. Photomicrographs of (a) mesenteric LN showing
a single PKH26-PCL labelled Mo outside the node and none within, (b)
One week after cell transfer some PKH26-PCL label is seen in the liver,
although commonly only specks of red fluorescence as pictured (x 200).
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Interestingly, the tissue distribution of PKH26-PCL with transfer of fixed
cells was remarkably similar to that observed following transfer of live
cells. Again there were collections of PKH26-PCL positive cells on the
omentum, commensurate with "milky spots" and the parathymic LN
were again specifically and strongly labelled with PKH26-PCL positive
cells, late labelling was detected in the liver and spleen as before. No label
was seen in the lung, heart, or kidney at any time after transfer of live of
fixed donor Mo and only occasional labelled cells were seen in the para¬
aortic and mesenteric lymph nodes. This indicated that the pattern of
emigration of recipient Mo that had phagocytosed donor cells was similar
to that of live adoptively transferred donor Mo.
Disrupted spleen and para-aortic lymph nodes, analyzed using flow
cytometry to detect PKH26-PCL labelled Mo, showed less than 1% percent
of splenic and para-aortic Mo were labelled at any time point. Both
mechanical and enzymatic disruption resulted in > 10% trypan blue
positive cells, the presence of which made interpretation of dual labelling
difficult as the antibodies were non-specifically bound by damaged cells.
Parathymic nodes were all used for frozen or paraffin sections hence
none were disrupted for flow cytometric analysis.
7. 2. 7 Adoptively Transferred Live Macrophages are Not
Phagocytosed Prior to Emigration.
To confirm that adoptively transferred live Mo were indeed emigrating
to the parathymic LN and not being carried there passively after being
phagocytosed by recipient Mo prior to emigration, frozen sections were
examined for the presence of H-2d.
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Figure 7.12 Donor Cells are Not Phagocytosed Prior to Emigration to the
Draining Lymph Nodes.
a b c
Legend for Figure 7.12 Photomicrographs demonstrate (a) Positive
control for H-2d immunostaining: CB1 parathymic node stained with
biotinylated anti-H-2d, using avidin/biotin-alkaline phosphatase and
Vector® red alkaline phosphatase substrate, taken under red
fluorescence, demonstrating H-2d expression on all the cells, (b)
Parathymic LN from C3HF/KAM mouse as a negative control stained as
for (a) showing no H-2d expression, (c) H-2d immunostaining of
parathymic node from recipient C3HF/KAM mouse 1 week after
adoptive transfer of live H-2k/d donor Mo now showing a number of
positive donor cells within the node (all taken at x 200).
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As processing for anti-H2d immunostaining destroyed PKH26-PCL
fluorescence, double staining was not possible. Instead serial sections
demonstrated that after live cell transfer, H-2d staining was always and
only present when there was PKH26-PCL staining on adjacent sections.
The distribution of PKH26-PCL label and H-2d expression within the
nodes was the same. Positive H-2d staining in the parathymic LN
confirmed it was the live donor Mo themselves that had emigrated from
the inflamed site (Figure 7. 12). In contrast, there was no H-2d staining in
the parathymic LN after return of fixed Mo, despite strong PHK26-PCL
fluorescence. These data demonstrate that live donor Mo emigrated
intact from the inflamed site to the draining LN whereas fixed Mo were
phagocytosed within the peritoneal cavity, a proportion of the
phagocytosing Mo then emigrating to the draining LN where they could
be detected by the presence of the ingested red fluorescent label. Staining
for presence of H-2d in the spleen demonstrated only occasional intact
donor cells, these cells were not detected before 48 hours after cell
transfer. This suggests that the bulk of the PKH26-PCL fluorescence
detected at 1 week did not represent further migration of Mo from the
LN.
7. 2. 8 Parathymic Lymph Node Histology.
Macroscopically the parathymic lymph nodes were grossly enlarged by 5
days after i.p. TG but regressed steadily to normal size over the ensuing
week (Figure 7.13). This was confirmed by the reduction in wet weights
of the parathymic lymph nodes from 67 ± 6.8 mg (mean ± SD) at the time
of cell transfer to 11.25 ± 10.7 mg 1 week later (p < 0.01, n = 5).
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Figure 7.13 Macroscopic Changes in Parathymic Lymph Nodes with
Acute Inflammation and Resolution of Inflammation.
Legend for Figure 7.13 Grossly enlarged parathymic lymph nodes (left)
five days after i.p injection of TG, compared with normal sized nodes
(right) seven days later. Parathymic lymph nodes are indicated with the
pointer, they lie lateral to the internal mammary vessels and thymus. In
each case the heart is reflected to the left, the lungs deflated and the liver
seen below.
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Figure 7.14 Histology of Parathymic Lymph Nodes
Acute Inflammation.
During Resolution of
Legend for Figure 7. 14 Photomicrographs of H&E stained paraffin
sections of (a) reactive parathymic LN six days after i.p. injection of TG
showing an enlarged subcapsular space (SC) containing many vacuolated
Mo (x 100). (b) Parathymic LN six days later demonstrating subcapsular
space returning to normal with the resolution of inflammation (x 100).
(c) After transfer of formalin fixed cells, Mo could be seen in the
subcapsular space of parathymic LN that has clearly phagocytosed other
Mo (arrow) (x 400).
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The inflammatory reaction in these LN was consistent with a resolving
granulomatous response with several multinucleate giant cells detected
per section. Over the first 3 days after cell transfer the subcapsular space
was packed with intensely vacuolated Mo (Figure 7. 14), these Mo
decreased steadily in number and apparent size and the subcapsular space
returned to near normality. Throughout the entire time course very low
levels of apoptosis could be seen within the LN. There was little
evidence of a wave of apoptosis at any particular time and it was not
possible to confirm the identity of the apoptotic cells. Transfer of
phagocytosed fixed cells from the peritoneal cavity to the parathymic LN
was suggested on haematoxylin and eosin sections by the appearance of a
number of Mo bearing identifiable Mo within phagocytic vacuoles
(Figure 7. 14). Histology of lung, liver, kidney, heart and spleen was
normal.
7. 2. 9 Comparison of Resident and Inflammatory Macrophage
Emigration Kinetics.
A series of preliminary experiments were performed to investigate
whether there were different emigration kinetics for resident Mo from
the non-inflamed peritoneum and inflammatory Mo from the inflamed
site. To establish whether the act of adoptive cell transfer into the non-
inflamed peritoneum would in itself induce inflammation, peritoneal
lavageates 24 hours after i.p. injection of TG, 5 x 106 Mo or PBS alone
were compared with no injection at all, determining the number of cells
and the percent PMN as indicators of acute inflammation, results are
shown in Table 7. 3. This shows that the injection of cells into the non-
inflamed peritoneum did not cause significant inflammation.
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Table 7. 3
Intraperitoneal Injection of Macrophages Causes Minimal Inflammation.











Legend for Table 7. 3
Mice were sacrificed 24 hours after i.p injection and their peritoneal
cavities lagaved with 5 mis PBS. Cells were counted by
haemocytometer and % PMN determined from cytospin
preparations, duplicate slides were prepared for each mouse and 500
cells per slide counted. The % PMN in peritoneal lavage after i.p. Mo
injection was variable, 2 mice had 13 and 15% PMN respectively
whilst the rest all had < 5%. The total cell number was still very low
despite the addition of a further 5 x 106 Mo into the peritoneal space.
To determine whether there were differences in the emigration of
resident Mo from the non-inflamed peritoneum when compared with
inflammatory Mo from the inflamed peritoneum, a comparative study
was performed. The peritoneal cavity of mice were lavaged after in vivo
red fluorescent labelling in the absence of any inflammatory challenge.
To increase the Mo labelling, 1 ml of PKH26-PCL dye was used and 3 to 4 x
106 cells were recovered in the lavage with 1.5 -2 x 106 being labelled Mo.
To allow transfer of 4 x 106 labelled Mo, 3 donor mice were sacrificed for
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each recipient. After semi-allogeneic cell transfer into mice who had also
not received any inflammatory challenge, recipients were sacrificed and
the percent labelled cells remaining in their peritoneal cavity with time
determined, results are shown in Figure 7. 15 and compared with that of
inflammatory Mo transfer into the inflamed peritoneum.
Figure 7.15
Emigration Kinetics of Resident and
Inflammatory Mo are Different
24 48 72 96 168
Hours After Cell Transfer
Legend for Figure 7.15
PKH26-PCL labelled resident, non-inflamed Mo were adoptively
transferred into the non-inflamed peritoneal cavity of semi-
allogeneic mice. The % labelled cells recovered with time was
determined and compared with that of inflammatory Mo after
transfer into the peritoneum with resolving inflammation. None of
the resident Mo and <10% of the inflammatory Mo were
phagocytosed over the course of the experiment. The results were
compared using Wilcoxon's rank sum test for non-parametric data,
p<0.05 taken as significant. Four mice were examined at each time
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point for the inflammatory challenge and 10 for the resident transfer
(except at 48 and 72 hours when 2 mice were examined at each point).
These results suggest that in the absence of inflammation the Mo
emigration rate is retarded, consistent with the prolonged turnover time
for resident peritoneal Mo reported by others (Rosser, 1970; Haskill, 1985;
van Furth, 1989).
7. 2.10 Effect on Macrophage Emigration of Blocking CDllb.
Mo migration into inflammatory sites has been shown to be dependent
on functional expression of specific adhesion molecules including CDllb.
Cells leaving the inflammatory site must cross the peritoneal membrane,
this emigration may be an active process requiring cell adhesion, as it is
for cell recruitment. Stomata between mesothelial cells overlying
draining lymphatics dilate with inflammation (Beelen, 1980; Leak, 1983),
which could allow direct passage of Mo into lymphatics without
necessitating cell adhesion. To begin the process of investigating whether
adhesion molecules were important in the emigration of inflammatory
Mo from the inflamed peritoneum, I employed the CDllb blocking mAb
Ml/70 (Pharmingen - low endotoxin, no azide). Titration of this mAb on
inflammatory Mo showed that binding was saturated at 0.5 pg/106 cells.
The blocking action of this mAb on Mo adhesion was confirmed by
preventing adherence to tissue culture plastic (Figure 7. 16). In a
preliminary experiment inflammatory Mo were elicited with TG and
labelled with i.p. PKH26-PCL in standard fashion, 36 x 106 of these cells
were incubated with 450 pg ofMl/70 (a x 25 excess) for 10 minutes at 4°C.
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Figure 7.16 The Antibody Ml/70, an Anti CDllb mAb Blocks
Macrophage Adherence.
Pre Washing
Legend for Figure 7. 16 Suspension cultured Human Mo are adhered to
tissue culture plastic i) after 30 minutes incubation in medium and ii)
after 30 minutes incubation in the presence of the mAb Ml/70. Cells
exposed to medium alone remain adherent after vigorous washing
whilst those exposed to Ml/70 are non-adherent and all wash off (x 200).
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18 x 106 cells (>85% M0 <5% trypan blue positive, unwashed hence in the
presence of 225 pg antibody/mouse) were then injected i.p. into each of 2
mice who had been injected with TG 5 days earlier, these mice were
sacrificed 24 hours later. The dual colour flow cytometry data from
peritoneal lavage of the two recipient mice are shown below in Table 7. 4.
Table 7. 4
Blocking CDllb on Semi-allogeneically Transferred Donor Inflammatory
Macrophages Increases Their Emigration Rate
Quad-stats Mouse A Mouse B
Region Antibody Antibody
D cD K cK D cD K cK
1 2.1 1.4 40.2 0 3.1 0.4 11.2 0.5
2 1.4 1.5 9.6 1.5 5.3 0.1 2.1 0.2
3 86 96.3 50.2 96.2 91.3 98.6 86.7 99.1
4 10.5 0.8 0 2.3 0.3 0.9 0 0.2
Mouse Mouse
A B
PKH26-PCL labelled cells (K2-cK2) 8.1% 1.9%
H-2k/d cells (D1 + D2)- (cDl + cD2) 0.6% 7.9%
Phagocytosed donor cells (D4 - K4) 10.5% 0%
Legend for Table 7. 4
Two mice labelled A and B each had 18 x 106 cells (>85% Mo) in the
presence of 225 pg Ml/70 blocking anti CDllb mAb injected i.p. 5 days
after i.p. TG. Cells were lavaged from their peritoneal cavities 24
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hours later and the % cells labelled with anti-H-2d and anti-H-2k mAb
(green fluorescence), as well as with PKH26-PCL (red fluorescence) are
shown for each mouse. D = Anti H-2d, cD = Isotype control, K = Anti
H-2k, cK = Isotype control: values shown are percent cells in each
region defined by the quad-stats settings. Four regions are identified
for each antibody using quad-stats: 1 = green positive, red negative, 2
= green positive, red positive, 3 = green negative, red negative and 4 =
green negative, red positive. PKH26-PCL red fluorescent labelled cells
were thus {anti-k region 2 - isotype control region 2} whilst H-2^
positive cells were {anti-d region 1 and 2 - isotype control region 1 and
2}. Phagocytosed cells were {anti-d region 4 - anti-k region 4}
These results are inconclusive and require further experimentation,
however interesting trends were apparent in the cell kinetics. In mouse
A there was significant phagocytosis of adoptively transferred Mo, not
encountered with adoptive transfer of live cells in the absence of mAb.
Phagocytosis was not observed in mouse B. In both mice the percent of
donor cells remaining within the peritoneal cavity after 24 hours (10.5%
and 7.9%) is markedly reduced when compared with cells transferred in
the absence of Ml/70 (31% H-2d cells recovered at 24 hours). This may
suggest that CDllb is important in retaining the Mo at the inflammatory
site. Tissue distribution was similar to that reported in Table 7. 2, with
milky spot collections seen and fluorescent cells detected in the draining
lymph nodes of both mice. Anti H-2d staining confirmed these were
donor cells in the parathymic lymph node of mouse B.
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7.3 DISCUSSION.
Although much work has been undertaken on constitutive resident Mo
turnover in the non-inflamed "steady state" peritoneum, this is the first
detailed study of the fate of the inflammatory Mo during the resolution
of inflammation using adoptive transfer of labelled Mo to quantify the
cellular kinetics. By contrast with the PMN or mesangial cell, this work
provides clear evidence that inflammatory Mo do not meet their fate
locally by apoptosis and phagocytosis but that they emigrate from the
peritoneum to the draining LN. It has long been known that Mo are able
to migrate to lymph nodes (Harmensen, 1985; van Furth, 1992; Lan, 1993;
Thepen, 1993) but in this study I demonstrate that this is the major
mechanism for the removal of inflammatory Mo from the peritoneum
during the resolution of inflammation and that the time course for this
clearance is rapid. The emigration process takes longer than 4 hours but
most adoptively transferred Mo have been cleared within 96 hours.
Upon reaching the LN the cells become localized initially to the
subcapsular space, by 48 hours after cell transfer however many cells were
detected deeper within the LN, surrounded by lymphocytes. The
emigration of the inflammatory Mo occurs specifically to the draining
LN, there being little evidence of migration of donor Mo to other LN or
other tissues. Although PKH26-PCL label could be detected in the liver
and spleen 1 week after transfer this was accompanied by the detection of
very few H-2d positive cells. Hence the draining node apparently
represents the "final resting place" for the bulk of the inflammatory Mo.
These data suggest that monocyte/Mo undergo a two stage migration
process; initially as monocytes they emigrate from the blood to the
inflamed site where they fulfill their inflammatory and scavenging roles.
Thereafter, a matter of days later in this model of resolving
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inflammation, the inflammatory Mo migrate to the draining LN where
they would be well positioned to contribute to the generation of an
immune response.
Previous studies with tritiated thymidine labelling of dividing cells have
given an indication of the local rates of cell turnover in certain
inflammatory circumstances (Ryan, 1970; Hopper, 1986). Loss of label
from the inflammatory site would not have indicated whether this was
due to cell death or emigration. Indeed should there have been
significant reutilization of radiolabel subsequent to the phagocytosis of
dead labelled cells, cell life-span would have appeared falsely prolonged.
Detection of radioactivity at local or distant sites would not necessarily
have indicated the fate of the adoptively transferred labelled cells
themselves. Moreover, as Mo are capable of significant proliferation,
even at the site of inflammation (Coggle, 1982; Bitterman, 1984; Bouwens,
1986), uncertainty about the relative contributions of cell proliferation
and cell influx could cause further interpretation difficulties. Our data
using a unique dual labelling technique showed that the decline in Mo
recovery at the inflamed site was not due to local phagocytosis and that
the cells detected distantly in the parathymic LN were indeed live intact
donor cells.
The reduction in recovery of donor cells from the peritoneal cavities of
recipient mice was not due to a reaction to the presence of foreign antigen
(H-2d), as demonstrated by the similar kinetics for semi-allogeneic and
syngeneic cells after adoptive cell transfer. Other workers using
allogeneic or semi-allogeneic cell transfer have also found little difference
in cell kinetics over the first few days compared with syngeneic transfers
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(Bell, 1984). Consistent with this interpretation there was no evidence for
a secondary inflammatory response histologically or in the peritoneal
lavageates after adoptive cell transfer.
The reduction in recovery of donor cells in the peritoneal cavity with
time was also not due to widespread adherence to the peritoneum.
Although Mo adhered to the omentum in "milky spot" aggregates, these
did not increase in number or size over the time course studied. Hence
increased adherence alone was unlikely to account for the observed
decrease in donor cell recovery. After adoptive transfer of live Mo there
was little evidence of their phagocytosis; the PKH26-PCL labelled cells
recovered expressed the donor H-2k/d rather than the recipient H-2k
surface antigen. The decrease in the percent donor cells recovered was
not due to a dilution effect from the influx of unlabelled cells, since the
total number of lavageable Mo also declined, consistent with resolving
inflammation.
PKH26-PCL labelled cells were not handled differently from unlabelled
cells, the decline in H-2k/d cells being proportional to that of PKH26-PCL
labelled cells and both detection methods indicating a steady drop in
number of adoptively transferred cells free in the peritoneum. The
decline in the percent PKH26-PCL positive cells recovered was not due to
loss of the label as demonstrated both by in vitro culture and in vivo
tissue section results. Other groups have confirmed that although
labelling intensity declines slowly with time, labelled Mo can still be
distinguished from unlabelled Mo for up to seven weeks (Melnicoff,
1988b and 1989). In conjunction with data demonstrating the
accumulation of labelled cells within the draining LN, this suggests that
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emigration of the inflammatory Mo from the peritoneum was the main
mechanism responsible for the clearance of these cells.
In contrast to the results for live cell transfer, transferred formalin-fixed
cells were phagocytosed quickly and efficiently, with very few remaining
free by 24 hours, suggesting efficient clearance of dead or effete cells by
inflammatory Mo. This observation also confirmed that TG elicited Mo
were effective phagocytes, despite reported differences in their bactericidal
capacity when compared with Mo induced by other inflammatory
stimuli, (Hopper, 1986). The kinetics of removal of the phagocytosed
fixed transferred cells was slower than that of the live transferred cells.
Recipient Mo remained functionally intact after phagocytosing formalin-
fixed donor cells, since they were able to emigrate to the draining LN.
Thus it was unlikely that the delay in clearance of labelled cells was due
to toxicity of the formalin-fixed donor cells. A sub-population of
phagocytic Mo with slower emigration capability was also unlikely since
the populations of donor and recipient cells were elicited in the same
way. An alternative and plausible explanation is that phagocytosis of the
killed transferred Mo activated the phagocytosing Mo in a manner which
prolonged their presence at the inflamed site. We have previously
shown in vitro that Mo uptake of opsonized cells (Meagher, 1992) and
necrotic eosinophils (Haslett, 1994) caused Mo activation and secretion of
thromboxane B2 and other pro-inflammatory mediators which did not
occur when Mo ingested apoptotic cells (Meagher, 1994).
Experiments using starch as an alternative inflammatory stimulus
showed that the time course of Mo accumulation and the clearance
pattern appeared identical to that of TG elicited Mo. These findings are
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likely to be broadly relevant to the mechanisms by which acute
inflammation resolves.
The rate of turnover for resident peritoneal Mo in the "steady state"
reported in the literature differs markedly from the data presented here
for inflammatory Mo during the resolution of sterile inflammation. This
was corroborated by the experiments showing that resident Mo
transferred into the non-inflamed peritoneum had significantly slower
emigration kinetics than inflammatory Mo from the inflamed site.
Previous work on the kinetics of resident peritoneal Mo suggested a
mean turn-over time of 14.9 days (van Furth, 1989). Adoptive transfer of
radiolabeled resident peritoneal Mo indicated that even 2 weeks after cell
transfer more than half the labelled cells could be recovered in peritoneal
lavage (Rosser, 1970). More recent experiments using fluorescent labelled
resident peritoneal Mo are somewhat contradictory, one group using an
in vitro labelling technique reported rapid decline in cell retrieval
(Rosen, 1990) whilst others using in vivo labelling again demonstrating a
prolonged half life of several weeks or more for the resident peritoneal
Mo population (Haskill, 1985; Melnicoff, 1988b). The reasons for the
differences between emigration kinetics of resident and inflammatory Mo
are unknown. Differences may be related to cell factors such as adhesion
molecule expression, altered sensitivity to chemotactic agents or to
changes in cell mobility, an assertion which might be tested further using
adoptive transfer of inflammatory Mo into the non-inflamed
peritoneum. Differences in emigration kinetics may represent a potential
control point in the resolution of inflammation. To study this further
transfer of green fluorescent resident Mo and red fluorescent
inflammatory Mo into the non-inflamed and inflamed peritoneum
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would allow determination of the degree to which cell and
environmental factors control emigration kinetics. Preliminary data on
blocking CDllb function is exciting as it raises the possibility that this
molecule may be important in retarding Mo emigration. It is worth
noting that the anti-CR3 blocking mAb 5C6 caused apoptosis in microglia
(Reid, 1993). Whether the anti-CR3 mAb Ml/70 is capable of inducing
apoptosis is unknown, this needs to be borne in mind in view of the
rapid phagocytosis of live donor cells in mouse A (section 7. 2. 10).
The tissue distribution of PKH26-PCL labelled cells after leaving the
inflammatory site is in accordance with that reported previously for
resident Mo emigration (Rosser, 1970; Rosen, 1990). The lymphatics
draining the peritoneum arise from the sub-diaphragmatic surface,
entering ducts running with the internal mammary vessels to reach the
anterior mediastinal LN. Efferent lymphatics from these usually run to
the right lymphatic duct, with some cross-communication to the thoracic
duct (Yoffey, 1970). Elegant electron microscopy studies have confirmed
that stomata exist between the mesothelial cells overlying lymphatic
spaces and these widen during inflammation allowing for cell emigration
(Beelen, 1980; Leak, 1983). Within the parathymic LN themselves, the
PKH26-PCL labelled cells were initially distributed in the subcapsular
region, with many labelled cells present deep in the node 48 hours or
more after cell transfer. This is in accordance with previous work on
resident peritoneal Mo emigration; cells being detectable in the outer
cortex and medullary cords of LN (Rosen, 1990; Soesatyo, 1993). Mo
migration to LN has been demonstrated in other systems (Harmensen,
1985; Lan, 1993; Thepen, 1993, van Vugt, 1993b) but quantification of rates
of emigration and cell death has not been performed. The distribution
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pattern of inflammatory Mo in the draining LN would allow for antigen
presentation to lymphocytes. Since Mo are widely recognized as
"professional" antigen presenting cells, their emigration to the LN where
interaction with immunocompetent cells is maximized, may well have
functional implications beyond that of simple cell clearance. This need
not necessarily be to augment immune responses. The presence of Mo
along with dendritic cells has been shown to down-modulate
lymphoproliferative responses in vitro (van Vugt, 1993a).
It is interesting to review this work in the light of what is known of the
fate of the PMN with resolving inflammation. The PMN is a short lived
cell that dies at the site of inflammation where it is phagocytosed by the
inflammatory Mo (Haslett, 1994). Similarly the mesangial cell, a
myelofibroblast-like cell with phagocytic potential in the kidney, has been
shown in experimental inflammation to die in significant numbers by
apoptosis and to be cleared by local phagocytosis (Baker, 1994). In contrast
the inflammatory Mo does not seem to die locally at the inflamed site but
rather, after migration into the inflamed site, emigrates non-randomly to
the draining LN, a situation more analogous with that of lymphocyte
trafficking or Langerhans and dendritic cell migration (Austyn 1990; van
Vugt, 1993b). The clearance of inflammatory Mo from the site of acute
inflammation is rapid, large numbers of Mo emigrating daily during
resolution. This two stage migration process in the life-span of the
inflammatory Mo is well suited to phagocytosis of materials at the
inflamed site and subsequent antigen presentation in the LN and thus
may have implications for the initiation and amplification of immune






In this thesis I have examined a number of aspects of the cell biology of
mononuclear phagocytes relevant to the process of the resolution of
inflammation. In particular I have examined the fate of the
inflammatory Mo both in vitro and in vivo, neither of which had
hitherto been studied in detail. At the outset of this project only Mangan
et al. had documented monocyte apoptosis (Mangan 1991 a and b) and
there were only two reports on Mo apoptosis (Waring, 1990; Hogquist,
1991a). Robust methods for identifying and quantifying apoptotic
monocytes and Mo in both suspension and adherent culture were not
established and no comparison of the sensitivity to apoptosis of these
cells had been made. Furthermore the physiological relevance of Mo
migration from tissues and inflamed sites to LN and to other tissues such
as the gut and its significance as a clearance mechanism for inflammatory
Mo were unknown. Although several groups had studied monocyte
migration into inflamed sites (Issekutz, 1981; Rosen, 1990, van Furth,
1992) there was no data on the fate of the inflammatory Mo. My aim was
to study the regulation of cell death in monocytes and Mo which may be a
critical factor determining the extent of Mo accumulation in tissues, to
characterize the process of apoptotic cell death in mononuclear
phagocytes in terms of cell surface phenotype and physical parameters
and to look at potential mechanisms controlling Mo longevity. I also
wished to gain some insights into the in vivo mechanisms of clearance
of inflammatory Mo from tissues.
Other phagocytic cells (PMN and mesangial cells) have been shown to die
by apoptosis and become ingested by Mo during the resolution of
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inflammation (Savill, 1989; Baker, 1994). Mo, in contrast, are believed to
be long lived cells, a suggestion supported by data on the kinetics of
resident tissue Mo and on studies of chronic inflammatory lesions (van
Furth, 1992). Mo are now known to undergo apoptosis in response to a
number of different stimuli, including agents known to be present at the
inflamed site such as pathogenic bacteria (Zychlinsky, 1994), NO- (Albina,
1993) or silica (Sarih, 1993b), however the extent to which Mo apoptosis
contributes to Mo clearance had not been addressed. Monocytes are
sensitive to pro-apoptotic stimuli (Mangan, 1991a and b) and I
hypothesized that there may be differences in the survival characteristics
between these two related cells although no direct comparison had been
made. In this work, I have shown that monocytes are more sensitive to
the induction of apoptosis than Mo and that certain physiological agents
(serum and TNF-a) can prolong monocyte survival (Chapter 4). Mo are
much more resistant to the induction of apoptosis, with significant
differences in the constitutive losses between monocytes and Mo in
culture as well as in the pro-apoptotic effects of serum withdrawal
(Chapter 4) and ROI (Chapter 6) on these cells.
With the onset of apoptosis there were specific changes in surface
molecule expression of monocytes, Mo and U937 cells (Chapters 3 and 5).
A range of cytokine receptors and CD14 were expressed at reduced levels
whilst certain receptors were retained late into the apoptotic process
including Fas and IFNyR, this pattern was independent of the method by
which apoptosis was induced. Apoptosis in monocytes and Mo could be
induced by protein synthesis inhibition (Chapter 3), suggesting that there
may be continued synthesis of a short-lived anti-apoptotic protein by
these cells. Interestingly, although the oncogene product Bcl-2 has been
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shown to protect a wide range of cells from the induction of apoptosis
(Jacobson, 1995), only low levels of Bcl-2 were detected in monocytes and
these fell even further with maturation into Mo (Chapter 6). Expression
of c-myc and abl also failed to correlate with monocyte and Mo
apoptosis. The comparative resistance of Mo to ROI induced apoptosis
was shown, these cells requiring 60 fold more H2O2 than HL60 cells to
induce the same degree of apoptosis, a difference which may be explained
by the endogenous anti-oxidant capacity of Mo. Whether a difference in
anti-oxidant capacity accounts for the differences between monocyte and
Mo sensitivity to apoptosis remains to be determined but the sensitivity
of monocytes to ROI induced apoptosis was greatly increased in the
absence of serum which provides some anti-oxidant capacity.
During the course of this work a number of papers have been published
on agents that induce Mo apoptosis (Chapter 3). Recently studies have
also focused on mechanisms controlling Mo survival, with descriptions
of specific activation induced apoptotic pathways (Munn, 1995; Bingisser,
1996) and of monocyte expression of the oncogene product Bcl-2 (Iwai,
1994) and of Fas (Richardson, 1994). These studies corroborate many of
the findings of this work, demonstrating that sensitivity to apoptosis is
down-regulated during monocyte differentiation into Mo. With
hindsight it would have been interesting to include IL 10, IFN-y and MIP-
la in studies on monocyte and Mo survival and the induction of
apoptosis. Although survival characteristics of these cells were studied in
suspension and in adherent cultures, further time would have allowed
the effects of exposure to different matrix components to be determined
and the effect of prior cell activation on the induction of apoptosis to be
investigated.
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Having characterized apoptosis in both monocytes and Mo and
demonstrated that Mo are less susceptible to the induction of cell death, I
then investigated the physiological significance of this in the clearance of
inflammatory Mo from the inflamed site. This work establishes that
unlike PMN and mesangial cells, Mo are not cleared by local phagocytosis
(Chapter 7). Rather, having performed their pleotropk roles during
inflammation, Mo emigrate specifically to the draining LN during the
resolution of inflammation. There was minimal local phagocytosis of
Mo at the inflamed site and also little further emigration from the lymph
nodes to other more distant sites within the time course studied. Thus,
although the Mo is clearly capable of undergoing apoptosis, it seems that
Mo clearance from the inflamed site is by active emigration rather than
cell death. The kinetics of Mo clearance from the inflamed and non-
inflamed site are very different, with inflammatory Mo exhibiting
significantly faster rates of emigration than resident Mo (Chapter 7). The
mechanisms by which these differences occur are unknown and are the
subject of continued investigation.
Putting this work into context with other developments in the field it is
possible to view the circulating monocyte as a relatively short lived cell
which dies by apoptosis in the absence of pro-survival stimuli (Mangan,
1991a and b; Munn, 1995). Tissue Mo are relatively long lived cells that
may either die locally or emigrate to the draining LN (van Furth, 1992;
Bellingan, 1996a and b). For peritoneal Mo, emigration has been shown
to be the major route of clearance, the situation for other resident Mo
remains to be clarified. Tissue Mo can be replaced by self replication or by
influx of circulating monocytes (Volkman, 1976; Bouwens, 1986; van
Furth, 1992; Ginsel, 1993). It may be that in the absence of inflammation
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the usual fate of monocytes is to die and that the bulk of tissue Mo
replacement is by self replication, the relative extent to which monocytes
replace tissue Mo losses is still a matter for debate (Ginsel, 1993). During
acute inflammation monocytes are rapidly called into the inflamed site.
Inflammatory cytokines act to promote monocyte survival and their
differentiation into Mo (Dougherty, 1984; Mangan, 1991a and b; Leenen,
1993; Munn, 1995). Having orchestrated successful clearance of the
inflammatory agent, Mo promote resolution by phagocytosing senescent
PMN (Savill, 1989a; Haslett, 1994; Ren, 1994) and emigrating to the
draining LN (Bellingan, 1996a). The controls on Mo emigration and the
reasons for Mo persistence in chronic inflammation await elucidation.
Exciting glimpses at possible controlling factors are seen with the data on
blocking CDllb function leading to enhanced Mo emigration and on the
differences between resident and inflammatory Mo emigration kinetics
(Chapter 7). Whether certain stimuli such as pathogenic bacteria
(Zychlinsky, 1991, 1992, 1994), or overwhelming ROI (including NO-)
concentrations (Albina, 1993) can alter clearance mechanisms by inducing
local Mo apoptosis remains to be seen. It would be attractive to speculate
that acute inflammation resolves appropriately without significant
disruption of tissue integrity when Mo are capable of clearing the inciting
stimulus without any significant toxicity to themselves. However, an
excessive or particularly pathogenic inflammatory stimulus may
overwhelm Mo protective mechanisms and alter susceptibility to
apoptosis resulting in Mo death locally, a failure in clearance and as a
consequence, persistent inflammation as occurs with the induction of
systemic inflammatory responses leading to the acute respiratory distress
syndrome or septic shock (Bone, 1992).
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M0 which have emigrated to the draining LN during resolving
inflammation are well positioned to interact with other immune cells.
The fate of Mo thereafter remains to be determined but during the first
twelve days following inflammatory stimulus there was little evidence
that Mo accrued in other sites in significant numbers. It may be that the
LN does represent their final resting place although this has not been
established. The unique architecture of the lymph node promotes
interaction of antigen presenting cells and T cells (Gretz, 1996). It would
be an attractive notion that, having interacted with cells in the LN, Mo
receive a signal to die by apoptosis and in this regard Mo expression of Fas
is of interest. In common with other investigators, I demonstrated that
anti-Fas mAb were not capable of inducing Mo apoptosis, however these
cells may require activation before ligation of Fas can induce apoptosis
(Schattner, 1995; Rovere, 1996). Thus it may be possible that
inflammatory Mo recently arrived at the draining LN may be primed to
receive a pro-apoptotic signal in this way. Both activated T cells and
cytotoxic T cells express the Fas ligand and interaction of Fas ligand with
Fas can lead to apoptotic cell death (Lowin, 1994, Liles, 1996). This may be
a route for elimination of Mo after appropriate interaction with immune
competent cells; indeed cytotoxic T cell induction of Mo apoptosis has
already been demonstrated (Hogquist, 1991a).
This thesis raises a number of interesting questions that could be
addressed in future experiments. The mechanism of the increased
resistance of Mo to the induction of apoptosis by oxidants and the possible
role of antioxidants in this can be addressed by determining the relative
contribution of endogenous antioxidants to protection of the cells against
oxidant stress. Potential protective antioxidant mechanisms such as
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glutathione and enzymatic detoxification pathways could be blocked by
employing specific inhibitors and comparison then made between
monocyte and Mo survival characteristics. Patients with chronic
granulomatous disease are deficient in superoxide production and the
use of monocytes and Mo from these subjects would also help to
elucidate the role of these free radicals in inflammatory cell death.
With the wider range of probes for members of the bcl-2 family and other
proto-oncogenes now available, the genetic basis of this increased Mo
resistance to apoptosis could be further investigated. The potential
requirement for Mo activation prior to Fas induced apoptosis can be
investigated and the possibility that this is the mechanism of activated T
cells promoting Mo apoptosis can be determined in co-culture
experiments.
Of considerable interest is the differential emigration kinetics of resident
and inflammatory Mo (Bellingan, 1996b). The mechanisms underlying
this are open to investigation in a number of ways. Resident and
inflammatory Mo can be differentially labelled, mixed and introduced
into the non-inflamed or inflamed peritoneum to identify whether cell
or environmental characteristics are responsible for the different rates of
emigration observed. The in vivo use of blocking antibodies to a wide
range of adhesion molecules, as described in Chapter 7 for CDllb, is an
obvious route to follow. The effect of these mAb on Mo emigration can
be determined and the expression of specific adhesion molecules on
mesothelium and "milky spots" in non-inflamed and inflamed
conditions demonstrated. A different approach would be to use gene
knockout mice (specific knockouts of CR3 and L selectin already exist) and
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use of these for Mo migration studies would be potentially less
problematic than employing blocking antibodies. The state of activation
of adoptively transferred Mo can be altered by pre-exposure to potentially
activating (TNF-a, IL-1, IL-6) or "deactivating" cytokines such as IL-10
(Bogdan, 1991) and IL-4 (Gautam, 1992; Standiford, 1993) or by incubating
Mo in supernatant from acute or resolving inflammatory lesions.
Likewise the effect of phagocytosis on Mo emigration can be investigated,
we postulate that phagocytosis of apoptotic cells will not materially alter
Mo emigration kinetics whilst phagocytosis by Fc or complement
mediated mechanisms will activate Mo and delay emigration. As
demonstrated in Chapter 7, phagocytosis of fixed cells delayed Mo
emigration and it has been previously shown that Mo uptake of apoptotic
PMN does not stimulate the phagocytosing Mo (Meagher, 1992). It would
have been interesting to using PKH labelled rather than fluorescent
microsphere labelled Mo (section 3. 2. 10) to determine the rate and
mechanism of Mo phagocytosis of apoptotic Mo. It has been reported that
anticoagulants, in particular heparin can alter the Mo disappearance
reaction (MDR) (Nelson, 1965; Barth, 1995). The MDR is a physiological
response of Mo - both resident and inflammatory - whereby Mo
"disappear" from free peritoneal fluid in response to a number of stimuli.
It has been postulated to involve Mo adherence and formation of fibrin
aggregates, heparin prevents this "disappearance" reaction. The effect of
heparin could be investigated on resident Mo and on Mo in acute and
chronic inflammation to determine if it has any effect on emigration
kinetics. Finally thoracic duct cannulation (Bell, 1984) would facilitate
collection of emigrating Mo, enabling accurate quantification of cell
trafficking and collection of Mo for analysis of their functional capacity
and surface phenotype. It would be of interest to determine the effect of
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these emigrating Me on lymphocyte responses, focusing on antigen
presentation and on effects of lymphoid cells on Mo survival. A
comparison of Mo emigration responses to known stimuli of acute
versus chronic inflammation may help elucidate the reasons for Mo
persistence at the site of unresolving inflammation.
Summary of Findings.
In this work I have demonstrated that the Mo is a robust cell which,
during its maturation from the monocyte, has gained considerable
resistance to the induction of apoptosis. Although these cells can be
induced to undergo apoptosis and this process can be characterized in
terms of specific surface molecular changes, apoptosis does not represent
the normal physiological mechanism of clearance of Mo from the
inflamed site. Rather Mo can be shown to emigrate specifically to the
draining lymph nodes, inflammatory Mo emigrate rapidly whilst
resident Mo follow the same pathways at a much slower rate. I have
considered the implications of these findings and further experiments to
elucidate the potential underlying mechanisms controlling Mo survival
and the controls on their clearance.
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In Vivo Fate of the Inflammatory Macrophage During the
Resolution of Inflammation
Inflammatory Macrophages Do Not Die Locally, but Emigrate to the Draining
Lymph Nodes1
Geoffrey J. Bellingan,2'3* Helen Caldwell,* Sarah E. M. Howie/ Ian Dransfield,* and
Christopher Haslett*
The resolution of acute inflammation requires bulk clearance of extravasated inflammatory cells in an ordered manner. Neu¬
trophils undergo apoptosis and are ingested by macrophages via a novel recognition mechanism that fails to provoke
proinflammatory responses. Thereafter, the fate of inflammatory M<j> themselves remains unclear. We investigated this in vivo,
developing a semiallogeneic adoptive transfer system to track the fate of inflammatory M</> in a murine model of resolving
peritonitis. Fluorescently labeled M<f> from H-2k/d mice were transferred into the peritoneal cavity of H-2k mice at the same
stage of resolving inflammation as the donor mice. Dual color flow cytometry permitted discrimination among donor cells,
recipient cells, and donor cells that had been phagocytosed by recipient Mcf>. Despite the absence of significant local phago¬
cytosis, the number of transferred M(f> free in the peritoneum of recipient mice declined rapidly, being undetectable by 96 h.
These data suggest that inflammatory Md> normally emigrate rapidly from the peritoneal cavity during the resolution of in¬
flammation, contrasting with resident M</>, which persist in the noninflamed peritoneum for weeks. Accordingly, labeled non-
phagocytosed cells were detected in the draining lymph nodes, but not in a variety of other tissues. Thus, unlike the polymor¬
phonuclear leukocyte, which dies by apoptosis and is ingested by M<J>, the inflammatory M«/> itself does not die locally. Having
performed its acute inflammatory and scavenging roles, it emigrates in a nonrandom fashion to the draining lymph node, where
it may play an important part in the presentation of Ags from the inflamed site. The Journal of Immunology, 1996, 157:
2577-2585.
The inflammatory macrophage (M<f>)4 plays a central rolein the inflammatory process, being able to secrete andrespond to a range of powerful cytokines that control key
events in the initiation, resolution, and repair processes of inflam¬
mation, but its fate during the resolution of inflammation is un¬
known (1). The resolution of acute inflammation is characterized
by the clearance of extravasated neutrophils (PMN) and M<f> and
the return of normal tissue architecture. However, in a number of
disease processes inflammation does not resolve; rather, it persists
and is often associated with fibrosis and loss of organ function, as
exemplified by chronic bronchitis, emphysema, glomerulonephri¬
tis, or rheumatoid arthritis (1, 2). The mechanisms underlying the
development of chronic inflammation are poorly understood, but
much attention has been focused on the role of the inflammatory
M<f>. Although M<f> are able to debride tissue and promote wound
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healing (3), continued M<f> accumulation is also a hallmark of
chronic inflammation. The M</> can damage tissue by the release of
histotoxic enzymes, proinflammatory and profibrogenic cytokines,
or the presentation of Ag to T cells (1,4, 5). Thus, definition of the
mechanisms controlling not only the influx but also the persistence
and removal of inflammatory M</> are important to our understand¬
ing of the pathogenesis of both acute and chronic inflammation.
The origin and influx of monocytes have been well documented
(6-8), while the fate of the inflammatory has received com¬
paratively little attention. Inflammatory M(j> are known to be de¬
rived from circulating monocytes that migrate into acute inflam¬
matory reactions, mixing with the resident M(/> population (9). The
kinetics of resident tissue M<j> in the noninflamed steady state have
also been the subject of investigation (7, 10), but resident and
inflammatory M<j> differ in cell physiology and activation status
(11-14) and may differ in ontogeny (15-17); hence, the direct
relevance of studies on the resident M<j> to our understanding of the
tissue kinetics of the inflammatory M(j) is uncertain.
Some insights into the cellular mechanisms underlying resolu¬
tion of inflammation have been provided recently by studies relat¬
ing to the fate of extravasated PMN during the resolution of in¬
flammation. These cells have been shown to undergo apoptosis
(18, 19) and become ingested by inflammatory M</> using a novel
recognition mechanism (20, 21) that fails to stimulate the release
of proinflammatory mediators (22). Thus, it has been suggested
that this process may represent a nonphlogistic mechanism for the
silent clearance of large numbers of PMNs and their potentially
histotoxic contents during the resolution of acute inflammation
(23). M<J> in vitro have also been shown to undergo apoptosis in
Copyright © 1996 by The American Association of Immunologists 0022-1 767/96/$02.00
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response to a number of stimuli (24-29). Hence, it was entirely
conceivable that, in a fashion analogous to the PMN or another
phagocyte, the mesangial cell (2), the inflammatory M<f>, might
undergo apoptosis in large numbers locally and themselves be¬
come ingested by local phagocytes. However, exhaustive histo¬
logic examinations of resolving inflamed sites in the lung and sy¬
novial cavity (C. Haslett, unpublished observations) provided no
visual evidence of the occurrence of such a process and suggested
that the inflammatory M<p might meet its fate at a distant site.
To address this question we examined the kinetics of the in¬
flammatory M<)> using two independent labeling systems. Inflam¬
matory Mcf> from H-2k/d donor mice were labeled with a red flu¬
orescent dye and transferred into the peritoneal cavity of recipient
H-2k mice at the same stage of resolving inflammation as the donor
mice. The use of fluorescent tracking dyes is now a well estab¬
lished technique allowing the stable labeling of cells in a nontoxic
manner without apparently altering normal cell physiology (30,
31). Immunofluorescence analysis using a FITC anti-H-2d Ab pro¬
vided the second method of distinguishing donor or recipient cells,
and dual color flow cytometry allowed identification of donor M<)>
that had been phagocytosed by recipient cells.
In the noninflamed peritoneal cavity, the half-life of resident
M<£ has been estimated to be 2 wk or longer (13, 14). In our studies
we show that during the resolution process, adoptively transferred
inflammatory M<f> rapidly emigrate intact from the inflamed peri¬
toneum specifically to the draining LN, and this emigration is com¬
plete by 96 h, with little evidence of death or engulfment of M<£ at
the inflamed site.
Materials and Methods
Mice and inflammatory challenge
BALB/c (H-2d), C3HF/KAM (H-2k), and F1 hybrid CB1 mice (H-2k/d)
breeding colonies were established locally. Female CB1 mice were used as
donor mice, and female C3HF/KAM were used as recipients; all mice were
used at 11 to 14 wk of age. The kinetics of the inflammatory cell response
to the i.p. injection of 2 ml of thioglycolate (TG; Difco, East Molesey,
U.K.) or 2 ml of 1% starch (Sigma Chemical Co., Poole, U.K.) Was fol¬
lowed for 21 days (days 3, 5, and 10 for starch) to identify the resolution
phase of inflammation in both CB1 and C3H/KAM mice. A minimum of
four mice per strain were terminally anesthetized with ether at each time
point, and total cell number, viability, and differential counts were deter¬
mined in the peritoneal lavagates.
Adoptive cell transfer
Peritoneal M<f> were labeled in vivo with the red fluorescent dye PKH26-
PCL (Sigma Chemical Co.). A freshly prepared sterile solution of dye (0.5
ml of 0.5 pM) was injected i.p. into donor mice 1.5 h before peritoneal
lavage. Control mice received PBS injection. For adoptive cell transfer
experiments, peritoneal inflammation was induced by i.p. TG (or starch) in
both donor and recipient mice 5 days before cell transfer. Inflammatory
cells (>85% >95% viable), 1.5 h after PKH26-PCL labeling, were
lavaged from the peritoneal cavity of the donor mice using 5 ml of sterile
PBS (Life Technologies, Paisley, U.K.). Cells were washed twice (250 g)
and counted, and viability was determined by the ability to exclude trypan
blue. For certain experiments, washed, formalin-fixed cells were employed.
Transferred cells (live or fixed) in 2 ml of PBS at the concentrations stated
were reinjected into the peritoneal cavity of recipient mice (at the same
stage of inflammation as the donors). Recipient mice were killed at various
times between 4 h and 1 wk later, their peritoneal cavities were lavaged,
and tissue was taken for histology and fluorescence studies. Some mice
received unlabeled inflammatory Mc/> to serve as controls for flow cytom¬
etry and tissue studies.
Tissue and cell staining
Tissue for frozen sections was immediately snap-frozen in liquid nitrogen,
3-/um sections were cut and mounted unfixed on microscope slides, and the
distribution of the PKH26-PCL label was determined using an Olympus
BH-2 RFCA fluorescent microscope. Staining for the presence of H-2d was
also performed on these sections; as acetone fixation abolished the PKH26-
PCL fluorescence, an unfixed section was first viewed for the presence of
PKH26-PCL, and the remainder were fixed. Sections were stained in a
Sequenza (Shandon, Pittsburgh, PA) to reduce background staining. Slides
were blocked sequentially with NMS, avidin D, and biotin blocking solu¬
tions (Vector Laboratories, Bretton, U.K.) before the addition of biotin
conjugated mouse anti-mouse H-2Dd mAb (PharMingen, San Diego, CA).
Slides were washed, and ABComplex/AP (avidin/biotinylated alkaline
phosphatase kit, Dako, High Wycombe, U.K.) and Vector Red alkaline
phosphatase substrate kit (Vector Laboratories) were added before coun-
terstaining with hematoxylin. Control slides were stained in the absence of
the biotinylated anti-H-2d Ab; tissue from H-2k/d mice acted as the positive
controls and that from H-2k mice acted as negative controls in each staining
run. Formalin-fixed tissue was paraffin embedded, and cut sections were
stained with hematoxylin and eosin. Cytospin (Shandon, Cytospin 2) prep¬
arations of peritoneal lavage cells were stained with Diff-Quik (Baxter,
Thetford, U.K.) or for nonspecific esterase (Sigma Chemical Co.). Differ¬
ential cell counts were performed, counting 400 cells/slide.
Immunofluorescence and flow cytometry
Cells were blocked with NMS at 4°C for 15 min before immunofluores¬
cence. Both direct and indirect immunofluorescence were performed fol¬
lowing standard protocols. For direct immunofluorescence the Abs used
were FITC-conjugated mouse anti-mouse H-2Dd monoclonal IgM Ab
(PharMingen) and FITC-conjugated mouse anti-human CD 15 IgM mAb
(Dako) as the control, and FITC-conjugated mouse anti-mouse H-2Kk
monoclonal IgG2a Ab (PharMingen) and FITC-conjugated mouse anti-
human T cell CD45RO IgG2a mAb (Dako) as the control. Indirect immu¬
nofluorescence was performed using F4/80 (HB 198 from American Type
Culture Collection, Rockville, MD; IgG2b), Ml/70 anti-CR3 (Serotec, Ki-
dlington, U.K.; IgG2b) Abs to detect M<j>, and anti-phytochrome (Mac 51
from European Collection of Animal Cell Cultures, Porton Down, U.K.) as
the control (IgG2b) and was detected with the F(ab'), rabbit anti-rat IgG-
FITC conjugate (Serotec). Cells from peritoneal lavagates were examined
for the expression of PKH26-PCL (red fluorescence), H-2d, H-2k, or Mtp
surface markers using a Coulter EPICS II flow cytometer. Dual color im¬
munofluorescence was used to assess anti-H-2d and anti-H-2k binding and
concomitant PKH26-PCL labeling; Mc/> forward and side scatter charac¬
teristics were first determined by identification of M<f> using F4/80 and
Ml/70. The gating parameters and immunofluorescence patterns were
checked using pure M<j> obtained by adherence. As shown in Figure 1 FITC
anti-H-2d and anti-H-2k binding was expressed relative to isotype control
Abs. PKH26-PCL positivity in Mcj> was expressed relative to unlabeled
control M<f>.
Cell culture in vitro
To determine the retention of PKH26-PCL label with time and the effect of
labeling on viability, cells were cultured in Iscove's modified DMEM (Life
Technologies) supplemented with 100 U of penicillin and streptomycin and
10% FCS in hydrophobic Teflon foils at 37°C in 5% CO,; samples were
examined daily for viability, PKH26-PCL expression, and M<j> number.
Formalin fixation was confirmed by cell adherence to tissue culture-treated
plastic slides; live cells were strongly adherent, while fixed cells were
completely nonadherent (not shown). To obtain very pure populations of
inflammatory peritoneal M<j>, peritoneal lavage cells were cultured on pre-
warmed BHK matrix-coated plates in Iscove's DMEM (Life Technologies)
for 1 h. Nonadherent cells were washed off; adherent cells were then lifted
off by 5-min incubation with 5 mM EDTA on ice. These cells (>94% M<f>
by nonspecific esterase staining and indirect immunofluorescence) were
used to confirm the flow cytometry parameters used. These adherence-
purified cells were not used for adoptive cell transfer because the adherence
may have altered their characteristics. Matrix-coated plates were prepared
by growing BHK cells (BHK 21, clone 13: European Collection of Animal
Cell Cultures) to confluence, then removing them with trypsin/EDTA
(Sigma Chemical Co.).
Statistics
The percentages of PKH26-PCL-labeled, H-2k/d, and phagocytosed donor
cells in peritoneal lavagates were logarithmically transformed, normalizing
the data and allowing calculation of geometric means and confidence in¬
tervals. Linearity in the decline of labeled cells was tested for by means of
orthogonal polynomials. Regression analysis was employed to determine
whether there was coincidence at 96 h after cell transfer of the curves for
transfer of 15 and 30 million donor cells. The total numbers ofMcfi free in
the peritoneal cavity at each time point for CB1 and C3HF/KAM mice
were compared using ANOVA.
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FIGURE 1. Representative experiment
showing two-color flow cytometry of M<f>
from peritoneal lavage of a C3HF/KAM
mouse (H-2k) 48 h after adoptive transfer of
live donor cells from a CB1 (H-2d/k) mouse
(approximately one-third of which were
PKH26-PCL labeled). Green fluorescence
(FITC-conjugated Abs) is shown on the y-
axis; red fluorescence (PKH26-PCL) is
shown on the x-axis. Binding of anti-H-2d
and anti-H-2k Abs relative to their isotype
controls was determined. Four regions are
identified for each Ab using quad-stats: 1 =
green positive, red negative; 2 = green pos¬
itive, red positive; 3 = green negative, red
negative; and 4 = green negative, red pos¬
itive. PKH26-PCL red fluorescent-labeled
cells were thus (anti-k region 2 - isotype
control region 2), while H-2d-positive cells
were (anti-d regions 1 and 2 - isotype con¬
trol regions 1 and 2). Phagocytosed cells
were (anti-d region 4 - anti-k region 4).
ANTI H-2 ISOTYPE CONTROL
. ■ 4
Log Red Fluorescence. Log Red Fluorescence.
Results
Time course of inflammatory response to TC: identification
of resolution of inflammation
Both CB1 mice and C3HF/KAM mice had <3 X 106 resident M<f>
in the peritoneal cavity before the induction of inflammation. Ap¬
proximately 40% of these cells were M<f>, demonstrated by differ¬
ential counts and immunofluorescence; the bulk of the remainder
were lymphocytes, in accordance with results previously published
(30). TG induced a prompt PMN influx that declined after 2 days,
while both the M<J> number and relative percentage reached a peak
on the fifth day after i.p. TG, with 19.6 ± 1.8 X 106 (mean ± SD)
cells recovered per mouse, >85% of which were M<f>. As shown in
Figure 2, both the total number of cells and the number of M</>
steadily declined thereafter; thus, day 5 after TG was chosen as the
optimum for cell transfer to follow M<b kinetics during resolution.
There was no difference in the M <f> kinetic response in CB1 or
C3HF/KAM mice. A similar, although less pronounced, pattern
was found using starch as the inflammatory agent, with 9.2 ±
1.4 X 10s cells recovered on the fifth day after i.p. starch and
>85% again being MA- This declined significantly to 4.1 ± 0.9 X
106 cells by day 10 (p < 0.05).
In vivo fluorescent cell labeling
At the concentration used, in the presence of inflammation, the
fluorescent dye PKH26-PCL strongly labeled approximately one
third (range, 27-42%) of the Mc(> population in vivo; the remaining
cells were unlabeled (Fig. 3). This labeling pattern may reflect
rapid uptake of the dye as the labeling percentage did not increase
if the dye was left in situ for 1.5 or 18 h before lavage. Further¬
more, supernatant from the lavage, after cell labeling, could not
further label fresh cells in vitro, suggesting that the dye is rapidly
taken up in the local region of the injection, rather than specifically
labelling a subset of VIA. Moreover the characteristics of the la¬
beled and unlabeled Mcj> were identical in regard to their expres¬
sion of CR3, F4/80, H-2d, H-2k, cell size, adherence, and viability
(data not shown). In vitro culture of labeled cells confirmed the
retention of PKH26-PCL over the course of the experiment, with
no difference in the viability of labeled or unlabeled cells. Forma¬
lin fixation did not affect this.
Adoptively transferred M(f> numbers at the inflamed site
decline rapidly
To follow the resolution kinetics of inflammatory M<J>, 30 X 106
CB1 cells, all expressing H-2k/d and approximately one-third
PKH26-PCL labeled (>95% viable; >85% M<J>) were transferred
into the peritoneal cavities of C3HF/KAM (H-2k) recipients that
were at the same stage of resolving inflammation. Figure 4 shows
the recovery of labeled cells from peritoneal lavagates at different
times after cell transfer. The percentage of H-2k/d cells and red
fluorescent PKH26-PCL-labeled cells declined proportionally over
96 h effectively to zero. The ratio of PKH26-PCL-labeled cells to
H-2k/d cells remained at approximately one-third over these 4 days,
indicating that the labeled cells were not handled differently from
the nonlabeled cells. There was little evidence for phagocytosis of
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FIGURE 2. Inflammatory cell response to i.p. TG for CB1 mice. The
total number of leukocytes (closed squares), the total number of M<f>
(open squares), and PMN (open circles) in peritoneal lavage with time
are shown. Two milliliters of TG was injected i.p. on day 0, cells were
recovered using 5 ml of PBS lavage. The total cell number was esti¬
mated by hemocytometer; >400 cells were counted. M<j> and PMN
number were obtained from relative percentages on duplicate cyto-
spins. There was no difference in the percentage of M<f> estimated using
Diff-Quik staining, nonspecific esterase staining, or immunofluores-
ence with M1/70. The inflammatory response in C3HF/KAM mice was
identical. Lymphocytes account for the remaining cells in differential
counts (not shown). Each point represents the mean for at least four
mice; all SD are within 10% of the means.
W ' ■ -v •"
FIGURE 3. PKH26-PCL labeling of inflammatory M<f>. Cytospin of
peritoneal lavage cells was performed 5 days after i.p. TG and 1.5 h
after i.p. PKH26-PCL labeling, shown by red fluorescent light (A) and
the same field under light microscopy (B). In this particular field, less
than one-third of the M<j) are strongly red fluorescent labeled. Both
fields were photographed at X200 magnification.
transferred Mcj> in the peritoneal cavity during this time, with
>90% of PKH26-PCL labeled Mtj> expressing donor E1-2k/d rather
than recipient H-2k Ag. At 1 wk after adoptive cell transfer, the
small percentage of red fluorescent cells remaining represented
those that had phagocytosed labeled cells; all were H-2k recipient
Mcj>. Transfer of half the donor cell number did not alter the pattern
of cell recovery; donor cells still took 96 h to completely disappear
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FIGURE 4. The percentage of donor (H-2k/d) M<f> recovered from the
peritoneal cavity of recipient (H-2k) mice with time after adoptive transfer
of 30 x 106 live PKH26-PCL-labeled donor cells. H^^-positive cells
(closed squares), PKH26-PCL positive cells (open squares), and phagocy¬
tosed cells (PKH26-PCL labeled cells expressing only recipient H-2k sur¬
face Ag; dashed line) are shown. Each point represents the geometric
mean for at least six mice, with 95% confidence intervals.
of M4>, the total number of Mc/> free in the peritoneal cavity de¬
clined steadily, with approximately 7 X 106 free cells 1 wk after
adoptive transfer. Using starch as the inflammatory challenge in an
identical set of experiments, a similar pattern of clearance was
seen. The percentage of donor cells recovered declined from 25 ±
5% 24 h after semiallogeneic cell transfer to 1.1 ± 1.9% 1 wk after
cell transfer (p < 0.05; n = 3). Again there was no evidence of
local phagocytosis of donor M(j> in the peritoneal cavity.
Adoptively transferred formalin-fixed M4> are rapidly
phagocytosed at the inflamed site
To address the question of whether the decline in live adoptively
transferred cells required active emigration and to confirm that the
system was capable of detecting phagocytosis of donor cells, for¬
malin-fixed donor M<p were transferred in a set of identical exper¬
iments. The time course for recovery of these fixed CB1 cells
(>91% M$) into C3HF/KAM recipients is shown in Figure 5.
Virtually all the fixed cells were phagocytosed within 24 h; in
contrast, < 10% of the live cells were ingested during the first 96 h.
Not only was the magnitude of the phagocytic signals grossly dif¬
ferent between transfer of live cells and that of fixed cells, but the
kinetics of live and fixed PKH26-PCL cells also differed signifi¬
cantly by 96 h after transfer, with live labeled donor cells exhib¬
iting a linear decline to just above zero (1.5%) at 96 h, while fixed
cells exhibited no discernible trend.
Semiallogeneic M<p kinetics are the same as those of
syngeneic M<i>
To investigate whether the presence of foreign Ags on the adop¬
tively transferred cells altered the kinetics of Mcj) emigration over
the time course investigated, PKH26-PCL-labeled M<j> from
C3HF/KAM mice were transferred into C3HF/KAM recipients in
an otherwise identical model of inflammation. The detection of
PKH26-PCL-labeled cells with time in peritoneal lavage for syn¬
geneic and semiallogeneic cell transfer is shown in Figure 6; the
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FIGURE 5. Recovery of formalin-fixed donor M</> from the perito¬
neal cavity of recipient mice with time after adoptive transfer of 30 X
106 formalin-fixed, PKH26-PCL labeled cells. PKH26-PCL-labeled
cells (solid bar), phagocytosed cells (PKH26-PCL-labeled cells express¬
ing only recipient H-2k surface Ag; stippled bar), and nonphagocy-
tosed \A-2W6 cells (hatched bar) are shown. Each point represents the
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FIGURE 6. Comparison of syngeneic and semiallogeneic cell trans¬
fer. The percentage of PKH26-PCL-labeled donor M<f> recovered from
the peritoneal cavity of recipient mice with time after adoptive transfer
of 30 x 106 cells was determined. Syngeneic cell transfer (C3HF/KAM
into C3HF/KAM; closed squares) and semiallogeneic cell transfer (CB1
into C3HF/KAM; open squares) are shown. Each point represents the
geometric mean of at least four mice, with 95% confidence intervals.
kinetics of the semiallogeneic cells closely mimic those of the
syngeneic cells. Similar results were obtained for BALB/c as well
as CB1 syngeneic cell transfers (not shown).
M(p emigrate from the inflammatory site to the draining LN
Since the number of live, adoptively transferred, M<f> free in the
peritoneal cavity declined rapidly, and we could not detect
phagocytosis, we sought to identify the tissue fate of these cells.
Table I. Tissue distribution of PKH26-PCL-labeled cells after
adoptive cell transfer of in vivo-labeled live cellsa
Hours Post-Cell Transfer
Tissue 4 24 48 72 96 1 Wk
Lung - - ± - - -
Heart — — - - —
Kidney - - - - - -
Spleen - sp± sp± - sp + +
Liver - - sp± - - + +
Peritoneum - - Hh - - +
Omentum + + + + + + + + + + + + +
Lymph nodes
Parathymic - + + + + + + + + + + + + +
Para-aortic - - -
Mesenteric - - ± - +
'' Tissue distribution of PKH26-PCL label with time after transfer of 30 X 106
donor cells (>85% M<t>) into peritoneal cavity of recipient mice at the same stage
of resolving inflammation as the donor mice. Unfixed 3-p.m frozen sections
viewed under red fluorescence. "Peritoneum" represented peritoneal lining tis¬
sue adjacent to anterior abdominal wall. Semiquantitative assessment of PHK26-
PCL-labeled cells thus: — = no PKH26-PCL-labeled cells per section; ± = 1-3;
+ = 4-8; ++ = 8-15; + + + = >15 PKH26-PCL-labeled cells per section, sp
= specks, not whole cells. Results are means for eight mice per time point (four
mice for 4-h time point).
Frozen sections of peritoneum including omentum, a range of
LN, liver, spleen, kidney, lung, and heart were examined for
PKH26-PCL-positive cells. Table I shows the tissue distribu¬
tion of PKH26-PCL-labeled cells with time. There was no ev¬
idence of widespread adherence of transferred to the peri¬
toneal lining, with adherent labeled cells confined only to
collections on the omentum. These collections of varying num¬
bers of PKH26-PCL-positive cells, ranging from a few cells to
several dozen cells, appeared to represent "milky spots" on the
omentum (32). These aggregates did not change in size or fre¬
quency with time, being as numerous 4 h after transfer as they
were 96 h after transfer. A large number of labeled M</> was
detected specifically in the draining LN of the peritoneum, the
parathymic LN (Fig. 7). The appearance of labeled cells did not
occur before 4 h after cell transfer; thereafter, they were de¬
tected for 1 wk. These cells were initially located in the sub¬
capsular region (Fig. 7A), but by 48 h after cell transfer, many
labeled cells were also detected deep within the node tissue
(Fig. 7B), surrounded by lymphocytes. Despite quantification
difficulties, it was clear that there were more labeled cells in the
parathymic LN at the later time points (72 h, 96 h, and 1 wk)
than at the earlier points (4, 24, and 48 h) after cell transfer.
PKH26-PCL label was detected in the liver and spleen 1 wk
after cell transfer, but was often very faint.
Interestingly, the tissue distribution of PKH26-PCL with trans¬
fer of fixed M</> was remarkably similar to that observed following
transfer of live cells (data not shown). Again, there were collec¬
tions of PKH26-PCL-positive cells on the omentum, commensu¬
rate with milky spots, and the parathymic LN were again specif¬
ically and strongly labeled with PKH26-PCL-positive cells, label
was detected in the liver and spleen at 1 wk. No label was seen in
the lung, heart, or kidney at any time after transfer of live or for¬
malin-fixed donor M<J>, and only occasional labeled cells were seen
in the para-aortic and mesenteric LN. This indicated that recipient
cells with phagocytosed donor M<J> were capable of emigration,
and this followed a similar pattern to that seen with transfer of live
donor Mtf>.





















FIGURE 7. Donor M<f> migrate intact to the draining LN. A, Photograph under red fluorescence of parathymic LN frozen section from recipient
mouse 24 h after adoptive transfer of live donor PKH26-PCL-labeled M<f>, showing strongly fluorescent cells especially in the subcapsular region.
B, Parathymic LN from recipient mouse 48 h after live adoptive cell transfer, PKH26-PCL-labeled cells are now widely scattered throughout the
node. C, Positive control for H-2d immunostaining; CB1 parathymic node stained with biotinylated anti-H-2d, using avidin/biotin-alkaline phos¬
phatase and Vector Red alkaline phosphatase substrate, taken under red fluorescence, demonstrating H-2d expression on all the cells. D, Para¬
thymic node from C3HF/KAM mouse as a negative control stained as described for C, showing no H-2d expression. E, H-2d staining of parathymic
node of recipient C3HF/KAM mouse 1 wk after transfer of live H-2k/d donor M4>, now showing a number of positive donor cells within the node.
All photographs were taken at X200 magnification.
Adoptively transferred live M(f> are not phagocytosed before
emigration
To confirm that adoptively transferred live M^> were indeed emi¬
grating to the parathymic LN and not being passively carried there
after phagocytosis by recipient M</>, frozen sections were exam¬
ined for the presence of H-2d. As processing for anti-H-2d staining
destroyed PKH26-PCL fluorescence, no double staining was pos¬
sible. However, serial sectioning demonstrated that after live cell
transfer, H-2d staining was always and only present when there
was PKH26-PCL staining on adjacent sections. Positive staining
for H-2d in the parathymic LN confirmed that it was the live donor
M(f> themselves that had emigrated from the inflamed site (Fig.
IE). In contrast, there was no H-2d staining in the parathymic LN
after the return of fixed M(j>, despite the strong PKH26-PCL flu¬
orescence. Thus, live donor Mc/> emigrated intact to the draining
LN, while fixed M<j> were phagocytosed within the peritoneal cav¬
ity; a proportion of the phagocytosing M<j> then emigrated to the
draining LN, where they could be detected by the presence of the
ingested red fluorescent label. Staining for the presence of H-2d in
the spleen demonstrated only occasional intact donor cells, sug¬
gesting that the bulk of the PKH26-PCL fluorescence detected at 1
wk did not represent further migration of cells from the LN.
Parathymic LN histology
Macroscopically at early time points after cell transfer the LN were
grossly enlarged, returning to normal size by 1 wk, as confirmed
by the reduction in weight of the LN from 67 ± 6.8 mg at the time
of cell transfer to 11.25 ± 10.7 mg (mean ± SD) 1 wk later. The
inflammatory reaction in these LN was consistent with a resolving
granulomatous response, with several multinucleate giant cells be¬
ing detected per section. Over the first 3 days after cell transfer, the
subcapsular space was packed with intensely vacuolated M<j>; the
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FIGURE 8. The subcapsular space M<f> predominance accompany¬
ing inflammation diminishes with resolution. Hematoxylin and eosin
(H&E)-stained sections of parathymic LN 6 days after i.p. TG during
acute inflammation, demonstrating the grossly enlarged subcapsular
space (SC) full of vacuolated M<£ (a), and 12 days after i.p. TG with
resolution of inflammation the subcapsular space returns to normal
(b). Both sections taken at X100 magnification, c, Paraffin section
stained with H&E of parathymic LN from mouse that had received
30 X 106 formalin-fixed adoptively transferred M<f> i.p. 48 h before
showing a phagocytosed M<f> (arrow) lying within a vacuole.
number of Mc/> and their apparent size then declined steadily (Fig.
8, a and b). Transfer of phagocytosed fixed cells from the perito¬
neal cavity to the parathymic LN was suggested on hematoxylin-
and eosin-stained sections by the appearance of a number of Mc/>
bearing identifiable M<f> within phagocytic vacuoles (Fig. 8c).
Discussion
Although much work has been undertaken on constitutive resident
Mc/> turnover in the noninfiamed steady state peritoneum, this is the
first detailed study of the fate of the inflammatory Mc/> during the
resolution of inflammation using adoptive transfer of labeled M</>
to quantify the cellular kinetics. By contrast with the PMN or
mesangial cell, there is clear evidence that inflammatory Mc/> do
not meet their fate locally by apoptosis and phagocytosis, but that
they emigrate from the peritoneum to the draining LN. It has long
been known that M</> are able to migrate to lymph nodes (7, 33-
35), but in this study we demonstrate that this is the major mech¬
anism for the removal of inflammatory Mc/> from the peritoneum
during the resolution of inflammation and that the time course for
this clearance is rapid. The emigration process takes longer than
4 h, but most adoptively transferred Mc/> had been cleared within
96 h. Upon reaching the LN, the cells become localized initially to
the subcapsular space; by 48 h after cell transfer, however, many
cells were detected deeper within the LN, surrounded by lympho¬
cytes. The emigration of the inflammatory Mc/> occurs specifically
to the draining LN; there is little evidence of migration of donor
M<fi to other LN. Although PKH26-PCL label could be detected in
the liver and spleen 1 wk after transfer, this was accompanied by
the detection of very few H-2d-positive cells. Hence, the draining
node apparently represents the "final resting place" for the bulk of
the inflammatory Mc/x Thus, these data suggest that monocyte/M</)
undergo a two-stage migration process. Initially as monocytes they
emigrate from the blood to the inflamed site where they fulfill their
inflammatory and scavenging roles. Thereafter, a matter of days
later in this particular model of resolving inflammation, the in¬
flammatory Mc/> migrate to the draining LN, where they would be
well positioned to contribute to the generation of an immune
response.
Previous studies with tritiated thymidine labeling of dividing
cells have given an indication of the local rates of cell turnover in
certain inflammatory events (36, 37). Loss of label from the in¬
flammatory site would not, however, have indicated whether this
was due to cell death or emigration. Indeed, should there have been
significant reutilization of radiolabel subsequent to the phagocy¬
tosis of dead labeled cells, the cell life-span would have appeared
falsely prolonged. Thus, if significant reutilization of radiolabel
occurs, detection of radioactivity at local or distant sites would not
necessarily have indicated the fate of the adoptively transferred
labeled cells themselves. Moreover, as M4> are capable of signif¬
icant proliferation at the site of inflammation (17, 38, 39), uncer¬
tainty about the relative contributions of cell proliferation and cell
influx causes further interpretation difficulties. Our data using this
dual labeling technique showed that the decline in M<j> recovery at
the inflamed site was not due to local phagocytosis and that the
cells detected distantly in the parathymic LN were indeed intact
donor cells. The reduction in recovery of donor cells in the peri¬
toneal cavity with time was not due to widespread adherence to the
peritoneum. Although Mc/> adhered to the omentum in milky spot
aggregates, these did not increase in number or size over the time
course studied. Hence, increased adherence alone was unlikely to
account for the observed decrease in donor cell recovery. After
adoptive transfer of live M</), there was little evidence of their
phagocytosis; the PKH26-PCL-labeled cells recovered expressed
the donor H-2k/d rather than the recipient H-2k surface Ag. Nor
was the decrease in the percent donor cells recovered due to a
dilution effect from the influx of unlabeled cells, since the total
number of lavagable Mcf> also declined, consistent with resolving
inflammation. This, in conjunction with the tissue data demonstrat¬
ing the accumulation of labeled cells within the draining LN, sug¬
gested that emigration of the inflammatory Mc/) from the perito¬
neum was the main mechanism responsible for the clearance of
these cells.
The reduction in recovery of donor cells from the peritoneal
cavities of recipient mice was not due to a reaction to the presence
of foreign Ag (H-2d), as demonstrated by the similar kinetics for
semialiogeneic and syngeneic cells after adoptive cell transfer.
Other workers using allogeneic or semialiogeneic cell transfer
have also found little difference in cell kinetics over the first few
days compared with syngeneic transfers (40). Consistent with this
interpretation, there was no evidence for a secondary inflammatory
response histologically or in the peritoneal lavagates after adoptive
cell transfer.
PKH26-PCL-labeied cells were not handled differently from un¬
labeled cells; the decline in H-2k/d cells was proportional to that in
PKH26-PCL-labeled cells, and both detection methods indicated a
steady drop in the number of adoptively transferred cells free in the
peritoneum. The decline in the percentage of PKH26-PCL-positive
cells recovered was not due to loss of the label. This was demon¬
strated both by in vitro culture and in vivo tissue section results,
and other groups have confirmed that although labeling intensity
declines slowly with time, labeled Mc/> can still be distinguished
from unlabeled M<j> for up to 7 wk (12, 41).
In contrast to the results for live cell transfer, transferred for¬
malin-fixed cells were phagocytosed quickly and efficiently, with
very few remaining free by 24 h, suggesting efficient clearance of
dead or effete cells by inflammatory Mc/). This observation also
confirmed that TG-elicited Mc/) were effective phagocytes, despite
reported differences in their bactericidal capacity compared with
Mc/) induced by other inflammatory stimuli (37). The experiments
using starch as the inflammatory stimulus showed that not only
was the time course of Mc/) accumulation similar, but the clearance
pattern appeared almost exactly the same as that for TG-elicited
M4>. This suggests that the results with TG may be broadly rele¬
vant to the resolution of acute inflammation.
The kinetics of removal of the phagocytosed fixed transferred
cells was slower than that of the live transferred cells. There was
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clear evidence that the recipient remained functionally intact
after phagocytosing formalin-fixed donor cells, since they were
able to emigrate to the draining LN. Thus, the delay in clearance
of labeled cells was unlikely to be due to the formalin-fixed donor
cells being toxic to the engulfing cells. The possibility that a sub-
population of M</> with slower emigration capability was involved
in phagocytosis of fixed cells was also unlikely, since the popula¬
tions of donor and recipient cells were elicited in the same way. An
alternative and plausible explanation is that phagocytosis of the
deliberately killed, transferred M^> activated the phagocytosing
M^> in a manner that prolonged their presence at the inflamed
site. We have previously shown in vitro (22, 42) that uptake
of necrotic, but not apoptotic, neutrophils and eosinophils
caused M(f> activation and secretion of thromboxane B2 and
granulocyte-macrophage CSF.
The rate of turnover for resident peritoneal M<£> in the steady
state reported in the literature differs markedly from the data pre¬
sented here for inflammatory Mc/) during the resolution of sterile
inflammation. Previous work on the kinetics of resident peritoneal
Mcf> suggested a mean turnover time of 14.9 days (13). Adoptive
transfer of radiolabeled resident peritoneal M</> indicated that even
2 wk after cell transfer, more than half the labeled cells could be
recovered in the peritoneal lavagate (10). More recent experiments
using fluorescent-labeled resident peritoneal M(£ are somewhat
contradictory; one group using an in vitro labeling technique re¬
ported a rapid decline in cell retrieval (8), while others using in
vivo labeling again demonstrated a prolonged half-life of several
weeks or more for the resident peritoneal M<£ population (12. 14).
The tissue distribution of PKH26-PCL-labeled cells after leav¬
ing the inflammatory site is in accordance with that reported pre¬
viously for resident M(/> emigration (8, 10). The lymphatics drain¬
ing the peritoneum arise from the subdiaphragmatic surface,
entering ducts running with the internal mammary vessels to reach
the anterior mediastinal LN. Efferent lymphatics from these usu¬
ally run to the right lymphatic duct, with some cross-communica¬
tion to the thoracic duct (43). Elegant electron microscopy studies
have confirmed that stomata exist between the mesothelial cells
overlying lymphatic spaces, and these widen during inflammation,
allowing for cell emigration (32, 44). Within the parathymic LN
themselves, the PKH26-PCL-labeled cells were initially distrib¬
uted in the subcapsular region, consistent with the histologic find¬
ings. However, 48 h or more after cell transfer, many labeled cells
were also observed deep in the node. This, again, is in accordance
with previous work on resident peritoneal M</) emigration; cells
were detectable in the outer cortex and medullary cords of LN (8,
31). M(/> migration to LN has been demonstrated in other systems
(33-35), but quantification of rates of emigration and cell death has
not been performed. The distribution pattern that we have demon¬
strated for inflammatory M<f> in the draining LN would allow for
Ag presentation to lymphocytes. Since M</> are widely recognized
as "professional" APC, their emigration to the LN, where interac¬
tion with immunocompetent cells is maximized, may well have
functional implications beyond that of simple cell clearance.
It is interesting to review this work in the light of what is known
of the fate of the PMN with resolving inflammation. The PMN is
a short-lived cell that dies at the site of inflammation, where it is
phagocytosed by the inflammatory M</>. Similarly, the mesangial
cell, a myelofibroblast-like cell with phagocytic potential in the
kidney, has been shown in experimental inflammation to die in
significant numbers by apoptosis and to be cleared by local phago¬
cytosis (2). In contrast, the inflammatory M<f> is a potentially long-
lived cell with a much broader repertoire of functions, including
Ag presentation. It does not seem to die locally at the inflamed site,
but, rather, after migration into the inflamed site as the monocyte,
it is seen later to emigrate nonrandomly to the draining LN, a
situation more analogous with that of lymphocyte trafficking or
Langerhans cell migration. The clearance of inflammatory M4>
from the site of acute inflammation is rapid, with large numbers of
emigrating daily during resolution. This two-stage migration
process in the life-span of the inflammatory M<f> is well suited to
its functions, allowing for phagocytosis of materials at the in¬
flamed site and Ag presentation in the LN, and thus may have
implications for the initiation and amplification of immune re¬
sponses against agents derived from the inflamed site.
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Abstract Neutrophil apoptosis represents a major mechanism
involved in the resolution of inflammation. Since hypoxia induces
apoptosis in several cell lines and is of particular relevance in
many disease states, we studied the effect of oxygen concentra¬
tion on neutrophil survival in vitro. Hypoxia caused a dramatic
decrease in neutrophil apoptosis (% apoptosis 20 h: 78.7 ± 2.2%
in 21% 02, 61.4 ± 6.5% in 2.5% 02, 23.1 ± 3.2% in 0% 02,
n = 5). This was additive to the effect of GM-CSF (50 U/ml), not
associated with induction of bcl-2 expression, and was not mim¬
icked by methionine (5 mM), superoxide dismutase (200 /xg/ml)
or Trolox (10 mM) but was mimicked by catalase (250 /u.g/ml).
Hence, hypoxia has a Ac/-2-independent effect on neutrophil ap¬
optosis that may adversely affect the clearance of these cells from
an inflammatory focus.
Key words: Hypoxia; Neutrophil; Apoptosis; Bcl-2; Oxidant;
Antioxidant
1. Introduction
During a bacterial invasion the body mounts an immune
response involving recruitment of inflammatory cells into the
area of infection [1], One of the principal cells involved in this
resp.onse is the neutrophil, which, when stimulated by a patho¬
gen, degranulates and undergoes respiratory burst activity, to
release a variety of histotoxic enzymes and short-lived reactive
oxygen species (ROS) [2]. Many of the antiproteinases that
protect the host against neutrophil-mediated injury [3] are inac¬
tivated by oxidation, and hence local oxidant-antioxidant bal¬
ance appears to be a critical factor determining the extent of
tissue damage [4], The many deleterious contents of neutrophils
necessitate that for complete resolution of inflammation these
cells should be removed in a way that limits cell activation, and
neutrophil apoptosis represents an important mechanism
wherby this may be achieved [5,6,7],
When neutrophils die by apoptosis they retain their granule
contents but lose chemotactic and secretory responsiveness [8]
and thereafter are recognised and phagocytosed intact by mac¬
rophages [9] which fail to release pro-inflammatory mediators
in response to this interaction [10], Although neutrophils un¬
*Corresponding author. Fax: (44) (131) 650-6528.
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Abbreviations: ROS, reactive oxygen species; GM-CSF, granulocyte-
macrophage colony-stimulating factor; fMLP, A-formyl-methionyl-
leucyl-phenylalanine; IPS. lipopolysaccharide; SOD, superoxide dis¬
mutase.
dergo constitutive apoptosis in vitro [11], their survival may be
increased by the addition of certain cytokines such as granulo¬
cyte-macrophage colony-stimulating factor (GM-CSF) and
bacterial products such as lipopolysaccharide (LPS) [12,13],
However, the intracellular signalling pathways that regulate
neutrophil survival are unclear.
Studies on the nematode, C. elegans, have shown that indi¬
vidual cell survival is signalled by the gene, ced-9 [14]. The
mammalian homologue of the Ced-9 protein is Bcl-2 [15], which
is capable of causing survival of a number of cell-lines and
B-lymphocytes [16,17], an effect potentially mediated by the
ability of Bcl-2 to inhibit oxidant-mediated cell damage [18,19].
This hypothesis arose from studies in which oxidant treatment
of FL5.12 cells, an IL-3 dependent pro-B lymphocyte cell-line,
caused an increase in apoptosis that could be counteracted by
over-expression of bcl-2 [18], and studies in GT1-7 neural cells
where bcl-2 expression prevented death induced by glutathione
depletion [19]. Bcl-2 did not prevent free radical production but
did appear to block the damaging effects of these agents. In
contrast, Jacobson and Raff [20], and Shimizu et al. [21], have
shown that the protective effects of Bcl-2 are observed even
under extreme hypoxic conditions where the generation of ROS
is negligible. These latter studies also demonstrate that hypoxia
alone can induce apoptosis in certain cells [20,21].
To date, all the studies examining the potential involvement
of reactive oxygen intermediates in regulating apoptosis have
been undertaken in cell lines to allow manipulation of bcl-2
levels. This is the first report to examine the effects of hypoxia
on apoptosis in the neutrophil, a terminally differentiated cell
that lacks detectable Bcl-2 [22]. In contrast to the above studies,
we demonstrate a profound inhibition of neutrophil apoptosis
by hypoxia. This effect of hypoxia on neutrophils may be of
considerable relevance to conditions in vivo where the oxidant
potential at sites of inflammatory disease may be extremely low
[23,24],
2. Materials and methods
2.1. Materials
Unless otherwise stated, all chemicals and enzymes were purchased
from Sigma (Dorset, UK), and all antibodies obtained from Dako
(Bucks., UK). The plasticware was supplied by Becton Dickinson
(Leics., UK) or Nunc (Paisley, UK), and the culture media were ob¬
tained from Life Technologies (Paisley, UK). Percoll and dextran were
purchased from Pharmacia (Milton Keynes, UK), and GM-CSF (spe¬
cific activity 1.25 x 107 U/mg) from Genzyme Diagnostics (Kent, UK).
Trolox (6-hydroxy-2,3,7,8-tetramethylchroman-2-carboxylic acid) was
obtained from Aldrich (Dorset, UK).
2.2. Isolation of neutrophils
Peripheral venous blood was collected from healthy volunteers and
placed in citrated polypropylene tubes (0.38% (v/v) final concentration
0014-5793/95/89.50 © 1995 Federation of European Biochemical Societies. All rights reserved.
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of sodium citrate solution). The whole blood was centrifuged (300 x g)
for 20 min and the plasma removed. The leukocyte-rich fraction was
separated from the erythrocytes in the remaining portion by dextran
sedimentation [25], Neutrophils in the leukocyte-rich fraction were sep¬
arated from mononuclear cells using a discontinuous plasma/Percoll
gradient and collected from the 42%/51% plasma/Percoll interface. The
isolated neutrophils were >95% pure (<0.1% mononuclear cells) and
>99% viable as determined by Trypan-blue dye exclusion. Previous
studies have demonstrated that neutrophils isolated by this method are
non-activated since they display < 5% basal shape change, minimal
basal superoxide or lysozyme generation and, unlike cells prepared
using Ficoll-Hypaque gradients, exhibit normal chemotactic responses
to iV-formyl-methionyl-leucyl-phenylalanine (fMLP) [25],
2.3. Neutrophil culture
Freshly harvested neutrophils were suspended at a density of 5 x 106/
ml in Iscove's DMEM supplemented with 10% autologous serum, pen¬
icillin (100 U/ml) and streptomycin (100 /tg/ml). Neutrophils
(6.75 x 10s) were cultured in a final volume of 150 p\ in flat-bottomed
96-well polypropylene flexiwell inserts. The plates were placed in sealed
air-tight plastic boxes that were flushed through for 15 min with gas
mixtures containing either 2.5% 02/5% C02 or 21% 0,/5% CO, (con¬
trol), with the balance made up with nitrogen. The boxes were then
incubated at 37°C for the time periods indicated. More extreme hypoxic
conditions were achieved by placing cultured neutrophils in an MK3
anaerobic incubator (0% O,, Don Whitley Scientific Ltd., Yorkshire,
UK) fitted with a palladium catalyst. The level and stability of pO,
achieved using the 2.5% O, mixture was measured using a blood-gas
analyser (model ABL-330 Radiometer, Copenhagen, Denmark). The
p02 values obtained were 8.69 ± 0.73 kPa, 8.6 ± 0.32 kPa and
9.55 ± 1.66 kPa after 0, 6 and 20 h, respectively, in culture in 2.5% O,.
Equilibrium of the pO, and pCO, in the medium took less than 30 min
with the boxes (2.5% O,) and less than 1 h with the anaerobic incubator
(0% O,). To assess whether the effects of hypoxia influenced the known
ability ofGM-CSF to prolong neutrophil survival, cells were also incu¬
bated under hypoxic or normoxic conditions in the presence of absence
of GM-CSF (50U/ml).
2.4. Morphological assessment of apoptosis
At the stated time points, neutrophils were gently resuspended, har¬
vested and cytocentrifuged. The resulting slides were fixed and stained
with Diff-Quick. Cell recovery and viability by Trypan-blue dye exclu¬
sion were measured in parallel. Cell morphology was examined under
a 100 x objective and apoptotic cells defined as cells containing darkly
stained pyknotic nuclei [26]. Triplicate slides were prepared for each
condition and at least 500 neutrophils counted per slide in random
fields.
2.5. Treatment with oxidants and antioxidants
Freshly isolated neutrophils were suspended at a density of 5 x 106/ml
in Iscove's DMEM supplemented with 10% autologous serum, penicil¬
lin (100 U/ml) and streptomycin (100 pglml) and dispensed into flat-
bottomed 96-well polypropylene flexiwell inserts. The neutrophils were
treated with 200 pg/ml bovine erythrocyte SOD (750 U/ml), 250 pglml
bovine liver catalase (4750 U/ml), 200 /tg/ml SOD and 250 pg/ml cata-
lase or 5 mM methionine. Control, untreated cells were also prepared.
The cells were cultured for 6 or 20 h at 37°C under normoxic (5%
CO,:air) conditions, after which cytocentrifuge preparations were made
and apoptosis assessed morphologically.
Assessment of the effect of hydrogen peroxide on the rate of neutro¬
phil apoptosis was studied by treating freshly isolated neutrophils
(1 x 106/ml of Iscove's DMEM supplemented with 2% autologous
serum, 100 U/ml penicillin and 100 pglml streptomycin) with hydrogen
peroxide (0.1-5 mM) in the presence or absence of the soluble vitamin
E analogue 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
(Trolox, 10 mM). Control, untreated cells, and cells treated with antiox¬
idant alone were also examined. The cells were cultured for 8 h at 37° C
under normoxic (5% CO,:air) conditions, after which cytocentrifuge
preparations were made and apoptosis assessed morphologically.
2.6. Immunocytochemistry
Cultured cells (1 x 105) were transferred into round-bottomed 96-well
polypropylene, flexiwell inserts. The cells were simultaneously fixed and
permeabilised with 50 pi 0.01% (w/v) L-a-lysophosphatidylcholine in
PBS containing 3.7% (v/v) formaldehyde for 15 min at 37°C [27], The
cells were then washed with PBS containing 0.5% (w/v) BSA and incu¬
bated (4°C) for 1 h with a saturating concentration of a mouse mono¬
clonal antibody raised against human Bcl-2 protein. As a positive con¬
trol, parallel samples were stained with MAC 387, a mouse monoclonal
antibody which recognises p8,14, an intracellular calcium binding pro¬
tein complex found in neutrophils. The amount of primary antibody
binding was detected using a FITC-conjugated goat anti-mouse poly¬
clonal antibody. Negative control cells were stained with second layer
antibody alone. The samples were analysed using an EPICS profile II
(Coulter Electronics, Luton, UK).
2.7. Statistics
All data are presented as mean ± S.E.M. for (n) separate experi¬
ments. Values were compared using the Student's /-test for paired data
with P < 0.05 considered to be significant.
3. Results and discussion
Incubation of neutrophils under hypoxic conditions resulted
in a dramatic inhibition of apoptosis (Fig. la) to the extent that
cells incubated for 44 h in 0% O, were >95% viable and <25%
apoptotic compared to nearly 100% apoptosis/ necrosis under
normoxic (21% O,) conditions (Fig. lb). These findings are in
complete contrast to those of Jacobson and Raff [20] and
Shimizu et al. [21] who have shown that hypoxia induces apop¬
tosis in SV-40 transformed human fibroblasts (that lacked mi¬
tochondria) and a rat pheochromacytoma cell line, respectively.
A similar induction of apoptosis by hypoxia has been reported
in WEHI 7.1 T-lymphoma cells [28], adenocarcinoma HT29
cells [29] and superior cervical ganglia cells [30], In the studies
of Jacobson and Raff [20] and Shimizu et al. [21], apoptosis
could be inhibited under both normoxic and hypoxic conditions
by transfected bcl-2. Since we were unable to detect any Bcl-2
protein in neutrophils aged under either hypoxic or normoxic
conditions (Table 1), it is unlikely that the enhanced survival
of neutrophils under hypoxic conditions was Z>c/-2-mediated.
We have previously demonstrated that cytokine growth fac¬
tors such as GM-CSF are capable of extending the life of the
neutrophil [31], and hence we investigated whether the effects
of GM-CSF and hypoxia were mediated by a common mecha¬
nism. In fact, GM-CSF- and hypoxia-mediated survival of neu¬
trophils were additive (Fig. 2), suggesting that the hypoxia and
GM-CSF effects are independent.
To examine whether the effect of hypoxia was mediated by
inhibition of ROS generation, we investigated whether ex¬
ogenous addition of antioxidant enzymes and methionine, an
essential thiol containing amino acid, would mimic the hypoxic
Table 1
Effect of hypoxic culture on Bcl-2 in neutrophils
% oxygen Amount of detectable Bcl-2 (Relative Mean Fluorescence)
-GMCSF +GMCSF
0% 1.14 ±0.14 1.01 ±0.24
21% 1.09 ±0.12 1.01+0.014
Neutrophils were incubated in the presence or absence of GMCSF (50
U/ml) for 20 h in atmospheres containing 0% or 21% 02. The amount
of Bcl-2 in the cells was measured as detailed in section 2 and expressed
as mean fluorescence relative to negative control. In all cases, Bcl-2
could not be detected in the neutrophils. HL60 cells, which are known
to express Bcl-2, were used as a positive control (relative mean fluores¬
cence = 4.43). MAC 387, which recognises an intracellular antigen in
neutrophils, was used confirm the efficient permeabilisation of the
neutrophils (relative mean fluorescence > 50).
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effect. These agents had no effect on cell viability after 20 h of
culture as measured by Trypan-blue exclusion which supports
a previous study [32], Methionine and SOD did not influence
the rate of neutrophil apoptosis (Fig. 3) suggesting that hy-
pochlorous and superoxide radicals do not play a significant





Time in culture (Hrs)
Fig. 1. Effect of hypoxia on neutrophil apoptosis. Neutrophils were
incubated in atmospheres containing either 21%, 2.5% or 0% 02 for 6
hrs (open bars) or 20 hrs (closed bars) in (a) or 21% (closed symbols)
and 0% (open symbols) in (b). The percentage apoptosis was assessed
morphologically as detailed in section 2 at the time points indicated.
Data in (a) represent mean ± S.E.M. of n = 5 separate experiments,
each performed in triplicate. In (b), culture of cells for 44 h in the
presence of 21% 02 caused a major increase in the percentage necrotic
cells (as assessed by Trypan-blue dye exclusion) and therefore it was not
possible to determine the percentage of apoptotic cells at this time
point. The data in (b) represent mean ± S.E.M. of triplicate incubations






Fig. 2. Modulation of the GMCSF survival effect in neutrophils by
hypoxia. Neutrophils were incubated with GMCSF (50 U/ml) for 20
h in atmospheres containing 21%, 2.5% or 0% 02 (closed bars). The
control cells were incubated under the same conditions but in the
absence of cytokine (open bars). The data are expressed as the
mean ± S.E.M. of n = 5 separate experiments each performed in tripli¬
cate. Under each 02 condition tested, the addition of GM-CSF caused
a significant inhibition of apoptosis (P < 0.05).
ous a study which demonstrated that SOD was ineffective in
preventing cell death in human lung fetal fibroblasts [33]. In
contrast, catalase, both alone, and in combination with SOD,
caused a significant inhibition of neutrophil apoptosis (Fig. 3).
It is probable, however, that this effect of catalase is independ¬
ent of its effects on hydrogen peroxide levels since a similar
anti-apoptotic effect of catalase has been demonstrated in
WEHI 231 cells [34] and catalase has now been identified as the
anti-apoptotic factor present in the conditioned medium of
CCRF-CEM T-cell leukaemia cells [35]. This conclusion is sup¬
ported by the lack of effect of SOD and Trolox. Of interest, we
also observed that the endogenous SOD and catalase levels in
neutrophils measured by standard methods [36,37], was signif¬
icantly increased under hypoxic culture conditions (SOD activ¬
ity after 20 h culture in 21% 02 was 10.05 ± 0.287 U/mg protein
and in 0% O, was 18.68 ± 3.32 U/mg protein (P < 0.05). Cata¬
lase activity after 20 h culture in 21% 02 was 125 ± 13.83 U/mg
protein and in 0% 02 was 263 ± 32.71 U/protein (P < 0.05)). It
is likely that this induction of antioxidant enzymes represents
a stress response to the hypoxia since Das et al. have shown that
Mn SOD and catalase are two of a number of stress-related
genes up-regulated in cardiac biopsy tissue following repeated
ischaemia [38]. Whether the anti-apoptotic effect of hypoxia
relates to the induction of other stress-related proteins or
changes in poly-ADP-ribose transferase activity and hence
ATP levels [39,40], lipid oxidation [41], regulation of NF/cB
activation [42], or some alternative mechanism, requires further
investigation.
Having shown that neutrophil survival in vitro can be pro¬
longed by hypoxia where the cells' capacity to generate ROS,
at least in 0% 02, is severely diminished [18] we investigated the
direct effect of ROS on the rate ofneutrophil apoptosis. Hydro-
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gen peroxide (0.1-5 mM) induced a concentration-dependent
increase in the rate of apoptosis observed at 8 hrs (Fig. 4a). Cell
viability as judged by Trypan-blue dye exclusion was not af¬
fected by hydrogen peroxide treatments below 5 mM (half-life
of the hydrogen peroxide in this system was 2.25 h as deter¬
mined by the reduction of absorbance at 240 nm). In view of
the potent antioxidant capacity of serum (in our donors equiv¬
alent to a Trolox concentration of 1.08-1.12 mM [43], data not
shown), the serum concentration in the Iscove's DMEM these
experiments was reduced from 10% to 2%. The ability of 1 mM
hydrogen peroxide to increase the number of cells undergoing
apoptosis could be reversed by the addition of the antioxidant
Trolox (10 mM), a soluble vitamin E analogue (Fig. 4b). This
suggests that a potential pathway exists for oxidants to induce
neutrophil apoptosis. However, it is important to note that
activation of the respiratory burst by agents such as fMLP and
1L-8 does not increase the rate of neutrophil apoptosis [13].
This, together with the observation that only an extremely high,
supraphysiological concentration of hydrogen peroxide in¬
creases neutrophil apoptosis, and the inability of SOD,
methionine and Trolox to mimic the effect of withdrawal of
oxygen (Fig. 4b), implies that generation of superoxide anion,
hypochlorous and peroxyl radicals may not be a major regula¬
tor of neutrophil apoptosis in vivo.
In conclusion, hypoxia caused a profound inhibition of neu¬
trophil apoptosis in vitro. This effect is directly opposite to the
pro-apoptotic effect of hypoxia observed in a number of cell-
lines [20-21,28-30]. The ability of hypoxia to prolong neutro¬
phil survival is additive to that induced by GM-CSF, is not
associated with bcI-2 expression, and is not mimicked by ex¬
ogenous SOD, methionine or Trolox. However, apoptosis was
inhibited by catalase, but the exact mechanism underlying this
effect and the potential role of hydroxyl radicals and hydro¬
gen peroxide require further investigation. These data also im¬
ply that examination of apoptosis under routine hyperoxic
80 -i
CONTROL 900 CATALASE SOD + METHIONINE
CATALASE
Fig. 3. Effect of SOD. catalase and methionine on neutrophil apoptosis.
Neutrophils were cultured for 6 h (open bars) or 20 h (closed bars)
in the presence of 200 //g/ml SOD. 250 //g/ml catalase, 200 /rg/ml SOD
and 250 ^tg/ml catalase, or 5 mM methionine. Control, untreated neu¬
trophils were also prepared. Apoptosis was assessed morphologically.
Data represent mean ± S.E.M. of n = 3 separate experiments, each
performed in triplicate.
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PEROXIDE
Fig. 4. Effects of hydrogen peroxide and Trolox on neutrophil apopto¬
sis. Neutrophils were incubated for 8 h in the presence or absence of
(a) increasing concentrations of hydrogen peroxide or (b) 10 mM
Trolox ± 1 mM hydrogen peroxide. Apoptosis was assessed morpho¬
logically. Both sets of data represent mean ± S.E.M. of n = 3 separate
experiments, each performed in triplicate. The rate of neutrophil apop¬
tosis in response to 1, 2 and 5 mM hydrogen peroxide was significantly
different from the control apoptosis (*P < 0.05). In (b) the rate of
apoptosis when cells were treated with both Trolox and hydrogen
peroxide was significantly less than the rate of apoptosis when treated
with hydrogen peroxide alone (*P < 0.005); there was no significant
difference between the rates of apoptosis of the control cells, Trolox
treated cells and Trolox and hydrogen peroxide treated cells.
(21% 02) culture conditions may alter the susceptibility of cells
to apoptosis and not accurately reflect the O, environment in
vivo. In addition, neutrophils may remain alive and viable for
considerably longer periods when recruited to an inflammatory
S. Hannah et al. IFEBS Letters 372 (1995) 233-237 237
focus where there is local, and often systemic, hypoxia [23,24], [18
The effect on neutrophil survival, and hence delay in their
removal, could potentially exacerbate the disease state and re- P9
suit in additional neutrophil-mediated tissue destruction. This
finding may also have the practical consequence of stimulating [20
research into the role of hypoxic conditions for prolonged gran- [21
ulocyte storage prior to transfusion.
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